Variant and risk allele,P-value,P-value annotation,RAF,OR,Beta,CI,Mapped gene,Reported trait,Trait(s),Study accession,Location
rs112248293-<b>A</b>,3 x 10-9,,0.024318,1.8208302,'-,NR,RORA,Kidney cancer,kidney cancer,GCST90011818,15:61208153
rs556301564-<b>A</b>,7 x 10-7,,0.03237,1.6479894,'-,NR,PDCD6IP,Kidney cancer,kidney cancer,GCST90011818,3:33805371
rs73045247-<b>G</b>,4 x 10-7,,0.041683,1.543448,'-,NR,KIF19BP,Kidney cancer,kidney cancer,GCST90011818,7:2388319
chr10:83754296-<b>C</b>,2 x 10-8,,NR,1.4705882,'-,NR,'-,Kidney cancer,kidney cancer,GCST90011818,Mapping not available
rs2556575-<b>G</b>,1 x 10-7,,0.797857,1.3196094,'-,NR,"IMPA1P1, FABP12",Kidney cancer,kidney cancer,GCST90011818,8:81581494
rs7939721-<b>C</b>,5 x 10-7,,NR,1.5567,'-,NR,"MYEOV, LINC02747",Kidney cancer,kidney cancer,GCST90011818,11:69419887
rs117037288-<b>T</b>,3 x 10-7,,NR,5.0864697,'-,NR,"RPL37P2, UNC93B5",Kidney cancer,kidney cancer,GCST90011818,11:67704248
rs141862746-<b>T</b>,1 x 10-8,,NR,4.3271313,'-,NR,MCPH1,Kidney cancer,kidney cancer,GCST90011818,8:6459947
rs149401382-<b>A</b>,1 x 10-9,,0.009974,2.5043826,'-,NR,VN2R19P,Kidney cancer,kidney cancer,GCST90011818,19:58014836
rs138040332-<b>T</b>,1 x 10-7,,0.012757,2.0981956,'-,NR,CARD9,Kidney cancer,kidney cancer,GCST90011818,9:136368120
rs1063348-<b>G</b>,9 x 10-23,,0.6,3.33,'-,[2.62-4.23],"HLA-DQB1, HLA-DQB1-AS1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST006252,6:32660146
rs59882675-<b>?</b>,6 x 10-8,,'-,'-,'-,'-,BTC,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST006252,4:74763902
rs2858829-<b>?</b>,7 x 10-8,,'-,'-,'-,'-,"CBX3P9, DSE",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST006252,6:116447754
rs28366266-<b>C</b>,4 x 10-20,,0.17,3.03,'-,[2.40-3.85],"HLA-DRB1, HLA-DQA1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST006252,6:32591976
rs9348883-<b>T</b>,9 x 10-7,(conditioned on rs1063348 & rs28366266),0.94,3.5,'-,[2.13-5.83],TSBP1-AS1,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST006252,6:32390772
rs1063348-<b>?</b>,1 x 10-8,,0.61,2.96,'-,[2.04-4.29],"HLA-DQB1, HLA-DQB1-AS1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST009711,6:32660146
rs28366266-<b>?</b>,6 x 10-6,,0.17,2.25,'-,[1.59-3.2],"HLA-DRB1, HLA-DQA1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST009711,6:32591976
rs1063348-<b>?</b>,3 x 10-7,,0.48,3.24,'-,[1.93-5.45],"HLA-DQB1, HLA-DQB1-AS1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST009709,6:32660146
rs2076523-<b>?</b>,2 x 10-9,,NR,4.8,'-,[2.9-7.9],"TSBP1-AS1, BTNL2",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST009709,6:32403058
rs28383254-<b>?</b>,3 x 10-8,,NR,5.7,'-,[3.1-10.6],"HLA-DRB1, HLA-DQA1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST009710,6:32617861
chr2:46485186-<b>C</b>,2 x 10-10,,0.01,3.92,'-,[2.57-5.98],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr2:151713161-<b>A</b>,2 x 10-9,,0.08,1.52,'-,[1.33-1.74],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr3:165051826-<b>T</b>,4 x 10-10,,0.06,1.62,'-,[1.39-1.89],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
rs76971802-<b>T</b>,9 x 10-6,,0.087,1.35,'-,[1.19-1.54],LPP,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,3:188889282
rs5863506-<b>TA</b>,2 x 10-6,,0.33,1.22,'-,[1.12-1.32],FSTL5,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,4:161988066
chr5:29705905-<b>C</b>,1 x 10-16,,0.01,6.81,'-,[4.33-10.72],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr5:78050391-<b>G</b>,1 x 10-8,,0.01,5.91,'-,[3.22-10.85],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr6:12618492-<b>G</b>,3 x 10-11,,0.03,2.22,'-,[1.76-2.81],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr6:42474989-<b>T</b>,1 x 10-10,,0.01,3,'-,[2.15-4.2],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr8:49547701-<b>C</b>,1 x 10-12,,0.01,5.38,'-,[3.38-8.57],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr8:74004192-<b>A</b>,4 x 10-15,,0.01,6.39,'-,[4.02-10.15],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
rs141746998-<b>C</b>,9 x 10-6,,0.969,1.6129031,'-,[1.32-2.00],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,8:53398379
rs11997465-<b>C</b>,3 x 10-6,,0.28,1.22,'-,[1.12-1.33],"KCNV1, U2",Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,8:109879748
chr10:13527266-<b>G</b>,1 x 10-9,,0.11,1.45,'-,[1.29-1.63],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr10:114758349-<b>T</b>,2 x 10-16,,0.3,1.4,'-,[1.29-1.52],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr11:2149116-<b>G</b>,4 x 10-8,,0.14,1.36,'-,[1.22-1.52],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr13:107093993-<b>G</b>,2 x 10-8,,0.01,2.88,'-,[1.99-4.16],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr17:7289638-<b>A</b>,2 x 10-9,,0.01,3.86,'-,[2.48-5.98],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr17:77708184-<b>A</b>,3 x 10-12,,0.01,4.3,'-,[2.85-6.47],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr18:65489501-<b>C</b>,6 x 10-9,,0.02,2.52,'-,[1.84-3.44],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr19:2570002-<b>A</b>,2 x 10-8,,0.05,1.67,'-,[1.4-2],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr19:53034652-<b>C</b>,1 x 10-8,,0.02,2.53,'-,[1.84-3.47],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr20:10760829-<b>C</b>,2 x 10-15,,0.01,7.97,'-,[4.78-13.31],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr21:32804223-<b>C</b>,8 x 10-22,,0.01,9.41,'-,[5.95-14.87],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr22:36656555-<b>G</b>,9 x 10-11,,0.55,1.2987013,'-,[1.19-1.39],'-,Type 2 diabetes and end-stage kidney disease,type 2 diabetes nephropathy,GCST007949,Mapping not available
chr2:151713161-<b>A</b>,7 x 10-10,,0.08,1.5804348,'-,[1.366-1.829],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr5:29705905-<b>C</b>,4 x 10-14,,0.01,7.0090346,'-,[4.235-11.601],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr6:12617159-<b>C</b>,1 x 10-9,,0.02,2.2846208,'-,[1.752-2.979],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr6:42474989-<b>T</b>,2 x 10-9,,0.01,3.0823739,'-,[2.13-4.46],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr8:49547701-<b>C</b>,4 x 10-12,,0.01,6.141076,'-,[3.673-10.267],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr8:74005904-<b>T</b>,3 x 10-12,,0.01,4.9713926,'-,[3.173-7.789],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr10:114758349-<b>T</b>,1 x 10-15,,0.3,1.421482,'-,[1.304-1.55],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr12:87670213-<b>G</b>,4 x 10-8,,0.91,1.4827522,'-,[1.29-1.71],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr17:77708184-<b>A</b>,1 x 10-11,,0.01,4.6562014,'-,[2.985-7.263],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr20:10760829-<b>C</b>,3 x 10-13,,0.01,8.038158,'-,[4.593-14.066],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr21:32799557-<b>C</b>,2 x 10-19,,0.01,9.542925,'-,[5.839-15.595],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
chr22:36618953-<b>C</b>,2 x 10-10,,0.74,1.3563536,'-,[1.23-1.49],'-,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,Mapping not available
rs1495965-<b>G</b>,2 x 10-11,,0.51,1.35,'-,[1.24-1.47],"DNAJB6P4, IL12RB2",Behcet's disease,Behcet's syndrome,GCST000728,1:67287825
rs1800871-<b>T</b>,1 x 10-14,,0.31,1.45,'-,[1.32-1.60],"IL19, IL10",Behcet's disease,Behcet's syndrome,GCST000728,1:206773289
rs75029938-<b>T</b>,2 x 10-9,(corrected for genomic control),0.042,1.89,'-,[1.54-2.34],GRAMD2B,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,"APOL1 risk genotype carrier status, type 2 diabetes nephropathy",GCST007950,5:126437641
rs3115229-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,"KIAA1109, RN7SL335P",Vaso-occlusive pain in sickle-cell anemia,"Sickle cell anemia, vaso-occlusive pain measurement",GCST004644,4:122088578
rs4234795-<b>G</b>,2 x 10-7,,0.94,'-,0.84 unit decrease,[0.55-1.13],SORCS2,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,4:7209075
rs9714060-<b>G</b>,7 x 10-7,,0.43,'-,0.39 unit decrease,[0.23-0.55],MUC4,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,3:195760605
rs146893001-<b>C</b>,1 x 10-6,,0.01,'-,2.04 unit decrease,[1.26-2.82],PTPN3,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,9:109419337
rs7216169-<b>T</b>,1 x 10-7,,0.22,'-,0.45 unit increase,[0.27-0.63],RABEP1,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,17:5316216
rs543023132-<b>G</b>,1 x 10-6,,0.02,'-,1.54 unit decrease,[0.95-2.13],RNU7-152P,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,6:155652652
rs144995469-<b>T</b>,1 x 10-6,,0.03,'-,1.15 unit decrease,[0.7-1.6],"TMEM260, OTX2",Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,14:56732364
rs74989317-<b>A</b>,2 x 10-6,,0.04,'-,0.99 unit decrease,[0.6-1.38],LINC00649,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,21:33923835
rs73108077-<b>C</b>,2 x 10-6,,0.06,'-,0.83 unit decrease,[0.5-1.16],"DEFB121, DEFB122",Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,20:31419056
rs114402357-<b>T</b>,2 x 10-6,,0.01,'-,2.03 unit increase,[1.25-2.81],LINC00424,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,13:21919496
rs77141833-<b>C</b>,2 x 10-6,,0.03,'-,1.12 unit decrease,[0.69-1.55],VSIG8,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,1:159855400
rs62015549-<b>T</b>,2 x 10-6,,0.01,'-,2.44 unit decrease,[1.48-3.4],THSD4,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,15:71379079
rs76513454-<b>C</b>,2 x 10-6,,0.01,'-,2.17 unit decrease,[1.33-3.01],SCYL3,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,1:218688227
rs139628543-<b>C</b>,2 x 10-6,,0.06,'-,0.75 unit increase,[0.46-1.04],KLHL30,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,2:238144404
rs59264502-<b>A</b>,2 x 10-6,,0.46,'-,0.37 unit increase,[0.21-0.53],RNA5SP38,Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,13:106193924
rs147900370-<b>C</b>,2 x 10-6,,0.04,'-,0.92 unit decrease,[0.57-1.27],"TSHB, SYCP1",Red blood cell density in sickle cell anemia,"Sickle cell anemia, red blood cell density measurement",GCST004379,1:115010304
HLA-B*51-<b>?</b>,7 x 10-32,,0.079,3.82,'-,'-,'-,Behcet's disease,Behcet's syndrome,GCST007551,Mapping not available
rs2848479-<b>A</b>,3 x 10-10,,0.401,1.66,'-,[1.24-1.94],ZBTB44-DT,Behcet's disease,Behcet's syndrome,GCST007551,11:98216871
rs1874886-<b>A</b>,2 x 10-8,,0.37,1.61,'-,[1.36-1.89],IL12A-AS1,Behcet's disease,Behcet's syndrome,GCST007551,3:160011868
rs7130875-<b>G</b>,3 x 10-6,,0.248,1.22,'-,'-,"RNU6-376P, DDX6",Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005535,11:118742965
rs201933111-<b>?</b>,1 x 10-6,,NR,'-,1.4628 unit decrease,[0.92-2.00],"GNE, CLTA",Frequency of relapse in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, disease progression measurement",GCST009999,9:36231131
rs8057024-<b>?</b>,3 x 10-6,,NR,'-,1.4127 unit decrease,[0.83-1.99],PMM2,Frequency of relapse in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, disease progression measurement",GCST009999,16:8814954
rs60731826-<b>?</b>,9 x 10-6,,NR,'-,0.9781 unit decrease,[0.58-1.37],KLHL20,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,1:209087883
rs6748896-<b>?</b>,5 x 10-6,,NR,'-,1.0261 unit decrease,[0.63-1.42],'-,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,2:220159818
rs138754151-<b>?</b>,5 x 10-6,,NR,'-,1.2345 unit decrease,[0.75-1.71],"GAPDHP50, ICE2P2",Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,3:89032462
rs71648192-<b>?</b>,4 x 10-6,,NR,'-,1.0477 unit increase,[0.65-1.45],"C1QTNF7-AS1, CPEB2",Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,4:15035212
rs58722526-<b>?</b>,6 x 10-6,,NR,'-,1.1664 unit decrease,[0.71-1.63],MCUB,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,4:109648695
rs13176353-<b>?</b>,6 x 10-6,,NR,'-,1.0022 unit increase,[0.61-1.4],MRPL36,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,5:1801312
rs5877241-<b>?</b>,2 x 10-6,,NR,'-,0.8202 unit increase,[0.51-1.13],COL19A1,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,6:70148926
rs79825511-<b>?</b>,5 x 10-6,,NR,'-,1.5068 unit decrease,[0.92-2.09],FGF19,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,11:69700928
rs3018529-<b>?</b>,4 x 10-6,,NR,'-,0.7885 unit decrease,[0.48-1.09],"OR10D3, OR8F1P",Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,11:124205080
rs3782788-<b>?</b>,9 x 10-6,,NR,'-,0.8059 unit increase,[0.48-1.13],TSPAN9,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,12:3248826
rs670142-<b>?</b>,2 x 10-6,,NR,'-,0.8528 unit increase,[0.54-1.17],KRT73-AS1,Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,12:52607203
rs12971298-<b>?</b>,7 x 10-6,,NR,'-,1.0665 unit increase,[0.65-1.49],"IGFL1P2, HIF3A",Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"Churg-Strauss syndrome, response to mepolizumab, Glucocorticoid use measurement",GCST009998,19:46272899
rs72751931-<b>?</b>,4 x 10-7,,NR,'-,0.9796 unit increase,[0.64-1.32],RHOU,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,1:228751382
rs11681484-<b>?</b>,3 x 10-6,,NR,'-,0.763 unit increase,[0.47-1.05],CTNNA2,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,2:79741032
rs9869380-<b>?</b>,4 x 10-6,,NR,'-,0.9182 unit increase,[0.57-1.27],"RN7SKP227, NBPF21P",Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,3:36669806
rs891193-<b>?</b>,6 x 10-6,,NR,'-,0.8882 unit increase,[0.54-1.24],'-,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,5:4662408
rs6450419-<b>?</b>,6 x 10-6,,NR,'-,0.8618 unit decrease,[0.52-1.2],Y_RNA,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,5:57160768
rs36094591-<b>?</b>,2 x 10-6,,NR,'-,0.8653 unit increase,[0.54-1.19],LCP2,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,5:170274013
rs12682188-<b>?</b>,8 x 10-6,,NR,'-,0.8264 unit increase,[0.49-1.16],"TUSC3, PPM1AP1",Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,8:15772149
rs2978233-<b>?</b>,4 x 10-7,,NR,'-,0.8597 unit decrease,[0.56-1.16],"LINC01592, C8orf34",Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,8:68829081
rs2243951-<b>?</b>,3 x 10-6,,NR,'-,0.7938 unit decrease,[0.49-1.1],CELF2-DT,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,10:10444248
rs569630056-<b>?</b>,9 x 10-6,,NR,'-,0.9931 unit decrease,[0.59-1.4],PWRN1,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,15:24373321
rs7209938-<b>?</b>,4 x 10-6,,NR,'-,0.8148 unit increase,[0.5-1.13],HS3ST3A1,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,17:13490565
rs3136644-<b>?</b>,7 x 10-7,,NR,'-,1.1388 unit decrease,[0.74-1.54],NFKBIB,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,19:38907991
rs61138008-<b>?</b>,4 x 10-6,,NR,'-,1.5243 unit decrease,[0.94-2.11],"AVP, RN7SL555P",Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,20:3086608
rs2076380-<b>?</b>,8 x 10-6,,NR,'-,0.9316 unit decrease,[0.56-1.31],TGM2,Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis,"disease free survival, Churg-Strauss syndrome, response to mepolizumab",GCST010000,20:38165127
rs2285450-<b>A</b>,7 x 10-28,,NR,1.88,'-,[1.68-2.11],NPHS1,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST010731,19:35851365
rs4979462-<b>T</b>,5 x 10-11,,NR,1.33,'-,[1.22-1.44],TNFSF15,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST010731,9:114804733
rs35677470-<b>A</b>,1 x 10-20,,0.05949,1.6241,'-,'-,DNASE1L3,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005533,3:58197909
rs77583790-<b>A</b>,2 x 10-11,,0.004013,2.814,'-,'-,IL12A-AS1,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005533,3:159976265
rs9373839-<b>G</b>,8 x 10-7,,0.1893,1.1966,'-,'-,ATG5,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005533,6:106207742
rs3902025-<b>C</b>,2 x 10-6,,0.4405,1.1484,'-,'-,GSDMA,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005533,17:39963001
rs35677470-<b>A</b>,1 x 10-12,,0.08,1.6029233,'-,'-,DNASE1L3,Systemic sclerosis,systemic scleroderma,GCST009876,3:58197909
rs2736346-<b>A</b>,2 x 10-12,,0.245,1.3051527,'-,'-,BLK,Systemic sclerosis,systemic scleroderma,GCST009876,8:11501603
rs4731532-<b>A</b>,2 x 10-12,,0.506,1.2317858,'-,'-,"KCP, IRF5",Systemic sclerosis,systemic scleroderma,GCST009876,7:128932712
rs8109496-<b>?</b>,4 x 10-11,,0.8,1.3026713,'-,'-,IL12RB1,Systemic sclerosis,systemic scleroderma,GCST009876,19:18079534
rs1422673-<b>T</b>,1 x 10-8,,0.194,1.2280027,'-,'-,TNIP1,Systemic sclerosis,systemic scleroderma,GCST009876,5:151059427
rs10892299-<b>?</b>,2 x 10-8,,0.83,1.247548,'-,'-,"Y_RNA, CXCR5",Systemic sclerosis,systemic scleroderma,GCST009876,11:118856134
rs7574865-<b>T</b>,3 x 10-7,,0.223,1.4094732,'-,'-,STAT4,Systemic sclerosis,systemic scleroderma,GCST009876,2:191099907
rs60600003-<b>G</b>,2 x 10-6,,0.097,1.2531207,'-,'-,ELMO1,Systemic sclerosis,systemic scleroderma,GCST009876,7:37342861
rs1054609-<b>C</b>,9 x 10-6,,0.463,1.141461,'-,'-,ZPBP2,Systemic sclerosis,systemic scleroderma,GCST009876,17:39877024
rs4769612-<b>C</b>,4 x 10-14,,0.52,1.19,'-,[1.13-1.24],"EIF4A1P7, FLT1",Preeclampsia (fetal genotype effect),"preeclampsia, fetal genotype effect measurement",GCST90013475,13:28564361
rs11614652-<b>G</b>,2 x 10-7,,0.21,1.18,'-,[1.1-1.23],ITPR2,Preeclampsia (fetal genotype effect),"preeclampsia, fetal genotype effect measurement",GCST90013475,12:26805069
rs5866671-<b>T</b>,2 x 10-7,,0.2,1.17,'-,[1.1-1.25],CDH10,Preeclampsia (fetal genotype effect),"preeclampsia, fetal genotype effect measurement",GCST90013475,5:24557204
rs75293382-<b>C</b>,1 x 10-6,,0.06,1.3,'-,[1.18-1.45],C2orf83,Preeclampsia (fetal genotype effect),"preeclampsia, fetal genotype effect measurement",GCST90013475,2:227645620
rs4655789-<b>G</b>,8 x 10-6,,0.14,1.14,'-,[1.08-1.19],WLS,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,1:68228568
rs708119-<b>C</b>,4 x 10-7,,0.6771,1.1,'-,[1.06-1.14],WNT3A,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,1:228015567
rs1918975-<b>T</b>,1 x 10-8,,0.598,1.1,'-,[1.07-1.14],"MECOM, MECOM-AS1",Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,3:169462088
rs35630707-<b>C</b>,7 x 10-6,,0.02,1.47,'-,[1.23-1.72],'-,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,4:59999871
rs1458038-<b>T</b>,1 x 10-8,,0.3288,1.11,'-,[1.07-1.15],"FGF5, PRDM8",Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,4:80243569
rs140479110-<b>GGA</b>,2 x 10-7,,0.32,1.1,'-,[1.06-1.15],LINC02119,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,5:38050783
rs9263761-<b>G</b>,2 x 10-6,,0.76,1.11,'-,[1.06-1.16],CCHCR1,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,6:31148962
rs10774624-<b>G</b>,2 x 10-8,,0.4,1.11,'-,[1.07-1.15],LINC02356,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,12:111395984
rs7318880-<b>T</b>,8 x 10-8,,0.5008,1.1,'-,[1.06-1.13],"FLT1, EIF4A1P7",Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,13:28564148
rs1421085-<b>C</b>,1 x 10-9,,0.39,1.11,'-,[1.07-1.15],FTO,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,16:53767042
rs181793400-<b>T</b>,6 x 10-6,,0.0216,1.41,'-,[1.22-1.63],PIGN,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,18:61921970
rs259983-<b>C</b>,3 x 10-10,,0.14,1.17,'-,[1.11-1.23],ZNF831,Preeclampsia (maternal genotype effect),"preeclampsia, parental genotype effect measurement",GCST90013478,20:59160402
rs2844678-<b>?</b>,6 x 10-47,,NR,2.71,'-,NR,"MUC21, NAPGP2",Takayasu arteritis,Takayasu arteritis,GCST011939,6:30982273
rs12524487-<b>?</b>,6 x 10-38,(conditional on rs2844678),NR,3.12,'-,NR,"MICA, HLA-S",Takayasu arteritis,Takayasu arteritis,GCST011939,6:31386461
rs17193507-<b>?</b>,7 x 10-30,(conditional on rs2844678 and rs12524487),NR,3.28,'-,NR,"MICA, HLA-S",Takayasu arteritis,Takayasu arteritis,GCST011939,6:31383277
rs12526858-<b>?</b>,2 x 10-10,"(conditional on rs2844678, rs12524487 and rs17193507)",NR,2.7,'-,NR,HLA-B,Takayasu arteritis,Takayasu arteritis,GCST011939,6:31355944
rs28749167-<b>?</b>,2 x 10-9,"(conditional on rs2844678, rs12524487, rs17193507 and rs12526858)",NR,1.43,'-,NR,"HLA-A, HLA-W",Takayasu arteritis,Takayasu arteritis,GCST011939,6:29953257
HLA-B*5201-<b>?</b>,4 x 10-36,,NR,4.37,'-,NR,'-,Takayasu arteritis,Takayasu arteritis,GCST011939,Mapping not available
HLA-B*1302-<b>?</b>,3 x 10-25,(conditional on HLA-B*5201),NR,3.21,'-,NR,'-,Takayasu arteritis,Takayasu arteritis,GCST011939,Mapping not available
HLA-B*1501-<b>?</b>,1 x 10-15,(conditional on HLA-B*5201 and HLA-B*1302),NR,3.07,'-,NR,'-,Takayasu arteritis,Takayasu arteritis,GCST011939,Mapping not available
HLA-DQB1*0502-<b>?</b>,4 x 10-8,"(conditional on HLA-B*5201, HLA-B*1302 and HLA-B*1501)",NR,1.9,'-,NR,'-,Takayasu arteritis,Takayasu arteritis,GCST011939,Mapping not available
rs12515766-<b>G</b>,2 x 10-8,,0.3123,1.458,'-,[1.277-1.664],"IL12B, LINC01845",Takayasu arteritis,Takayasu arteritis,GCST011938,5:159370719
rs2322599-<b>A</b>,2 x 10-6,,0.3542,0.7166,'-,[0.6238-0.8231],PTK2B,Takayasu arteritis,Takayasu arteritis,GCST011938,8:27354393
rs2836883-<b>A</b>,8 x 10-7,,0.2574,0.6721,'-,[0.5738-0.7872],RPL23AP12,Takayasu arteritis,Takayasu arteritis,GCST011938,21:39094818
rs3812560-<b>C</b>,2 x 10-6,,0.3196,1.374,'-,[1.204-1.567],"CARD9, SNAPC4",Takayasu arteritis,Takayasu arteritis,GCST011938,9:136375453
rs1376741-<b>T</b>,7 x 10-7,,0.07147,1.732,'-,[1.395-2.151],LINC02165,Takayasu arteritis,Takayasu arteritis,GCST011938,16:63726808
rs34629529-<b>A</b>,1 x 10-6,,0.308,1.567,'-,[1.308-1.877],"TSEN34, RPS9",Takayasu arteritis,Takayasu arteritis,GCST011938,19:54197981
rs2844678-<b>?</b>,2 x 10-42,,NR,'-,'-,'-,"MUC21, NAPGP2",Takayasu arteritis,Takayasu arteritis,GCST011938,6:30982273
rs9262437-<b>?</b>,5 x 10-31,(conditional on rs2844678),NR,'-,'-,'-,"MUC21, MUC22",Takayasu arteritis,Takayasu arteritis,GCST011938,6:31001408
rs61444472-<b>?</b>,2 x 10-17,(conditional on rs2844678 and rs9262437),NR,'-,'-,'-,PSORS1C1,Takayasu arteritis,Takayasu arteritis,GCST011938,6:31134528
rs17193507-<b>?</b>,2 x 10-18,"(conditional on rs2844678, rs9262437 and rs61444472)",NR,'-,'-,'-,"MICA, HLA-S",Takayasu arteritis,Takayasu arteritis,GCST011938,6:31383277
rs9271066-<b>?</b>,2 x 10-11,"(conditional on rs2844678, rs9262437, rs61444472 and rs17193507)",NR,'-,'-,'-,"HLA-DRB1, HLA-DQA1",Takayasu arteritis,Takayasu arteritis,GCST011938,6:32607854
HLAB*5201-<b>?</b>,3 x 10-20,,NR,'-,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST011938,Mapping not available
HLAB*1302-<b>?</b>,2 x 10-16,(conditional on HLAB*5201),NR,'-,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST011938,Mapping not available
HLA-DQB1*0502-<b>?</b>,1 x 10-7,(conditional on HLAB*5201 and HLA-B*1302),NR,'-,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST011938,Mapping not available
rs9540128-<b>T</b>,1 x 10-7,,0.1176,2.046,'-,[1.571-2.664],'-,Takayasu arteritis,Takayasu arteritis,GCST011937,13:64504335
rs2242944-<b>A</b>,6 x 10-6,,0.3617,0.5838,'-,[0.4625-0.737],RPL23AP12,Takayasu arteritis,Takayasu arteritis,GCST011937,21:39093252
rs115155040-<b>A</b>,6 x 10-6,,0.01976,3.303,'-,[1.968-5.543],"CAV3, RAD18",Takayasu arteritis,Takayasu arteritis,GCST011937,3:8807896
rs76139923-<b>T</b>,7 x 10-6,,0.01517,3.532,'-,[2.035-6.13],CCR7,Takayasu arteritis,Takayasu arteritis,GCST011937,17:40563356
rs12524487-<b>?</b>,7 x 10-20,,NR,'-,'-,'-,"MICA, HLA-S",Takayasu arteritis,Takayasu arteritis,GCST011937,6:31386461
rs62392216-<b>?</b>,3 x 10-11,(conditional on rs12524487),NR,'-,'-,'-,HLA-W,Takayasu arteritis,Takayasu arteritis,GCST011937,6:29958100
rs45479291-<b>?</b>,2 x 10-16,(conditional on rs12524487and rs62392216),NR,'-,'-,'-,"HLA-V, HCG4",Takayasu arteritis,Takayasu arteritis,GCST011937,6:29792252
HLAB*5201-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST011937,Mapping not available
HLAB*1501-<b>?</b>,1 x 10-11,(conditional on HLAB*5201),NR,'-,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST011937,Mapping not available
rs74712413-<b>A</b>,1 x 10-5,,0.02812,5.07,'-,[2.47-10.4],MIR466,Takayasu arteritis,Takayasu arteritis,GCST011936,3:31071900
rs136301-<b>A</b>,6 x 10-6,,0.4173,2.4,'-,[1.644-3.514],OSBP2,Takayasu arteritis,Takayasu arteritis,GCST011936,22:30785584
rs12110437-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"ZNRD1ASP, MCCD1P2",Takayasu arteritis,Takayasu arteritis,GCST011936,6:29997052
rs1264697-<b>?</b>,1 x 10-8,(conditional on rs12110437),NR,'-,'-,'-,"RNF39, TRIM31",Takayasu arteritis,Takayasu arteritis,GCST011936,6:30099791
rs28752871-<b>?</b>,5 x 10-8,(conditional on rs12110437 and rs1264697),NR,'-,'-,'-,"LINC02571, HLA-B",Takayasu arteritis,Takayasu arteritis,GCST011936,6:31333859
rs142314071-<b>T</b>,6 x 10-7,,0.007519,12.02,'-,[4.524-31.94],PPP2R2B,Takayasu arteritis,Takayasu arteritis,GCST011934,5:146767857
rs62392216-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,HLA-W,Takayasu arteritis,Takayasu arteritis,GCST011934,6:29958100
rs58693904-<b>T</b>,4 x 10-9,,NR,1.5086,'-,NR,VPS8,Takayasu arteritis,Takayasu arteritis,GCST011939,3:184894533
rs4379175-<b>T</b>,3 x 10-9,,NR,1.3624,'-,NR,"IL12B, LINC01845",Takayasu arteritis,Takayasu arteritis,GCST011939,5:159377920
rs28834970-<b>C</b>,1 x 10-9,,NR,0.7143,'-,NR,PTK2B,Takayasu arteritis,Takayasu arteritis,GCST011939,8:27337604
rs7038415-<b>A</b>,5 x 10-8,,NR,1.4528,'-,NR,"SVEP1, TXNDC8",Takayasu arteritis,Takayasu arteritis,GCST011939,9:110354903
rs9540128-<b>T</b>,2 x 10-8,,NR,2.0193,'-,NR,'-,Takayasu arteritis,Takayasu arteritis,GCST011939,13:64504335
rs76457959-<b>T</b>,3 x 10-9,,NR,1.62,'-,NR,"RPL12P6, CFL2",Takayasu arteritis,Takayasu arteritis,GCST011939,14:34720708
rs2836883-<b>A</b>,1 x 10-12,,NR,0.6387,'-,NR,RPL23AP12,Takayasu arteritis,Takayasu arteritis,GCST011939,21:39094818
rs115155040-<b>A</b>,6 x 10-6,,NR,3.303,'-,NR,"CAV3, RAD18",Takayasu arteritis,Takayasu arteritis,GCST011939,3:8807896
rs74712413-<b>A</b>,1 x 10-5,,NR,5.069,'-,NR,MIR466,Takayasu arteritis,Takayasu arteritis,GCST011939,3:31071900
rs12492780-<b>T</b>,5 x 10-6,,NR,2.8085,'-,NR,CACNA2D3,Takayasu arteritis,Takayasu arteritis,GCST011939,3:54236514
rs1877209-<b>T</b>,7 x 10-6,,NR,1.4774,'-,NR,RBPJ,Takayasu arteritis,Takayasu arteritis,GCST011939,4:26297503
rs113569359-<b>A</b>,6 x 10-6,,NR,1.8318,'-,NR,"RBPJ, CCKAR",Takayasu arteritis,Takayasu arteritis,GCST011939,4:26445765
rs142314071-<b>T</b>,6 x 10-7,,NR,12.02,'-,NR,PPP2R2B,Takayasu arteritis,Takayasu arteritis,GCST011939,5:146767857
rs3847061-<b>C</b>,9 x 10-6,,NR,1.4064,'-,NR,EPHB4,Takayasu arteritis,Takayasu arteritis,GCST011939,7:100814752
rs1051957-<b>G</b>,9 x 10-7,,NR,1.2998,'-,NR,ENTR1,Takayasu arteritis,Takayasu arteritis,GCST011939,9:136404141
rs1250566-<b>A</b>,9 x 10-6,,NR,0.7581,'-,NR,ZMIZ1,Takayasu arteritis,Takayasu arteritis,GCST011939,10:79286696
rs1462717-<b>T</b>,5 x 10-6,,NR,1.3512,'-,NR,"TDGP1, MIR4302",Takayasu arteritis,Takayasu arteritis,GCST011939,12:25860350
rs1376741-<b>T</b>,4 x 10-7,,NR,1.5152,'-,NR,LINC02165,Takayasu arteritis,Takayasu arteritis,GCST011939,16:63726808
rs35409540-<b>A</b>,7 x 10-7,,NR,0.7278,'-,NR,"VAT1L, CLEC3A",Takayasu arteritis,Takayasu arteritis,GCST011939,16:78007968
rs12596533-<b>G</b>,3 x 10-6,,NR,3.7889,'-,NR,PLCG2,Takayasu arteritis,Takayasu arteritis,GCST011939,16:81822338
rs76139923-<b>T</b>,7 x 10-6,,NR,3.532,'-,NR,CCR7,Takayasu arteritis,Takayasu arteritis,GCST011939,17:40563356
rs176237-<b>T</b>,5 x 10-6,,NR,1.7857,'-,NR,"LINC01254, APCDD1",Takayasu arteritis,Takayasu arteritis,GCST011939,18:10439156
rs2852306-<b>G</b>,5 x 10-6,,NR,1.546,'-,NR,SLC14A2,Takayasu arteritis,Takayasu arteritis,GCST011939,18:45565696
rs34629529-<b>A</b>,1 x 10-6,,NR,1.567,'-,NR,"TSEN34, RPS9",Takayasu arteritis,Takayasu arteritis,GCST011939,19:54197981
rs136301-<b>A</b>,6 x 10-6,,NR,2.404,'-,NR,OSBP2,Takayasu arteritis,Takayasu arteritis,GCST011939,22:30785584
rs4381241-<b>C</b>,3 x 10-10,,0.44,1.11,'-,1.07–1.15,FAF1,Renal cell carcinoma,renal cell carcinoma,GCST004710,1:50441766
rs67311347-<b>G</b>,3 x 10-8,,0.69,1.11,'-,'-,ZNF620,Renal cell carcinoma,renal cell carcinoma,GCST004710,3:40491752
rs10936602-<b>T</b>,9 x 10-9,,0.73,1.11,'-,'-,"LRRC34, LRRIQ4",Renal cell carcinoma,renal cell carcinoma,GCST004710,3:169818849
rs2241261-<b>T</b>,6 x 10-9,,0.51,1.1,'-,1.06–1.13,RHOBTB2,Renal cell carcinoma,renal cell carcinoma,GCST004710,8:23019226
rs11813268-<b>T</b>,4 x 10-8,,0.16,1.12,'-,1.07–1.17,"STN1, SLK",Renal cell carcinoma,renal cell carcinoma,GCST004710,10:103922538
rs74911261-<b>A</b>,2 x 10-10,,0.02,1.41,'-,1.27—1.57,POGLUT3,Renal cell carcinoma,renal cell carcinoma,GCST004710,11:108486410
rs1800057-<b>G</b>,9 x 10-9,,0.02,1.38,'-,1.23–1.53,ATM,Renal cell carcinoma,renal cell carcinoma,GCST004710,11:108272729
rs4903064-<b>C</b>,2 x 10-24,,0.23,1.21,'-,1.16–1.25,DPF3,Renal cell carcinoma,renal cell carcinoma,GCST004710,14:72812712
rs7579899-<b>?</b>,5 x 10-15,,0.49,1.15,'-,1.11-1.20,EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST004710,2:46310465
rs11894252-<b>?</b>,3 x 10-15,,0.49,1.16,'-,1.12-1.20,EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST004710,2:46306237
rs12105918-<b>?</b>,4 x 10-9,,0.06,1.25,'-,1.16-1.34,ZEB2,Renal cell carcinoma,renal cell carcinoma,GCST004710,2:144450626
rs64070588-<b>?</b>,3 x 10-12,,0.44,1.13,'-,1.10-1.18,'-,Renal cell carcinoma,renal cell carcinoma,GCST004710,Mapping not available
rs7105934-<b>?</b>,5 x 10-22,,0.82,1.43,'-,[1.33-1.54],"LINC02747, MYEOV",Renal cell carcinoma,renal cell carcinoma,GCST004710,11:69424973
rs718314-<b>?</b>,2 x 10-16,,0.26,1.18,'-,1.14-1.23,"SSPN, ITPR2",Renal cell carcinoma,renal cell carcinoma,GCST004710,12:26300350
rs1049380-<b>?</b>,2 x 10-12,,0.44,1.15,'-,1.11-1.19,ITPR2,Renal cell carcinoma,renal cell carcinoma,GCST004710,12:26336611
rs4765623-<b>?</b>,3 x 10-12,,0.34,1.14,'-,1.10-1.18,SCARB1,Renal cell carcinoma,renal cell carcinoma,GCST004710,12:124836304
rs7913447-<b>?</b>,1 x 10-6,,NR,1.0879025,'-,[1.05-1.13],ANAPC16,Renal cell carcinoma,renal cell carcinoma,GCST004710,10:72232282
rs77774900-<b>?</b>,8 x 10-6,,NR,1.1285,'-,[1.0701-1.1900],MAML2,Renal cell carcinoma,renal cell carcinoma,GCST004710,11:96097569
rs11637556-<b>?</b>,2 x 10-7,,NR,1.0985,'-,[1.0606-1.1377],MAP2K1,Renal cell carcinoma,renal cell carcinoma,GCST004710,15:66436613
rs4804368-<b>?</b>,5 x 10-7,,NR,1.0855407,'-,[1.05-1.12],INSR,Renal cell carcinoma,renal cell carcinoma,GCST004710,19:7190279
rs13376700-<b>?</b>,5 x 10-10,,NR,1.1046,'-,[1.0704-1.1398],"CDKN2C, MIR4421",Renal cell carcinoma,renal cell carcinoma,GCST004710,1:51011971
rs4662750-<b>?</b>,2 x 10-7,,NR,1.0893246,'-,[1.05-1.12],MYO7B,Renal cell carcinoma,renal cell carcinoma,GCST004710,2:127634972
rs2203002-<b>?</b>,7 x 10-8,,NR,1.1918951,'-,[1.12-1.27],TFDP2,Renal cell carcinoma,renal cell carcinoma,GCST004710,3:142077397
rs234043-<b>?</b>,1 x 10-7,,NR,1.0980564,'-,[1.06-1.14],LINC02068,Renal cell carcinoma,renal cell carcinoma,GCST004710,3:172595577
rs7697932-<b>?</b>,7 x 10-8,,NR,1.0962509,'-,[1.06-1.13],H2AZ1-DT,Renal cell carcinoma,renal cell carcinoma,GCST004710,4:100084161
rs59294613-<b>?</b>,8 x 10-8,,NR,1.0982976,'-,[1.06-1.14],POT1,Renal cell carcinoma,renal cell carcinoma,GCST004710,7:124914213
rs4903064-<b>C</b>,2 x 10-14,,NR,1.38,'-,[1.27-1.50],DPF3,Renal cell carcinoma,renal cell carcinoma,GCST008225,14:72812712
rs12930199-<b>?</b>,5 x 10-6,,NR,1.18,'-,[1.10-1.27],RBFOX1,Renal cell carcinoma,renal cell carcinoma,GCST008225,16:6233320
rs6554676-<b>T</b>,6 x 10-6,,NR,1.4705882,'-,[1.23-1.72],SLC6A18,Renal cell carcinoma,renal cell carcinoma,GCST008225,5:1233235
rs13027293-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,STEAP3,Renal cell carcinoma x sex interaction,"sex interaction measurement, renal cell carcinoma",GCST008224,2:119243542
rs78971134-<b>A</b>,2 x 10-8,,NR,1.3333333,'-,[1.2-1.47],SETP7,Renal cell carcinoma,renal cell carcinoma,GCST008226,12:107258753
rs10484683-<b>A</b>,2 x 10-8,,NR,1.2048193,'-,[1.12-1.28],SAMD5,Renal cell carcinoma,renal cell carcinoma,GCST008226,6:147830941
rs2121266-<b>C</b>,2 x 10-9,,NR,1.18,'-,[1.12-1.25],EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST008226,2:46308785
rs7579899-<b>?</b>,1 x 10-6,,NR,1.19,'-,[1.12-1.26],EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST008226,2:46310465
rs11894252-<b>?</b>,9 x 10-7,,NR,1.19,'-,[1.12-1.26],EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST008226,2:46306237
rs7105934-<b>?</b>,3 x 10-8,,NR,1.5151515,'-,[1.3-1.79],"LINC02747, MYEOV",Renal cell carcinoma,renal cell carcinoma,GCST008226,11:69424973
rs718314-<b>?</b>,2 x 10-9,,NR,1.25,'-,[1.18-1.33],"SSPN, ITPR2",Renal cell carcinoma,renal cell carcinoma,GCST008226,12:26300350
rs1049380-<b>?</b>,7 x 10-10,,NR,1.27,'-,[1.17-1.37],ITPR2,Renal cell carcinoma,renal cell carcinoma,GCST008226,12:26336611
rs4134466-<b>G</b>,7 x 10-10,,NR,'-,0.16 unit decrease,[0.11-0.21],ATG5,Systemic sclerosis,systemic scleroderma,GCST004202,6:106129493
rs3894194-<b>A</b>,1 x 10-10,,NR,'-,0.166 unit decrease,[0.12-0.22],GSDMA,Systemic sclerosis,systemic scleroderma,GCST004202,17:39965740
rs7574865-<b>T</b>,5 x 10-10,,'-,'-,0.332 unit increase,[0.23-0.44],STAT4,Systemic sclerosis,systemic scleroderma,GCST004202,2:191099907
rs7574865-<b>T</b>,4 x 10-7,(East Asian),'-,'-,0.375 unit increase,[0.23-0.52],STAT4,Systemic sclerosis,systemic scleroderma,GCST004202,2:191099907
rs35677470-<b>A</b>,9 x 10-7,(EA),'-,'-,0.654 unit increase,[0.4-0.91],DNASE1L3,Systemic sclerosis,systemic scleroderma,GCST004202,3:58197909
rs2230926-<b>G</b>,3 x 10-7,,'-,'-,0.525 unit increase,[0.33-0.72],TNFAIP3,Systemic sclerosis,systemic scleroderma,GCST004202,6:137874929
rs2230926-<b>G</b>,2 x 10-6,(EA),'-,'-,0.801 unit increase,[0.48-1.12],TNFAIP3,Systemic sclerosis,systemic scleroderma,GCST004202,6:137874929
rs148240484-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,DPEP1,Chronic kidney disease,chronic kidney disease,GCST007920,16:89637333
rs149847328-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,GCKR,Chronic kidney disease,chronic kidney disease,GCST007920,2:27503548
rs145048495-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,INHBC,Chronic kidney disease,chronic kidney disease,GCST007920,12:57449402
rs143709408-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,KCNQ1,Chronic kidney disease,chronic kidney disease,GCST007920,11:2527999
rs9830664-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,LPP,Chronic kidney disease,chronic kidney disease,GCST007920,3:188874357
rs147372871-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,"SLC25A26, LRIG1",Chronic kidney disease,chronic kidney disease,GCST007920,3:66386050
rs200469773-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,LRP2,Chronic kidney disease,chronic kidney disease,GCST007920,2:169237232
rs199749272-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,NFAT5,Chronic kidney disease,chronic kidney disease,GCST007920,16:69695279
rs141310123-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,NFATC1,Chronic kidney disease,chronic kidney disease,GCST007920,18:79411390
rs141635364-<b>?</b>,7 x 10-15,,1.93E-04,'-,'-,'-,RREB1,Chronic kidney disease,chronic kidney disease,GCST007920,6:7230882
rs6672843-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,SDCCAG8,Chronic kidney disease,chronic kidney disease,GCST007920,1:243316789
rs186459505-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,SFMBT1,Chronic kidney disease,chronic kidney disease,GCST007920,3:52907083
rs142085340-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,SIPA1L3,Chronic kidney disease,chronic kidney disease,GCST007920,19:38106538
rs149454410-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,SLC2A9,Chronic kidney disease,chronic kidney disease,GCST007920,4:9942000
rs201761378-<b>?</b>,2 x 10-16,,8.69E-04,'-,'-,'-,UMOD,Chronic kidney disease,chronic kidney disease,GCST007920,16:20341292
rs690346-<b>?</b>,2 x 10-16,,1.93E-04,'-,'-,'-,WDR72,Chronic kidney disease,chronic kidney disease,GCST007920,15:53716648
rs10018951-<b>T</b>,1 x 10-14,,0.1555,1.31,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005754,Mapping not available
rs607850-<b>G</b>,2 x 10-6,,0.1,1.569,'-,[NR],"LINC01646, LINC01777",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,1:4521563
rs1234315-<b>A</b>,9 x 10-6,,0.53,1.2786,'-,[NR],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,1:173209324
rs67269402-<b>A</b>,1 x 10-6,,0.35,1.331,'-,[NR],"FAM20B, RALGPS2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,1:178943270
rs7582694-<b>C</b>,8 x 10-16,,0.48,1.5675,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,2:191105394
rs7668917-<b>A</b>,6 x 10-6,,0.27,1.3285,'-,[NR],LINC02273,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,4:152099409
rs11132627-<b>G</b>,7 x 10-6,,0.08,0.6493,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,4:189228942
rs11747688-<b>G</b>,8 x 10-7,,0.09,1.6624,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,5:3000871
rs76835745-<b>A</b>,5 x 10-6,,0.1,1.5347,'-,[NR],FBN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,5:128282950
rs74989671-<b>G</b>,2 x 10-8,,0.16,1.5447,'-,[NR],FBN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,5:128398268
rs6595836-<b>A</b>,1 x 10-6,,0.18,1.4294,'-,[NR],FBN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,5:128525194
rs1737002-<b>A</b>,2 x 10-6,,0.08,1.6334,'-,[NR],HLA-V,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:29795126
rs1116221-<b>A</b>,3 x 10-6,,0.08,1.594,'-,[NR],TRIM31,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:30103553
rs3095152-<b>A</b>,6 x 10-7,,0.03,2.4584,'-,[NR],SFTA2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:30931873
rs9263715-<b>A</b>,2 x 10-9,,0.32,1.4329,'-,[NR],PSORS1C1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:31128024
rs12174396-<b>G</b>,2 x 10-7,,0.18,0.6904,'-,[NR],MICA,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:31406802
rs2763979-<b>A</b>,6 x 10-6,,0.36,1.2994,'-,[NR],"HSPA1B, HSPA1A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:31826815
rs422951-<b>G</b>,7 x 10-7,,0.36,1.3345,'-,[NR],NOTCH4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:32220606
rs9270970-<b>G</b>,4 x 10-26,,0.42,1.8293,'-,[NR],"HLA-DRB1, HLA-DQA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:32605797
rs113206908-<b>G</b>,4 x 10-7,,0.21,1.4327,'-,[NR],"PSMB9, TAP1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:32850253
rs78598955-<b>C</b>,2 x 10-6,,0.03,2.3272,'-,[NR],GABRR2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:89269986
rs73366469-<b>G</b>,2 x 10-11,,0.14,1.7317,'-,[NR],"GTF2I, GTF2IRD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,7:74619286
rs10233510-<b>G</b>,1 x 10-6,,0.34,0.755,'-,[NR],ZNF804B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,7:89141313
rs4731530-<b>G</b>,2 x 10-6,,0.48,1.3014,'-,[NR],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,7:128922524
rs35677470-<b>A</b>,3 x 10-16,,0.05949,1.4677,'-,'-,DNASE1L3,Systemic sclerosis,systemic scleroderma,GCST005534,3:58197909
rs77583790-<b>A</b>,1 x 10-11,,0.004013,2.5673,'-,'-,IL12A-AS1,Systemic sclerosis,systemic scleroderma,GCST005534,3:159976265
rs9373839-<b>G</b>,4 x 10-8,,0.1893,1.1895,'-,'-,ATG5,Systemic sclerosis,systemic scleroderma,GCST005534,6:106207742
rs7130875-<b>G</b>,1 x 10-7,,0.2479,1.1656,'-,'-,"RNU6-376P, DDX6",Systemic sclerosis,systemic scleroderma,GCST005534,11:118742965
rs61219050-<b>A</b>,3 x 10-6,,0.2473,1.1562,'-,'-,DDX6,Systemic sclerosis,systemic scleroderma,GCST005534,11:118777915
rs11893432-<b>?</b>,3 x 10-12,,'-,1.44,'-,'-,STAT4,Systemic sclerosis,systemic scleroderma,GCST005534,2:191057148
rs62478615-<b>?</b>,1 x 10-10,,'-,1.53,'-,'-,TNPO3,Systemic sclerosis,systemic scleroderma,GCST005534,7:129044262
rs35677470-<b>A</b>,4 x 10-31,(ACA positive),0.05949,2.0283,'-,'-,DNASE1L3,Systemic sclerosis,systemic scleroderma,GCST005534,3:58197909
rs77583790-<b>A</b>,2 x 10-8,(ACA positive),0.004013,2.7624,'-,'-,IL12A-AS1,Systemic sclerosis,systemic scleroderma,GCST005534,3:159976265
rs3902025-<b>C</b>,2 x 10-6,(ACA positive),0.4405,1.1908,'-,'-,GSDMA,Systemic sclerosis,systemic scleroderma,GCST005534,17:39963001
rs4681851-<b>?</b>,4 x 10-8,(ACA positive),'-,1.58,'-,'-,PXK,Systemic sclerosis,systemic scleroderma,GCST005534,3:58410164
rs77583790-<b>A</b>,9 x 10-6,(ATA positive),0.004013,2.6382,'-,'-,IL12A-AS1,Systemic sclerosis,systemic scleroderma,GCST005534,3:159976265
rs35975406-<b>C</b>,1 x 10-18,(Lysine/Serine),NR,'-,0.373312 unit increase,[0.29-0.45],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32866527
rs12460876-<b>C</b>,3 x 10-17,(Lysine/Asparagine),NR,'-,0.356427 unit increase,[0.28-0.44],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs12460876-<b>C</b>,8 x 10-17,(Lysine/Phenylalanine),NR,'-,0.351713 unit increase,[0.27-0.43],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs12460876-<b>C</b>,9 x 10-17,(Lysine/Tryptophan),NR,'-,0.350727 unit increase,[0.27-0.43],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs1799958-<b>A</b>,2 x 10-33,(Carnitine (free)/Butyrylcarnitine / Isobutyrylcarnitine),NR,'-,0.484864 unit decrease,[0.41-0.56],ACADS,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,12:120738280
rs1799958-<b>A</b>,6 x 10-37,(Butyrylcarnitine / Isobutyrylcarnitine/Isovalerylcarnitine / 2-Methylbutyrylcarnitine / Valerylcarnitine),NR,'-,0.541971 unit increase,[0.46-0.62],ACADS,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,12:120738280
rs34708625-<b>C</b>,3 x 10-40,(Propionylcarnitine/Butyrylcarnitine / Isobutyrylcarnitine),NR,'-,0.54364 unit decrease,[0.47-0.62],"ACADS, SPPL3",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,12:120742216
rs686548-<b>T</b>,4 x 10-16,(Phosphatidylcholine with acyl-alkyl residue sum C36:0/Phosphatidylcholine with acyl-alkyl residue sum C40:2),NR,'-,0.326566 unit increase,[0.25-0.4],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs686548-<b>T</b>,2 x 10-12,(Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.28471 unit decrease,[0.21-0.36],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs686548-<b>T</b>,2 x 10-15,(Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C42:2),NR,'-,0.321292 unit decrease,[0.24-0.4],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs686548-<b>T</b>,6 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C42:3),NR,'-,0.302724 unit decrease,[0.22-0.38],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs686548-<b>T</b>,6 x 10-15,(Sphingomyelin with acyl residue sum C24:1/Sphingomyelin with acyl residue sum C26:1),NR,'-,0.317197 unit increase,[0.24-0.4],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs686548-<b>T</b>,5 x 10-14,(Hydroxysphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.311299 unit decrease,[0.23-0.39],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs686548-<b>T</b>,5 x 10-16,(Hydroxysphingomyelin with acyl residue sum C24:1/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.333831 unit decrease,[0.25-0.41],LINC01723,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,20:12992873
rs7253584-<b>C</b>,2 x 10-14,(Hydroxysphingomyelin with acyl residue sum C22:1/Sphingomyelin with acyl residue sum C18:0),NR,'-,0.39057 unit decrease,[0.29-0.49],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8222034
rs7253584-<b>C</b>,4 x 10-12,(Hydroxysphingomyelin with acyl residue sum C22:2/Sphingomyelin with acyl residue sum C18:1),NR,'-,0.353524 unit decrease,[0.25-0.45],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8222034
rs7253584-<b>C</b>,1 x 10-12,(Sphingomyelin with acyl residue sum C16:0/Sphingomyelin with acyl residue sum C18:0),NR,'-,0.359092 unit decrease,[0.26-0.46],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8222034
rs9749262-<b>T</b>,5 x 10-12,(Sphingomyelin with acyl residue sum C18:0/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.34754 unit increase,[0.25-0.44],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8223873
rs7259572-<b>G</b>,8 x 10-14,(Sphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C18:0),NR,'-,0.382112 unit decrease,[0.28-0.48],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8226788
rs7259572-<b>G</b>,6 x 10-19,(Sphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C18:1),NR,'-,0.44741 unit decrease,[0.35-0.54],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8226788
rs2208338-<b>A</b>,2 x 10-13,(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with diacyl residue sum C42:5),NR,'-,0.351992 unit increase,[0.26-0.44],ELOVL2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,6:11028421
rs174560-<b>C</b>,5 x 10-13,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C42:1),NR,'-,0.324237 unit increase,[0.24-0.41],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174562-<b>G</b>,3 x 10-21,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.418017 unit increase,[0.33-0.5],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61817672
rs174562-<b>G</b>,6 x 10-16,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.355629 unit increase,[0.27-0.44],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61817672
rs174560-<b>C</b>,1 x 10-12,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C40:4),NR,'-,0.315009 unit increase,[0.23-0.4],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs1535-<b>G</b>,2 x 10-16,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.359791 unit increase,[0.28-0.44],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs1535-<b>G</b>,1 x 10-16,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:5),NR,'-,0.359305 unit increase,[0.28-0.44],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs3834458-<b>C</b>,6 x 10-21,(Phosphatidylcholine with diacyl residue sum C36:5/Lysophosphatidylcholine with acyl residue C20:3),NR,'-,0.400902 unit decrease,[0.32-0.48],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61827449
rs5792235-<b>C</b>,2 x 10-25,(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with diacyl residue sum C38:3),NR,'-,0.454654 unit decrease,[0.37-0.54],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs3834458-<b>C</b>,3 x 10-26,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.464179 unit increase,[0.38-0.55],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61827449
rs968567-<b>T</b>,5 x 10-14,(Phosphatidylcholine with diacyl residue sum C42:0/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.395747 unit increase,[0.29-0.5],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828092
rs174574-<b>C</b>,2 x 10-17,(Phosphatidylcholine with diacyl residue sum C42:4/Phosphatidylcholine with acyl-alkyl residue sum C38:2),NR,'-,0.366461 unit increase,[0.28-0.45],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61832870
rs174581-<b>A</b>,1 x 10-15,(Phosphatidylcholine with acyl-alkyl residue sum C34:0/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.341664 unit decrease,[0.26-0.42],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839211
rs1535-<b>G</b>,1 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.321785 unit increase,[0.24-0.41],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs1535-<b>G</b>,2 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.371389 unit increase,[0.29-0.45],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs174581-<b>A</b>,3 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.360322 unit increase,[0.28-0.44],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839211
rs174581-<b>A</b>,4 x 10-25,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.42572 unit increase,[0.35-0.5],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839211
rs174594-<b>A</b>,5 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5),NR,'-,0.301599 unit decrease,[0.22-0.38],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61852357
rs1535-<b>G</b>,3 x 10-19,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.385795 unit increase,[0.3-0.47],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs1535-<b>G</b>,2 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Hydroxysphingomyelin with acyl residue sum C22:2),NR,'-,0.372567 unit increase,[0.29-0.46],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs174574-<b>C</b>,1 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.328301 unit decrease,[0.24-0.41],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61832870
rs1535-<b>G</b>,3 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Hydroxysphingomyelin with acyl residue sum C22:2),NR,'-,0.326039 unit increase,[0.24-0.41],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs174580-<b>G</b>,5 x 10-12,(Phosphatidylcholine with acyl-alkyl residue sum C36:4/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.30041 unit decrease,[0.22-0.38],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839170
rs174592-<b>G</b>,3 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C38:4/Sphingomyelin with acyl residue sum C16:0),NR,'-,0.311966 unit decrease,[0.23-0.39],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61851136
rs174580-<b>G</b>,1 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C38:5/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.372766 unit decrease,[0.29-0.46],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839170
rs174583-<b>T</b>,7 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C38:5/Sphingomyelin with acyl residue sum C16:0),NR,'-,0.361779 unit decrease,[0.28-0.44],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61842278
rs5792235-<b>C</b>,6 x 10-19,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C36:2),NR,'-,0.395416 unit decrease,[0.31-0.48],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs5792235-<b>C</b>,9 x 10-15,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C38:3),NR,'-,0.343531 unit decrease,[0.26-0.43],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs174581-<b>A</b>,7 x 10-15,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.330756 unit decrease,[0.25-0.41],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839211
rs3834458-<b>C</b>,5 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C44:3),NR,'-,0.335787 unit decrease,[0.25-0.42],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61827449
rs174574-<b>C</b>,3 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C42:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.323843 unit decrease,[0.24-0.41],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61832870
rs201631095-<b>CA</b>,3 x 10-13,(Sphingomyelin with acyl residue sum C18:0/Sphingomyelin with acyl residue sum C24:1),NR,'-,0.29578 unit increase,[0.22-0.37],CERS4,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,19:8208084
rs174541-<b>C</b>,3 x 10-12,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C42:4),NR,'-,0.302653 unit increase,[0.22-0.39],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61798436
rs174541-<b>C</b>,1 x 10-15,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4),NR,'-,0.349222 unit increase,[0.26-0.43],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61798436
rs174541-<b>C</b>,9 x 10-16,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.348321 unit increase,[0.26-0.43],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61798436
rs174541-<b>C</b>,3 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4),NR,'-,0.3193 unit increase,[0.23-0.4],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61798436
rs174541-<b>C</b>,2 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.380947 unit increase,[0.3-0.46],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61798436
rs174541-<b>C</b>,6 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:5),NR,'-,0.365348 unit increase,[0.28-0.45],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61798436
rs174561-<b>C</b>,3 x 10-17,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:1),NR,'-,0.384602 unit increase,[0.3-0.47],"FADS1, MIR1908, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61815236
rs174561-<b>C</b>,2 x 10-19,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.404607 unit increase,[0.32-0.49],"FADS1, MIR1908, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61815236
rs174561-<b>C</b>,1 x 10-18,(Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.400157 unit decrease,[0.31-0.49],"FADS1, MIR1908, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61815236
rs174561-<b>C</b>,3 x 10-16,(Phosphatidylcholine with acyl-alkyl residue sum C32:1/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.371213 unit decrease,[0.28-0.46],"FADS1, MIR1908, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61815236
rs174561-<b>C</b>,5 x 10-34,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C36:3),NR,'-,0.545071 unit decrease,[0.46-0.63],"FADS1, MIR1908, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61815236
rs11320420-<b>G</b>,8 x 10-36,(Lysophosphatidylcholine with acyl residue C16:1/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.526048 unit increase,[0.45-0.61],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs174528-<b>C</b>,9 x 10-14,(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.323791 unit increase,[0.24-0.41],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61776027
rs174528-<b>C</b>,8 x 10-15,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.329919 unit increase,[0.25-0.41],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61776027
rs11320420-<b>G</b>,5 x 10-13,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.310827 unit increase,[0.23-0.39],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,9 x 10-22,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.414984 unit increase,[0.33-0.5],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,7 x 10-15,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.342667 unit increase,[0.26-0.43],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,2 x 10-17,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.372488 unit increase,[0.29-0.46],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,5 x 10-12,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.304972 unit increase,[0.22-0.39],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,7 x 10-24,(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C34:1),NR,'-,0.440607 unit decrease,[0.36-0.52],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs174528-<b>C</b>,4 x 10-13,(Phosphatidylcholine with diacyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.314088 unit decrease,[0.23-0.4],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61776027
rs11320420-<b>G</b>,1 x 10-20,(Phosphatidylcholine with acyl-alkyl residue sum C34:1/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.402542 unit increase,[0.32-0.49],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,2 x 10-19,(Phosphatidylcholine with acyl-alkyl residue sum C34:1/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.392775 unit increase,[0.31-0.48],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs6497490-<b>G</b>,1 x 10-30,(indoleacetylglutamine),0.13,'-,0.64 unit decrease,[0.53-0.75],ACSM2A,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:20466152
rs1747551-<b>G</b>,7 x 10-24,(indolelactate),0.25,'-,0.361 unit decrease,[0.29-0.43],SLC17A3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25851301
rs11854689-<b>A</b>,1 x 10-26,(inosine),0.32,'-,0.402 unit increase,[0.33-0.48],"SLC28A2, H3P39",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,15:45223854
rs662138-<b>G</b>,3 x 10-13,(isobutyrylcarnitine (C4)),0.16,'-,0.328 unit decrease,[0.24-0.42],SLC22A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:160143444
rs1047891-<b>A</b>,7 x 10-18,(isobutyrylglycine),0.33,'-,0.273 unit increase,[0.21-0.34],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs7513363-<b>G</b>,3 x 10-24,(isocaproylglutamine),0.32,'-,0.327 unit decrease,[0.26-0.39],"ACADM, SLC44A5",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75677758
rs3799340-<b>T</b>,8 x 10-32,(isocaproylglutamine),0.45,'-,0.353 unit decrease,[0.29-0.41],SLC17A4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25762418
rs7513363-<b>G</b>,6 x 10-25,(isocaproylglycine),0.32,'-,0.335 unit decrease,[0.27-0.4],"ACADM, SLC44A5",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75677758
rs1047891-<b>A</b>,1 x 10-25,(isocaproylglycine),0.33,'-,0.351 unit increase,[0.28-0.42],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs1047891-<b>A</b>,4 x 10-12,(isovalerylglycine),0.33,'-,0.216 unit increase,[0.16-0.28],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs6913474-<b>C</b>,3 x 10-88,(isoxanthopterin),0.42,'-,0.825 unit increase,[0.74-0.91],"NQO2, NQO2-AS1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:2996087
rs61825638-<b>T</b>,7 x 10-18,(kynurenate),0.23,'-,0.17 unit increase,[0.13-0.21],KMO,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:241550102
rs11133665-<b>A</b>,9 x 10-16,(kynurenine),0.27,'-,0.365 unit decrease,[0.28-0.45],"CTD-3080P12.3, SLC6A19",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:1188170
rs12465802-<b>A</b>,9 x 10-18,(lactose),0.46,'-,0.274 unit increase,[0.21-0.34],R3HDM1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:135623778
rs4805801-<b>T</b>,4 x 10-21,(lysine),0.17,'-,0.377 unit increase,[0.3-0.46],NUDT19,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:32692906
rs140254647-<b>C</b>,4 x 10-24,(mannose),0.22,'-,0.803 unit increase,[0.65-0.96],SPATA6,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:48409997
rs291468-<b>A</b>,2 x 10-14,(methylmalonate (MMA)),0.4,'-,0.38 unit decrease,[0.28-0.48],HIBCH,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:190323393
rs3916-<b>C</b>,3 x 10-11,(methylsuccinate),0.26,'-,0.161 unit increase,[0.11-0.21],ACADS,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:120739469
rs12410239-<b>A</b>,4 x 10-18,(methylsuccinoylcarnitine),0.38,'-,0.235 unit increase,[0.18-0.29],"SLC1A7, CPT2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:53191923
rs72770483-<b>G</b>,7 x 10-30,(myo-inositol),0.08,'-,1.153 unit increase,[0.95-1.35],"ARHGAP17, SLC5A11",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:24914993
rs4240520-<b>G</b>,7 x 10-12,"(N1,N12-diacetylspermine)",0.14,'-,0.469 unit increase,[0.34-0.6],PAOX,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:133383915
rs13538-<b>G</b>,1 x 10-149,"(N2,N6-diacetyllysine)",0.21,'-,0.735 unit increase,[0.68-0.79],"NAT8, ALMS1P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73641201
rs10168931-<b>A</b>,8 x 10-357,(N2-acetyllysine),0.21,'-,0.888 unit increase,[0.84-0.93],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73650092
rs13410232-<b>T</b>,5 x 10-19,(N6-carboxyethyllysine),0.21,'-,0.185 unit decrease,[0.14-0.23],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73644562
rs6546861-<b>T</b>,1 x 10-111,(N-acetyl-1-methylhistidine),0.21,'-,0.731 unit increase,[0.67-0.8],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73622734
rs115897075-<b>C</b>,4 x 10-11,(X - 24462),0.02,'-,0.532 unit increase,[0.38-0.69],DNPEP,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:219385510
rs12190495-<b>A</b>,1 x 10-179,(X - 24515),0.29,'-,1.073 unit increase,[1-1.15],GLYATL3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:49520769
rs3949301-<b>G</b>,2 x 10-32,(X - 24518),0.36,'-,0.391 unit increase,[0.33-0.46],DDAH1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:85397700
rs37369-<b>T</b>,9 x 10-56,(X - 24518),0.08,'-,0.873 unit decrease,[0.76-0.98],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs6718843-<b>A</b>,3 x 10-44,(X - 24519),0.21,'-,0.428 unit decrease,[0.37-0.49],"NAT8, ALMS1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73625378
rs73069021-<b>A</b>,9 x 10-19,(X - 24546),0.19,'-,0.722 unit increase,[0.56-0.88],"SLCO1A2, SLCO1B1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21247021
rs12460876-<b>C</b>,9 x 10-12,(X - 24736),0.38,'-,0.369 unit increase,[0.26-0.47],SLC7A9,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:32865985
rs37377-<b>G</b>,1 x 10-22,(X - 24796),0.1,'-,0.703 unit decrease,[0.56-0.84],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35045389
rs13384756-<b>T</b>,2 x 10-37,(X - 24809),0.21,'-,0.86 unit increase,[0.73-0.99],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73644538
rs2147896-<b>G</b>,4 x 10-574,(X - 24809),0.36,'-,1.82 unit decrease,[1.75-1.89],PYROXD2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:98388419
rs2147896-<b>G</b>,3 x 10-520,(X - 24983),0.36,'-,1.103 unit decrease,[1.06-1.15],PYROXD2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:98388419
rs111540621-<b>G</b>,3 x 10-43,(N-acetyl-3-methylhistidine),0.21,'-,0.873 unit increase,[0.75-1],"ALMS1, NAT8",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73627267
rs6546861-<b>T</b>,6 x 10-163,(N-acetylarginine),0.21,'-,0.537 unit increase,[0.5-0.58],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73622734
rs4547554-<b>C</b>,7 x 10-159,(N-acetylasparagine),0.21,'-,0.784 unit increase,[0.73-0.84],NAT8,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73640735
rs55728336-<b>C</b>,3 x 10-96,(N-acetyl-aspartyl-glutamate (NAAG)),0.05,'-,0.676 unit decrease,[0.61-0.74],FOLH1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:49156256
rs61898064-<b>T</b>,1 x 10-73,(N-acetyl-aspartyl-glutamate (NAAG)),0.05,'-,0.625 unit decrease,[0.56-0.69],'-,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:55064850
rs6546861-<b>T</b>,3 x 10-249,(N-acetylcitrulline),0.21,'-,0.918 unit increase,[0.87-0.97],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73622734
rs113590482-<b>T</b>,5 x 10-37,(N-acetylglucosamine conjugate of C24H40O4 bile acid),0.14,'-,1.079 unit decrease,[0.91-1.25],UGT3A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35979443
rs530686-<b>A</b>,6 x 10-18,(N-acetylglucosamine/N-acetylgalactosamine),0.39,'-,0.095 unit increase,[0.073-0.117],"CDRT15P11, C4orf33",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:129118729
rs66559683-<b>G</b>,7 x 10-33,(N-acetylglucosamine/N-acetylgalactosamine),0.12,'-,0.197 unit increase,[0.16-0.23],UNC93A,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:167295745
rs66559683-<b>G</b>,2 x 10-46,(N-acetylglucosaminylasparagine),0.12,'-,0.271 unit decrease,[0.23-0.31],UNC93A,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:167295745
rs4547554-<b>C</b>,4 x 10-113,(N-acetylglutamine),0.21,'-,0.8 unit increase,[0.73-0.87],NAT8,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73640735
rs10195357-<b>G</b>,9 x 10-30,(N-acetylhistidine),0.22,'-,0.218 unit increase,[0.18-0.26],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73485902
rs7607014-<b>G</b>,4 x 10-24,(N-acetylkynurenine (2)),0.22,'-,0.737 unit increase,[0.59-0.88],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73503047
rs4547554-<b>C</b>,3 x 10-35,(N-acetylleucine),0.21,'-,0.437 unit increase,[0.37-0.51],NAT8,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73640735
rs7547112-<b>A</b>,2 x 10-16,(N-acetylmethionine sulfoxide),0.47,'-,0.233 unit increase,[0.18-0.29],"GM2AP2, SRP14P4",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:171379727
rs4547554-<b>C</b>,2 x 10-84,(N-acetylmethionine sulfoxide),0.21,'-,0.614 unit increase,[0.55-0.68],NAT8,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73640735
rs10195357-<b>G</b>,1 x 10-47,(N-acetylphenylalanine),0.22,'-,0.499 unit increase,[0.43-0.57],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73485902
rs2514032-<b>T</b>,1 x 10-11,(N-acetylphenylalanine),0.17,'-,0.266 unit decrease,[0.19-0.34],ACY3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:67643949
rs35246381-<b>C</b>,3 x 10-35,(N-acetylputrescine),0.22,'-,0.229 unit increase,[0.19-0.27],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18415025
rs13538-<b>G</b>,3 x 10-84,(N-acetylpyrraline),0.21,'-,0.747 unit increase,[0.67-0.82],"NAT8, ALMS1P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73641201
rs10168931-<b>A</b>,9 x 10-66,(N-acetyltyrosine),0.21,'-,0.654 unit increase,[0.58-0.73],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73650092
rs2514032-<b>T</b>,8 x 10-13,(N-acetyltyrosine),0.17,'-,0.311 unit decrease,[0.23-0.4],ACY3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:67643949
rs111540621-<b>G</b>,2 x 10-46,(N-alpha-acetylornithine),0.21,'-,0.35 unit increase,[0.3-0.4],"ALMS1, NAT8",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73627267
rs13431529-<b>C</b>,2 x 10-109,(N-delta-acetylornithine),0.21,'-,1.057 unit decrease,[0.96-1.15],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73648914
rs72897838-<b>G</b>,1 x 10-27,(N-formylanthranilic acid),0.1,'-,0.505 unit increase,[0.41-0.6],AFMID,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,17:78202506
rs7660268-<b>?</b>,2 x 10-7,,'-,1.63,'-,[1.32-2.00],'-,End stage renal disease x APOL1 genotype interaction,"chronic kidney disease, APOL1 risk genotype carrier status",GCST006813,4:14348076
rs79741405-<b>?</b>,8 x 10-8,,'-,2.97,'-,[2.01-4.39],"PLG, LPA",End stage renal disease x APOL1 genotype interaction,"chronic kidney disease, APOL1 risk genotype carrier status",GCST006813,6:160673237
rs1551122-<b>?</b>,9 x 10-7,,'-,1.49,'-,[1.27-1.76],OTOGL,End stage renal disease x APOL1 genotype interaction,"chronic kidney disease, APOL1 risk genotype carrier status",GCST006813,12:80372020
rs2404298-<b>?</b>,4 x 10-7,,NR,1.76,'-,'-,DLGAP2,End stage renal disease in APOL1 risk genotype-negative individuals,"chronic kidney disease, APOL1 risk genotype carrier status",GCST006815,8:1420853
rs17112571-<b>?</b>,3 x 10-6,,NR,1.45,'-,'-,RNLS,End stage renal disease in APOL1 risk genotype-negative individuals,"chronic kidney disease, APOL1 risk genotype carrier status",GCST006815,10:88476640
rs13084795-<b>?</b>,6 x 10-7,(adjusted for APOL1 genotype),NR,'-,'-,'-,'-,End-stage renal disease,chronic kidney disease,GCST006814,3:152612677
rs479618-<b>?</b>,3 x 10-6,,'-,1.36,'-,[1.19-1.55],'-,End-stage renal disease,chronic kidney disease,GCST006814,1:193928755
rs2404298-<b>?</b>,1 x 10-6,,'-,1.55,'-,[1.29-1.85],DLGAP2,End-stage renal disease,chronic kidney disease,GCST006814,8:1420853
rs4292733-<b>?</b>,2 x 10-6,,'-,1.33,'-,[1.18-1.50],"KBTBD11-OT1, ARHGEF10",End-stage renal disease,chronic kidney disease,GCST006814,8:1891807
rs73520599-<b>?</b>,3 x 10-6,,'-,1.51,'-,[1.27-1.79],"ECM2, CENPP",End-stage renal disease,chronic kidney disease,GCST006814,9:92503403
rs7142086-<b>?</b>,2 x 10-6,,'-,1.4705882,'-,[1.25-1.72],"DPF3, DCAF4",End-stage renal disease,chronic kidney disease,GCST006814,14:72924885
APOL1-<b>?</b>,6 x 10-76,,'-,4.74,'-,[3.67-6.12],'-,End-stage renal disease,chronic kidney disease,GCST006814,Mapping not available
rs553908921-<b>T</b>,2 x 10-8,,9.20E-04,'-,4.312875 unit increase,[2.8-5.82],CCSER1,Chronic kidney disease,chronic kidney disease,GCST007879,4:91329657
rs769354275-<b>G</b>,3 x 10-8,,1.93E-04,'-,12.229734 unit increase,[7.9-16.56],'-,Chronic kidney disease,chronic kidney disease,GCST007879,10:10650339
chr13:101428834-<b>T</b>,3 x 10-8,,9.96E-05,'-,19.37709 unit increase,[12.52-26.23],'-,Chronic kidney disease,chronic kidney disease,GCST007879,Mapping not available
rs10753074-<b>T</b>,6 x 10-12,(conditional),'-,1.21,'-,[NR],PRDX6-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:173377204
rs10995092-<b>T</b>,2 x 10-7,,'-,1.22,'-,[NR],RTKN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,10:62241941
rs11185603-<b>C</b>,4 x 10-7,,'-,1.15,'-,[NR],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,7:50267214
rs11889341-<b>T</b>,2 x 10-76,,'-,1.68,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,2:191079016
rs820077-<b>G</b>,1 x 10-8,,'-,1.19,'-,[NR],ANKS1A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:35066077
rs7941765-<b>C</b>,2 x 10-8,,'-,1.16,'-,[NR],"FLI1, ETS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,11:128629105
rs7200786-<b>A</b>,2 x 10-8,,'-,1.15,'-,[NR],CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,16:11083944
rs12531540-<b>C</b>,3 x 10-8,,'-,1.15,'-,[NR],JAZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,7:28123055
rs6568431-<b>A</b>,5 x 10-14,,'-,1.2,'-,[NR],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:106140931
rs3024493-<b>A</b>,6 x 10-8,,'-,1.2,'-,[NR],IL10,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:206770623
rs2532871-<b>C</b>,7 x 10-8,,'-,1.32,'-,[NR],TASL,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,X:30555616
rs10516487-<b>G</b>,8 x 10-8,,'-,1.16,'-,[NR],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,4:101829919
rs143123127-<b>A</b>,6 x 10-9,,'-,1.51,'-,[NR],IKZF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,17:39850937
rs11059919-<b>G</b>,8 x 10-9,,'-,1.16,'-,[NR],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,12:128804645
rs58721818-<b>T</b>,3 x 10-19,,'-,1.82,'-,[NR],"TNFAIP3, LINC02528",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:137922602
rs10912578-<b>A</b>,4 x 10-19,,'-,1.27,'-,[NR],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:173282717
rs2736332-<b>C</b>,2 x 10-22,,'-,1.31,'-,[NR],"FAM167A, BLK",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,8:11482456
rs268134-<b>G</b>,1 x 10-10,,'-,1.21,'-,[NR],SPRED2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,2:65381229
rs10048743-<b>G</b>,2 x 10-10,,'-,1.25,'-,[NR],IKZF2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,2:213025508
rs597808-<b>A</b>,6 x 10-10,,'-,1.18,'-,[NR],ATXN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,12:111535554
rs2289583-<b>A</b>,6 x 10-10,,'-,1.18,'-,[NR],SCAMP5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,15:75018695
rs4388254-<b>T</b>,7 x 10-10,,'-,1.4,'-,[NR],"VDAC1, TCF7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,5:134092910
rs1150757-<b>A</b>,6 x 10-107,,'-,2.33,'-,[NR],TNXB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:32061428
rs77583790-<b>A</b>,6 x 10-11,,'-,2.15,'-,[NR],IL12A-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,3:159976265
rs6671847-<b>A</b>,1 x 10-12,,'-,1.2,'-,[NR],FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:161509020
rs74290525-<b>G</b>,1 x 10-12,(conditional),'-,2.06,'-,[NR],SLC44A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:31867385
rs9398235-<b>A</b>,1 x 10-7,,'-,1.15,'-,[1.09–1.21],DDO,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:110410913
rs4660116-<b>C</b>,2 x 10-7,,'-,1.17,'-,[NR],LYST,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:235865541
rs7097397-<b>G</b>,9 x 10-12,,'-,1.2,'-,[NR],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,10:48817351
rs11085727-<b>C</b>,1 x 10-13,,'-,1.24,'-,[NR],TYK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,19:10355447
rs387619-<b>C</b>,3 x 10-13,,'-,1.21,'-,[NR],"CD44, PDHX",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,11:35076646
rs3747093-<b>A</b>,3 x 10-13,,'-,1.26,'-,[NR],"YDJC, CCDC116",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,22:21630090
rs58688157-<b>A</b>,5 x 10-13,,'-,1.24,'-,[NR],CDHR5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,11:625085
rs9273076-<b>T</b>,8 x 10-13,(conditional),'-,1.3,'-,[NR],HLA-DQA1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:32644524
rs1990760-<b>T</b>,4 x 10-8,,'-,1.15,'-,[NR],IFIH1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,2:162267541
rs6679677-<b>A</b>,1 x 10-15,,'-,1.39,'-,[NR],"RSBN1, PHTF1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:113761186
rs6736175-<b>C</b>,9 x 10-17,(conditional),'-,1.24,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,2:191081596
rs13332649-<b>A</b>,2 x 10-18,,'-,1.34,'-,[NR],"LINC02132, IRF8",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,16:85933077
rs2431098-<b>G</b>,4 x 10-18,,'-,1.25,'-,[NR],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,5:160460329
rs114090659-<b>C</b>,6 x 10-92,(conditional),'-,1.99,'-,[NR],"MUC21, NAPGP2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:30973212
rs114092478-<b>T</b>,3 x 10-93,(conditional),'-,2,'-,[NR],"HLA-DQB3, MTCO3P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,6:32714358
rs6889239-<b>C</b>,4 x 10-24,,'-,1.33,'-,[NR],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,5:151078210
rs3757387-<b>C</b>,1 x 10-48,(conditional),'-,1.45,'-,[NR],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,7:128936032
rs35472514-<b>G</b>,4 x 10-53,,'-,1.7,'-,[NR],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,16:31272002
rs17849501-<b>T</b>,2 x 10-59,,'-,2.01,'-,[NR],"SMG7, NCF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,1:183573188
rs4902562-<b>A</b>,2 x 10-6,,'-,1.13,'-,[NR],RAD51B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,14:68264741
rs79404002-<b>A</b>,3 x 10-6,,'-,1.29,'-,[NR],"GLTPD2, PSMB6",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,17:4793960
rs35000415-<b>T</b>,1 x 10-60,,'-,1.83,'-,[NR],IRF5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003156,7:128945562
rs1267499-<b>A</b>,8 x 10-8,,'-,1.15,'-,[1.09–1.20],RNU6-793P,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:14715651
rs7090925-<b>A</b>,9 x 10-8,,'-,1.13,'-,[1.08–1.18],KRT8P37,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,10:8437905
rs1874791-<b>A</b>,3 x 10-7,,'-,1.14,'-,[1.09–1.20],IL12RB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:67340749
rs6914831-<b>C</b>,4 x 10-7,,'-,1.11,'-,[1.07–1.16],AHI1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:135318506
rs912784-<b>T</b>,6 x 10-7,,'-,1.29,'-,[1.17–1.42],LCP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,13:46211386
rs494003-<b>T</b>,2 x 10-6,,'-,1.13,'-,[1.08–1.19],AP5B1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,11:65774827
rs11908000-<b>T</b>,2 x 10-6,,'-,3.03,'-,[1.92–4.77],MIR8062,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,20:7377776
rs959260-<b>A</b>,3 x 10-6,,'-,1.14,'-,[1.08–1.20],GRB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,17:75373341
rs2288012-<b>A</b>,4 x 10-6,,'-,1.12,'-,[1.07–1.17],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,Mapping not available
rs9402743-<b>G</b>,5 x 10-6,,'-,1.1,'-,[1.06–1.15],LINC00271,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:135679896
rs2476601-<b>A</b>,1 x 10-28,,'-,1.43,'-,[1.34–1.53],PTPN22,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:113834946
rs1801274-<b>C</b>,1 x 10-12,,'-,1.16,'-,[1.11–1.21],FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:161509955
rs704840-<b>G</b>,3 x 10-19,,'-,1.22,'-,[1.17–1.27],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:173257056
rs17849501-<b>T</b>,3 x 10-88,,'-,2.1,'-,[1.95–2.26],"SMG7, NCF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:183573188
rs3024505-<b>T</b>,5 x 10-9,,'-,1.17,'-,[1.11–1.24],"IL10, Y_RNA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:206766559
rs9782955-<b>C</b>,1 x 10-9,,'-,1.16,'-,[1.11–1.22],LYST,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,1:235876577
rs2111485-<b>G</b>,1 x 10-11,,'-,1.15,'-,[1.11–1.20],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,Mapping not available
rs11889341-<b>T</b>,6 x 10-122,,'-,1.73,'-,(1.65–1.81],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,2:191079016
rs3768792-<b>C</b>,1 x 10-13,,'-,1.24,'-,[1.17–1.31],IKZF2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,2:213006985
rs9311676-<b>C</b>,3 x 10-14,,'-,1.17,'-,[1.13–1.22],"KCTD6, PDHB",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,3:58484624
rs564799-<b>C</b>,2 x 10-9,,'-,1.14,'-,[1.09–1.18],IL12A-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,3:160011200
rs10028805-<b>G</b>,4 x 10-17,,'-,1.2,'-,[1.15–1.25],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,4:101816093
rs7726414-<b>T</b>,4 x 10-16,,'-,1.45,'-,[1.32–1.58],"VDAC1, TCF7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,5:134096143
rs10036748-<b>T</b>,1 x 10-45,,'-,1.38,'-,[1.32–1.45],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,5:151078585
rs2431697-<b>T</b>,8 x 10-28,,'-,1.26,'-,[1.21–1.31],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,5:160452971
rs1270942-<b>C</b>,2 x 10-165,,'-,2.28,'-,[2.15–2.42],CFB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:31951083
rs9462027-<b>A</b>,8 x 10-9,,'-,1.14,'-,[1.09–1.19],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:34829464
rs6568431-<b>A</b>,5 x 10-14,,'-,1.21,'-,[1.15–1.27],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:106140931
rs6932056-<b>C</b>,2 x 10-31,,'-,1.83,'-,[1.65–2.02],"LINC02528, TNFAIP3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,6:137921300
rs849142-<b>A</b>,9 x 10-11,,'-,1.14,'-,[1.10–1.19],JAZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,7:28146272
rs4917014-<b>T</b>,6 x 10-14,,'-,1.18,'-,[1.13–1.24],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,7:50266267
rs10488631-<b>C</b>,9 x 10-110,,'-,1.92,'-,[1.81–2.03],"IRF5, TNPO3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,7:128954129
rs2736340-<b>T</b>,6 x 10-20,,'-,1.29,'-,[1.22–1.37],"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,8:11486464
rs2663052-<b>C</b>,5 x 10-9,,'-,1.16,'-,[1.10–1.22],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,10:48861350
rs4948496-<b>C</b>,1 x 10-10,,'-,1.14,'-,[1.10–1.19],ARID5B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,10:62045858
rs12802200-<b>C</b>,9 x 10-10,,'-,1.23,'-,[1.15–1.31],MIR210HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,11:566936
rs2732549-<b>T</b>,1 x 10-23,,'-,1.24,'-,[1.19–1.29],"CD44, PDHX",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,11:35066852
rs3794060-<b>C</b>,1 x 10-20,,'-,1.23,'-,[1.18–1.29],NADSYN1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,11:71476633
rs7941765-<b>C</b>,1 x 10-10,,'-,1.14,'-,[1.10–1.19],"FLI1, ETS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,11:128629105
rs10774625-<b>A</b>,4 x 10-9,,'-,1.13,'-,[1.08–1.18],ATXN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,12:111472415
rs1059312-<b>C</b>,1 x 10-13,,'-,1.17,'-,[1.12–1.21],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,12:128794319
rs4902562-<b>A</b>,6 x 10-10,,'-,1.14,'-,[1.09–1.19],RAD51B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,14:68264741
rs2289583-<b>A</b>,6 x 10-15,,'-,1.19,'-,[1.14–1.24],SCAMP5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,15:75018695
rs9652601-<b>G</b>,7 x 10-17,,'-,1.21,'-,[1.15–1.26],CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,16:11080508
rs34572943-<b>A</b>,3 x 10-76,,'-,1.71,'-,[1.61–1.81],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,16:31261032
rs11644034-<b>G</b>,1 x 10-17,,'-,1.25,'-,[1.19–1.32],LINC02132,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,16:85939006
rs2286672-<b>T</b>,3 x 10-9,,'-,1.25,'-,[1.16–1.35],PLD2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,17:4809322
rs2941509-<b>A</b>,8 x 10-9,,'-,1.35,'-,[1.22–1.49],IKZF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,17:39764941
rs2304256-<b>C</b>,4 x 10-13,,'-,1.24,'-,[1.17–1.31],TYK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,19:10364976
rs7444-<b>C</b>,2 x 10-22,,'-,1.27,'-,[1.21–1.33],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,22:21622645
rs887369-<b>C</b>,5 x 10-10,,'-,1.15,'-,[1.10–1.21],TASL,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,X:30559729
rs1734787-<b>C</b>,2 x 10-15,,'-,1.31,'-,[1.22–1.40],MECP2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003155,X:154059995
rs6920220-<b>A</b>,4 x 10-7,,0.21,1.17,'-,[1.10-1.25],LINC02539,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,6:137685367
rs2269368-<b>T</b>,8 x 10-7,,0.14,1.11,'-,[1.01-1.22],ARHGAP4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,X:153924366
rs2431099-<b>G</b>,2 x 10-6,,0.52,1.15,'-,[1.09-1.22],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,5:160459613
rs5754217-<b>T</b>,2 x 10-6,,0.19,1.2,'-,[1.13-1.27],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,22:21585386
rs1990760-<b>T</b>,3 x 10-7,,0.6,1.17,'-,'-,IFIH1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,2:162267541
rs7708392-<b>C</b>,4 x 10-13,,0.24,1.27,'-,[1.10–1.35],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,5:151077924
rs6568431-<b>A</b>,7 x 10-10,,0.38,1.2,'-,[1.14–1.27],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,6:106140931
rs849142-<b>T</b>,2 x 10-9,,0.49,1.19,'-,[1.13–1.26],JAZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,7:28146272
rs11755393-<b>G</b>,2 x 10-8,,0.35,1.17,'-,[1.10–1.24],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,6:34856859
rs3024505-<b>A</b>,4 x 10-8,,0.16,1.19,'-,[1.11–1.28],"IL10, Y_RNA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,1:206766559
rs10911363-<b>T</b>,1 x 10-7,,0.27,1.19,'-,[1.12–1.26],"SMG7, NCF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,1:183580622
rs12444486-<b>T</b>,2 x 10-7,,0.5,1.16,'-,[1.10–1.23],LINC02132,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,16:85959043
rs11013210-<b>T</b>,2 x 10-7,,0.21,1.18,'-,[1.11–1.26 ],ARMC3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,10:22960180
rs1874791-<b>A</b>,3 x 10-7,,0.18,1.18,'-,[1.10–1.26],IL12RB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,1:67340749
rs9782955-<b>C</b>,5 x 10-7,,0.74,1.18,'-,[1.11–1.26],LYST,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,1:235876577
rs7683537-<b>T</b>,8 x 10-7,,0.82,1.23,'-,[1.14–1.33],CENPU,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,4:184710844
rs428073-<b>T</b>,8 x 10-7,,0.69,1.18,'-,[1.11–1.26],TAOK3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,12:118244946
rs497273-<b>G</b>,8 x 10-7,,0.65,1.14,'-,[1.08–1.21],SPPL3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,12:120766879
rs1861525-<b>G</b>,2 x 10-6,,0.05,1.27,'-,[1.12–1.45],CYCS,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,7:25121983
rs921916-<b>C</b>,2 x 10-6,,0.18,1.15,'-,[1.07–1.23],SPATA48,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,7:50189102
rs7333671-<b>G</b>,2 x 10-6,,0.08,1.22,'-,[1.11–1.34],KLF12,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,13:73704828
rs12992463-<b>A</b>,3 x 10-6,,0.5,1.12,'-,[1.06–1.19],RNA5SP87,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,2:22328233
rs12620999-<b>C</b>,3 x 10-6,,0.19,1.13,'-,[1.06–1.21],COPS8,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,2:237127724
rs503425-<b>C</b>,3 x 10-6,,0.2,1.16,'-,[1.08–1.24],"SETP16, DDX6",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,11:118822018
rs10742326-<b>G</b>,4 x 10-6,,0.59,1.14,'-,[1.08–1.21],APIP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,11:34788463
rs4766921-<b>G</b>,5 x 10-6,,0.67,1.18,'-,[1.09–1.27],"SRRM4, LINC02439",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,12:118913063
rs11951576-<b>C</b>,5 x 10-6,,0.69,1.14,'-,[1.08–1.22],TENT4A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,5:6731300
rs6438700-<b>C</b>,6 x 10-6,,0.82,1.18,'-,[1.09–1.27],"CASR, CD86",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,3:122153978
rs6486730-<b>G</b>,7 x 10-6,,0.41,1.13,'-,[1.07–1.19],"TMEM132C, SLC15A4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,12:128790482
rs4748857-<b>C</b>,7 x 10-6,,0.73,1.16,'-,[1.09–1.24],C10orf67,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,10:23310629
rs3914167-<b>G</b>,8 x 10-6,,0.27,1.15,'-,[1.09–1.23],"C9, DAB2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,5:39406395
rs7574865-<b>T</b>,1 x 10-41,,0.23,1.57,'-,[1.49–1.69],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,2:191099907
rs2070197-<b>C</b>,6 x 10-24,,0.11,1.88,'-,[1.78–1.95],IRF5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,7:128948946
rs11860650-<b>T</b>,2 x 10-20,,0.13,1.43,'-,[1.32–1.54],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,16:31315385
rs2736340-<b>T</b>,8 x 10-17,,0.25,1.35,'-,[1.27–1.43],"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,8:11486464
rs5029937-<b>T</b>,5 x 10-13,,0.03,1.71,'-,[1.51–1.95],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,6:137874014
rs2476601-<b>A</b>,3 x 10-12,,0.1,1.35,'-,[1.24–1.47],PTPN22,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,1:113834946
rs4963128-<b>C</b>,5 x 10-9,,0.67,1.2,'-,[1.13–1.27],PHRF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,11:589564
rs2205960-<b>T</b>,6 x 10-9,,0.23,1.22,'-,[1.15–1.30],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,1:173222336
rs2855772-<b>C</b>,1 x 10-15,,0.09772,1.4,'-,[NR],KIT,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005754,4:54682309
rs13116227-<b>T</b>,3 x 10-11,,0.09561,1.34,'-,[NR],"GPR78, TRMT44",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005754,4:8556539
rs2736332-<b>?</b>,3 x 10-14,(Chinese),0.718,1.5,'-,[NR],"FAM167A, BLK",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,8:11482456
rs10912578-<b>?</b>,2 x 10-15,(EA),0.306,1.28,'-,[NR],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:173282717
rs7444-<b>?</b>,2 x 10-6,(Chinese),0.519,1.23,'-,[NR],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,22:21622645
rs6889239-<b>?</b>,2 x 10-18,(EA),0.251,1.32,'-,[NR],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,5:151078210
rs17849501-<b>?</b>,2 x 10-59,(EA),0.051,2.24,'-,[NR],"SMG7, NCF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:183573188
rs1150757-<b>?</b>,2 x 10-101,(EA),0.092,2.53,'-,[NR],TNXB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:32061428
rs10048743-<b>?</b>,2 x 10-8,(EA),0.129,1.26,'-,[NR],IKZF2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:213025508
rs9311676-<b>?</b>,5 x 10-6,(EA),0.424,1.14,'-,[NR],"KCTD6, PDHB",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,3:58484624
rs564799-<b>?</b>,1 x 10-6,(EA),0.408,1.16,'-,[NR],IL12A-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,3:160011200
4:102721293-<b>?</b>,5 x 10-10,(EA),0.446,1.2,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,Mapping not available
rs4388254-<b>?</b>,4 x 10-10,(EA),0.045,1.47,'-,[NR],"VDAC1, TCF7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,5:134092910
rs1061502-<b>?</b>,9 x 10-11,(EA),0.273,1.23,'-,[NR],IRF7,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,11:614318
rs10774625-<b>?</b>,9 x 10-8,(EA),0.499,1.17,'-,[NR],ATXN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,12:111472415
rs2289583-<b>?</b>,9 x 10-9,(EA),0.291,1.2,'-,[NR],SCAMP5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,15:75018695
rs2941509-<b>?</b>,4 x 10-6,(EA),0.032,1.41,'-,[NR],IKZF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,17:39764941
rs2304256-<b>?</b>,2 x 10-12,(EA),0.286,1.26,'-,[NR],TYK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,19:10364976
rs9652601-<b>?</b>,4 x 10-7,(EA),0.332,1.17,'-,[NR],CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,16:11080508
rs1143679-<b>?</b>,5 x 10-48,(EA),0.12,1.78,'-,[NR],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,16:31265490
rs6705628-<b>?</b>,3 x 10-8,(Chinese),0.178,1.4,'-,[NR],DGUOK-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:73981235
rs7444-<b>?</b>,1 x 10-13,(EA),0.204,1.28,'-,[NR],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,22:21622645
rs17321999-<b>C</b>,2 x 10-9,(EA),0.809,1.1904762,'-,[1.12-1.27],LBH,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:30256991
rs11889341-<b>?</b>,4 x 10-22,(Chinese),0.339,1.56,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:191079016
rs17603856-<b>T</b>,3 x 10-8,(EA),0.645,1.1235955,'-,[1.08-1.18],ATXN1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:16630667
rs1887428-<b>G</b>,1 x 10-6,(EA),0.373,1.11,'-,[1.06-1.16],JAK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,9:4984530
rs1801274-<b>?</b>,6 x 10-11,(EA),0.497,1.21,'-,[NR],FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:161509955
rs7097397-<b>?</b>,5 x 10-7,(Chinese),0.694,1.27,'-,[NR],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,10:48817351
rs11889341-<b>?</b>,1 x 10-65,(EA),0.216,1.75,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:191079016
rs2476601-<b>?</b>,8 x 10-13,(EA),0.091,1.39,'-,[NR],PTPN22,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:113834946
rs2431098-<b>?</b>,2 x 10-15,(EA),0.481,1.26,'-,[NR],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,5:160460329
rs268134-<b>?</b>,2 x 10-7,(EA),0.249,1.19,'-,[NR],SPRED2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:65381229
rs2111485-<b>?</b>,3 x 10-6,(EA),0.404,1.15,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,Mapping not available
rs6568431-<b>?</b>,4 x 10-12,(EA),0.376,1.22,'-,[NR],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:106140931
rs2230926-<b>?</b>,2 x 10-16,(EA),0.035,1.75,'-,[NR],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:137874929
rs35000415-<b>?</b>,2 x 10-45,(EA),0.108,1.8,'-,[NR],IRF5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,7:128945562
rs2736332-<b>?</b>,5 x 10-18,(EA),0.273,1.32,'-,[NR],"FAM167A, BLK",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,8:11482456
rs7097397-<b>?</b>,9 x 10-11,(EA),0.383,1.22,'-,[NR],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,10:48817351
rs4948496-<b>?</b>,1 x 10-6,(EA),0.469,1.15,'-,[NR],ARID5B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,10:62045858
rs387619-<b>?</b>,4 x 10-11,(EA),0.444,1.22,'-,[NR],"CD44, PDHX",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,11:35076646
rs7941765-<b>?</b>,1 x 10-6,(EA),0.492,1.15,'-,[NR],"FLI1, ETS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,11:128629105
rs1059312-<b>?</b>,3 x 10-6,(EA),0.391,1.14,'-,[NR],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,12:128794319
rs9462027-<b>?</b>,1 x 10-10,(Chinese),0.286,1.46,'-,[NR],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:34829464
rs13385731-<b>?</b>,4 x 10-6,(Chinese),0.16,1.35,'-,[NR],RASGRP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:33476823
rs13332649-<b>?</b>,5 x 10-17,(EA),0.21,1.37,'-,[NR],"LINC02132, IRF8",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,16:85933077
rs7329174-<b>?</b>,3 x 10-6,(Chinese),0.211,1.27,'-,[NR],ELF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,13:40983974
rs10912578-<b>?</b>,2 x 10-8,(Chinese),0.46,1.28,'-,[NR],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:173282717
rs6762714-<b>T</b>,8 x 10-10,(EA),0.392,1.14,'-,[1.09-1.19],LPP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,3:188752450
rs6889239-<b>?</b>,3 x 10-6,(Chinese),0.743,1.28,'-,[NR],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,5:151078210
rs6568431-<b>?</b>,3 x 10-6,(Chinese),0.347,1.24,'-,[NR],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:106140931
rs2230926-<b>?</b>,1 x 10-12,(Chinese),0.031,2.03,'-,[NR],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:137874929
rs4917014-<b>?</b>,3 x 10-6,(Chinese),0.299,1.26,'-,[NR],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,7:50266267
rs494003-<b>A</b>,2 x 10-6,(EA),0.19,1.13,'-,[1.07-1.19],AP5B1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,11:65774827
rs34889541-<b>G</b>,3 x 10-10,(Chinese),0.86,1.2820514,'-,[1.19-1.39],"PTPRC, ATP6V1G3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:198625639
rs2297550-<b>G</b>,2 x 10-7,(Chinese),0.546,1.14,'-,[1.08-1.20],"IKBKE, SRGAP2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:206470429
rs7579944-<b>C</b>,6 x 10-6,(Chinese),0.359,1.1494253,'-,[1.09-1.22],"H3P5, LBH",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:30222160
rs17321999-<b>C</b>,1 x 10-8,(Chinese),0.836,1.2195122,'-,[1.14-1.3],LBH,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:30256991
rs6762714-<b>T</b>,6 x 10-7,(Chinese),0.825,1.2,'-,[1.12-1.29],LPP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,3:188752450
rs597325-<b>G</b>,1 x 10-10,(Chinese),0.48,1.1904762,'-,[1.12-1.25],BACH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:90292775
rs73135369-<b>C</b>,7 x 10-13,(Chinese),0.076,1.38,'-,[1.26-1.51],GTF2IRD1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,7:74526648
rs1887428-<b>G</b>,4 x 10-14,(Chinese),0.346,1.24,'-,[1.17-1.31],JAK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,9:4984530
rs1170426-<b>C</b>,4 x 10-8,(Chinese),0.176,1.2,'-,[1.12-1.28],ZFP90,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,16:68569895
rs34889541-<b>G</b>,2 x 10-12,,0.93,1.2345679,'-,[1.16-1.32],"PTPRC, ATP6V1G3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:198625639
rs2297550-<b>G</b>,1 x 10-11,,0.12,1.16,'-,[1.11-1.21],"IKBKE, SRGAP2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:206470429
rs7579944-<b>C</b>,1 x 10-9,,0.634,1.1111112,'-,[1.08-1.15],"H3P5, LBH",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:30222160
rs17321999-<b>C</b>,2 x 10-16,,0.809,1.2048193,'-,[1.15-1.27],LBH,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,2:30256991
rs6762714-<b>T</b>,4 x 10-15,,0.392,1.16,'-,[1.12-1.20],LPP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,3:188752450
rs17603856-<b>T</b>,3 x 10-12,,0.645,1.1363636,'-,[1.1-1.18],ATXN1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:16630667
rs597325-<b>G</b>,4 x 10-12,,0.615,1.1235955,'-,[1.09-1.16],BACH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:90292775
rs73135369-<b>C</b>,9 x 10-14,,0.022,1.32,'-,[1.23-1.42],GTF2IRD1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,7:74526648
rs1887428-<b>G</b>,2 x 10-17,,0.373,1.16,'-,[1.12-1.20],JAK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,9:4984530
rs494003-<b>A</b>,6 x 10-9,,0.19,1.14,'-,[1.09-1.19],AP5B1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,11:65774827
rs1170426-<b>C</b>,2 x 10-8,,0.235,1.12,'-,[1.08-1.17],ZFP90,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,16:68569895
rs12753920-<b>G</b>,6 x 10-7,,0.332,1.11,'-,[NR],"BTBD8, C1orf146",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,1:92200342
rs427221-<b>C</b>,5 x 10-6,,0.479,1.08,'-,[NR],LINC01967,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,3:28034494
rs9402743-<b>G</b>,5 x 10-6,,0.358,1.08,'-,[NR],LINC00271,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003622,6:135679896
rs117522574-<b>G</b>,3 x 10-8,,0.19,1.5082,'-,[NR],"MTCO3P1, HLA-DQB3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:32722109
rs422544-<b>C</b>,5 x 10-8,,0.15,0.6232,'-,[NR],"HLA-DPA1, HLA-DOA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,6:33058333
rs73366469-<b>C</b>,2 x 10-26,,0.18,2.62,'-,[2.44-2.80],"GTF2I, GTF2IRD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90014238,7:74619286
rs2362475-<b>A</b>,7 x 10-7,,NR,0.9,'-,[0.86-0.94],"KLF2, EPS15L1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011493,19:16329024
rs10082873-<b>G</b>,4 x 10-8,,NR,0.89,'-,[0.85-0.93],"C12orf42, LINC02401",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011493,12:103511597
rs4807205-<b>G</b>,8 x 10-9,,NR,1.12,'-,[1.08-1.16],DOT1L,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011493,19:2167879
rs11755393-<b>A</b>,2 x 10-12,,NR,0.87,'-,[0.83-0.91],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011493,6:34856859
rs4713853-<b>A</b>,3 x 10-12,,NR,1.18,'-,[1.13-1.23],PPARD,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011493,6:35359578
rs12153670-<b>G</b>,8 x 10-10,,NR,1.15,'-,[1.11-1.19],ST8SIA4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011493,5:100836660
rs4807205-<b>G</b>,3 x 10-6,,0.467,1.14,'-,[1.09-1.19],DOT1L,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011492,19:2167879
rs11755393-<b>A</b>,2 x 10-6,,0.65,0.87,'-,[0.81-0.93],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011492,6:34856859
rs12153670-<b>G</b>,2 x 10-6,,0.314,1.15,'-,[1.09-1.21],ST8SIA4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011492,5:100836660
rs2362475-<b>A</b>,2 x 10-9,,0.467,0.85,'-,[0.8-0.9],"KLF2, EPS15L1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011491,19:16329024
rs73366469-<b>C</b>,3 x 10-81,,0.18,2.52,'-,[2.43-2.61],"GTF2I, GTF2IRD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011491,7:74619286
rs11755393-<b>A</b>,1 x 10-7,,0.523,0.87,'-,[0.82-0.92],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011491,6:34856859
rs4713853-<b>A</b>,2 x 10-8,,0.33,1.17,'-,[1.12-1.22],PPARD,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011491,6:35359578
rs1780813-<b>?</b>,4 x 10-8,,NR,1.8181818,'-,[1.27-3.23],SMYD3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005831,1:246280780
rs55849330-<b>A</b>,5 x 10-8,,NR,1.16,'-,[1.11-1.21],ST8SIA4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005831,5:100848943
rs150518861-<b>A</b>,4 x 10-8,,NR,1.66,'-,[1.49-1.84],"LIMK1, EIF4H",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005831,7:74152347
rs114038709-<b>T</b>,4 x 10-8,,NR,1.16,'-,[1.11-1.22],"RNA5SP443, ARHGAP27",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005831,17:45379362
rs36023980-<b>C</b>,5 x 10-9,,NR,1.18,'-,[1.13-1.24],GRB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005831,17:75345203
rs12093154-<b>A</b>,4 x 10-6,,NR,0.844,'-,[0.77-0.92],C1QTNF12,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,1:1243545
rs28411034-<b>A</b>,6 x 10-6,,NR,0.859,'-,[0.79-0.92],MTF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,1:37811325
rs1016140-<b>T</b>,3 x 10-10,,NR,0.87,'-,[0.83-0.91],"CD58, NAP1L4P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,1:116533925
rs11264750-<b>G</b>,2 x 10-12,,NR,0.751,'-,[0.67-0.83],FCRL5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,1:157527370
rs12132445-<b>A</b>,7 x 10-8,,NR,1.171,'-,[1.11-1.23],MROH9,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,1:170842658
rs1547624-<b>T</b>,5 x 10-8,,NR,1.172,'-,[1.12-1.23],RGS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,1:192574707
rs2381401-<b>T</b>,1 x 10-7,,NR,1.179,'-,[1.12-1.24],ARHGAP15,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,2:143263405
rs9630991-<b>A</b>,3 x 10-6,,NR,0.85,'-,[0.78-0.92],"RN7SKP179, NAB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,2:190567413
rs3087243-<b>A</b>,6 x 10-6,,NR,0.879,'-,[0.82-0.94],"CTLA4, ICOS",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,2:203874196
rs438613-<b>C</b>,6 x 10-8,,NR,1.125,'-,[1.08-1.17],LINC01967,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,3:28030595
rs6927090-<b>T</b>,3 x 10-10,,NR,1.233,'-,[1.17-1.3],DUSP22,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,6:252145
rs9387400-<b>A</b>,3 x 10-8,,NR,0.743,'-,[0.64-0.85],DSE,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,6:116372957
rs13260060-<b>A</b>,2 x 10-8,,NR,0.889,'-,[0.85-0.93],NCOA2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,8:70306125
rs2445610-<b>G</b>,5 x 10-8,,NR,0.886,'-,[0.84-0.93],"CASC19, PCAT1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,8:127184843
rs7815944-<b>G</b>,2 x 10-9,,NR,0.862,'-,[0.81-0.91],LINC00824,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,8:128415272
rs4745876-<b>A</b>,1 x 10-6,,NR,0.876,'-,[0.82-0.93],ALDH7A1P4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,10:62665366
rs10999979-<b>A</b>,1 x 10-7,,NR,1.163,'-,[1.11-1.22],CDH23,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,10:71741309
rs7975703-<b>T</b>,1 x 10-6,,NR,0.869,'-,[0.81-0.93],CABP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,12:120661499
rs76725306-<b>A</b>,1 x 10-6,,NR,1.15,'-,[1.09-1.21],"RCBTB1, ARL11",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,13:49603317
rs1885889-<b>G</b>,8 x 10-10,,NR,0.87,'-,[0.82-0.92],"CCR12P, TM9SF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,13:99439046
rs405858-<b>T</b>,2 x 10-8,,NR,0.872,'-,[0.82-0.92],ANKRD27,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,19:32615715
rs3760667-<b>T</b>,1 x 10-6,,NR,0.863,'-,[0.8-0.92],SLC6A16,Systemic lupus erythematosus,systemic lupus erythematosus,GCST90011866,19:49311575
rs3795310-<b>T</b>,8 x 10-6,,NR,0.882,'-,[0.83-0.94],RERE,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,1:8371547
rs28411034-<b>A</b>,6 x 10-6,,NR,0.866,'-,[0.8-0.93],MTF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,1:37811325
rs6702599-<b>C</b>,2 x 10-8,,NR,0.821,'-,[0.75-0.89],IL12RB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,1:67359716
rs9630991-<b>A</b>,7 x 10-9,,NR,0.851,'-,[0.8-0.91],"RN7SKP179, NAB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,2:190567413
rs12148050-<b>G</b>,1 x 10-6,,NR,0.869,'-,[0.81-0.93],TRAF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,14:102797451
rs9899849-<b>A</b>,1 x 10-8,,NR,1.209,'-,[1.14-1.27],"ACAP1, NEURL4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,17:7331664
rs13344313-<b>A</b>,2 x 10-6,,NR,0.862,'-,[0.8-0.92],"SSBP4, LRRC25",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,19:18406957
rs10419308-<b>A</b>,2 x 10-7,,NR,0.827,'-,[0.75-0.9],TMEM86B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011097,19:55228445
rs1016140-<b>T</b>,1 x 10-8,,NR,0.89,'-,[0.85-0.93],"CD58, NAP1L4P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:116533925
rs10419308-<b>A</b>,4 x 10-8,,NR,0.84,'-,[0.78-0.9],TMEM86B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,19:55228445
rs10999979-<b>A</b>,5 x 10-8,,NR,1.17,'-,[1.12-1.22],CDH23,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,10:71741309
rs11264750-<b>G</b>,9 x 10-13,,NR,0.75,'-,[0.67-0.83],FCRL5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:157527370
rs11679484-<b>A</b>,6 x 10-8,,NR,1.12,'-,[1.08-1.16],PLCL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,2:198056880
rs12093154-<b>A</b>,3 x 10-9,,NR,0.84,'-,[0.78-0.9],C1QTNF12,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:1243545
rs12148050-<b>G</b>,3 x 10-8,,NR,0.91,'-,[0.87-0.95],TRAF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,14:102797451
rs13260060-<b>A</b>,8 x 10-8,,NR,0.9,'-,[0.86-0.94],NCOA2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,8:70306125
rs13344313-<b>A</b>,1 x 10-10,,NR,0.86,'-,[0.81-0.91],"SSBP4, LRRC25",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,19:18406957
rs1405209-<b>C</b>,2 x 10-8,,NR,1.11,'-,[1.07-1.15],"STX17-AS1, NR4A3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,9:99823263
rs1547624-<b>T</b>,2 x 10-7,,NR,1.13,'-,[1.08-1.18],RGS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:192574707
rs1885889-<b>G</b>,2 x 10-13,,NR,0.87,'-,[0.83-0.91],"CCR12P, TM9SF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,13:99439046
rs2381401-<b>T</b>,2 x 10-9,,NR,1.15,'-,[1.1-1.2],ARHGAP15,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,2:143263405
rs2384991-<b>C</b>,5 x 10-8,,NR,1.11,'-,[1.07-1.15],"IQCN, JUND",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,19:18275824
rs2445610-<b>G</b>,3 x 10-7,,NR,0.91,'-,[0.87-0.95],"CASC19, PCAT1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,8:127184843
rs28411034-<b>A</b>,2 x 10-10,,NR,0.86,'-,[0.81-0.91],MTF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:37811325
rs3087243-<b>A</b>,2 x 10-8,,NR,0.89,'-,[0.85-0.93],"CTLA4, ICOS",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,2:203874196
rs3760667-<b>T</b>,2 x 10-9,,NR,0.87,'-,[0.82-0.92],SLC6A16,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,19:49311575
rs3795310-<b>T</b>,3 x 10-8,,NR,0.88,'-,[0.83-0.93],RERE,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:8371547
rs405858-<b>T</b>,2 x 10-9,,NR,0.89,'-,[0.85-0.93],ANKRD27,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,19:32615715
rs438613-<b>C</b>,1 x 10-8,,NR,1.1,'-,[1.07-1.13],LINC01967,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,3:28030595
rs4690055-<b>A</b>,5 x 10-8,,NR,0.91,'-,[0.87-0.95],TNIP2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,4:2746936
rs4697651-<b>T</b>,6 x 10-8,,NR,0.88,'-,[0.83-0.93],"LINC02498, CLNK",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,4:10719809
rs4745876-<b>A</b>,4 x 10-8,,NR,0.88,'-,[0.83-0.93],ALDH7A1P4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,10:62665366
rs4978037-<b>C</b>,6 x 10-8,,NR,1.12,'-,[1.08-1.16],"IFNA17, IFNWP5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,9:21228424
rs549669428-<b>G</b>,5 x 10-8,,NR,0.84,'-,[0.78-0.9],RABGAP1L,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:174925885
rs6074813-<b>T</b>,3 x 10-8,,NR,1.12,'-,[1.08-1.16],"SIRPB1, SIRPD",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,20:1561106
rs6702599-<b>C</b>,3 x 10-9,,NR,0.84,'-,[0.78-0.9],IL12RB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,1:67359716
rs6871748-<b>C</b>,4 x 10-8,,NR,0.89,'-,[0.85-0.93],"IL7R, CAPSL",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,5:35885880
rs76725306-<b>A</b>,4 x 10-8,,NR,1.16,'-,[1.11-1.21],"RCBTB1, ARL11",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,13:49603317
rs7815944-<b>G</b>,2 x 10-9,,NR,0.87,'-,[0.82-0.92],LINC00824,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,8:128415272
rs7975703-<b>T</b>,3 x 10-8,,NR,0.88,'-,[0.84-0.92],CABP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,12:120661499
rs869310-<b>G</b>,2 x 10-8,,NR,0.88,'-,[0.83-0.93],"HMG20A, LINGO1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,15:77537964
rs9387400-<b>A</b>,6 x 10-6,,NR,0.89,'-,[0.84-0.94],DSE,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,6:116372957
rs9630991-<b>A</b>,1 x 10-13,,NR,0.85,'-,[0.81-0.89],"RN7SKP179, NAB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011096,2:190567413
rs9271366-<b>G</b>,1 x 10-7,,0.16,1.26,'-,[1.18-1.36],"HLA-DRB1, HLA-DQA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,6:32619077
rs3135394-<b>G</b>,2 x 10-60,,0.1,1.98,'-,[1.84–2.14],HLA-DRA,Systemic lupus erythematosus,systemic lupus erythematosus,GCST004867,6:32440720
rs9603612-<b>?</b>,3 x 10-13,(same effect),'-,1.098901,'-,[NR],COG6,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,13:39760715
rs4921283-<b>?</b>,1 x 10-7,(same effect),'-,1.0752687,'-,[NR],MIR3142HG,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,5:160443604
rs2476601-<b>?</b>,2 x 10-35,(same effect),'-,1.61,'-,[NR],PTPN22,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,1:113834946
rs6568431-<b>?</b>,1 x 10-7,(same effect),'-,1.14,'-,[NR],ATG5,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,6:106140931
rs5029924-<b>?</b>,2 x 10-19,(same effect),'-,1.74,'-,[NR],WAKMAR2,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,6:137866361
rs12531711-<b>?</b>,1 x 10-23,(same effect),'-,1.45,'-,[NR],TNPO3,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,7:128977412
rs2736340-<b>?</b>,9 x 10-12,(same effect),'-,1.21,'-,[NR],"BLK, FAM167A",Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,8:11486464
rs7258015-<b>?</b>,3 x 10-8,(same effect),'-,1.18,'-,[NR],ICAM3,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,19:10338682
rs2283790-<b>?</b>,2 x 10-11,(same effect),'-,1.22,'-,[NR],UBE2L3,Systemic lupus erythematosus or rheumatoid arthritis,"rheumatoid arthritis, systemic lupus erythematosus",GCST003620,22:21602364
rs111994823-<b>T</b>,3 x 10-11,,0.964,1.409,'-,[1.31-1.51],"FCGR2A, RNU6-481P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:161500484
rs75773410-<b>A</b>,4 x 10-15,,0.923,0.774,'-,[0.71-0.84],"FCGR2B, FCGR3B",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:161656008
rs117278480-<b>A</b>,2 x 10-52,,0.913,0.649,'-,[0.59-0.7],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:173241650
rs66977652-<b>T</b>,8 x 10-11,,0.623,0.907,'-,[0.88-0.94],"SMG7, NCF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:183571081
rs71403211-<b>T</b>,3 x 10-49,,0.884,1.462,'-,[1.41-1.51],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:191084261
rs115267018-<b>C</b>,9 x 10-11,,0.134,0.85,'-,[0.8-0.9],"VDAC1, TCF7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:134085418
rs4458721-<b>T</b>,3 x 10-10,,0.249,1.181,'-,[1.13-1.23],"HCP5, LINC01149",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31448075
rs3115674-<b>T</b>,1 x 10-8,,0.983,0.652,'-,[0.51-0.8],"HSPA1B, SNHG32",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31831299
rs554383943-<b>C</b>,2 x 10-13,,0.986,3.634,'-,[3.29-3.98],CYP21A1P,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32007481
rs9281714-<b>T</b>,2 x 10-6,,0.974,1.419,'-,[1.28-1.56],TSBP1-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32286483
rs9268989-<b>A</b>,6 x 10-14,,0.378,0.856,'-,[0.81-0.9],HLA-DRB9,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32467772
rs9269029-<b>A</b>,2 x 10-8,,0.176,0.866,'-,[0.82-0.92],HLA-DRB9,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32469767
rs34452045-<b>G</b>,3 x 10-31,,0.145,0.694,'-,[0.63-0.75],"HLA-DRB5, HLA-DRB9",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32474342
chr6:32449301-<b>?</b>,8 x 10-37,,0.128,0.616,'-,[0.54-0.69],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,Mapping not available
rs9269207-<b>T</b>,6 x 10-48,,0.622,0.754,'-,[0.72-0.79],"HLA-DRB5, HLA-DRB9",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32482119
rs9269233-<b>A</b>,3 x 10-11,,0.23,1.17,'-,[1.12-1.22],"HLA-DRB5, HLA-DRB9",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32483985
rs9270371-<b>T</b>,4 x 10-6,,0.306,0.886,'-,[0.84-0.94],"HLA-DRB1, HLA-DQA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32590413
rs2647078-<b>C</b>,9 x 10-21,,0.806,0.803,'-,[0.76-0.85],"HLA-DQA1, HLA-DRB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32598319
rs1966002-<b>T</b>,8 x 10-31,,0.454,1.337,'-,[1.29-1.39],"HLA-DQA1, HLA-DRB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32613907
rs189311301-<b>C</b>,3 x 10-10,,0.991,2.233,'-,[1.98-2.48],"MTCO3P1, HLA-DQB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32688139
rs17206287-<b>A</b>,2 x 10-12,,0.858,1.2,'-,[1.15-1.25],MTCO3P1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32706948
rs3135461-<b>A</b>,2 x 10-39,,0.841,0.726,'-,[0.68-0.77],"HLA-DQB3, MTCO3P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32712345
rs574879686-<b>A</b>,1 x 10-6,,0.018,0.701,'-,[0.56-0.84],"HLA-DQB2, HLA-DOB",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32781712
rs115910061-<b>T</b>,5 x 10-12,,0.059,0.721,'-,[0.63-0.81],"HLA-DPA1, HLA-DPB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:33076238
rs56285849-<b>T</b>,9 x 10-8,,0.956,1.35,'-,[1.24-1.46],"RAB44, CPNE5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:36736516
rs1059312-<b>?</b>,7 x 10-10,,NR,1.12,'-,[1.07-1.16],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,12:128794319
rs10795763-<b>?</b>,2 x 10-6,,NR,1.098901,'-,[1.06-1.15],IL2RA,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,10:6054236
rs10857635-<b>?</b>,7 x 10-10,,NR,1.1627907,'-,[1.1-1.22],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,10:48766611
rs10892286-<b>?</b>,2 x 10-6,,NR,1.1363636,'-,[1.08-1.2],DDX6,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,11:118771376
rs11117433-<b>?</b>,2 x 10-11,,NR,1.1764705,'-,[1.11-1.25],"LINC02132, LINC01081",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:85985910
rs11154801-<b>?</b>,4 x 10-7,,NR,1.11,'-,[1.06-1.16],AHI1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:135418217
rs1131665-<b>?</b>,9 x 10-21,,NR,1.1904762,'-,[1.15-1.23],IRF7,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,11:613208
rs1150755-<b>?</b>,6 x 10-117,,NR,1.3,'-,[1.19-1.41],TNXB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:32070773
rs1151988-<b>?</b>,9 x 10-6,,NR,1.1111112,'-,[1.05-1.16],"PPARG, TSEN2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:12470013
rs11629434-<b>?</b>,2 x 10-6,,NR,1.4285715,'-,[1.19-1.69],DPF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,14:72783972
rs11724582-<b>?</b>,2 x 10-8,,NR,1.1363636,'-,[1.08-1.19],IL2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,4:122470309
rs117846724-<b>?</b>,7 x 10-6,,NR,1.24,'-,[1.11-1.39],"ALDH7A1P4, ADO",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,10:62745326
rs212407-<b>?</b>,2 x 10-6,,NR,1.098901,'-,[1.05-1.14],TAGAP-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:159049385
rs2205960-<b>?</b>,1 x 10-30,,NR,1.3,'-,[1.23-1.38],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:173222336
rs2238573-<b>?</b>,6 x 10-6,,NR,1.1494253,'-,[1.08-1.22],ARID3A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,19:945013
rs2431098-<b>?</b>,3 x 10-21,,NR,1.19,'-,[1.14-1.23],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:160460329
rs2476601-<b>?</b>,1 x 10-24,,NR,1.42,'-,[1.28-1.57],PTPN22,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:113834946
rs2550333-<b>?</b>,3 x 10-6,,NR,1.13,'-,[1.07-1.18],CCDC113,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:58233568
rs11788118-<b>?</b>,2 x 10-8,,NR,1.1363636,'-,[1.09-1.19],STX17-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,9:99575049
rs12068671-<b>?</b>,7 x 10-8,,NR,1.1363636,'-,[1.09-1.19],"FASLG, SLC25A38P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:172711891
rs12574073-<b>?</b>,3 x 10-14,,NR,1.24,'-,[1.17-1.32],"ETS1, UBASH3B",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,11:128449583
rs12615624-<b>?</b>,4 x 10-7,,NR,1.1111112,'-,[1.08-1.16],DARS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:135964033
rs12636784-<b>?</b>,1 x 10-11,,NR,1.25,'-,[1.16-1.35],TMEM39A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:119455536
rs12664535-<b>?</b>,6 x 10-7,,NR,1.09,'-,[1.05-1.13],"RAB23, PRIM2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:57312868
rs13280095-<b>?</b>,2 x 10-7,,NR,1.098901,'-,[1.05-1.14],PVT1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:128166844
rs13344313-<b>?</b>,1 x 10-8,,NR,1.1111112,'-,[1.08-1.16],"SSBP4, LRRC25",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,19:18406957
rs13385731-<b>?</b>,1 x 10-6,,NR,1.2048193,'-,[1.11-1.3],RASGRP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:33476823
rs137956-<b>?</b>,5 x 10-8,,NR,1.1363636,'-,[1.09-1.19],"GRAP2, ENTHD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,22:39897459
rs1432296-<b>?</b>,1 x 10-8,,NR,1.18,'-,[1.10-1.26],LINC01185,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:60841032
rs1437466-<b>?</b>,5 x 10-6,,NR,1.1,'-,[1.06-1.14],"DNAJB12P1, SPRED2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:65437216
rs169080-<b>?</b>,1 x 10-6,,NR,1.0869565,'-,[1.05-1.14],KDM4B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,19:4980853
rs17484292-<b>?</b>,1 x 10-37,,NR,1.59,'-,[1.40-1.79],NMNAT2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:183330915
rs1749792-<b>?</b>,4 x 10-11,,NR,1.14,'-,[1.10-1.19],"ZFP90, RNU4-36P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:68535537
rs17630235-<b>?</b>,3 x 10-7,,NR,1.12,'-,[1.06-1.18],"TRAFD1, HECTD4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,12:112153882
rs1800797-<b>?</b>,8 x 10-6,,NR,1.1235955,'-,[1.06-1.19],"IL6-AS1, IL6, STEAP1B",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:22726602
rs1801274-<b>?</b>,2 x 10-14,,NR,1.16,'-,[1.11-1.20],FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:161509955
rs2041670-<b>?</b>,2 x 10-16,,NR,1.1764705,'-,[1.12-1.22],CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:11080795
rs2061831-<b>?</b>,1 x 10-40,,NR,1.31,'-,[1.25-1.37],"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:11482373
rs2111485-<b>?</b>,5 x 10-12,,NR,1.1363636,'-,[1.09-1.18],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
rs2953898-<b>?</b>,4 x 10-8,,NR,1.1904762,'-,[1.11-1.27],RPS20,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:56068244
rs2955587-<b>?</b>,6 x 10-10,,NR,1.11,'-,[1.06-1.17],"ALG1L13P, FAM86B3P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:8240557
rs2984920-<b>?</b>,2 x 10-6,,NR,1.1627907,'-,[1.09-1.23],RGS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:192575665
rs3024493-<b>?</b>,2 x 10-13,,NR,1.25,'-,[1.16-1.35],IL10,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:206770623
rs34536443-<b>?</b>,2 x 10-25,,NR,2.1276596,'-,[1.75-2.63],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
rs34572943-<b>?</b>,9 x 10-85,,NR,1.68,'-,[1.59-1.78],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:31261032
rs34840245-<b>?</b>,2 x 10-11,,NR,1.2,'-,[1.14-1.27],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:34844924
rs35000415-<b>?</b>,1 x 10-99,,NR,1.82,'-,[1.69-1.96],IRF5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:128945562
rs353592-<b>?</b>,1 x 10-8,,NR,1.1235955,'-,[1.08-1.18],"PDHX, CD44",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,11:35097935
rs3733345-<b>?</b>,2 x 10-11,,NR,1.1235955,'-,[1.09-1.18],DGKQ,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,4:960459
rs376072-<b>?</b>,5 x 10-6,,NR,1.1235955,'-,[1.06-1.18],LINC01967,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:28034792
rs4921230-<b>?</b>,7 x 10-6,(Hispanic),NR,1.3513513,'-,[1.19-1.54],LINC01845,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:159453388
rs6681482-<b>?</b>,8 x 10-7,(AA),NR,1.369863,'-,[1.2-1.56],PRDX6-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:173337507
rs1874252-<b>?</b>,9 x 10-6,(Hispanic),NR,1.369863,'-,[1.19-1.56],LINC02694,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,15:38670555
rs2092540-<b>?</b>,9 x 10-6,(Hispanic),NR,1.369863,'-,[1.19-1.59],"RSPH3, TAGAP-AS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:158995412
rs12107036-<b>?</b>,2 x 10-6,(Hispanic),NR,1.3888888,'-,[1.2-1.59],TP63,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:189882371
rs17552904-<b>?</b>,1 x 10-6,(AA),NR,1.4492754,'-,[1.25-1.69],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:50278712
rs2041862-<b>?</b>,2 x 10-7,(Hispanic),NR,1.5151515,'-,[1.3-1.75],IFNG-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,12:68067917
rs116165318-<b>?</b>,2 x 10-6,(Hispanic),NR,1.5625,'-,[1.3-1.89],PXK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:58380290
rs112047269-<b>?</b>,1 x 10-6,(Hispanic),NR,1.5873016,'-,[1.32-1.92],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:185151747
rs17881940-<b>?</b>,3 x 10-6,(Hispanic),NR,1.6393442,'-,[1.33-2.04],STAT3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,17:42324649
rs17005500-<b>?</b>,2 x 10-7,(Hispanic),NR,1.724138,'-,[1.41-2.13],SYT1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,12:79345104
rs8054198-<b>?</b>,2 x 10-8,(Hispanic),NR,2.7777777,'-,[1.96-4],"CLEC16A, CIITA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:10944503
rs11845506-<b>?</b>,5 x 10-10,(Hispanic),NR,5,'-,[3.03-8.33],GALC,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,14:87916691
DQA1*01:05-<b>?</b>,1 x 10-11,(AA),NR,5.263158,'-,[3.23-8.33],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
A*31:01-<b>?</b>,6 x 10-9,(HA),NR,1.724138,'-,[1.45-2.08],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
A*01:01-<b>?</b>,2 x 10-39,,NR,1.4,'-,[1.29-1.52],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
B*08:01-<b>?</b>,9 x 10-105,,NR,1.94,'-,[1.73-2.18],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
B*18:01-<b>?</b>,7 x 10-7,,NR,1.25,'-,[1.09-1.43],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
B*44:02-<b>?</b>,1 x 10-12,,NR,1.2658228,'-,[1.12-1.41],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
C*06:02-<b>?</b>,1 x 10-6,,NR,1.1627907,'-,[1.08-1.27],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
C*07:01-<b>?</b>,6 x 10-74,,NR,1.47,'-,[1.39-1.57],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
C*16:01-<b>?</b>,5 x 10-6,,NR,1.2195122,'-,[1.1-1.33],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DPB1*01:01-<b>?</b>,2 x 10-12,,NR,1.25,'-,[1.16-1.35],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*01:01-<b>?</b>,3 x 10-25,,NR,1.4705882,'-,[1.33-1.61],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*01:02-<b>?</b>,7 x 10-41,,NR,1.41,'-,[1.34-1.49],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*01:03-<b>?</b>,6 x 10-6,,NR,1.1363636,'-,[1.01-1.3],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*01:04-<b>?</b>,2 x 10-13,,NR,1.9607843,'-,[1.59-2.44],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*02:01-<b>?</b>,3 x 10-14,,NR,1.2195122,'-,[1.14-1.3],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*03:01-<b>?</b>,2 x 10-14,,NR,1.4492754,'-,[1.28-1.61],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*03:03-<b>?</b>,2 x 10-12,,NR,1.369863,'-,[1.18-1.59],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*05:01-<b>?</b>,9 x 10-112,,NR,1.74,'-,[1.63-1.86],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQA1*05:05-<b>?</b>,4 x 10-18,,NR,1.2820514,'-,[1.16-1.43],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*02:01-<b>?</b>,1 x 10-110,,NR,1.75,'-,[1.63-1.89],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*03:01-<b>?</b>,2 x 10-25,,NR,1.25,'-,[1.18-1.35],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*03:02-<b>?</b>,5 x 10-15,,NR,1.4084507,'-,[1.28-1.54],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*03:03-<b>?</b>,2 x 10-12,,NR,1.4492754,'-,[1.28-1.64],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*05:01-<b>?</b>,4 x 10-25,,NR,1.3333333,'-,[1.25-1.41],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*05:03-<b>?</b>,1 x 10-11,,NR,1.6129031,'-,[1.22-2.13],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DQB1*06:02-<b>?</b>,6 x 10-45,,NR,1.56,'-,[1.46-1.66],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*01:01-<b>?</b>,4 x 10-17,,NR,1.6666665,'-,[1.41-1.96],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*01:02-<b>?</b>,5 x 10-10,,NR,1.6666665,'-,[1.41-1.96],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*03:01-<b>?</b>,2 x 10-109,,NR,1.73,'-,[1.60-1.87],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*04:01-<b>?</b>,2 x 10-15,,NR,2.0408163,'-,[1.56-2.63],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*04:03-<b>?</b>,6 x 10-6,,NR,3.030303,'-,[1.89-4.76],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*04:04-<b>?</b>,7 x 10-7,,NR,1.5625,'-,[1.32-1.85],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*04:07-<b>?</b>,8 x 10-7,,NR,1.923077,'-,[1.47-2.5],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*07:01-<b>?</b>,8 x 10-14,,NR,1.2048193,'-,[1.12-1.3],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*11:01-<b>?</b>,5 x 10-13,,NR,1.6949153,'-,[1.45-2],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*11:04-<b>?</b>,7 x 10-7,,NR,2,'-,[1.39-2.86],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*12:01-<b>?</b>,3 x 10-17,,NR,2.3255813,'-,[1.85-2.94],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
rs2688608-<b>?</b>,7 x 10-6,,NR,1.1904762,'-,[1.11-1.3],"CAMK2G, PLAU",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,10:73898591
rs9652601-<b>?</b>,6 x 10-13,,NR,1.1904762,'-,[1.14-1.25],CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,16:11080508
rs2431697-<b>?</b>,4 x 10-14,,NR,1.1904762,'-,[1.14-1.23],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,5:160452971
rs2663054-<b>?</b>,1 x 10-8,,NR,1.2048193,'-,[1.14-1.28],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,10:48893932
rs11117431-<b>?</b>,6 x 10-11,,NR,1.2195122,'-,[1.15-1.28],LINC02132,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,16:85981710
rs112006329-<b>?</b>,1 x 10-16,,NR,1.2345679,'-,[1.18-1.3],CDHR5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,11:617228
rs4426778-<b>?</b>,1 x 10-12,,NR,1.2658228,'-,[1.19-1.35],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,4:101859567
rs34725611-<b>?</b>,5 x 10-23,,NR,1.2820514,'-,[1.22-1.35],TYK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,19:10366391
rs147622113-<b>?</b>,7 x 10-6,,NR,1.369863,'-,[1.19-1.56],ILF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,19:10661265
B*57:01-<b>?</b>,4 x 10-6,,NR,1.369863,'-,[1.19-1.56],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
C*08:02-<b>?</b>,6 x 10-6,,NR,1.3513513,'-,[1.19-1.56],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
DQB1*02:02-<b>?</b>,4 x 10-7,,NR,1.2345679,'-,[1.14-1.33],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
DQB1*06:03-<b>?</b>,5 x 10-6,,NR,1.2820514,'-,[1.15-1.43],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
B*27:05-<b>?</b>,3 x 10-6,,NR,1.3513513,'-,[1.19-1.54],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
rs1143679-<b>?</b>,3 x 10-62,,NR,1.72,'-,[1.61-1.83],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,16:31265490
rs6679677-<b>?</b>,2 x 10-23,,NR,1.41,'-,[1.32-1.51],"RSBN1, PHTF1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:113761186
rs2736336-<b>?</b>,6 x 10-32,,NR,1.34,'-,[1.28-1.41],"FAM167A, BLK",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,8:11484361
rs7249065-<b>?</b>,9 x 10-6,,NR,1.3,'-,[1.16-1.45],SBNO2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,19:1112944
rs180977001-<b>?</b>,2 x 10-8,,NR,1.27,'-,[1.17-1.39],"PXK, RPP14",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,3:58332737
rs12575600-<b>?</b>,6 x 10-10,,NR,1.24,'-,[1.16-1.33],ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,11:128454974
C*05:01-<b>?</b>,9 x 10-9,,NR,1.2658228,'-,[1.16-1.37],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
rs223889-<b>?</b>,1 x 10-8,,NR,1.21,'-,[1.13-1.29],"RPL23AP91, CCL22",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:57358329
rs6662618-<b>?</b>,1 x 10-7,,NR,1.14,'-,[1.08-1.21],"RN7SL824P, GFI1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:92469854
rs10036748-<b>?</b>,2 x 10-34,,NR,1.27,'-,[1.22-1.33],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:151078585
rs1039917-<b>?</b>,3 x 10-7,,NR,1.09,'-,[1.05-1.15],MFHAS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:8861340
rs7325747-<b>?</b>,4 x 10-6,,NR,1.5384616,'-,[1.27-1.89],UBAC2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,13:99377678
rs73366469-<b>?</b>,3 x 10-14,,NR,1.22,'-,[1.15-1.30],"GTF2I, GTF2IRD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:74619286
rs7444-<b>?</b>,1 x 10-20,,NR,1.2,'-,[1.15-1.24],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,22:21622645
rs74936631-<b>?</b>,1 x 10-6,,NR,1.32,'-,[1.09-1.60],"RPS29P10, RNU6-1145P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:61594642
rs7568275-<b>?</b>,1 x 10-77,,NR,1.42,'-,[1.36-1.48],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:191101726
rs7579944-<b>?</b>,5 x 10-8,,NR,1.1111112,'-,[1.08-1.16],"H3P5, LBH",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:30222160
rs7597017-<b>?</b>,4 x 10-6,,NR,1.0752687,'-,[1.03-1.12],IL18RAP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:102445656
rs7726414-<b>?</b>,7 x 10-7,,NR,1.19,'-,[1.11-1.27],"VDAC1, TCF7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:134096143
rs7795074-<b>?</b>,2 x 10-7,,NR,1.1235955,'-,[1.08-1.16],SKAP2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:26702535
rs8058578-<b>?</b>,2 x 10-6,,NR,1.11,'-,[1.06-1.16],SRCAP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:30714927
rs8072449-<b>?</b>,1 x 10-11,,NR,1.1904762,'-,[1.12-1.25],"GRB2, SLC25A19",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,17:75316103
rs8192282-<b>?</b>,4 x 10-6,,NR,1.1494253,'-,[1.09-1.23],IL6R,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:154429203
rs835573-<b>?</b>,2 x 10-7,,NR,1.13,'-,[1.08-1.18],NOTCH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:119921542
rs909788-<b>?</b>,1 x 10-7,,NR,1.1,'-,[1.06-1.15],ATXN1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:16636230
rs911263-<b>?</b>,3 x 10-8,,NR,1.1235955,'-,[1.08-1.18],RAD51B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,14:68286876
rs9373839-<b>?</b>,4 x 10-15,,NR,1.19,'-,[1.12-1.26],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:106207742
rs9852465-<b>?</b>,2 x 10-8,,NR,1.1,'-,[1.06-1.15],"PDHB, KCTD6",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:58479456
rs17849502-<b>?</b>,6 x 10-11,(Hispanic),NR,1.95,'-,[1.59-2.38],"NCF2, SMG7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:183563445
rs1804182-<b>?</b>,3 x 10-8,(AA),NR,1.94,'-,[1.53-2.45],PLAT,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:42176001
rs12928725-<b>?</b>,7 x 10-22,(Hispanic),NR,1.94,'-,[1.70-2.23],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:31272675
rs3757387-<b>?</b>,8 x 10-33,(Hispanic),NR,1.71,'-,[1.56-1.87],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:128936032
rs61839660-<b>?</b>,9 x 10-6,(Hispanic),NR,1.64,'-,[1.32-2.04],IL2RA,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,10:6052734
rs73846279-<b>?</b>,5 x 10-7,(Hispanic),NR,1.57,'-,[1.32-1.88],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:89842195
rs1143679-<b>?</b>,2 x 10-13,(AA),NR,1.54,'-,[1.37-1.73],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:31265490
rs11889341-<b>?</b>,6 x 10-16,(Hispanic),NR,1.48,'-,[1.34-1.63],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:191079016
rs3828069-<b>?</b>,2 x 10-9,,NR,1.1764705,'-,[1.11-1.27],IL12RB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:67373890
rs4252665-<b>?</b>,2 x 10-12,,NR,1.46,'-,[1.26-1.70],"MIEN1, ERBB2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,17:39729130
rs4355385-<b>?</b>,3 x 10-6,,NR,1.33,'-,[1.19-1.50],CLNK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,4:10565335
rs4382707-<b>?</b>,5 x 10-7,,NR,1.31,'-,[1.15-1.48],RSL24D1P4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:242802070
rs461193-<b>?</b>,1 x 10-7,,NR,1.13,'-,[1.08-1.18],LINC01511,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:1368882
rs4637409-<b>?</b>,1 x 10-17,,NR,1.1904762,'-,[1.15-1.25],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,4:101832251
rs4675354-<b>?</b>,4 x 10-6,,NR,1.21,'-,[1.11-1.31],"CD28, RAPH1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:203606750
rs4739134-<b>?</b>,3 x 10-8,,NR,1.12,'-,[1.07-1.17],"ZC2HC1A, PKIA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:78643913
rs4810485-<b>?</b>,1 x 10-8,,NR,1.43,'-,[1.17-1.76],CD40,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,20:46119308
rs489574-<b>?</b>,7 x 10-6,,NR,1.1111112,'-,[1.06-1.15],AP5B1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,11:65775268
rs4917014-<b>?</b>,3 x 10-14,,NR,1.2048193,'-,[1.14-1.27],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:50266267
rs5029939-<b>?</b>,5 x 10-29,,NR,1.48,'-,[1.38-1.60],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:137874586
rs56154925-<b>?</b>,2 x 10-8,,NR,1.1363636,'-,[1.09-1.19],"PTPRH, TMEM86B",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,19:55226430
rs564976-<b>?</b>,1 x 10-10,,NR,1.1235955,'-,[1.08-1.16],IL12A-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:160011272
rs586995-<b>?</b>,8 x 10-7,,NR,1.41,'-,[1.23-1.63],CEPT1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:111149818
rs653178-<b>?</b>,7 x 10-9,,NR,1.14,'-,[1.08-1.20],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
rs6601327-<b>?</b>,1 x 10-7,,NR,1.1,'-,[1.06-1.14],TNKS,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:9538022
rs6603785-<b>?</b>,9 x 10-6,,NR,1.1111112,'-,[1.05-1.16],"UBE2J2, C1QTNF12",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:1251122
rs6677604-<b>?</b>,6 x 10-6,,NR,1.12,'-,[1.07-1.17],CFH,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:196717788
rs6688100-<b>?</b>,4 x 10-6,,NR,1.098901,'-,[1.05-1.15],"SLAMF6, VANGL2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:160429796
rs6738825-<b>?</b>,2 x 10-7,,NR,1.098901,'-,[1.05-1.14],PLCL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,2:198032171
rs6869688-<b>?</b>,4 x 10-7,,NR,1.1494253,'-,[1.08-1.22],LINC01845,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:159456019
rs6886392-<b>?</b>,4 x 10-9,,NR,1.13,'-,[1.08-1.18],"RN7SKP62, ST8SIA4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:100800161
rs6945305-<b>?</b>,1 x 10-6,,NR,1.2,'-,[1.10-1.30],ICA1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:8136157
rs702814-<b>?</b>,2 x 10-11,,NR,1.15,'-,[1.10-1.20],JAZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:28133113
rs1131265-<b>?</b>,1 x 10-9,,NR,1.2345679,'-,[1.15-1.32],TIMMDC1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,3:119503609
rs115268109-<b>?</b>,2 x 10-7,,NR,1.31,'-,[1.18-1.45],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,Mapping not available
rs1170436-<b>?</b>,9 x 10-7,,NR,1.17,'-,[1.10-1.25],ZFP90,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,16:68573583
rs10819689-<b>?</b>,9 x 10-7,,NR,1.1494253,'-,[1.09-1.20],STX17-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,9:99637981
rs10905718-<b>?</b>,4 x 10-6,,NR,1.12,'-,[1.07-1.17],"RBM17, RPL32P23",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,10:6072893
rs11578098-<b>?</b>,5 x 10-7,,NR,1.13,'-,[1.08-1.19],EVI5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:92653853
rs11590283-<b>?</b>,1 x 10-7,,NR,1.1627907,'-,[1.10-1.22],PUSL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:1309988
rs11681718-<b>?</b>,1 x 10-7,,NR,1.1363636,'-,[1.09-1.20],IL18RAP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,2:102434684
rs11887156-<b>?</b>,5 x 10-7,,NR,1.1904762,'-,[1.11-1.28],MGAT5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,2:134308905
rs12156002-<b>?</b>,3 x 10-7,,NR,1.1494253,'-,[1.09-1.22],PVT1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,8:128178298
rs1966115-<b>?</b>,1 x 10-7,,NR,1.14,'-,[1.09-1.20],"ZC2HC1A, PKIA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,8:78644656
rs2196171-<b>?</b>,5 x 10-7,,NR,1.1235955,'-,[1.08-1.18],PLCL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,2:198025083
rs223883-<b>?</b>,2 x 10-7,,NR,1.15,'-,[1.09-1.21],"RPL23AP91, CCL22",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,16:57354818
rs2327832-<b>?</b>,2 x 10-13,,NR,1.22,'-,[1.15-1.28],LINC02539,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:137651931
rs2980512-<b>?</b>,4 x 10-10,,NR,1.15,'-,[1.10-1.20],"PRAG1, FAM86B3P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,8:8283379
rs35789010-<b>?</b>,5 x 10-19,,NR,1.46,'-,[1.35-1.59],CARMIL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:25513951
rs36014129-<b>?</b>,1 x 10-24,,NR,1.5,'-,[1.39-1.62],"H2AC3P, H2BP5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:25884291
rs41264285-<b>?</b>,8 x 10-7,,NR,1.14,'-,[1.08-1.20],ADAM15,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:155061442
rs4690229-<b>?</b>,2 x 10-8,,NR,1.13,'-,[1.09-1.19],DGKQ,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,4:976936
rs62149377-<b>?</b>,9 x 10-8,,NR,1.14,'-,[1.09-1.19],PAPOLG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,2:60759441
rs71567468-<b>?</b>,9 x 10-7,,NR,1.29,'-,[1.17-1.43],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:34848293
rs77000060-<b>?</b>,2 x 10-29,,NR,1.89,'-,[1.69-2.11],"LINC02528, TNFAIP3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:137916852
rs7720046-<b>?</b>,3 x 10-7,,NR,1.1235955,'-,[1.08-1.18],LINC01845,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,5:159457527
rs930297-<b>?</b>,1 x 10-7,,NR,1.2048193,'-,[1.12-1.30],"RNU6-938P, MIR3678",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,17:75408456
rs12971295-<b>?</b>,7 x 10-7,,NR,1.1363636,'-,[1.08-1.19],"LRRC25, SSBP4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,19:18406521
rs2299864-<b>?</b>,6 x 10-15,,NR,1.24,'-,[1.17-1.30],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:106220119
rs12706861-<b>?</b>,4 x 10-71,,NR,1.76,'-,[1.65-1.87],TNPO3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,7:128976528
rs7582694-<b>?</b>,4 x 10-69,,NR,1.56,'-,[1.48-1.64],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,2:191105394
rs131658-<b>?</b>,1 x 10-16,,NR,1.25,'-,[1.19-1.32],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,22:21563337
rs3122605-<b>?</b>,1 x 10-11,,NR,1.23,'-,[1.16-1.30],IL19,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:206781696
rs12129787-<b>?</b>,1 x 10-9,,NR,1.22,'-,[1.14-1.29],FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:161522797
rs11059927-<b>?</b>,2 x 10-8,,NR,1.21,'-,[1.13-1.30],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,12:128809788
rs4610334-<b>?</b>,4 x 10-6,,NR,1.19,'-,[1.10-1.28],SORCS2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,4:7256775
rs2453042-<b>?</b>,7 x 10-6,,NR,1.16,'-,[1.09-1.24],NOTCH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:119986309
rs4859711-<b>?</b>,3 x 10-6,,NR,1.16,'-,[1.09-1.24],"SHROOM3-AS1, SHROOM3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,4:76744126
rs11227302-<b>?</b>,3 x 10-6,,NR,1.15,'-,[1.08-1.21],"AP5B1, OVOL1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,11:65787031
rs10889681-<b>?</b>,1 x 10-6,,NR,1.15,'-,[1.09-1.21],IL12RB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:67333487
rs7819602-<b>?</b>,1 x 10-9,,NR,1.15,'-,[1.10-1.20],"PINX1, XKR6",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,8:10869332
rs9462027-<b>?</b>,2 x 10-8,,NR,1.15,'-,[1.09-1.20],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:34829464
rs10245867-<b>?</b>,4 x 10-8,,NR,1.14,'-,[1.09-1.19],JAZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,7:28102567
rs2548279-<b>?</b>,2 x 10-6,,NR,1.12,'-,[1.07-1.17],ST8SIA4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,5:100841815
rs1378942-<b>?</b>,5 x 10-6,,NR,1.11,'-,[1.06-1.16],CSK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,15:74785026
rs351758-<b>?</b>,4 x 10-6,,NR,1.11,'-,[1.06-1.16],ELP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,8:28171501
rs2015407-<b>?</b>,6 x 10-6,,NR,1.11,'-,[1.06-1.16],TRAF3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,14:102808210
rs4930194-<b>?</b>,4 x 10-6,,NR,1.1111112,'-,[1.06-1.16],"LINC02724, SLC22A11",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,11:64542619
rs2732549-<b>?</b>,1 x 10-6,,NR,1.1111112,'-,[1.06-1.16],"CD44, PDHX",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,11:35066852
rs6131014-<b>?</b>,1 x 10-7,,NR,1.1363636,'-,[1.09-1.19],"CD40, RPL13P2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,20:46108744
rs10798176-<b>?</b>,2 x 10-6,,NR,1.1494253,'-,[1.09-1.22],"FASLG, SLC25A38P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,1:172706385
rs916287-<b>?</b>,6 x 10-6,,NR,1.1627907,'-,[1.09-1.25],ETV7,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,6:36383081
rs7486855-<b>?</b>,3 x 10-6,,NR,1.1627907,'-,[1.09-1.23],IFNG-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST007400,12:68044153
rs3757387-<b>?</b>,1 x 10-17,(AA),NR,1.44,'-,[1.33-1.57],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,7:128936032
rs332398-<b>?</b>,1 x 10-6,(Hispanic),NR,1.44,'-,[1.24-1.67],"FCGR3A, FCGR2C",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:161566341
rs2205960-<b>?</b>,2 x 10-7,(Hispanic),NR,1.42,'-,[1.24-1.62],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,1:173222336
rs9402715-<b>?</b>,5 x 10-6,(Hispanic),NR,1.38,'-,[1.20-1.58],LINC00271,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:135538559
rs2618444-<b>?</b>,7 x 10-9,(AA),NR,1.36,'-,[1.22-1.51],"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:11480861
rs9394274-<b>?</b>,7 x 10-8,(Hispanic),NR,1.34,'-,[1.20-1.49],TCP11,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:35147134
rs1194-<b>?</b>,5 x 10-7,(AA),NR,1.32,'-,[1.19-1.48],ZNF76,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:35295778
rs1170436-<b>?</b>,8 x 10-7,(AA),NR,1.31,'-,[1.18-1.46],ZFP90,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:68573583
rs2731763-<b>?</b>,1 x 10-7,(Hispanic),NR,1.31,'-,[1.19-1.45],CCDC113,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:58246174
rs7708392-<b>?</b>,5 x 10-9,(Hispanic),NR,1.31,'-,[1.20-1.44],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:151077924
rs1127745-<b>?</b>,6 x 10-6,(AA),NR,1.29,'-,[1.16-1.44],ACOX2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,3:58526510
rs3750310-<b>?</b>,8 x 10-6,(Hispanic),NR,1.28,'-,[1.15-1.42],MSRA,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:10425916
rs229541-<b>?</b>,2 x 10-7,(Hispanic),NR,1.27,'-,[1.16-1.39],C1QTNF6,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,22:37195278
rs116356980-<b>?</b>,4 x 10-6,(AA),NR,1.24,'-,[1.13-1.37],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
rs10762171-<b>?</b>,4 x 10-6,(AA),NR,1.22,'-,[1.12-1.33],CTNNA3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,10:67531962
rs56886418-<b>?</b>,2 x 10-6,(AA),NR,1.21,'-,[1.12-1.31],"PRDM1, ATG5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:106090852
rs1590381-<b>?</b>,2 x 10-6,(AA),NR,1.21,'-,[1.12-1.30],"SCUBE3, TCP11",Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,6:35187010
rs10057690-<b>?</b>,3 x 10-6,(AA),NR,1.2,'-,[1.11-1.30],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:151065654
rs9894206-<b>?</b>,2 x 10-6,(AA),NR,1.25,'-,[1.15-1.39],GRB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,17:75364073
rs17266594-<b>?</b>,5 x 10-7,(AA),NR,1.2658228,'-,[1.15-1.39],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,4:101829765
rs1946007-<b>?</b>,7 x 10-6,(AA),NR,1.2820514,'-,[1.15-1.43],ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,11:128413550
rs9889107-<b>?</b>,1 x 10-6,(Hispanic),NR,1.2820514,'-,[1.16-1.41],SBK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,16:28295666
rs2431697-<b>?</b>,1 x 10-12,(AA),NR,1.3157895,'-,[1.22-1.43],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,5:160452971
rs12548184-<b>?</b>,1 x 10-7,(Hispanic),NR,1.3333333,'-,[1.2-1.47],XKR6,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,8:10928562
rs4795774-<b>?</b>,5 x 10-6,(Hispanic),NR,1.3513513,'-,[1.19-1.54],KSR1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,17:27595519
DRB1*13:01-<b>?</b>,2 x 10-7,,NR,1.25,'-,[1.11-1.41],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*14:01-<b>?</b>,1 x 10-11,,NR,1.6949153,'-,[1.22-2.38],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*15:01-<b>?</b>,3 x 10-39,,NR,1.71,'-,[1.53-1.92],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
DRB1*15:03-<b>?</b>,5 x 10-15,,NR,2.87,'-,[1.66-4.96],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST005752,Mapping not available
rs117026326-<b>T</b>,2 x 10-298,,0.175,2.137,'-,[2.1-2.18],GTF2I,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74711703
rs587621258-<b>A</b>,2 x 10-7,,0.008,1.854,'-,[1.62-2.09],POM121C,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:75449782
rs77009341-<b>C</b>,6 x 10-62,,0.037,2.089,'-,[2-2.18],HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:75559377
rs146063533-<b>T</b>,9 x 10-16,,0.028,1.612,'-,[1.5-1.73],HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:75692143
rs3757387-<b>T</b>,9 x 10-79,,0.863,0.693,'-,[0.65-0.73],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:128936032
rs28364822-<b>A</b>,1 x 10-17,,0.028,1.672,'-,[1.55-1.79],TPI1P2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:129055928
rs2736332-<b>C</b>,2 x 10-70,,0.734,1.36,'-,[1.33-1.39],"FAM167A, BLK",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,8:11482456
rs117627999-<b>T</b>,2 x 10-8,,0.083,0.827,'-,[0.76-0.89],IKBKB-DT,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,8:42246722
rs11347613-<b>G</b>,2 x 10-12,,0.368,0.888,'-,[0.85-0.92],NCOA2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,8:70397462
rs10111413-<b>A</b>,3 x 10-9,,0.415,0.918,'-,[0.89-0.95],MSC-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,8:71979513
rs16902895-<b>A</b>,1 x 10-13,,0.678,1.122,'-,[1.09-1.15],LINC00824,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,8:128413347
rs1887428-<b>C</b>,3 x 10-8,,0.664,0.915,'-,[0.88-0.95],JAK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,9:4984530
rs7858766-<b>T</b>,2 x 10-15,,0.538,1.139,'-,[1.11-1.17],"IFNA14, IFNA22P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,9:21267088
rs77448389-<b>A</b>,7 x 10-10,,0.913,0.855,'-,[0.81-0.9],ANKRD16,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:5868783
rs7097397-<b>A</b>,2 x 10-40,,0.651,0.81,'-,[0.78-0.84],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:48817351
rs7902146-<b>T</b>,3 x 10-12,,0.691,0.9,'-,[0.87-0.93],ARID5B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:62041271
rs10995254-<b>T</b>,4 x 10-8,,0.707,1.092,'-,[1.06-1.12],ALDH7A1P4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:62642076
rs10823829-<b>T</b>,1 x 10-9,,0.718,0.91,'-,[0.88-0.94],CDH23,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:71706952
rs11599734-<b>C</b>,6 x 10-8,,0.479,0.918,'-,[0.89-0.95],"NOLC1, ELOVL3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:102203640
rs111447985-<b>A</b>,2 x 10-8,,0.073,1.172,'-,[1.12-1.23],STN1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:103918153
rs58164562-<b>T</b>,3 x 10-12,,0.748,0.892,'-,[0.86-0.92],BBIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:110904356
rs3750996-<b>A</b>,2 x 10-12,,0.834,1.167,'-,[1.12-1.21],STIM1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:4091970
rs77885959-<b>T</b>,3 x 10-17,,0.978,1.694,'-,[1.57-1.82],GTF2H1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:18340835
rs2732540-<b>A</b>,1 x 10-20,,0.224,0.847,'-,[0.81-0.88],"PDHX, CD44",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:35073939
rs10896045-<b>A</b>,7 x 10-26,,0.551,1.168,'-,[1.14-1.2],OVOL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:65788053
rs4930642-<b>A</b>,6 x 10-13,,0.252,1.145,'-,[1.11-1.18],"TPCN2, MRGPRF-AS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:69048902
rs77971648-<b>T</b>,3 x 10-23,,0.909,1.291,'-,[1.24-1.34],FCHSD2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:72929435
rs480958-<b>A</b>,3 x 10-19,,0.624,0.871,'-,[0.84-0.9],"RNU6-376P, DDX6",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:118707281
rs4936441-<b>C</b>,6 x 10-16,,0.137,0.823,'-,[0.78-0.87],"Y_RNA, CXCR5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:118854951
rs11501246-<b>A</b>,2 x 10-58,,0.623,0.791,'-,[0.76-0.82],ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:128444529
rs684150-<b>T</b>,4 x 10-10,,0.381,0.914,'-,[0.89-0.94],FLI1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:128724266
rs2540119-<b>T</b>,4 x 10-8,,0.544,1.086,'-,[1.06-1.12],HSPA8P5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:4031710
rs4251697-<b>A</b>,1 x 10-43,,0.097,0.637,'-,[0.57-0.7],CDKN1B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:12721528
rs4622329-<b>A</b>,4 x 10-15,,0.561,1.119,'-,[1.09-1.15],DRAM1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:101928157
rs6539078-<b>T</b>,9 x 10-14,,0.591,0.894,'-,[0.86-0.92],"LINC02401, C12orf42",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:103522302
rs77465633-<b>A</b>,7 x 10-18,,0.068,1.34,'-,[1.27-1.41],ATXN2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:111495741
rs1131476-<b>A</b>,1 x 10-9,,0.756,1.11,'-,[1.08-1.14],OAS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:112919404
rs7139263-<b>A</b>,1 x 10-7,,0.51,1.083,'-,[1.05-1.11],"KSR2, RFC5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:117991171
rs35743748-<b>CT</b>,2 x 10-9,,0.444,1.101,'-,[1.07-1.13],SPPL3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:120790827
rs11059928-<b>A</b>,2 x 10-30,,0.786,0.823,'-,[0.79-0.86],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:128811558
rs200521476-<b>G</b>,6 x 10-9,,0.812,0.875,'-,[0.83-0.92],FBRSL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:132463597
rs57141708-<b>A</b>,7 x 10-22,,0.224,1.183,'-,[1.15-1.22],ELF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,13:41001255
rs2819426-<b>C</b>,3 x 10-30,,0.331,0.824,'-,[0.79-0.86],AHNAK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,14:104945922
rs7170151-<b>T</b>,3 x 10-12,,0.563,1.107,'-,[1.08-1.14],RASGRP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,15:38554477
rs12900640-<b>A</b>,2 x 10-11,,0.464,1.101,'-,[1.07-1.13],LINC02694,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,15:38682347
rs11553760-<b>T</b>,7 x 10-10,,0.235,1.111,'-,[1.08-1.14],CSK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,15:74798906
rs35985016-<b>A</b>,2 x 10-8,,0.93,0.843,'-,[0.78-0.9],LRRK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,15:100988807
rs34361002-<b>T</b>,1 x 10-17,,0.624,1.14,'-,[1.11-1.17],CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:11096178
rs79401250-<b>T</b>,1 x 10-12,,0.819,1.172,'-,[1.13-1.22],PRKCB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:23860136
rs534645300-<b>A</b>,3 x 10-9,,0.93,0.814,'-,[0.75-0.88],"Metazoa_SRP, ZNF629",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:30802134
rs111508444-<b>A</b>,2 x 10-19,,0.945,1.522,'-,[1.43-1.61],"GABBR1, SUMO2P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:29635735
rs566731348-<b>A</b>,4 x 10-12,,0.951,1.889,'-,[1.71-2.07],MUC22,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31027112
rs2263318-<b>A</b>,1 x 10-19,,0.059,0.597,'-,[0.49-0.71],HCP5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31464229
rs2256974-<b>A</b>,2 x 10-25,,0.375,0.842,'-,[0.81-0.88],LST1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31587615
rs117217736-<b>T</b>,1 x 10-12,,0.991,0.479,'-,[0.28-0.68],"NEU1, SNHG32",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31840951
rs200283861-<b>A</b>,3 x 10-23,,0.277,1.203,'-,[1.17-1.24],C4B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32026946
rs565981183-<b>CA</b>,1 x 10-11,,0.876,1.192,'-,[1.14-1.24],"PRRT1, FKBPL",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32143247
rs368529276-<b>A</b>,4 x 10-19,,0.961,2.522,'-,[2.32-2.72],"TSBP1, TSBP1-AS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32353696
rs9268807-<b>C</b>,5 x 10-117,,0.208,1.604,'-,[1.56-1.65],"HLA-DRB9, HLA-DRA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32456138
rs7753017-<b>A</b>,5 x 10-43,,0.237,0.745,'-,[0.7-0.79],HLA-DQB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32759548
rs1431403-<b>T</b>,1 x 10-22,,0.39,0.848,'-,[0.81-0.88],"HLA-DPB1, HLA-DPA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:33079254
rs3846852-<b>A</b>,4 x 10-6,,0.016,1.364,'-,[1.23-1.5],"SYNGAP1-AS1, SYNGAP1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:33445230
rs554962164-<b>A</b>,5 x 10-7,,0.982,1.964,'-,[1.7-2.23],"MIR1275, MIR7159",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:33987724
rs111658701-<b>T</b>,6 x 10-6,,0.949,1.356,'-,[1.22-1.49],"SMIM29, RPL35P2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:34260788
rs6457796-<b>T</b>,3 x 10-22,,0.864,0.808,'-,[0.76-0.85],UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:34860776
rs10484578-<b>A</b>,4 x 10-14,,0.628,1.131,'-,[1.1-1.16],ZNF76,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:35278542
rs34868004-<b>CA</b>,4 x 10-9,,0.225,1.104,'-,[1.07-1.14],CPNE5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:36747255
rs3857496-<b>T</b>,8 x 10-9,,0.814,1.116,'-,[1.08-1.15],BACH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:90009445
rs597325-<b>A</b>,5 x 10-11,,0.548,0.906,'-,[0.88-0.94],BACH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:90292775
rs548234-<b>T</b>,6 x 10-39,,0.705,0.819,'-,[0.79-0.85],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:106120159
rs9488914-<b>T</b>,1 x 10-8,,0.92,0.862,'-,[0.81-0.91],DSE,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:116369686
rs9494894-<b>T</b>,3 x 10-84,,0.941,0.586,'-,[0.53-0.64],"TNFAIP3, LINC02528",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:137907383
rs9322454-<b>A</b>,2 x 10-8,,0.659,1.09,'-,[1.06-1.12],IPCEF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:154249517
rs62447171-<b>A</b>,9 x 10-60,,0.292,0.767,'-,[0.74-0.8],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:50270294
rs10716716-<b>G</b>,8 x 10-10,,0.159,1.151,'-,[1.11-1.2],EIF4H,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74193613
rs9651076-<b>A</b>,3 x 10-13,,0.431,1.117,'-,[1.09-1.15],"LINC01762, CD58",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:116500680
rs116785379-<b>C</b>,7 x 10-16,,0.107,1.211,'-,[1.16-1.26],ETV3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:157138367
rs112806509-<b>A</b>,2 x 10-15,,0.097,0.812,'-,[0.76-0.86],FCRL5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:157532226
rs12120358-<b>A</b>,3 x 10-11,,0.893,0.842,'-,[0.79-0.89],"FCGR2A, RNU6-481P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:161474579
rs76107698-<b>C</b>,2 x 10-30,,0.254,0.788,'-,[0.75-0.83],FCGR2C,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:161600039
rs2205960-<b>T</b>,3 x 10-90,,0.265,1.368,'-,[1.34-1.4],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:173222336
rs2039982-<b>T</b>,2 x 10-37,,0.656,1.242,'-,[1.21-1.28],PRDX6-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:173390048
rs13306575-<b>A</b>,2 x 10-14,,0.047,1.311,'-,[1.24-1.38],"NCF2, SMG7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:183563302
rs4143303-<b>A</b>,4 x 10-9,,0.14,0.88,'-,[0.84-0.92],PTPRC,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:198701340
rs3806357-<b>A</b>,4 x 10-9,,0.251,1.106,'-,[1.07-1.14],"ELF3-AS1, ELF3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:202010327
rs4844538-<b>A</b>,2 x 10-10,,0.713,1.109,'-,[1.08-1.14],"IKBKE, SRGAP2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:206469377
rs75362385-<b>T</b>,8 x 10-13,,0.321,0.887,'-,[0.85-0.92],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:7432948
rs7579944-<b>T</b>,1 x 10-20,,0.62,0.876,'-,[0.85-0.9],"H3P5, LBH",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:30222160
rs13385731-<b>T</b>,1 x 10-33,,0.86,1.287,'-,[1.25-1.33],RASGRP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:33476823
rs11684155-<b>T</b>,3 x 10-10,,0.775,0.892,'-,[0.86-0.93],SPRED2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:65354166
rs10207954-<b>A</b>,2 x 10-12,,0.823,1.145,'-,[1.11-1.18],TET3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:73989388
rs73954925-<b>C</b>,5 x 10-11,,0.878,1.169,'-,[1.12-1.22],"BCL2L11, ACOXL, MIR4435-2HG",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:111119597
rs218174-<b>A</b>,2 x 10-13,,0.379,1.121,'-,[1.09-1.15],"MANEALP1, DARS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:135900775
rs11679244-<b>A</b>,3 x 10-8,,0.153,1.119,'-,[1.08-1.16],FAP,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:162225885
rs11889341-<b>T</b>,5 x 10-123,,0.348,1.407,'-,[1.38-1.43],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:191079016
rs11684176-<b>T</b>,2 x 10-14,,0.25,1.146,'-,[1.11-1.18],PLCL1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:198090050
rs7565158-<b>T</b>,3 x 10-10,,0.45,1.096,'-,[1.07-1.13],LINC01878,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:212729246
rs2371790-<b>A</b>,6 x 10-9,,0.224,1.107,'-,[1.07-1.14],IKZF2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,2:213019942
rs438613-<b>T</b>,8 x 10-9,,0.588,0.92,'-,[0.89-0.95],LINC01967,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,3:28030595
rs7637844-<b>A</b>,1 x 10-8,,0.871,0.877,'-,[0.83-0.92],"LINC00877, LINC00870",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,3:72176765
rs144104218-<b>A</b>,2 x 10-30,,0.31,0.833,'-,[0.8-0.86],TIMMDC1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,3:119518880
rs1317082-<b>A</b>,2 x 10-11,,0.43,1.102,'-,[1.07-1.13],MYNN,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,3:169779797
rs13101828-<b>A</b>,8 x 10-10,,0.61,0.91,'-,[0.88-0.94],DGKQ,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:971932
rs231694-<b>T</b>,1 x 10-8,,0.38,1.111,'-,[1.08-1.15],FAM193A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:2699117
rs113284964-<b>G</b>,1 x 10-16,,0.371,1.134,'-,[1.1-1.16],"RHOH, LINC02265",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:40305571
rs6533951-<b>A</b>,1 x 10-10,,0.35,1.111,'-,[1.08-1.14],"LINC01094, BMP2K",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:78723125
rs2867700-<b>A</b>,6 x 10-8,,0.833,1.113,'-,[1.07-1.15],"PRDM8, RPSAP39",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:80163195
rs11099582-<b>A</b>,1 x 10-9,,0.266,1.103,'-,[1.07-1.13],"PLAC8, COQ2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:83221591
rs144261754-<b>T</b>,3 x 10-10,,0.29,0.899,'-,[0.87-0.93],AFF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:86983537
rs4643809-<b>T</b>,4 x 10-24,,0.305,0.846,'-,[0.81-0.88],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:101834942
rs956237-<b>A</b>,4 x 10-11,,0.32,1.107,'-,[1.08-1.14],LEF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:108125804
rs7725218-<b>A</b>,2 x 10-17,,0.391,1.132,'-,[1.1-1.16],TERT,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:1282299
rs2544920-<b>A</b>,9 x 10-10,,0.226,1.122,'-,[1.08-1.16],"ST8SIA4, RN7SKP62",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:100805670
rs370449198-<b>A</b>,4 x 10-8,,0.922,0.721,'-,[0.6-0.84],FNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:131784646
rs2549002-<b>A</b>,2 x 10-10,,0.682,0.905,'-,[0.87-0.94],IRF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:132493886
rs6874758-<b>C</b>,4 x 10-14,,0.073,1.238,'-,[1.18-1.29],"TCF7, VDAC1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:134093501
rs138305363-<b>A</b>,4 x 10-8,,0.98,0.622,'-,[0.45-0.79],UBE2B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:134379182
rs10036748-<b>T</b>,6 x 10-26,,0.76,1.194,'-,[1.16-1.23],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:151078585
rs2421184-<b>A</b>,6 x 10-12,,0.497,1.106,'-,[1.08-1.14],LINC01845,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:159459931
rs2431697-<b>T</b>,1 x 10-28,,0.833,1.241,'-,[1.2-1.28],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,5:160452971
rs9503037-<b>A</b>,1 x 10-15,,0.693,0.881,'-,[0.85-0.91],"DUSP22, CICP18",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:243302
rs79774308-<b>A</b>,6 x 10-10,,0.96,1.452,'-,[1.33-1.57],"CMAHP, CARMIL1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:25410794
rs9295676-<b>T</b>,8 x 10-11,,0.598,1.105,'-,[1.08-1.13],SLC17A2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:25928148
rs77285596-<b>T</b>,2 x 10-19,,0.917,1.362,'-,[1.3-1.43],ZSCAN23,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:28442366
rs1033568-<b>A</b>,1 x 10-6,,0.429,1.081,'-,[1.05-1.11],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,Mapping not available
rs11288784-<b>G</b>,2 x 10-10,,0.365,0.902,'-,[0.87-0.93],"Metazoa_SRP, ACTG1P16",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:50055297
rs669763-<b>C</b>,3 x 10-15,,0.521,1.123,'-,[1.09-1.15],"CCL22, RPL23AP91",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:57356566
rs28410471-<b>A</b>,3 x 10-8,,0.181,1.128,'-,[1.08-1.17],"RPL35AP33, ZFP90",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:68520852
rs11376510-<b>G</b>,2 x 10-10,,0.737,0.898,'-,[0.86-0.93],LINC01229,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:79711776
rs2317230-<b>T</b>,5 x 10-10,(conditional),0.392,1.102,'-,[1.07-1.13],"VDAC1P9, FCRL3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:157705207
rs844646-<b>A</b>,8 x 10-14,(conditional),0.824,0.864,'-,[0.82-0.9],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,1:173247234
rs57634688-<b>T</b>,2 x 10-9,(conditional),0.366,1.109,'-,[1.08-1.14],LEF1-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,4:108190649
rs75460055-<b>T</b>,5 x 10-18,(conditional),0.039,0.47,'-,[0.3-0.64],"HCG4B, MCCD1P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:29921473
rs534723171-<b>T</b>,2 x 10-30,(conditional),0.061,2.735,'-,[2.56-2.91],HLA-A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:29942046
rs2523968-<b>A</b>,4 x 10-12,(conditional),0.429,1.132,'-,[1.1-1.17],MICD,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:29971371
rs1264585-<b>A</b>,1 x 10-13,(conditional),0.233,1.206,'-,[1.16-1.25],"HCG17, HCG18",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:30317873
rs3131933-<b>T</b>,7 x 10-9,(conditional),0.808,0.891,'-,[0.85-0.93],"NAPGP2, MUC21",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:30966087
rs75881311-<b>A</b>,3 x 10-13,(conditional),0.082,1.279,'-,[1.21-1.35],PSORS1C1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31134496
rs112262437-<b>C</b>,2 x 10-27,(conditional),0.994,6.006,'-,[5.68-6.33],"RPL3P2, USP8P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31279629
rs111743557-<b>T</b>,2 x 10-18,(conditional),0.888,0.729,'-,[0.66-0.8],"LINC02571, HLA-B",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31331721
rs2523483-<b>T</b>,3 x 10-11,(conditional),0.939,4.665,'-,[4.53-4.8],"HLA-S, MICA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31386015
rs28359827-<b>A</b>,2 x 10-71,(conditional),0.077,2.916,'-,[2.8-3.03],"MICA, HLA-S",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31392867
rs2516465-<b>T</b>,6 x 10-48,(conditional),0.095,2.113,'-,[2.01-2.21],"LINC01149, HCP5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31447129
rs542914466-<b>A</b>,2 x 10-37,(conditional),0.009,18.321,'-,[17.88-18.77],"AIF1, UQCRHP1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:31613260
rs113720465-<b>A</b>,6 x 10-30,(conditional),0.052,0.447,'-,[0.31-0.59],"CYP21A2, C4B-AS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32037578
rs7774739-<b>A</b>,1 x 10-10,(conditional),0.993,0.483,'-,[0.26-0.7],"CYP21A2, TNXB",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32041524
rs146280229-<b>C</b>,1 x 10-11,(conditional),0.007,1.815,'-,[1.64-1.99],TNXB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32049830
rs145396511-<b>T</b>,5 x 10-9,(conditional),0.989,1.574,'-,[1.42-1.72],"TSBP1, TSBP1-AS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32331681
rs146003878-<b>A</b>,5 x 10-11,(conditional),0.016,1.678,'-,[1.52-1.83],TSBP1-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32389462
rs9268486-<b>T</b>,8 x 10-27,(conditional),0.248,1.384,'-,[1.33-1.44],"TSBP1-AS1, BTNL2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32400783
rs574027387-<b>A</b>,3 x 10-23,(conditional),0.673,1.376,'-,[1.31-1.44],"TSBP1-AS1, HLA-DRA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32411537
rs116352702-<b>A</b>,8 x 10-18,(conditional),0.954,0.543,'-,[0.4-0.68],"HLA-DQA1, HLA-DRB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32626884
rs9273190-<b>A</b>,1 x 10-54,(conditional),0.364,1.79,'-,[1.72-1.86],HLA-DQA1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32645641
rs140780894-<b>T</b>,4 x 10-19,(conditional),0.224,1.41,'-,[1.34-1.48],"HLA-DQB1, HLA-DQA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32657607
rs3129843-<b>G</b>,2 x 10-48,,'-,2.18,'-,[1.97–2.42],"TSBP1-AS1, HLA-DRA",Dermatomyositis or juvenile dermatomyositis,"dermatomyositis, juvenile dermatomyositis",GCST006053,6:32427949
rs4702698-<b>G</b>,5 x 10-6,,'-,1.22,'-,[1.12–1.33],LINC02213,Dermatomyositis or juvenile dermatomyositis,"dermatomyositis, juvenile dermatomyositis",GCST006053,5:10517796
rs4921293-<b>G</b>,8 x 10-6,,'-,1.21,'-,[1.11–1.31],"MIR3142HG, ATP10B",Dermatomyositis or juvenile dermatomyositis,"dermatomyositis, juvenile dermatomyositis",GCST006053,5:160501869
rs1008723-<b>T</b>,9 x 10-6,,'-,1.2,'-,[1.11–1.30],GSDMB,Dermatomyositis or juvenile dermatomyositis,"dermatomyositis, juvenile dermatomyositis",GCST006053,17:39910014
rs11057864-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,SCARB1,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,12:124851404
rs7692514-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,"EPHA5, LINC02835",Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,4:65276878
rs1108131-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,CAMK1D,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,10:12455748
rs958476-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,BARX2,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,11:129451923
rs8009420-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,LINC02331,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,14:53797133
rs6696619-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,LINC01739,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,1:62987118
rs12589674-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,LINC02331,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,14:53779635
rs710987-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,LINC01019,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,5:3525326
rs1534618-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,LINC02439,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,12:118865390
rs10992211-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"OR7E31P, IL6RP1",Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,9:90129733
rs10954650-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,HIPK2,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,7:139641806
rs10142203-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,TMX1,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,14:51238072
rs4149228-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,EPHX1,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,1:225844976
rs6697139-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"Y_RNA, RPL31P11",Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,"response to cyclophosphamide, systemic lupus erythematosus, lupus nephritis",GCST003445,1:161690906
rs2647012-<b>?</b>,3 x 10-7,(Additive),NR,1.52,'-,[1.3-1.75],"HLA-DQB1, MTCO3P1",Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,6:32696681
rs9263871-<b>G</b>,9 x 10-6,(Dominant),NR,1.7,'-,[1.35-2.13],HCG27,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,6:31202751
rs967616-<b>?</b>,2 x 10-6,(Additive),NR,1.45,'-,[1.23-1.69],"RNU6ATAC13P, LINC02431",Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,4:170967071
rs752010-<b>?</b>,2 x 10-6,(Dominant),NR,1.7544,'-,[1.41-2.22],HIVEP3,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,1:41627344
rs2786111-<b>C</b>,5 x 10-6,(Recessive),NR,2.26,'-,[1.60-3.19],CRB1,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,1:197336969
rs1364989-<b>T</b>,5 x 10-7,(Recessive),NR,3.41,'-,[2.10-5.54],"GSX2, RPL22P13",Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,4:54145602
rs10041935-<b>C</b>,3 x 10-6,(Recessive),NR,2.5,'-,[1.71-3.66],LINC02225,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,5:57918990
rs7773456-<b>?</b>,7 x 10-7,(Dominant),NR,1.7544,'-,[1.43-2.17],LNC-LBCS,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,6:19823007
rs7834765-<b>T</b>,1 x 10-6,(Recessive),NR,3.15,'-,[1.97-5.03],'-,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,8:121263666
rs601162-<b>A</b>,1 x 10-6,(Recessive),NR,3.11,'-,[1.99-4.88],'-,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,9:29632144
rs2478118-<b>T</b>,5 x 10-6,(Dominant),NR,1.61,'-,[1.30-1.99],PRPF18,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,10:13608032
rs6538678-<b>A</b>,2 x 10-6,(Additive),'-,1.57,'-,[1.30-1.88],"SNRPF, CCDC38",Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,12:95867790
rs8012283-<b>G</b>,3 x 10-7,(Additive),'-,1.64,'-,[1.35-1.98],NIN,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,14:50767442
rs274068-<b>C</b>,5 x 10-7,(Recessive),NR,2.85,'-,[1.93-4.22],SLC5A11,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,16:24887651
rs2236178-<b>?</b>,5 x 10-6,(Additive),NR,1.4706,'-,[1.27-1.72],"KIZ, KIZ-AS1",Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,20:21162172
rs4901847-<b>T</b>,2 x 10-6,(Additive),NR,1.48,'-,[1.28-1.71],ARMH4,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,14:58092523
rs4699259-<b>A</b>,2 x 10-7,,0.3,0.66,'-,[0.54-0.81],'-,Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST012003,Mapping not available
rs9267972-<b>A</b>,2 x 10-6,(Dominant),NR,1.85,'-,"[1.46,2.33]","NOTCH4, TSBP1-AS1",Lupus nephritis in systemic lupus erythematosus,"systemic lupus erythematosus, lupus nephritis",GCST002479,6:32249455
rs61277444-<b>G</b>,2 x 10-6,,0.08,1.41,'-,[1.21-1.65],PTPN13,Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003862,4:86607925
rs7562121-<b>C</b>,4 x 10-7,,0.24,1.27,'-,[1.17-1.39],AFF3,Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003862,2:99767892
rs61277444-<b>G</b>,6 x 10-6,,0.08,1.42,'-,[1.20-1.67],PTPN13,Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003861,4:86607925
rs6027504-<b>T</b>,3 x 10-6,,0.6,1.21,'-,[1.12-1.30],MIR646HG,Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003863,20:60318758
rs1989248-<b>C</b>,6 x 10-7,,0.29,1.26,'-,[1.15-1.38],RN7SL72P,Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003863,7:148443990
rs72809865-<b>T</b>,7 x 10-6,,0.16,1.17,'-,[1.09-1.26],'-,Kidney disease (early and late stages) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003864,10:81531934
rs10186458-<b>C</b>,2 x 10-6,,0.44,1.24,'-,[1.13-1.35],"SLC7A15P, RNA5SP86",Kidney disease (early stage) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003865,2:20398749
rs317865-<b>G</b>,2 x 10-6,,0.12,1.37,'-,[1.19-1.57],"PROM1, TAPT1",Kidney disease (early stage) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003865,4:16155043
rs35612822-<b>A</b>,7 x 10-6,,0.68,1.24,'-,[1.13-1.37],RPL37A,Kidney disease (early stage) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003865,2:216505032
rs72831309-<b>A</b>,9 x 10-6,,0.04,1.66,'-,[1.34-2.06],TENM2,Kidney disease (late stage) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003866,5:167551225
rs13217044-<b>A</b>,4 x 10-6,,0.71,1.15,'-,[1.07-1.23],PDE10A,Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes,"type 1 diabetes nephropathy, chronic kidney disease",GCST003867,6:8226764
rs146679300-<b>A</b>,2 x 10-6,,0.032,2.54,'-,[1.74 - 3.72],"LINC01118, CRIPT",Hypertensive renal disease,hypertensive renal disease,GCST011909,2:46661369
rs142696488-<b>C</b>,6 x 10-7,,0.029,2.78,'-,[1.86 - 4.14],'-,Hypertensive renal disease,hypertensive renal disease,GCST011909,4:134037496
rs2485016-<b>C</b>,2 x 10-6,,0.056,2.11,'-,[1.55 - 2.86],"LINC00421, PARP4P2",Hypertensive renal disease,hypertensive renal disease,GCST011909,13:19347240
rs3783702-<b>A</b>,7 x 10-7,,0.125,1.77,'-,[1.41 - 2.21],FKBP3,Hypertensive renal disease,hypertensive renal disease,GCST011909,14:45129551
rs2239785-<b>G</b>,5 x 10-13,(AA),0.64,'-,'-,'-,APOL1,Glomerulosclerosis,focal segmental glomerulosclerosis,GCST000741,22:36265284
rs11102024-<b>T</b>,1 x 10-8,,0.075,3.28,'-,[2.25-4.79],"LINC01768, CSF1",Adult onset Still's disease,adult-onset Still's disease,GCST010175,1:109888892
rs11759064-<b>T</b>,3 x 10-9,,0.1298,2.19,'-,[NR],PRKN,Primary vesicoureteric reflux,vesicoureteral reflux,GCST005044,6:162379633
rs12472051-<b>?</b>,4 x 10-6,(EA),'-,1.47,'-,[1.12-1.92],LINC01191,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,2:113974664
rs73017308-<b>?</b>,7 x 10-6,(EA),'-,1.58,'-,[1.05-2.38],"GSTM5P1, SYN2",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,3:12213890
rs36025606-<b>?</b>,4 x 10-6,(EA),'-,1.48,'-,[1.15-1.90],"FOXP4-AS1, LINC01276",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,6:41519619
rs11961816-<b>?</b>,2 x 10-6,(EA),'-,1.81,'-,[1.10-2.97],"REPS1, ABRACL",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,6:139003738
rs4977388-<b>?</b>,3 x 10-6,(EA),'-,1.87,'-,[1.18-2.94],PBX3,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,9:20184333
rs141052170-<b>?</b>,3 x 10-6,(EA),'-,2.13,'-,[1.07-4.23],"LHX3, TMEM250",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,9:136140067
rs73206603-<b>?</b>,1 x 10-7,(EA),'-,1.83,'-,[1.17-2.87],RNU7-88P,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,13:59495931
chr14:95189723:D-<b>?</b>,4 x 10-6,(EA),'-,1.86,'-,[1.08-3.19],'-,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,Mapping not available
rs117897666-<b>?</b>,3 x 10-7,(EA),'-,3.02,'-,[0.95-9.59],"INSYN1-AS1, TBC1D21",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,15:73811619
rs76262407-<b>?</b>,2 x 10-6,(EA),'-,3.56,'-,[0.81-15.69],SCGB2B2,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,19:34600451
rs10404821-<b>?</b>,2 x 10-6,(EA),'-,1.26,'-,[1.08-1.48],C19orf81,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,19:50657831
rs36025606-<b>?</b>,9 x 10-6,,'-,1.47,'-,[1.14-1.88],"FOXP4-AS1, LINC01276",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,6:41519619
rs11961816-<b>?</b>,4 x 10-6,,'-,1.72,'-,[1.10-2.68],"REPS1, ABRACL",Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,6:139003738
rs10404821-<b>?</b>,9 x 10-6,,'-,1.25,'-,[1.07-1.46],C19orf81,Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD),"chronic kidney disease, diabetic nephropathy",GCST005893,19:50657831
chr6:32525987:I-<b>?</b>,5 x 10-6,,'-,1.17,'-,[1.08-1.26],'-,Chronic kidney disease and diabetic kidney disease in diabetes,"chronic kidney disease, diabetes mellitus, diabetic nephropathy",GCST005884,Mapping not available
rs743446-<b>?</b>,5 x 10-6,,0.49,2.4,'-,[1.64-3.49],"ERG, LINC00114",Neonatal lupus,neonatal systemic lupus erythematosus,GCST000738,21:38684499
rs2403106-<b>?</b>,3 x 10-6,,0.07,2.48,'-,[1.70-3.61],'-,Neonatal lupus,neonatal systemic lupus erythematosus,GCST000738,12:83614496
rs1391511-<b>?</b>,7 x 10-6,,0.36,1.84,'-,[1.41-2.40],'-,Neonatal lupus,neonatal systemic lupus erythematosus,GCST000738,Mapping not available
rs1890645-<b>?</b>,4 x 10-6,,0.3,2.98,'-,[1.88-4.73],'-,Neonatal lupus,neonatal systemic lupus erythematosus,GCST000738,1:195562293
rs3099844-<b>?</b>,5 x 10-10,,0.11,3.34,'-,[2.29-4.89],MICB-DT,Neonatal lupus,neonatal systemic lupus erythematosus,GCST000738,6:31481199
rs2736337-<b>C</b>,5 x 10-22,,NR,1.23,'-,[1.17-1.30],"BLK, FAM167A",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,8:11484371
rs7929541-<b>?</b>,2 x 10-10,,NR,1.1235955,'-,[1.05-1.2],"DRD4, SCT",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,11:633689
rs11066301-<b>T</b>,4 x 10-8,,NR,1.11,'-,[1.07-1.15],PTPN11,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,12:112433568
rs35929052-<b>?</b>,2 x 10-9,,NR,1.2048193,'-,[1.14-1.28],LINC02132,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,16:85960878
rs11085725-<b>?</b>,3 x 10-10,,NR,1.1363636,'-,[1.09-1.2],TYK2,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,19:10351837
rs76246107-<b>G</b>,3 x 10-8,,NR,1.28,'-,[1.14-1.43],PRR12,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,19:49618017
rs13101828-<b>G</b>,1 x 10-8,,NR,1.11,'-,[1.07-1.16],DGKQ,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,4:971932
rs4958880-<b>A</b>,1 x 10-11,,NR,1.16,'-,[1.10-1.22],TNIP1,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,5:151058916
rs5754467-<b>G</b>,1 x 10-13,,NR,1.2,'-,[1.13-1.27],"YDJC, CCDC116",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,22:21630805
rs6659932-<b>?</b>,6 x 10-11,,NR,1.1764705,'-,[1.1-0.01],IL12RB2,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,1:67336688
rs6679677-<b>A</b>,2 x 10-28,,NR,1.34,'-,[1.21-1.49],"RSBN1, PHTF1",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,1:113761186
rs2476601-<b>?</b>,2 x 10-28,,NR,1.3333333,'-,[1.2-1.49],PTPN22,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,1:113834946
rs1217393-<b>?</b>,5 x 10-9,,NR,1.1235955,'-,[1.09-1.18],AP4B1-AS1,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,1:113891324
rs2422345-<b>A</b>,3 x 10-8,,NR,1.11,'-,[1.05-1.18],PRDX6-AS1,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,1:173368608
rs17849502-<b>T</b>,4 x 10-15,,NR,1.36,'-,[1.16-1.59],"NCF2, SMG7",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,1:183563445
rs744600-<b>?</b>,7 x 10-11,,NR,1.1363636,'-,[1.09-1.18],NAB1,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,2:190700031
rs13389408-<b>C</b>,3 x 10-17,,NR,1.27,'-,[1.20-1.34],STAT4,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,2:191068557
rs10174238-<b>?</b>,3 x 10-42,,NR,1.369863,'-,[1.25-1.49],STAT4,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,2:191108308
rs35677470-<b>A</b>,5 x 10-9,,NR,1.22,'-,[1.14-1.30],DNASE1L3,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,3:58197909
rs112846137-<b>T</b>,1 x 10-8,,NR,1.27,'-,[1.17-1.37],"ARL14, RPL6P8",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,3:160595133
rs2431098-<b>G</b>,5 x 10-12,,NR,1.12,'-,[1.05-1.20],MIR3142HG,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,5:160460329
rs802791-<b>?</b>,4 x 10-12,,NR,1.1494253,'-,[1.09-1.2],ATG5,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,6:106121395
rs58721818-<b>T</b>,5 x 10-23,,NR,1.64,'-,[1.46-1.84],"TNFAIP3, LINC02528",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,6:137922602
rs193107685-<b>C</b>,3 x 10-9,,NR,1.52,'-,[1.27-1.83],"EIF4H, LIMK1",Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,7:74123572
rs10954214-<b>T</b>,7 x 10-17,,NR,1.18,'-,[1.13-1.23],IRF5,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,7:128949579
rs13238352-<b>T</b>,1 x 10-38,,NR,1.44,'-,[1.30-1.60],TNPO3,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),"systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus",GCST007278,7:129007888
rs2275247-<b>?</b>,1 x 10-10,(lcSSc),'-,1.51,'-,[NR],KIAA0319L,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,1:35442850
rs10498070-<b>?</b>,2 x 10-7,(lcSSc),'-,1.16,'-,[NR],"LINC01803, LINC02832",Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,2:219833404
rs2176082-<b>?</b>,5 x 10-11,(ACA),'-,1.21,'-,[NR],PXK,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,3:58345459
rs3827644-<b>?</b>,5 x 10-7,,'-,1.15,'-,[NR],ATG5,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,6:106237320
rs1635852-<b>?</b>,2 x 10-8,,'-,1.14,'-,[NR],JAZF1,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,7:28149792
rs1133906-<b>?</b>,2 x 10-7,(lcSSc),'-,1.21,'-,[NR],SAMD9L,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,7:93135669
rs1355223-<b>?</b>,4 x 10-6,(lcSSc),'-,1.12,'-,[NR],EHF,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,11:34742932
rs704840-<b>?</b>,4 x 10-7,,NR,1.182,'-,[NR],TNFSF4,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,1:173257056
rs16860537-<b>?</b>,5 x 10-6,(ACA),NR,1.496,'-,[NR],LAMC2,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,1:183211125
rs7601754-<b>?</b>,3 x 10-11,,NR,1.32,'-,[NR],STAT4,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,2:191075725
rs960709-<b>?</b>,2 x 10-8,,NR,1.212,'-,[NR],TNIP1,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,5:151081488
rs1535001-<b>?</b>,3 x 10-7,,NR,1.184,'-,[NR],ANKS1A,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,6:34959503
rs10499197-<b>?</b>,2 x 10-9,,NR,1.638,'-,[NR],"WAKMAR2, LINC02539",Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,6:137811379
rs13239597-<b>?</b>,1 x 10-29,,NR,1.664,'-,[NR],TPI1P2,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,7:129055929
rs2736340-<b>?</b>,1 x 10-8,,NR,1.217,'-,[NR],"BLK, FAM167A",Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,8:11486464
rs2396545-<b>?</b>,8 x 10-6,(ACA),NR,1.19,'-,[NR],PHRF1,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,11:601785
rs7172677-<b>?</b>,3 x 10-8,,NR,1.207,'-,[NR],"Metazoa_SRP, RPL36AP45",Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,15:75132252
rs11860650-<b>?</b>,1 x 10-10,,NR,1.319,'-,[NR],ITGAM,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,16:31315385
rs12711490-<b>?</b>,3 x 10-10,,NR,1.28,'-,[NR],LINC02132,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,16:85939422
rs9303277-<b>?</b>,7 x 10-6,(ACA),NR,1.191,'-,[NR],IKZF3,Systemic lupus erythematosus and Systemic sclerosis,"systemic scleroderma, systemic lupus erythematosus",GCST002069,17:39820216
rs3115573-<b>?</b>,1 x 10-9,,NR,1.62,'-,[1.39-1.90],"NOTCH4, TSBP1-AS1",Nephropathy,kidney disease,GCST000718,6:32251066
rs4927186-<b>?</b>,8 x 10-6,(EA),'-,1.43,'-,[1.30-1.57],BSND,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,1:55006692
rs12647735-<b>?</b>,2 x 10-6,(EA),'-,1.45,'-,[1.33-1.59],LINC02511,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,4:137078372
rs6997279-<b>?</b>,1 x 10-7,,'-,1.48,'-,[1.19-1.84],SLC30A8,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,8:116961613
chr19:48475266:I-<b>?</b>,7 x 10-6,,'-,1.38,'-,[1.23-1.53],'-,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,Mapping not available
rs10946177-<b>?</b>,4 x 10-6,,'-,'-,0.099 unit increase,[NR],RPS6KA2,Café-au-lait macule number in neurofibromatosis type1,"Neurofibromatosis type 1, Cafe-au-lait spot",GCST011464,6:166605233
rs1951646-<b>?</b>,8 x 10-6,,'-,'-,0.073 unit increase,[NR],TTC6,Café-au-lait macule number in neurofibromatosis type1,"Neurofibromatosis type 1, Cafe-au-lait spot",GCST011464,14:37677543
rs78064607-<b>?</b>,4 x 10-8,"(adjusted for atrial fibrillation, delirium, myocardial infarction and stroke)",NR,50,'-,[11.11-100],PHLPP2,Postoperative acute renal failure after cardiac surgery,"post-operative acute kidney injury, response to surgery",GCST007979,16:71689278
rs189437718-<b>?</b>,4 x 10-7,"(adjusted for atrial fibrillation, delirium, myocardial infarction and stroke)",NR,20,'-,[6.67-100],"Metazoa_SRP, ST3GAL1-DT",Postoperative acute renal failure after cardiac surgery,"post-operative acute kidney injury, response to surgery",GCST007979,8:133643176
rs72654815-<b>?</b>,7 x 10-7,"(adjusted for atrial fibrillation, delirium, myocardial infarction and stroke)",NR,9.090909,'-,[3.7-20],EIF4G3,Postoperative acute renal failure after cardiac surgery,"post-operative acute kidney injury, response to surgery",GCST007979,1:21028132
rs77876049-<b>?</b>,9 x 10-6,"(adjusted for atrial fibrillation, delirium, myocardial infarction and stroke)",NR,4,'-,[2.17-7.14],"CLMP, HSPA8",Postoperative acute renal failure after cardiac surgery,"post-operative acute kidney injury, response to surgery",GCST007979,11:123066103
rs17830558-<b>T</b>,4 x 10-10,,0.52,1.87,'-,[1.54–2.28],PLA2R1,Membranous nephropathy,membranous glomerulonephritis,GCST003402,2:160021853
rs9272729-<b>A</b>,2 x 10-39,,0.2,7.07,'-,[5.28–9.47],HLA-DQA1,Membranous nephropathy,membranous glomerulonephritis,GCST003402,6:32641817
rs4862110-<b>C</b>,2 x 10-6,,0.174,1.44,'-,[1.24-1.67],"TENM3, DCTD",Wegener's granulomatosis,Granulomatosis with Polyangiitis,GCST002160,4:182829876
rs1949829-<b>T</b>,4 x 10-7,,0.055,1.78,'-,[1.42-2.24],CICP17,Wegener's granulomatosis,Granulomatosis with Polyangiitis,GCST002160,7:51470190
rs595018-<b>A</b>,2 x 10-7,,0.216,1.46,'-,[1.27-1.69],"MS4A10, CCDC86",Wegener's granulomatosis,Granulomatosis with Polyangiitis,GCST002160,11:60824803
rs7503953-<b>A</b>,2 x 10-7,,0.171,1.5,'-,[1.29-1.76],"RNU6-1264P, BTF3P14",Wegener's granulomatosis,Granulomatosis with Polyangiitis,GCST002160,17:6238357
rs26595-<b>T</b>,2 x 10-8,,0.56,1.35,'-,[1.22-1.49],"COMMD10, SEMA6A",Wegener's granulomatosis,Granulomatosis with Polyangiitis,GCST002159,5:116423793
rs807624-<b>A</b>,1 x 10-14,,0.35,1.33,'-,[1.22-1.45],"LINC01804, DDX1",Wilms tumor,Nephroblastoma,GCST001500,2:15642347
rs3755132-<b>G</b>,1 x 10-14,,0.14,1.45,'-,[1.29-1.64],"NBAS, DDX1",Wilms tumor,Nephroblastoma,GCST001500,2:15589696
rs2495478-<b>T</b>,1 x 10-7,,0.04,1.4,'-,[1.15-1.72],PCSK9,Wilms tumor,Nephroblastoma,GCST001500,1:55047322
rs1027643-<b>T</b>,5 x 10-10,,0.05,1.43,'-,[1.18-1.73],'-,Wilms tumor,Nephroblastoma,GCST001500,5:92558085
rs790356-<b>G</b>,4 x 10-15,,0.5,1.28,'-,[1.17-1.39],DLG2,Wilms tumor,Nephroblastoma,GCST001500,11:83909744
rs2283873-<b>A</b>,5 x 10-12,,0.02,2.05,'-,[1.57-2.69],TCN2,Wilms tumor,Nephroblastoma,GCST001500,22:30617309
rs5955543-<b>G</b>,1 x 10-9,,0.01,2.64,'-,[1.74-4.01],NHS,Wilms tumor,Nephroblastoma,GCST001500,X:17680277
rs2412971-<b>?</b>,2 x 10-9,,0.49 (EA),1.25,'-,[NR],HORMAD2,Nephropathy,kidney disease,GCST001009,22:30098382
rs6677604-<b>?</b>,3 x 10-10,,0.77 (EA),1.47,'-,[NR],CFH,Nephropathy,kidney disease,GCST001009,1:196717788
rs16946160-<b>A</b>,3 x 10-7,,0.17,1.39,'-,[1.22-1.57],GPC5,Nephrotic syndrome (acquired),nephrotic syndrome,GCST001018,13:91551559
rs11086243-<b>T</b>,3 x 10-6,,0.23,1.37,'-,[1.20-1.57],MAVS,Nephrotic syndrome (acquired),nephrotic syndrome,GCST001018,20:48150492
rs11746443-<b>?</b>,9 x 10-12,,NR,1.19,'-,[1.13-1.24],RGS14,Nephrolithiasis,nephrolithiasis,GCST001432,5:177371305
rs1000597-<b>?</b>,2 x 10-14,,NR,1.22,'-,[1.16-1.29],"AQP1, MINDY4",Nephrolithiasis,nephrolithiasis,GCST001432,7:30897563
rs4142110-<b>?</b>,5 x 10-9,,NR,1.14,'-,[1.09-1.19],DGKH,Nephrolithiasis,nephrolithiasis,GCST001432,13:42180386
rs1222043-<b>C</b>,6 x 10-6,,0.036,3.41,'-,[2.00-5.80],RNU1-130P,Classic bladder exstrophy,Bladder exstrophy,GCST002807,1:96159941
rs184483498-<b>A</b>,8 x 10-6,,0.071,2.53,'-,[1.68-3.80],MROH9,Classic bladder exstrophy,Bladder exstrophy,GCST002807,1:170937617
rs12725009-<b>A</b>,2 x 10-7,,0.015,4.46,'-,[2.54-7.94],MEGF6,Classic bladder exstrophy,Bladder exstrophy,GCST002807,1:3497433
rs11580861-<b>T</b>,3 x 10-7,,0.031,3.3,'-,[2.08-5.22],'-,Classic bladder exstrophy,Bladder exstrophy,GCST002807,1:195026001
rs72748303-<b>A</b>,6 x 10-6,,0.023,3.33,'-,[1.98-5.60],LINC01717,Classic bladder exstrophy,Bladder exstrophy,GCST002807,1:208800288
rs180692175-<b>G</b>,9 x 10-6,,0.024,3.94,'-,[2.15-7.22],NCKAP5,Classic bladder exstrophy,Bladder exstrophy,GCST002807,2:132873485
rs181099388-<b>G</b>,8 x 10-6,,0.028,2.84,'-,[1.80-4.50],LIAS,Classic bladder exstrophy,Bladder exstrophy,GCST002807,4:39460410
rs115650236-<b>G</b>,5 x 10-6,,0.026,5.11,'-,[2.54-10.26],'-,Classic bladder exstrophy,Bladder exstrophy,GCST002807,4:58802664
rs7689350-<b>C</b>,5 x 10-6,,0.115,1.93,'-,[1.45-2.55],LINC02483,Classic bladder exstrophy,Bladder exstrophy,GCST002807,4:75282360
rs9291768-<b>T</b>,2 x 10-12,,0.377,2.18,'-,[1.75-2.71],HMGB1P47,Classic bladder exstrophy,Bladder exstrophy,GCST002807,5:51421959
rs9354654-<b>C</b>,2 x 10-6,,0.375,1.67,'-,[1.35-2.07],'-,Classic bladder exstrophy,Bladder exstrophy,GCST002807,6:68003507
rs76754339-<b>G</b>,7 x 10-6,,0.016,5.7,'-,[2.67-12.18],NUS1,Classic bladder exstrophy,Bladder exstrophy,GCST002807,6:117782973
rs192378410-<b>T</b>,2 x 10-6,,0.025,4.11,'-,[2.30-7.35],SMOC2,Classic bladder exstrophy,Bladder exstrophy,GCST002807,6:168571878
rs73077895-<b>A</b>,7 x 10-6,,0.016,5.35,'-,[2.58-11.11],CREB5,Classic bladder exstrophy,Bladder exstrophy,GCST002807,7:28780225
rs62505227-<b>A</b>,5 x 10-7,,0.086,2.23,'-,[1.63-3.06],SIRLNT,Classic bladder exstrophy,Bladder exstrophy,GCST002807,8:40429730
rs78315000-<b>G</b>,1 x 10-6,,0.042,3.83,'-,[2.22-6.60],PREX2,Classic bladder exstrophy,Bladder exstrophy,GCST002807,8:68190823
rs10119066-<b>T</b>,1 x 10-6,,0.057,2.51,'-,[1.74-3.64],"RPL4P5, PPIAP33",Classic bladder exstrophy,Bladder exstrophy,GCST002807,9:7509895
rs12345625-<b>T</b>,7 x 10-6,,0.03,2.72,'-,[1.76-4.20],"LINC01243, MTATP6P30",Classic bladder exstrophy,Bladder exstrophy,GCST002807,9:31479007
rs10993625-<b>C</b>,3 x 10-6,,0.149,1.97,'-,[1.48-2.63],"DIRAS2, OR7E109P",Classic bladder exstrophy,Bladder exstrophy,GCST002807,9:90679923
rs7310309-<b>T</b>,9 x 10-6,,0.15,1.83,'-,[1.40-2.39],SYT1,Classic bladder exstrophy,Bladder exstrophy,GCST002807,12:79417649
rs2361763-<b>C</b>,3 x 10-6,,0.494,1.72,'-,[1.37-2.16],LINC02132,Classic bladder exstrophy,Bladder exstrophy,GCST002807,16:85959528
rs410285-<b>G</b>,1 x 10-6,,0.011,6.45,'-,[3.04-13.67],PRAMENP,Classic bladder exstrophy,Bladder exstrophy,GCST002807,22:22027370
rs5767218-<b>C</b>,3 x 10-6,,0.367,1.71,'-,[1.37-2.14],CELSR1,Classic bladder exstrophy,Bladder exstrophy,GCST002807,22:46483417
rs113641325-<b>C</b>,6 x 10-6,,0.126,1.98,'-,[1.47-2.67],SYT1,Classic bladder exstrophy,Bladder exstrophy,GCST002807,12:79145979
rs76239813-<b>A</b>,7 x 10-6,,0.016,7.44,'-,[3.10-17.87],CCDC15,Classic bladder exstrophy,Bladder exstrophy,GCST002807,11:125039686
rs7919656-<b>A</b>,2 x 10-8,(Japanese),0.129,3.87,'-,[2.33-6.55],WDFY4,Clinically amyopathic dermatomyositis,clinically amyopathic dermatomyositis,GCST005338,10:48817975
rs741301-<b>?</b>,8 x 10-6,,NR,2.67,'-,[1.71-4.16],ELMO1,Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST000064,7:36878390
rs7382539-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"VTA1P1, THBS2",Liver disease severity in Alagille syndrome,"Alagille syndrome, liver disease",GCST003616,6:169268903
rs944961-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Liver disease severity in Alagille syndrome,"Alagille syndrome, liver disease",GCST003616,9:119810618
rs7750458-<b>A</b>,1 x 10-9,,0.09,2.5,'-,[1.80-3.44],"HLA-DPA1, HLA-DPB1",Dermatomyositis,dermatomyositis,GCST003522,6:33077921
rs9986765-<b>G</b>,7 x 10-7,,0.05,2.71,'-,[1.80-4.08],'-,Dermatomyositis,dermatomyositis,GCST003522,Mapping not available
rs3750716-<b>A</b>,9 x 10-7,,0.01,4.39,'-,[2.31-8.35],CPN1,Dermatomyositis,dermatomyositis,GCST003522,10:100057106
HLA_DPB1*17-<b>?</b>,3 x 10-10,,NR,3.844,'-,NR,'-,Dermatomyositis,dermatomyositis,GCST003522,Mapping not available
rs7572733-<b>?</b>,6 x 10-6,,NR,1.25,'-,[1.14-1.39],PLCL1,Dermatomyositis,dermatomyositis,GCST002151,2:198065082
rs4664308-<b>A</b>,9 x 10-29,,0.43,2.28,'-,[1.96-2.64],PLA2R1,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,2:160060986
rs2187668-<b>A</b>,8 x 10-93,,0.1297,4.32,'-,[NR],HLA-DQA1,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32638107
rs3134792-<b>C</b>,6 x 10-72,,0.114,3.93,'-,[NR],"LINC02571, HLA-B",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31344549
rs7775397-<b>G</b>,5 x 10-71,,0.1139,3.83,'-,[NR],"TSBP1-AS1, TSBP1",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32293475
rs389884-<b>C</b>,8 x 10-66,,0.1148,3.65,'-,[NR],STK19,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31973120
rs7750641-<b>T</b>,3 x 10-58,,0.1263,3.35,'-,[NR],'-,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,Mapping not available
rs3130544-<b>A</b>,9 x 10-58,,0.1238,3.34,'-,[NR],"C6orf15, RNU6-1133P",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31090563
rs3115663-<b>G</b>,7 x 10-57,,0.1812,3.04,'-,[NR],PRRC2A,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31634066
rs9267522-<b>G</b>,1 x 10-56,,0.1811,3.04,'-,[NR],PRRC2A,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31635993
rs3130618-<b>A</b>,2 x 10-56,,0.1811,3.03,'-,[NR],GPANK1,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31664357
rs1980493-<b>G</b>,1 x 10-48,,0.1656,2.87,'-,[NR],"BTNL2, TSBP1-AS1",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32395438
rs2233956-<b>G</b>,6 x 10-48,,0.1813,2.77,'-,[NR],"C6orf15, PSORS1C1",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31113428
rs652888-<b>C</b>,3 x 10-46,,0.2021,2.71,'-,[NR],"EHMT2-AS1, EHMT2",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31883457
rs3130564-<b>T</b>,1 x 10-42,,0.1934,2.62,'-,[NR],PSORS1C1,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31133897
rs3096697-<b>T</b>,1 x 10-41,,0.2054,2.58,'-,[NR],"EGFL8, PPT2-EGFL8",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32166733
rs3134945-<b>T</b>,2 x 10-40,,0.2049,2.54,'-,[NR],RNF5,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32178715
rs3129939-<b>G</b>,2 x 10-40,,0.1772,2.6,'-,[NR],"TSBP1-AS1, TSBP1",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32368989
rs3132580-<b>T</b>,3 x 10-40,,0.1379,2.74,'-,[NR],"SFTA2, HCG21, MUCL3",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:30952347
rs204999-<b>G</b>,9 x 10-40,,0.2643,2.44,'-,[NR],'-,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,Mapping not available
rs1480380-<b>T</b>,4 x 10-39,,0.0877,3.05,'-,[NR],"HLA-DMB, HLA-DMA",Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:32945469
rs1265159-<b>T</b>,4 x 10-37,,0.2191,2.42,'-,[NR],POU5F1,Idiopathic membranous nephropathy,membranous glomerulonephritis,GCST000984,6:31172270
rs10238682-<b>A</b>,1 x 10-9,,0.51,'-,0.26 unit increase,'-,C1GALT1,Serum galactose-deficient IgA1 levels in IgA nephropathy,"IGA glomerulonephritis, serum galactose-deficient IgA1 measurement",GCST90011884,7:7215386
rs7856182-<b>T</b>,2 x 10-9,,0.04,'-,0.73 unit increase,'-,"NME2P3, GALNT12",Serum galactose-deficient IgA1 levels in IgA nephropathy,"IGA glomerulonephritis, serum galactose-deficient IgA1 measurement",GCST90011884,9:98871030
HLA-<b>DQB1*03:03</b>,1 x 10-8,,NR,'-,'-,'-,'-,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,Mapping not available
HLA-<b>DQB1*03</b>,2 x 10-8,,NR,'-,'-,'-,'-,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,Mapping not available
rs2858317-<b>?</b>,4 x 10-31,(conditioned on rs9273542),NR,'-,'-,'-,"HLA-DQB1, MTCO3P1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,6:32694503
HLA-<b>DQA1*02:01</b>,1 x 10-32,,0.15,3.42,'-,[2.80-4.16],'-,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,Mapping not available
HLA-<b>DQA1*01</b>,2 x 10-31,,0.38,'-,'-,'-,'-,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,Mapping not available
rs9273542-<b>T</b>,2 x 10-43,,0.24,3.39,'-,[2.86-4.03],HLA-DQB1,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,6:32661035
rs2637678-<b>?</b>,1 x 10-17,,0.6,1.9607843,'-,[1.67-2.27],"CALHM6, TRAPPC3L",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,6:116466215
rs10518133-<b>A</b>,3 x 10-8,,0.06,1.96,'-,[1.57-2.45],PARM1,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,4:75025495
rs113752715-<b>?</b>,2 x 10-6,,0.92,2.1276596,'-,[1.52-3.03],PTPRC,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,1:198738388
rs530462-<b>?</b>,3 x 10-6,,0.79,1.5873016,'-,[1.3-1.92],KALRN,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,3:124510192
rs6763024-<b>C</b>,9 x 10-6,,0.27,1.41,'-,[1.21-1.63],TSC22D2,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,3:150452068
rs487575-<b>?</b>,1 x 10-6,,0.78,1.5873016,'-,[1.3-1.92],LINC01991,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,3:187880609
rs6531527-<b>G</b>,7 x 10-6,,0.38,1.38,'-,[1.20-1.58],NWD2,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,4:37351175
rs2674382-<b>?</b>,9 x 10-6,,0.93,2.173913,'-,[1.47-3.12],"LINC02531, U3",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,6:92777658
rs2746419-<b>A</b>,1 x 10-6,,0.46,1.42,'-,[1.23-1.63],AHI1,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,6:135332717
rs111796602-<b>C</b>,3 x 10-6,,0.1,1.63,'-,[1.34-1.99],ELMO1,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,7:37362887
rs201899638-<b>?</b>,5 x 10-7,,0.98,9.090909,'-,[2.5-33.33],PTPRD,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,9:9932324
rs1891621-<b>G</b>,4 x 10-6,,0.47,1.39,'-,[1.21-1.60],"LINC02664, ZNF438",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,10:31101198
rs34217742-<b>A</b>,8 x 10-6,,0.12,1.56,'-,[1.29-1.88],ZNF345,Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST008456,19:36885928
rs6703976-<b>T</b>,4 x 10-9,,0.11,1.18,'-,[1.12-1.25],ALPL,Kidney stones,nephrolithiasis,GCST009599,1:21510441
rs1256332-<b>A</b>,6 x 10-11,,0.16,1.17,'-,[1.12-1.23],ALPL,Kidney stones,nephrolithiasis,GCST009599,1:21566851
rs838717-<b>G</b>,2 x 10-8,,0.43,1.11,'-,[1.07-1.15],'-,Kidney stones,nephrolithiasis,GCST009599,Mapping not available
rs10051765-<b>C</b>,8 x 10-15,,0.33,1.16,'-,[1.11-1.20],"RGS14, SLC34A1",Kidney stones,nephrolithiasis,GCST009599,5:177372991
rs28495851-<b>C</b>,5 x 10-9,,0.03,1.35,'-,[1.22-1.50],SLC22A2,Kidney stones,nephrolithiasis,GCST009599,6:160198886
rs7790498-<b>A</b>,3 x 10-10,,0.3,1.13,'-,[1.08-1.17],HIBADH,Kidney stones,nephrolithiasis,GCST009599,7:27613588
rs1170174-<b>A</b>,5 x 10-11,,0.18,1.16,'-,[1.11-1.22],DGKH,Kidney stones,nephrolithiasis,GCST009599,13:42114075
rs77924615-<b>A</b>,2 x 10-8,,0.2,1.13,'-,[1.09-1.18],PDILT,Kidney stones,nephrolithiasis,GCST009599,16:20381010
rs17216707-<b>T</b>,1 x 10-11,,0.81,1.17,'-,[1.12-1.22],"CYP24A1, BCAS1",Kidney stones,nephrolithiasis,GCST009599,20:54115823
rs2776288-<b>A</b>,6 x 10-19,,0.63,1.18,'-,[1.14-1.22],"CLDN14, CHAF1B",Kidney stones,nephrolithiasis,GCST009599,21:36446573
rs13054904-<b>A</b>,3 x 10-12,,0.26,1.15,'-,[1.11-1.20],RSPH14,Kidney stones,nephrolithiasis,GCST009599,22:23068739
rs1155347-<b>C</b>,3 x 10-7,,0.22,1.12,'-,[1.07-1.17],"SAYSD1, KCNK5",Kidney stones,nephrolithiasis,GCST009599,6:39178454
rs578595-<b>C</b>,3 x 10-6,,0.46,1.09,'-,[1.05-1.13],WDR72,Kidney stones,nephrolithiasis,GCST009599,15:53704892
rs889299-<b>G</b>,8 x 10-6,,0.76,1.1,'-,[1.05-1.14],SCNN1B,Kidney stones,nephrolithiasis,GCST009599,16:23370593
rs4793434-<b>G</b>,2 x 10-6,,0.5,1.09,'-,[1.05-1.13],LINC00511,Kidney stones,nephrolithiasis,GCST009599,17:72356396
rs10917002-<b>T</b>,3 x 10-11,,0.11,1.13,'-,[1.09-1.17],ALPL,Kidney stones,nephrolithiasis,GCST009598,1:21509847
rs780093-<b>T</b>,1 x 10-13,,0.38,1.1,'-,[1.08-1.13],GCKR,Kidney stones,nephrolithiasis,GCST009598,2:27519736
rs13003198-<b>T</b>,4 x 10-11,,0.39,1.11,'-,[1.07-1.14],"DGKD, SAG",Kidney stones,nephrolithiasis,GCST009598,2:233348459
rs1481012-<b>G</b>,3 x 10-8,,0.11,1.11,'-,[1.07-1.16],ABCG2,Kidney stones,nephrolithiasis,GCST009598,4:88117930
rs56235845-<b>G</b>,3 x 10-21,,0.33,1.16,'-,[1.13-1.20],RGS14,Kidney stones,nephrolithiasis,GCST009598,5:177371039
rs1155347-<b>C</b>,9 x 10-11,,0.22,1.13,'-,[1.09-1.17],"SAYSD1, KCNK5",Kidney stones,nephrolithiasis,GCST009598,6:39178454
rs77648599-<b>G</b>,5 x 10-10,,0.03,1.3,'-,[1.20-1.42],SLC22A2,Kidney stones,nephrolithiasis,GCST009598,6:160203083
rs12539707-<b>T</b>,1 x 10-10,,0.3,1.12,'-,[1.08-1.16],HIBADH,Kidney stones,nephrolithiasis,GCST009598,7:27586546
rs12666466-<b>G</b>,3 x 10-8,,0.03,1.19,'-,[1.12-1.26],"INMT-MINDY4, MINDY4",Kidney stones,nephrolithiasis,GCST009598,7:30876815
rs4529910-<b>T</b>,4 x 10-10,,0.27,1.09,'-,[1.06-1.12],POU2AF1,Kidney stones,nephrolithiasis,GCST009598,11:111372377
rs1037271-<b>C</b>,1 x 10-24,,0.39,1.15,'-,[1.12-1.18],DGKH,Kidney stones,nephrolithiasis,GCST009598,13:42205274
rs578595-<b>C</b>,6 x 10-11,,0.46,1.09,'-,[1.07-1.12],WDR72,Kidney stones,nephrolithiasis,GCST009598,15:53704892
rs77924615-<b>A</b>,1 x 10-13,,0.2,1.14,'-,[1.10-1.19],PDILT,Kidney stones,nephrolithiasis,GCST009598,16:20381010
rs889299-<b>G</b>,2 x 10-8,,0.76,1.09,'-,[1.06-1.13],SCNN1B,Kidney stones,nephrolithiasis,GCST009598,16:23370593
rs1010269-<b>G</b>,4 x 10-15,,0.83,1.13,'-,[1.10-1.17],BCAS3,Kidney stones,nephrolithiasis,GCST009598,17:61371584
rs4793434-<b>G</b>,5 x 10-9,,0.5,1.09,'-,[1.06-1.12],LINC00511,Kidney stones,nephrolithiasis,GCST009598,17:72356396
rs3760702-<b>A</b>,2 x 10-9,,0.33,1.09,'-,[1.07-1.13],"PTGER1, GIPC1",Kidney stones,nephrolithiasis,GCST009598,19:14477425
rs17216707-<b>T</b>,8 x 10-18,,0.81,1.19,'-,[1.14-1.23],"CYP24A1, BCAS1",Kidney stones,nephrolithiasis,GCST009598,20:54115823
rs12626330-<b>G</b>,7 x 10-21,,0.49,1.15,'-,[1.12-1.18],CLDN14,Kidney stones,nephrolithiasis,GCST009598,21:36463684
rs13054904-<b>A</b>,4 x 10-12,,0.26,1.14,'-,[1.10-1.19],RSPH14,Kidney stones,nephrolithiasis,GCST009598,22:23068739
rs1256328-<b>T</b>,6 x 10-10,,0.1779,1.21,'-,[NR],ALPL,Kidney stones,nephrolithiasis,GCST003086,1:21570274
rs12654812-<b>A</b>,6 x 10-11,,0.4184,1.18,'-,[NR],RGS14,Kidney stones,nephrolithiasis,GCST003086,5:177367190
rs199565725-<b>AAC</b>,5 x 10-13,,0.7632,1.2345679,'-,[NR],CLDN14,Kidney stones,nephrolithiasis,GCST003086,21:36462941
rs7627468-<b>A</b>,2 x 10-8,,0.268,1.16,'-,[NR],CASR,Kidney stones,nephrolithiasis,GCST003086,3:122227252
rs219780-<b>C</b>,4 x 10-12,,0.79,1.25,'-,[1.17-1.33],CLDN14,Kidney stones,nephrolithiasis,GCST000429,21:36461009
rs10488631-<b>?</b>,9 x 10-7,(EA),'-,'-,'-,'-,"IRF5, TNPO3",Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005333,7:128954129
rs11642873-<b>?</b>,4 x 10-6,(EA),'-,'-,'-,'-,LINC02132,Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005333,16:85958099
rs4554699-<b>?</b>,6 x 10-14,(EA),NR,'-,'-,'-,"FCGR2B, FCGR3B",Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005552,1:161638578
rs10174238-<b>?</b>,2 x 10-9,(EA),NR,'-,'-,'-,STAT4,Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005552,2:191108308
rs16991498-<b>?</b>,8 x 10-7,(EA),NR,'-,'-,'-,PARVB,Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005552,22:44107052
rs10488631-<b>?</b>,4 x 10-7,(EA),'-,'-,'-,'-,"IRF5, TNPO3",Systemic sclerosis (anti-topoisomerase-positive),anti-topoisomerase-I-antibody-positive systemic scleroderma,GCST005332,7:128954129
rs10024216-<b>?</b>,2 x 10-6,(EA),'-,'-,'-,'-,"TLR10, RNA5SP158",Systemic sclerosis (anti-topoisomerase-positive),anti-topoisomerase-I-antibody-positive systemic scleroderma,GCST005332,4:38762491
rs1641047-<b>?</b>,5 x 10-7,(EA),NR,'-,'-,'-,METTL22,Systemic sclerosis (anti-topoisomerase-positive),anti-topoisomerase-I-antibody-positive systemic scleroderma,GCST005551,16:8638375
rs17340351-<b>?</b>,1 x 10-8,(EA),NR,'-,'-,'-,"CYCSP20, TPI1P2",Systemic sclerosis (anti-topoisomerase-positive),anti-topoisomerase-I-antibody-positive systemic scleroderma,GCST005551,7:129068743
rs3809804-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,CAMKK1,Systemic sclerosis (anti-topoisomerase-positive),anti-topoisomerase-I-antibody-positive systemic scleroderma,GCST005551,17:3884181
rs2307293-<b>?</b>,3 x 10-6,(EA),NR,'-,'-,'-,MBD4,Systemic sclerosis (anti-topoisomerase-positive),anti-topoisomerase-I-antibody-positive systemic scleroderma,GCST005551,3:129431542
rs9277554-<b>C</b>,2 x 10-50,,0.708,4.17,'-,[3.33-5.00],HLA-DPB1,Wegener's granulomatosis,Granulomatosis with Polyangiitis,GCST002160,6:33087761
rs1883414-<b>?</b>,5 x 10-9,,0.67 (EA),1.28,'-,[NR],HLA-DPB2,Nephropathy,kidney disease,GCST001009,6:33118671
rs9357155-<b>?</b>,2 x 10-12,,0.87 (EA),1.41,'-,[NR],PSMB8,Nephropathy,kidney disease,GCST001009,6:32842071
rs9275596-<b>?</b>,2 x 10-26,,0.73 (EA),1.59,'-,[NR],"HLA-DQB3, MTCO3P1",Nephropathy,kidney disease,GCST001009,6:32713854
rs56094641-<b>?</b>,8 x 10-10,,NR,1.21,'-,[1.14-1.29],FTO,Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST007021,16:53772541
rs895157-<b>?</b>,1 x 10-6,,NR,1.23,'-,[1.13-1.34],"CYGB, PRCD",Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST007021,17:76544835
rs10144968-<b>?</b>,4 x 10-7,,NR,1.31,'-,[1.18-1.45],RAD51B,Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST007021,14:68684168
rs13306536-<b>?</b>,1 x 10-6,,NR,1.3,'-,[1.16-1.42],LRP8,Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST007021,1:53257550
rs7544082-<b>?</b>,3 x 10-6,,NR,1.16,'-,[1.04-1.31],"LINC01738, TRABD2B",Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST007021,1:47738318
rs11101179-<b>?</b>,9 x 10-6,,NR,1.15,'-,[1.08-1.23],"HMGB1P50, CHAT",Type 2 diabetes nephropathy,type 2 diabetes nephropathy,GCST007021,10:49602845
rs56094641-<b>G</b>,2 x 10-9,,NR,1.18,'-,[1.12-1.24],FTO,Type 2 diabetes nephropathy including microalbuminuria,"Moderate albuminuria, type 2 diabetes nephropathy",GCST007022,16:53772541
rs78954674-<b>A</b>,1 x 10-6,,NR,1.17,'-,[1.10-1.25],WWC1,Type 2 diabetes nephropathy including microalbuminuria,"Moderate albuminuria, type 2 diabetes nephropathy",GCST007022,5:168365677
rs16977473-<b>G</b>,2 x 10-7,,NR,1.27,'-,[1.15-1.39],CGNL1,Type 2 diabetes nephropathy including microalbuminuria,"Moderate albuminuria, type 2 diabetes nephropathy",GCST007022,15:57404428
rs895157-<b>G</b>,1 x 10-6,,NR,1.2,'-,[1.11-1.29],"CYGB, PRCD",Type 2 diabetes nephropathy including microalbuminuria,"Moderate albuminuria, type 2 diabetes nephropathy",GCST007022,17:76544835
rs16940484-<b>T</b>,6 x 10-7,,NR,1.13,'-,[1.08-1.19],TTC39C,Type 2 diabetes nephropathy including microalbuminuria,"Moderate albuminuria, type 2 diabetes nephropathy",GCST007022,18:24102336
rs73048515-<b>C</b>,5 x 10-7,,NR,1.52,'-,[1.28-1.79],LINC02114,Type 2 diabetes nephropathy including microalbuminuria,"Moderate albuminuria, type 2 diabetes nephropathy",GCST007022,5:4741874
rs10488631-<b>?</b>,1 x 10-9,(EA),'-,'-,'-,'-,"IRF5, TNPO3",Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005335,7:128954129
rs10235235-<b>?</b>,2 x 10-6,(EA),'-,'-,'-,'-,"ZNF394, ZNF789",Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005335,7:99478208
rs10488631-<b>?</b>,1 x 10-9,(EA),'-,'-,'-,'-,"IRF5, TNPO3",Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005335,7:128954129
rs11640251-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,VAC14,Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005553,16:70708633
rs12534421-<b>?</b>,4 x 10-6,(EA),NR,'-,'-,'-,TNPO3,Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005553,7:128984019
rs17340351-<b>?</b>,7 x 10-7,(EA),NR,'-,'-,'-,"CYCSP20, TPI1P2",Diffuse cutaneous systemic sclerosis,diffuse scleroderma,GCST005553,7:129068743
rs9268905-<b>?</b>,2 x 10-54,,0.37,1.79,'-,[1.67-1.93],HLA-DRB9,Giant cell arteritis,temporal arteritis,GCST003928,6:32464300
rs9275592-<b>?</b>,1 x 10-40,,0.11,2.08,'-,[1.87-2.32],"MTCO3P1, HLA-DQB3",Giant cell arteritis,temporal arteritis,GCST003928,6:32712843
rs4252134-<b>?</b>,1 x 10-10,,0.28,1.28,'-,[1.19-1.39],PLG,Giant cell arteritis,temporal arteritis,GCST003928,6:160732495
rs128738-<b>?</b>,5 x 10-9,,0.17,1.32,'-,[1.20-1.45],P4HA2,Giant cell arteritis,temporal arteritis,GCST003928,5:132205182
rs2256175-<b>?</b>,8 x 10-6,,NR,1.18,'-,'-,MICA,Giant cell arteritis,temporal arteritis,GCST003928,6:31412672
rs10160518-<b>A</b>,4 x 10-6,,0.494,1.2,'-,[1.11-1.29],"LINC02757, EMSY",Giant cell arteritis,temporal arteritis,GCST006198,11:76585627
rs477515-<b>?</b>,4 x 10-40,,'-,1.73,'-,[1.59-1.87],"HLA-DRB1, HLA-DQA1",Giant cell arteritis,temporal arteritis,GCST006198,6:32601914
rs6679677-<b>A</b>,1 x 10-6,,0.095,1.39,'-,[1.22-1.58],"RSBN1, PHTF1",Giant cell arteritis,temporal arteritis,GCST006198,1:113761186
rs3094013-<b>T</b>,6 x 10-76,,0.12,2.97,'-,[2.64–3.33],HCP5,Polymyositis,polymyositis,GCST006052,6:31466589
rs2476601-<b>A</b>,8 x 10-11,,0.09,1.58,'-,[1.38–1.81],PTPN22,Polymyositis,polymyositis,GCST006052,1:113834946
rs9905921-<b>C</b>,2 x 10-6,,0.43,1.26,'-,[1.14–1.39],SDK2,Polymyositis,polymyositis,GCST006052,17:73531104
rs7956536-<b>?</b>,4 x 10-6,,0.53,1.25,'-,'-,"MMAB, UBE3B",Polymyositis,polymyositis,GCST006052,12:109542711
rs2286896-<b>G</b>,4 x 10-6,,0.13,1.35,'-,[1.19–1.53],NAB1,Polymyositis,polymyositis,GCST006052,2:190670850
rs17799348-<b>?</b>,4 x 10-6,,0.61,1.25,'-,'-,"FAM167A, BLK",Polymyositis,polymyositis,GCST006052,8:11476012
rs1420095-<b>?</b>,6 x 10-6,,0.91,1.5873016,'-,'-,IL18R1,Polymyositis,polymyositis,GCST006052,2:102396442
rs4690220-<b>G</b>,8 x 10-6,,0.45,1.25,'-,[1.13–1.37],"DGKQ, SLC26A1",Polymyositis,polymyositis,GCST006052,4:986676
rs9266490-<b>G</b>,2 x 10-44,(Greater Middle Eastern),0.279,2.73,'-,[2.35-3.17],"RNU6-283P, FGFR3P1",Behcet's disease,Behcet's syndrome,GCST009887,6:31372381
rs681343-<b>T</b>,5 x 10-9,,0.435,1.3,'-,[1.19-1.41],FUT2,Behcet's disease,Behcet's syndrome,GCST009887,19:48703205
rs17810546-<b>G</b>,1 x 10-10,,'-,1.66,'-,[1.42-1.93],IL12A-AS1,Behcet's disease,Behcet's syndrome,GCST002824,3:159947262
rs17006292-<b>?</b>,5 x 10-9,,0.925,4.17,'-,[2.50-5.00],TFCP2L1,Behcet's disease,Behcet's syndrome,GCST001768,2:121261187
rs897200-<b>A</b>,6 x 10-9,,0.529,1.45,'-,[1.30-1.60],'-,Behcet's disease,Behcet's syndrome,GCST001768,Mapping not available
"rs7572482-<b>T</b>, rs7574070-<b>T</b>, rs897200-<b>A</b>",4 x 10-8,,NR,1.44,'-,[1.3-1.6],STAT4; STAT4; No mapped genes,Behcet's disease,Behcet's syndrome,GCST001768,2:191150346|2:191145762
rs4947296-<b>?</b>,1 x 10-11,,NR,2.57,'-,[1.96-3.37],"C6orf15, RNU6-1133P",Behcet's disease,Behcet's syndrome,GCST001768,6:31090401
rs4959053-<b>?</b>,2 x 10-20,,0.11,4.38,'-,[3.20-5.99],PSORS1C1,Behcet's disease,Behcet's syndrome,GCST001768,6:31131800
rs9266406-<b>?</b>,2 x 10-10,,0.4,2.29,'-,[1.77-2.95],"RNU6-283P, DHFRP2",Behcet's disease,Behcet's syndrome,GCST001768,6:31368641
rs7616215-<b>C</b>,4 x 10-13,,0.654,1.39,'-,[1.27-1.52],CCR3,Behcet's disease,Behcet's syndrome,GCST001804,3:46164194
rs7574070-<b>A</b>,1 x 10-9,,0.421,1.27,'-,[1.17-1.37],STAT4,Behcet's disease,Behcet's syndrome,GCST001804,2:191145762
rs2617170-<b>T</b>,1 x 10-9,,0.63,1.28,'-,[1.18-1.39],"KLRC4-KLRK1, KLRC4",Behcet's disease,Behcet's syndrome,GCST001804,12:10408358
rs17810546-<b>A</b>,6 x 10-7,(All Turkish cases),0.05,1.55,'-,[1.30-1.85],IL12A-AS1,Behcet's disease,Behcet's syndrome,GCST001804,3:159947262
rs17482078-<b>T</b>,5 x 10-11,(Turkish cases with Uveitis - Recessive Model),0.02,4.56,'-,[2.88-7.22],ERAP1,Behcet's disease,Behcet's syndrome,GCST001804,5:96783162
rs17482078-<b>T</b>,4 x 10-8,(All Turkish cases - Recessive Model),0.02,3.08,'-,[2.04-4.65],ERAP1,Behcet's disease,Behcet's syndrome,GCST001804,5:96783162
rs9344-<b>G</b>,1 x 10-11,,NR,1.7,'-,[1.46-1.98],CCND1,Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile),"AL amyloidosis, IgG isotype profile measurement",GCST004804,11:69648142
rs7820212-<b>A</b>,2 x 10-8,,NR,1.86,'-,[1.50-2.31],"ST18, ALKAL1",Immunoglobulin light chain (AL) amyloidosis (liver involvement),"AL amyloidosis, liver amyloid deposition measurement",GCST004807,8:52506268
rs6752376-<b>T</b>,3 x 10-8,,NR,1.54,'-,[1.32-1.79],LINC01247,Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement),"heart amyloid deposition measurement, AL amyloidosis, kidney amyloid deposition measurement",GCST004806,2:6303084
rs9344-<b>G</b>,2 x 10-12,,NR,1.62,'-,[1.42-1.85],CCND1,Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile),"AL amyloidosis, IgG isotype profile measurement",GCST004811,11:69648142
rs9344-<b>G</b>,9 x 10-11,,NR,1.4,'-,[1.27-1.55],CCND1,Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile),"AL amyloidosis, IgG isotype profile measurement",GCST004809,11:69648142
rs10507419-<b>A</b>,3 x 10-8,,NR,1.57,'-,[1.34-1.85],"LINC02343, LINC00457",Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile),"AL amyloidosis, IgG isotype profile measurement",GCST004809,13:34612315
rs9344-<b>G</b>,3 x 10-9,,NR,1.39,'-,[1.24-1.54],CCND1,Immunoglobulin light chain (AL) amyloidosis (heart involvement),"heart amyloid deposition measurement, AL amyloidosis",GCST004805,11:69648142
rs9344-<b>G</b>,7 x 10-8,,NR,1.34,'-,[1.20-1.48],CCND1,Immunoglobulin light chain (AL) amyloidosis (kidney involvement),"AL amyloidosis, kidney amyloid deposition measurement",GCST004812,11:69648142
rs10507419-<b>A</b>,6 x 10-8,,NR,1.49,'-,[1.29-1.72],"LINC02343, LINC00457",Immunoglobulin light chain (AL) amyloidosis (serum IgG profile),"AL amyloidosis, IgG isotype profile measurement",GCST004808,13:34612315
rs10799599-<b>C</b>,1 x 10-6,,0.62,1.26,'-,[1.15-1.39],"PLA2G2E, RN7SL304P",Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,1:19968007
rs142802669-<b>C</b>,3 x 10-6,,0.17,1.3,'-,[1.16-1.45],ULK4,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,3:41827935
rs4487645-<b>C</b>,2 x 10-9,,0.67,1.35,'-,[1.22-1.49],DNAH11,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,7:21898622
rs79419269-<b>C</b>,5 x 10-8,,0.12,1.41,'-,[1.25-1.60],SMARCD3,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,7:151239990
rs9344-<b>G</b>,8 x 10-11,,0.56,1.35,'-,[1.23-1.48],CCND1,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,11:69648142
rs11219122-<b>C</b>,2 x 10-6,,0.35,1.25,'-,[1.14-1.37],GRAMD1B,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,11:123369465
rs2273156-<b>C</b>,3 x 10-6,,0.19,1.29,'-,[1.16-1.44],SRP54-AS1,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,14:34969593
rs35629860-<b>A</b>,4 x 10-6,,0.26,1.26,'-,[1.14-1.39],FBRS,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,16:30660211
rs4792800-<b>G</b>,2 x 10-6,,0.12,1.36,'-,[1.20-1.54],TNFRSF13B,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,17:16941853
rs1005300-<b>G</b>,8 x 10-8,,0.59,1.29,'-,[1.17-1.41],CBX7,Immunoglobulin light chain (AL) amyloidosis,AL amyloidosis,GCST004028,22:39151886
rs1794275-<b>A</b>,3 x 10-13,,0.15,1.3,'-,[1.21-1.39],"MTCO3P1, HLA-DQB1",IgA nephropathy,IGA glomerulonephritis,GCST001364,6:32703471
rs3803800-<b>A</b>,9 x 10-11,,0.35,1.21,'-,[1.14-1.28],"TNFSF12-TNFSF13, TNFSF13",IgA nephropathy,IGA glomerulonephritis,GCST001364,17:7559652
rs4227-<b>G</b>,4 x 10-10,,0.21,1.23,'-,[1.16-1.32],MPDU1,IgA nephropathy,IGA glomerulonephritis,GCST001364,17:7587859
rs12537-<b>C</b>,1 x 10-11,,0.81,1.28,'-,[1.19-1.39],"MTMR3, HORMAD2-AS1",IgA nephropathy,IGA glomerulonephritis,GCST001364,22:30027471
rs2523946-<b>C</b>,2 x 10-11,,0.5,1.21,'-,[1.15-1.28],"HCG9, MICD",IgA nephropathy,IGA glomerulonephritis,GCST001364,6:29974166
rs660895-<b>G</b>,4 x 10-20,,0.24,1.34,'-,[1.26-1.42],"HLA-DRB1, HLA-DQA1",IgA nephropathy,IGA glomerulonephritis,GCST001364,6:32609603
rs4849121-<b>G</b>,4 x 10-7,,NR,1.15,'-,[1.09-1.22],ACOXL,IgA nephropathy,IGA glomerulonephritis,GCST001364,2:110842129
rs3925075-<b>?</b>,5 x 10-6,,NR,1.15,'-,[1.09-1.23],"ITGAX, ITGAM",IgA nephropathy,IGA glomerulonephritis,GCST001364,16:31336427
rs2738048-<b>A</b>,3 x 10-14,,0.68,1.27,'-,[1.19-1.35],"DEFA10P, DEFA9P",IgA nephropathy,IGA glomerulonephritis,GCST001364,8:6965263
rs2240335-<b>A</b>,8 x 10-8,(East Asian),0.547939232,1.1091988,'-,[1.0679854661803-1.15200265619976],PADI4,IgA nephropathy,IGA glomerulonephritis,GCST011781,1:17348042
rs6427389-<b>C</b>,5 x 10-9,(East Asian),0.768097488,1.1437908,'-,[1.09331878146096-1.19659278934148],"FCRL3, FCRL4",IgA nephropathy,IGA glomerulonephritis,GCST011781,1:157662221
rs6942325-<b>G</b>,3 x 10-11,(East Asian),0.764568298,1.162756,'-,[1.11206852374203-1.21575366390916],DUSP22,IgA nephropathy,IGA glomerulonephritis,GCST011781,6:249714
rs10086568-<b>A</b>,1 x 10-13,(East Asian),0.28504555,1.1676031,'-,[1.12074814397968-1.21641687788474],"DEFA5, DEFA7P",IgA nephropathy,IGA glomerulonephritis,GCST011781,8:7042814
rs11150612-<b>A</b>,5 x 10-6,(East Asian),0.676569222,1.1907115,'-,[1.10482834167314-1.28327066246977],"ITGAM, ITGAX",IgA nephropathy,IGA glomerulonephritis,GCST011781,16:31346439
rs4227-<b>G</b>,2 x 10-6,(East Asian),0.220607815,1.2215236,'-,[1.12553426820976-1.32569940367022],MPDU1,IgA nephropathy,IGA glomerulonephritis,GCST011781,17:7587859
rs2412971-<b>G</b>,6 x 10-13,(East Asian),0.696817033,1.3089627,'-,[1.21637835700499-1.40859410174048],HORMAD2,IgA nephropathy,IGA glomerulonephritis,GCST011781,22:30098382
rs11617740-<b>?</b>,7 x 10-7,(Afro-Caribbean),NR,16.69,'-,[5.53-51.97],FGF14,Preeclampsia,preeclampsia,GCST001949,13:102027776
rs2839440-<b>?</b>,1 x 10-6,(Afro-Caribbean),NR,5.31,'-,[2.70-10.42],ZNF295-AS1,Preeclampsia,preeclampsia,GCST001949,21:42023389
rs12641856-<b>?</b>,2 x 10-6,(Afro-Caribbean),NR,15.19,'-,[4.98-46.35],'-,Preeclampsia,preeclampsia,GCST001949,4:181688712
rs4815879-<b>?</b>,2 x 10-6,(Afro-Caribbean),NR,14.57,'-,[4.81-44.17],MCM8,Preeclampsia,preeclampsia,GCST001949,20:5968888
rs28360974-<b>?</b>,3 x 10-6,(Afro-Caribbean),NR,10.13,'-,[3.85-26.67],"MUC21, MUC22",Preeclampsia,preeclampsia,GCST001949,6:31008442
rs1248993-<b>?</b>,6 x 10-6,(Afro-Caribbean),NR,4.27,'-,[2.28-8.01],"BAMBI, LINC01517",Preeclampsia,preeclampsia,GCST001949,10:28738294
rs975369-<b>?</b>,8 x 10-6,(Afro-Caribbean),NR,4.55,'-,[2.34-8.83],'-,Preeclampsia,preeclampsia,GCST001949,7:25573041
rs1556832-<b>?</b>,9 x 10-6,(Afro-Caribbean),NR,4.33,'-,[2.27-8.27],ADRA1D,Preeclampsia,preeclampsia,GCST001949,20:4234910
rs11600901-<b>?</b>,9 x 10-6,(Afro-Caribbean),NR,9.83,'-,[3.58-27.00],"SCN4B, SCN2B",Preeclampsia,preeclampsia,GCST001949,11:118161271
rs7322722-<b>?</b>,1 x 10-6,(EA),NR,2.93,'-,[1.90-4.52],MYCBP2,Preeclampsia,preeclampsia,GCST001949,13:77305241
rs10989019-<b>?</b>,2 x 10-6,(EA),NR,3.21,'-,[1.98-5.20],INVS,Preeclampsia,preeclampsia,GCST001949,9:100214259
rs10883969-<b>?</b>,3 x 10-6,(EA),NR,2.97,'-,[1.88-4.69],SFR1,Preeclampsia,preeclampsia,GCST001949,10:104124358
rs7028939-<b>?</b>,3 x 10-6,(EA),NR,3.17,'-,[1.95-5.15],ERP44,Preeclampsia,preeclampsia,GCST001949,9:100046403
rs17787940-<b>?</b>,3 x 10-6,(EA),NR,3.17,'-,[1.95-5.16],WWTR1,Preeclampsia,preeclampsia,GCST001949,3:149532802
rs9976946-<b>?</b>,5 x 10-6,(EA),NR,5.5,'-,[2.65-11.39],RUNX1,Preeclampsia,preeclampsia,GCST001949,21:34835765
rs6563695-<b>?</b>,5 x 10-6,(EA),NR,3.65,'-,[2.09-6.36],LHFPL6,Preeclampsia,preeclampsia,GCST001949,13:39329106
rs17412740-<b>?</b>,2 x 10-6,(Hispanic),NR,6.08,'-,[2.88-12.81],LZTS1,Preeclampsia,preeclampsia,GCST001949,8:20389247
rs17636747-<b>?</b>,4 x 10-6,(Hispanic),NR,8.35,'-,[3.41-20.46],"GPR45, TGFBRAP1",Preeclampsia,preeclampsia,GCST001949,2:105261413
rs4642516-<b>T</b>,7 x 10-13,,0.73,3.030303,'-,[2.44-3.85],"HLA-DQB1, MTCO3P1",Childhood steroid-sensitive nephrotic syndrome,nephrotic syndrome,GCST006246,6:32689766
rs10174238-<b>?</b>,8 x 10-8,(EA),NR,'-,'-,'-,STAT4,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005334,2:191108308
rs10488631-<b>?</b>,3 x 10-10,(EA),NR,'-,'-,'-,"IRF5, TNPO3",Limited cutaneous systemic scleroderma,limited scleroderma,GCST005334,7:128954129
rs11642873-<b>?</b>,3 x 10-10,(EA),NR,'-,'-,'-,LINC02132,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005334,16:85958099
rs11724804-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,DGKQ,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005334,4:971991
rs4543123-<b>?</b>,2 x 10-7,(EA),NR,'-,'-,'-,TLR1,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005334,4:38790903
rs4959270-<b>?</b>,9 x 10-6,(EA),NR,'-,'-,'-,"IRF4, EXOC2",Limited cutaneous systemic scleroderma,limited scleroderma,GCST005334,6:457748
rs4554699-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,"FCGR2B, FCGR3B",Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,1:161638578
rs10174238-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,STAT4,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,2:191108308
rs11893432-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,STAT4,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,2:191057148
rs4554699-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,"FCGR2B, FCGR3B",Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,1:161638578
rs13239597-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,TPI1P2,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,7:129055929
rs11159878-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,TTC8,Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,14:88916597
rs10488631-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,"IRF5, TNPO3",Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,7:128954129
rs4256472-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"EXOC2, IRF4",Limited cutaneous systemic scleroderma,limited scleroderma,GCST005555,6:434915
rs4953345-<b>A</b>,5 x 10-10,(Western European),NR,1.25,'-,[1.17-1.33],EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST002835,2:46325462
rs72858496-<b>T</b>,2 x 10-7,(Western European),NR,1.46,'-,[1.32-1.60],ZEB2,Renal cell carcinoma,renal cell carcinoma,GCST002835,2:144452349
rs11263654-<b>C</b>,1 x 10-9,(Western European),NR,1.53,'-,[1.39-1.67],"MYEOV, LINC02747",Renal cell carcinoma,renal cell carcinoma,GCST002835,11:69423355
rs12105918-<b>?</b>,2 x 10-8,,0.056,1.45,'-,[1.20-1.75],ZEB2,Renal cell carcinoma,renal cell carcinoma,GCST001750,2:144450626
rs10054504-<b>?</b>,8 x 10-7,,0.11,1.37,'-,[1.19-1.58],PDZD2,Renal cell carcinoma,renal cell carcinoma,GCST001750,5:32000377
"rs6470588-<b>C</b>, rs35252396-<b>CG</b>, rs6470589-<b>G</b>",5 x 10-11,,0.46,1.27,'-,[1.18-1.37],PVT1; No mapped genes; No mapped genes,Renal cell carcinoma,renal cell carcinoma,GCST002273,8:127877125
rs1669539-<b>T</b>,1 x 10-6,,0.74,'-,1.52 mmHg increase,[0.89-2.15],ECRG4,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,2:105998818
rs3105491-<b>T</b>,2 x 10-6,,0.3,'-,1.52 mmHg increase,[0.89-2.15],SEPHS1P7,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,2:114223390
rs11568377-<b>A</b>,4 x 10-6,,0.17,'-,1.64 mmHg decrease,[0.95-2.33],ABCB11,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,2:168996710
rs826221-<b>A</b>,7 x 10-6,,0.93,'-,2.66 mmHg decrease,[1.50-3.82],THRB,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,3:24226945
rs10520528-<b>T</b>,2 x 10-6,,0.43,'-,1.3 mmHg increase,[0.77-1.83],TENM3,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,4:182339448
rs4869931-<b>A</b>,8 x 10-6,,0.47,'-,1.21 mmHg increase,[0.68-1.74],PLEKHG1,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,6:150688753
rs1442407-<b>T</b>,8 x 10-6,,0.1,'-,1.98 mmHg increase,[1.12-2.84],CSMD1,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,8:3234062
rs7045640-<b>A</b>,8 x 10-6,,0.76,'-,1.75 mmHg decrease,[0.99-2.51],CARM1P1,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,9:2978377
rs7952106-<b>G</b>,9 x 10-7,,0.23,'-,1.54 mmHg increase,[0.93-2.15],DRD2,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,11:113553836
rs11053548-<b>A</b>,5 x 10-6,,0.91,'-,2.12 mmHg increase,[1.22-3.02],CLEC12B,Systolic blood pressure in sickle cell anemia,"Sickle cell anemia, systolic blood pressure",GCST002187,12:10018128
rs766432-<b>C</b>,3 x 10-10,,0.29,'-,'-,'-,'-,Hemoglobin A2 levels in sickle cell anemia,"Sickle cell anemia, hemoglobin A2 measurement",GCST002536,Mapping not available
rs17020489-<b>A</b>,3 x 10-6,(AA),0.3,'-,'-,'-,RNA5SP99,Hemoglobin A2 levels in sickle cell anemia,"Sickle cell anemia, hemoglobin A2 measurement",GCST002536,2:81595057
rs67072384-<b>T</b>,7 x 10-7,,0.11,6.22,'-,[NR],ARAP1,Alloimmunization response to red blood cell transfusion in sickle cell anemia,"Sickle cell anemia, alloimmunization, response to red blood cell transfusion",GCST002691,11:72739679
rs1318772-<b>G</b>,1 x 10-6,,0.33,'-,0.91 unit decrease,[0.54-1.28],MCC,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,5:113387870
rs12559632-<b>A</b>,3 x 10-6,,0.25,'-,1.16 unit decrease,[0.69-1.63],PHEX,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,X:22142875
rs2577720-<b>C</b>,8 x 10-6,,0.33,'-,0.82 unit decrease,[0.47-1.17],KLHL29,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,2:23325743
rs11968814-<b>A</b>,9 x 10-7,,0.16,'-,1.17 unit decrease,[0.70-1.64],BECN1P2,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,6:71067268
rs3800569-<b>C</b>,6 x 10-6,,0.13,'-,1.2 unit increase,[0.69-1.71],ATP6V0A4,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,7:138726680
rs1845344-<b>T</b>,7 x 10-6,,0.27,'-,0.97 unit increase,[0.56-1.38],"LINC02502, MAD2L1",F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,4:120041230
rs10017284-<b>G</b>,6 x 10-6,,0.43,'-,0.85 unit decrease,[0.50-1.20],PRDM5,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,4:120592060
rs17135859-<b>C</b>,8 x 10-6,,0.19,'-,0.97 unit increase,[0.54-1.40],YTHDC2,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,5:113660957
rs12073837-<b>T</b>,2 x 10-6,,0.19,'-,1.39 unit increase,[0.82-1.96],HLX-AS1,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,1:220836863
rs924080-<b>?</b>,7 x 10-9,,NR,1.28,'-,[1.18-1.39],"IL12RB2, DNAJB6P4",Behcet's disease,Behcet's syndrome,GCST000726,1:67294457
rs1518111-<b>?</b>,4 x 10-18,,NR,1.45,'-,[1.34-1.58],"IL19, IL10",Behcet's disease,Behcet's syndrome,GCST000726,1:206771300
"rs9314614-<b>C</b>, rs2738058-<b>T</b>, rs12716641-<b>T</b>",5 x 10-22,,0.246,1.257,'-,[NR],GS1-24F4.2; DEFA9P - DEFA10P; No mapped genes,IgA nephropathy,IGA glomerulonephritis,GCST002943,8:6840209|8:6964095
rs7190997-<b>C</b>,2 x 10-19,,0.692,1.223,'-,[1.171-1.278],ITGAX,IgA nephropathy,IGA glomerulonephritis,GCST002943,16:31356857
rs2074038-<b>T</b>,4 x 10-9,,0.288,1.136,'-,[1.089-1.185],ACCS,IgA nephropathy,IGA glomerulonephritis,GCST002943,11:44066439
rs2033562-<b>C</b>,1 x 10-9,,0.477,1.128,'-,[1.085-1.173],"ODF1, RNU6-1224P",IgA nephropathy,IGA glomerulonephritis,GCST002943,8:102535511
rs7634389-<b>C</b>,7 x 10-10,,0.435,1.132,'-,[1.088-1.178],ST6GAL1,IgA nephropathy,IGA glomerulonephritis,GCST002943,3:187020633
rs2738058-<b>T</b>,2 x 10-27,,0.666,1.267,'-,[1.214-1.323],"DEFA10P, DEFA9P",IgA nephropathy,IGA glomerulonephritis,GCST002943,8:6964095
rs9314614-<b>C</b>,9 x 10-10,,0.36,1.135,'-,[1.1090-1.1182],GS1-24F4.2,IgA nephropathy,IGA glomerulonephritis,GCST002943,8:6840209
rs12716641-<b>T</b>,1 x 10-18,,0.743,1.233,'-,[1.177-1.292],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
rs12537-<b>C</b>,3 x 10-9,,0.817,1.407,'-,[1.258-1.573],"MTMR3, HORMAD2-AS1",IgA nephropathy,IGA glomerulonephritis,GCST002943,22:30027471
rs4227-<b>G</b>,2 x 10-6,,0.225,1.298,'-,[1.188-1.418],MPDU1,IgA nephropathy,IGA glomerulonephritis,GCST002943,17:7587859
rs2523946-<b>C</b>,5 x 10-11,,0.511,1.317,'-,[1.217-1.426],"HCG9, MICD",IgA nephropathy,IGA glomerulonephritis,GCST002943,6:29974166
rs660895-<b>G</b>,1 x 10-10,,0.259,1.289,'-,[1.184-1.402],"HLA-DRB1, HLA-DQA1",IgA nephropathy,IGA glomerulonephritis,GCST002943,6:32609603
HLA-<b>B*4001</b>,6 x 10-7,,0.1678,1.301,'-,[1.173-1.443],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
HLA-<b>DQB1*0302</b>,6 x 10-7,,0.0715,1.441,'-,[1.248-1.664],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
HLA-<b>DRB1*0901</b>,1 x 10-6,,0.1611,1.34,'-,[1.19-1.51],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
HLA-<b>DQB1*0303</b>,4 x 10-7,,0.1638,1.36,'-,[1.21-1.53],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
HLA-<b>DQA1*0102</b>,2 x 10-6,,0.174,1.31,'-,[1.18-1.47],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
HLA-<b>DQB1*0201</b>,1 x 10-6,,0.1093,1.44,'-,[1.25-1.67],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
HLA-<b>DQA1*0101</b>,9 x 10-6,,0.1033,1.299,'-,[1.157-1.458],'-,IgA nephropathy,IGA glomerulonephritis,GCST002943,Mapping not available
"rs9314614-<b>?</b>, rs2738058-<b>?</b>, rs12716641-<b>?</b>",1 x 10-7,,NR,1.18,'-,[NR],GS1-24F4.2; DEFA9P - DEFA10P; No mapped genes,IgA nephropathy,IGA glomerulonephritis,GCST002943,8:6840209|8:6964095
rs11264799-<b>C</b>,2 x 10-7,,0.775,1.135,'-,[1.082-1.191],"VDAC1P9, FCRL3",IgA nephropathy,IGA glomerulonephritis,GCST002943,1:157700967
rs2738048-<b>A</b>,5 x 10-9,,0.675,1.326,'-,[1.215-1.447],"DEFA10P, DEFA9P",IgA nephropathy,IGA glomerulonephritis,GCST002943,8:6965263
"rs9314614-<b>?</b>, rs2738058-<b>?</b>, rs12716641-<b>?</b>",4 x 10-13,,NR,1.29,'-,[NR],GS1-24F4.2; DEFA9P - DEFA10P; No mapped genes,IgA nephropathy,IGA glomerulonephritis,GCST002943,8:6840209|8:6964095
rs2523946-<b>C</b>,2 x 10-8,(East Asian),0.507759489,1.2170416,'-,[1.13667796674979-1.3030869883916],"HCG9, MICD",IgA nephropathy,IGA glomerulonephritis,GCST011781,6:29974166
rs2071543-<b>G</b>,1 x 10-6,(East Asian),0.818783623,1.2505606,'-,[1.14305470436016-1.36817776509077],PSMB8,IgA nephropathy,IGA glomerulonephritis,GCST011781,6:32843852
rs660895-<b>G</b>,1 x 10-14,(East Asian),0.253325587,1.3539767,'-,[1.25335647918749-1.46267487262285],"HLA-DRB1, HLA-DQA1",IgA nephropathy,IGA glomerulonephritis,GCST011781,6:32609603
rs2295119-<b>T</b>,3 x 10-14,(East Asian),0.229604271,1.3605813,'-,[1.25664462393162-1.47311444258073],HLA-DPA2,IgA nephropathy,IGA glomerulonephritis,GCST011781,6:33093093
rs9275596-<b>T</b>,2 x 10-13,(East Asian),0.846602517,1.4409347,'-,[1.3070519220741-1.58853123859263],"HLA-DQB3, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST011781,6:32713854
rs17212014-<b>?</b>,1 x 10-41,,NR,'-,2 unit increase,NR,"HLA-DQB1, MTCO3P1",Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive),Churg-Strauss syndrome,GCST009248,6:32669695
rs78478398-<b>?</b>,1 x 10-8,,NR,'-,1.62 unit increase,NR,"RNU7-106P, RPL7P38",Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive),Churg-Strauss syndrome,GCST009248,12:80034750
rs72689399-<b>?</b>,7 x 10-10,,NR,'-,1.78 unit increase,NR,GPA33,Eosinophilic granulomatosis with polyangiitis (ANCA negative),Churg-Strauss syndrome,GCST009249,1:167068884
rs6931740-<b>?</b>,3 x 10-9,,NR,'-,0.55 unit increase,NR,"HLA-DQB1, MTCO3P1",Eosinophilic granulomatosis with polyangiitis (ANCA negative),Churg-Strauss syndrome,GCST009249,6:32679692
rs72946301-<b>?</b>,9 x 10-11,,NR,'-,0.59 unit increase,NR,"ACOXL-AS1, ACOXL, MIR4435-2HG",Eosinophilic granulomatosis with polyangiitis,Churg-Strauss syndrome,GCST009250,2:111104261
rs1837253-<b>?</b>,5 x 10-11,,NR,'-,0.42 unit increase,NR,TSLP,Eosinophilic granulomatosis with polyangiitis,Churg-Strauss syndrome,GCST009250,5:111066174
rs9274704-<b>?</b>,1 x 10-20,,NR,'-,0.7 unit increase,NR,"MTCO3P1, HLA-DQB1",Eosinophilic granulomatosis with polyangiitis,Churg-Strauss syndrome,GCST009250,6:32669436
rs34574566-<b>?</b>,3 x 10-8,,NR,'-,0.36 unit decrease,NR,LINC02676,Eosinophilic granulomatosis with polyangiitis,Churg-Strauss syndrome,GCST009250,10:9000782
rs773506-<b>G</b>,6 x 10-6,,0.77,1.32,'-,[1.18-1.49],"LINC00484, AUH",Type 2 diabetes nephropathy,diabetic nephropathy,GCST000909,9:91213189
rs7769051-<b>A</b>,2 x 10-6,,0.29,1.28,'-,[1.16-1.42],"HMGB1P13, RPS12",Type 2 diabetes nephropathy,diabetic nephropathy,GCST000909,6:132825657
rs2358944-<b>G</b>,4 x 10-6,,0.77,1.33,'-,[1.18-1.49],"PCNPP3, RPSAP52",Type 2 diabetes nephropathy,diabetic nephropathy,GCST000909,12:65723778
rs6930576-<b>A</b>,7 x 10-7,,0.28,1.31,'-,[1.18-1.45],SASH1,Type 2 diabetes nephropathy,diabetic nephropathy,GCST000909,6:148383818
rs2106294-<b>T</b>,4 x 10-6,,0.94,1.75,'-,[1.39-2.22],LIMK2,Type 2 diabetes nephropathy,diabetic nephropathy,GCST000909,22:31249773
rs2099684-<b>C</b>,7 x 10-12,,0.26,1.54,'-,[1.36-1.75],"RPS23P10, HSPA6",Takayasu arteritis,Takayasu arteritis,GCST006984,1:161530340
rs17133698-<b>C</b>,3 x 10-9,,0.68,1.5151515,'-,[1.32-1.75],DUSP22,Takayasu arteritis,Takayasu arteritis,GCST006984,6:255562
rs2322599-<b>G</b>,3 x 10-13,,0.79,1.94,'-,[1.62-2.31],PTK2B,Takayasu arteritis,Takayasu arteritis,GCST006984,8:27354393
rs1713450-<b>C</b>,7 x 10-9,,0.13,1.55,'-,[1.34-1.80],KLHL33,Takayasu arteritis,Takayasu arteritis,GCST006984,14:20428086
rs103294-<b>T</b>,3 x 10-8,,0.75,1.53,'-,[1.31-1.77],"LILRA5, MIR4752",Takayasu arteritis,Takayasu arteritis,GCST006984,19:54293995
rs4817988-<b>G</b>,3 x 10-10,,0.8,1.77,'-,[1.48-2.11],RPL23AP12,Takayasu arteritis,Takayasu arteritis,GCST006984,21:39096912
rs117298325-<b>C</b>,4 x 10-34,,NR,'-,'-,'-,"LINC02571, HLA-B",Takayasu arteritis,Takayasu arteritis,GCST006984,6:31312441
rs12524487-<b>T</b>,6 x 10-16,,0.04,3.29,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST006863,Mapping not available
rs113452171-<b>T</b>,4 x 10-9,,0.093,2.34,'-,'-,"HLA-DQB1, HLA-DQA1",Takayasu arteritis,Takayasu arteritis,GCST006863,6:32658490
rs10919543-<b>G</b>,6 x 10-12,,0.413,1.81,'-,'-,"RPS23P10, FCGR3A",Takayasu arteritis,Takayasu arteritis,GCST006863,1:161538827
rs56167332-<b>A</b>,2 x 10-6,,NR,1.54,'-,'-,"LINC01845, IL12B",Takayasu arteritis,Takayasu arteritis,GCST006863,5:159400761
chr21:40462378:D-<b>?</b>,4 x 10-7,,NR,1.62,'-,'-,'-,Takayasu arteritis,Takayasu arteritis,GCST006863,Mapping not available
rs75853687-<b>A</b>,7 x 10-9,,0.008,16.5,'-,[3.9-69.3],LINC01847,Alloimmunization response to red blood cell transfusion in sickle cell anemia,"Sickle cell anemia, alloimmunization, response to red blood cell transfusion",GCST007210,5:159850278
rs766432-<b>?</b>,9 x 10-7,,NR,'-,0.22 unit increase,NR,'-,Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,Mapping not available
rs7948471-<b>A</b>,3 x 10-10,,0.21,'-,0.26 unit decrease,[0.18-0.34],"OR51B5, HBG2, OR51I2, HBE1",Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,11:5450516
rs7203560-<b>C</b>,2 x 10-9,,0.07,'-,0.44 unit decrease,[0.30-0.58],NPRL3,Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,16:134391
rs2445284-<b>G</b>,1 x 10-29,,0.05,'-,0.82 unit decrease,[0.68-0.96],"OR51L1, OR51P1P",Sickle cell anemia (haemolysis),Sickle cell anemia,GCST001862,11:5008473
rs1427407-<b>?</b>,4 x 10-53,,0.78,'-,0.3 unit decrease,[NR],'-,Fetal hemoglobin levels in sickle cell anemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST002687,Mapping not available
rs9494145-<b>?</b>,2 x 10-10,,0.05,'-,0.23 unit increase,[NR],"MYB, HBS1L",Fetal hemoglobin levels in sickle cell anemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST002687,6:135111414
rs1113932-<b>G</b>,9 x 10-6,(AA),0.06,'-,0.2881 unit increase,[NR],TMEFF2,Hemoglobin A2 levels in sickle cell anemia,"Sickle cell anemia, hemoglobin A2 measurement",GCST002536,2:192187627
"rs7557939-<b>?</b>, rs766432-<b>?</b>, rs1896296-<b>?</b>, rs10172646-<b>?</b>, rs10195871-<b>?</b>, rs11886868-<b>?</b>, rs7565301-<b>?</b>, rs7584113-<b>?</b>, rs7599488-<b>?</b>, rs7606173-<b>?</b>, rs6738440-<b>?</b>, rs1427407-<b>?</b>, rs1896294-<b>?</b>, rs6545816-<b>?</b>, rs4671393-<b>?</b>, rs6729815-<b>?</b>, rs6545817-<b>?</b>, rs1896295-<b>?</b>, rs10189857-<b>?</b>, rs6706648-<b>?</b>",2 x 10-7,,0.42,'-,1.07 unit increase,[0.68-1.46],BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; BCL11A; BCL11A; No mapped genes,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,2:60494212|2:60491212|2:60498316|2:60496537|2:60488044|2:60496951|2:60486100
"rs7557939-<b>?</b>, rs766432-<b>?</b>, rs1896296-<b>?</b>, rs10172646-<b>?</b>, rs10195871-<b>?</b>, rs11886868-<b>?</b>, rs7565301-<b>?</b>, rs7584113-<b>?</b>, rs7599488-<b>?</b>, rs7606173-<b>?</b>, rs6738440-<b>?</b>, rs1427407-<b>?</b>, rs1896294-<b>?</b>, rs6545816-<b>?</b>, rs4671393-<b>?</b>, rs6729815-<b>?</b>, rs6545817-<b>?</b>, rs1896295-<b>?</b>, rs10189857-<b>?</b>, rs6706648-<b>?</b>",2 x 10-16,,0.254,'-,1.98 unit increase,[1.57-2.39],BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; BCL11A; BCL11A; BCL11A; BCL11A; No mapped genes,F-cell distribution in sickle cell anaemia,"fetal hemoglobin measurement, Sickle cell anemia",GCST000982,2:60494212|2:60491212|2:60498316|2:60496537|2:60488044|2:60496951|2:60486100
rs887829-<b>A</b>,5 x 10-25,,0.45,'-,0.19 unit increase,[NR],"UGT1A10, UGT1A3, UGT1A5, UGT1A6, UGT1A8, UGT1A7, UGT1A9, UGT1A4",Cholelithiasis-related traits in sickle cell anemia,"Sickle cell anemia, cholelithiasis, bilirubin measurement",GCST001497,2:233759924
HLA-DRB1*11:04-<b>?</b>,2 x 10-24,,NR,3.14,'-,[2.52-3.91],'-,Systemic sclerosis,systemic scleroderma,GCST006493,Mapping not available
rs17424921-<b>C</b>,1 x 10-7,,NR,1.68,'-,[1.39-2.03],"CYCSP20, TPI1P2",Systemic sclerosis,systemic scleroderma,GCST006493,7:129068068
rs10488631-<b>C</b>,6 x 10-7,,NR,1.63,'-,[1.34-1.97],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST006493,7:128954129
rs4648133-<b>C</b>,3 x 10-7,,NR,1.47,'-,[1.27-1.7],NFKB1,Systemic sclerosis,systemic scleroderma,GCST006493,4:102615256
rs9821717-<b>?</b>,2 x 10-6,,NR,1.4285715,'-,[1.25-1.67],LMCD1-AS1,Systemic sclerosis,systemic scleroderma,GCST006493,3:7865390
rs12452554-<b>C</b>,4 x 10-6,,NR,1.81,'-,[1.41-2.33],UNC45B,Systemic sclerosis,systemic scleroderma,GCST006493,17:35174625
rs2059413-<b>?</b>,6 x 10-6,,NR,1.4084507,'-,[1.22-1.64],"PXDN, MYT1L",Systemic sclerosis,systemic scleroderma,GCST006493,2:1781887
rs917238-<b>G</b>,7 x 10-6,,NR,1.45,'-,[1.23-1.71],SPAG16,Systemic sclerosis,systemic scleroderma,GCST006493,2:150917165
rs3002626-<b>?</b>,7 x 10-6,,NR,1.4285715,'-,[1.22-1.67],ATF6,Systemic sclerosis,systemic scleroderma,GCST006493,1:161968102
rs9968446-<b>A</b>,8 x 10-6,,NR,1.37,'-,[1.19-1.57],"HOPX, RPL17P20",Systemic sclerosis,systemic scleroderma,GCST006493,4:56691923
rs473299-<b>A</b>,9 x 10-6,,NR,1.42,'-,[1.21-1.65],'-,Systemic sclerosis,systemic scleroderma,GCST006493,9:75428011
rs17831251-<b>C</b>,5 x 10-103,,NR,2.25,'-,[2.09-2.42],PLA2R1,Membranous nephropathy,membranous glomerulonephritis,GCST010004,2:160057645
rs230540-<b>C</b>,3 x 10-12,,NR,1.25,'-,[1.17-1.33],NFKB1,Membranous nephropathy,membranous glomerulonephritis,GCST010004,4:102575510
rs9405192-<b>G</b>,1 x 10-14,,NR,1.29,'-,[1.21-1.37],"IRF4, DUSP22",Membranous nephropathy,membranous glomerulonephritis,GCST010004,6:382537
rs9271573-<b>A</b>,3 x 10-154,,NR,2.41,'-,[2.26-2.57],"HLA-DQA1, HLA-DRB1",Membranous nephropathy,membranous glomerulonephritis,GCST010004,6:32622724
rs17831251-<b>C</b>,5 x 10-48,,0.61,1.98,'-,[1.81-2.17],PLA2R1,Membranous nephropathy,membranous glomerulonephritis,GCST010005,2:160057645
rs230540-<b>C</b>,8 x 10-7,,0.32,1.25,'-,[1.14-1.36],NFKB1,Membranous nephropathy,membranous glomerulonephritis,GCST010005,4:102575510
rs9271573-<b>A</b>,2 x 10-60,,0.44,2.06,'-,[1.89-2.25],"HLA-DQA1, HLA-DRB1",Membranous nephropathy,membranous glomerulonephritis,GCST010005,6:32622724
rs17831251-<b>C</b>,4 x 10-61,,0.7,2.81,'-,[2.48-3.17],PLA2R1,Membranous nephropathy,membranous glomerulonephritis,GCST010006,2:160057645
rs230540-<b>C</b>,2 x 10-61,,0.35,1.24,'-,[1.14-1.36],NFKB1,Membranous nephropathy,membranous glomerulonephritis,GCST010006,4:102575510
rs9405192-<b>G</b>,9 x 10-14,,0.42,1.4,'-,[1.28-1.53],"IRF4, DUSP22",Membranous nephropathy,membranous glomerulonephritis,GCST010006,6:382537
rs9271573-<b>A</b>,4 x 10-102,,0.35,2.97,'-,[2.69-3.28],"HLA-DQA1, HLA-DRB1",Membranous nephropathy,membranous glomerulonephritis,GCST010006,6:32622724
rs10911184-<b>?</b>,5 x 10-6,(additive),NR,1.2345679,'-,[1.11-1.35],"LAMC1, RNU6-41P",Diabetic kidney disease,diabetic nephropathy,GCST003099,1:182996532
rs1249910-<b>?</b>,8 x 10-6,(dominant),NR,1.3888888,'-,[1.19-1.61],"CCDC80, LINC02042",Diabetic kidney disease,diabetic nephropathy,GCST003099,3:112672327
rs13120432-<b>?</b>,4 x 10-6,(dominant),NR,1.5384616,'-,[1.25-1.92],'-,Diabetic kidney disease,diabetic nephropathy,GCST003099,4:96021887
rs6927188-<b>?</b>,6 x 10-6,(additive),NR,1.3513513,'-,[1.18-1.54],"RPL24P4, CNPY3",Diabetic kidney disease,diabetic nephropathy,GCST003099,6:42944851
rs594074-<b>?</b>,5 x 10-6,(dominant),NR,1.4084507,'-,[1.22-1.64],LY86-AS1,Diabetic kidney disease,diabetic nephropathy,GCST003099,6:6552761
rs12531478-<b>A</b>,4 x 10-6,(additive),NR,2.24,'-,1.59-3.15,AGMO,Diabetic kidney disease,diabetic nephropathy,GCST003099,7:15200269
rs2243480-<b>?</b>,8 x 10-6,(additive),NR,1.4084507,'-,[1.2-1.64],CRCP,Diabetic kidney disease,diabetic nephropathy,GCST003099,7:66134209
rs17373728-<b>C</b>,2 x 10-6,(additive),NR,1.34,'-,1.19-1.52,CASC9,Diabetic kidney disease,diabetic nephropathy,GCST003099,8:75313281
rs2780902-<b>?</b>,3 x 10-7,"(African American, dominant)",0.41,1.923077,'-,[1.52-2.5],JAK1,Diabetic kidney disease,diabetic nephropathy,GCST003099,1:64863417
rs1249910-<b>?</b>,1 x 10-6,"(African American, dominant)",0.35,2.0408163,'-,[1.54-2.78],"CCDC80, LINC02042",Diabetic kidney disease,diabetic nephropathy,GCST003099,3:112672327
rs1945380-<b>?</b>,2 x 10-6,"(African American, additive)",0.5,1.3888888,'-,[1.22-1.59],"ARL6IP1P3, LINC02720",Diabetic kidney disease,diabetic nephropathy,GCST003099,11:80707921
rs1396626-<b>?</b>,3 x 10-6,"(African American, recessive)",0.51,1.724138,'-,[1.37-2.17],LINC02607,Diabetic kidney disease,diabetic nephropathy,GCST003099,1:95559990
rs4598084-<b>?</b>,3 x 10-6,"(African American, recessive)",0.64,1.6666665,'-,[1.33-2.04],FUT9,Diabetic kidney disease,diabetic nephropathy,GCST003099,6:96082223
rs6962291-<b>?</b>,5 x 10-6,"(African American, additive)",0.6,1.3888888,'-,[1.2-1.61],TBXAS1,Diabetic kidney disease,diabetic nephropathy,GCST003099,7:139971318
rs2596230-<b>G</b>,9 x 10-6,"(African American, additive)",0.14,1.56,'-,1.28-1.89,RYR3,Diabetic kidney disease,diabetic nephropathy,GCST003099,15:33428525
rs8020941-<b>?</b>,9 x 10-6,"(African American, dominant)",0.78,1.5625,'-,[1.28-1.92],LINC02304,Diabetic kidney disease,diabetic nephropathy,GCST003099,14:97067025
rs1677894-<b>G</b>,9 x 10-6,(additive),NR,1.44,'-,1.22-1.70,NAV3,Diabetic kidney disease,diabetic nephropathy,GCST003099,12:77944156
rs11105956-<b>?</b>,6 x 10-6,(additive),NR,1.3513513,'-,[1.18-1.54],KERA,Diabetic kidney disease,diabetic nephropathy,GCST003099,12:91053746
rs490049-<b>?</b>,2 x 10-6,(dominant),NR,2,'-,[1.37-2.94],"TOMM22P3, KL",Diabetic kidney disease,diabetic nephropathy,GCST003099,13:32990725
rs903552-<b>?</b>,2 x 10-6,(dominant),NR,1.3513513,'-,[1.18-1.54],'-,Diabetic kidney disease,diabetic nephropathy,GCST003099,Mapping not available
rs4817984-<b>?</b>,3 x 10-8,(Turkish),0.71,1.8518518,'-,[1.49-2.27],RPL23AP12,Takayasu arteritis,Takayasu arteritis,GCST006575,21:39093140
rs7603494-<b>?</b>,2 x 10-7,(Turkish),0.5,1.6129031,'-,[1.35-1.92],"MSH6, MSH2",Takayasu arteritis,Takayasu arteritis,GCST006575,2:47676957
rs12047961-<b>A</b>,2 x 10-7,(EA),0.01,6.37,'-,[2.89-14.03],"SLAMF6P1, UHMK1",Takayasu arteritis,Takayasu arteritis,GCST006575,1:162479619
rs12511310-<b>?</b>,8 x 10-6,(Turkish),0.61,1.5625,'-,[1.28-1.89],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,4:10915291
rs10470752-<b>?</b>,2 x 10-6,(Turkish),0.75,1.754386,'-,[1.39-2.22],RN7SKP82,Takayasu arteritis,Takayasu arteritis,GCST006575,4:42823845
rs1868971-<b>?</b>,3 x 10-6,(EA),0.74,2.5,'-,[1.67-3.7],LINC02152,Takayasu arteritis,Takayasu arteritis,GCST006575,16:8235826
rs6904014-<b>T</b>,5 x 10-6,(EA),0.02,3.85,'-,[2.07-7.19],"AMD1P4, HIVEP1",Takayasu arteritis,Takayasu arteritis,GCST006575,6:11938439
rs4410768-<b>G</b>,2 x 10-10,(Turkish),0.03,3.52,'-,[2.34-5.30],PSORS1C1,Takayasu arteritis,Takayasu arteritis,GCST006575,6:31121931
rs4463283-<b>A</b>,1 x 10-6,(EA),0.06,2.61,'-,[1.74-3.90],"OR2J1, OR2B3",Takayasu arteritis,Takayasu arteritis,GCST006575,6:29097215
rs9266745-<b>G</b>,2 x 10-8,(Turkish),0.17,1.87,'-,[1.50-2.34],"MICA, HLA-S",Takayasu arteritis,Takayasu arteritis,GCST006575,6:31383435
rs9380141-<b>C</b>,1 x 10-6,(EA),0.29,1.94,'-,[1.48-2.55],"MICG, RPL7AP7",Takayasu arteritis,Takayasu arteritis,GCST006575,6:29809899
rs4713281-<b>A</b>,1 x 10-6,(EA),0.28,1.97,'-,[1.49-2.59],ZNRD1ASP,Takayasu arteritis,Takayasu arteritis,GCST006575,6:30010575
rs375244-<b>A</b>,3 x 10-6,(Turkish),0.28,1.57,'-,[1.30-1.90],NOTCH4,Takayasu arteritis,Takayasu arteritis,GCST006575,6:32223680
rs3817971-<b>C</b>,5 x 10-6,(Turkish),0.03,2.62,'-,[1.71-4.01],TSBP1-AS1,Takayasu arteritis,Takayasu arteritis,GCST006575,6:32393356
rs2736173-<b>A</b>,2 x 10-7,(EA),0.03,3.58,'-,[2.14-5.98],PRRC2A,Takayasu arteritis,Takayasu arteritis,GCST006575,6:31621958
rs28381348-<b>C</b>,5 x 10-6,(EA),0.04,2.81,'-,[1.77-4.47],"MSH5, MSH5-SAPCD1",Takayasu arteritis,Takayasu arteritis,GCST006575,6:31741133
rs41267090-<b>T</b>,8 x 10-7,(EA),0.05,2.82,'-,[1.84-4.33],"EHMT2-AS1, EHMT2",Takayasu arteritis,Takayasu arteritis,GCST006575,6:31880663
rs9380294-<b>C</b>,7 x 10-6,(EA),0.01,4.76,'-,[2.25-10.07],"TSBP1-AS1, HLA-DRA",Takayasu arteritis,Takayasu arteritis,GCST006575,6:32413132
rs1383258-<b>A</b>,2 x 10-10,(EA),0.04,3.68,'-,[2.40-5.64],HLA-DOB,Takayasu arteritis,Takayasu arteritis,GCST006575,6:32815628
rs12608210-<b>A</b>,1 x 10-6,(EA),0.29,1.95,'-,[1.48-2.56],LINC01894,Takayasu arteritis,Takayasu arteritis,GCST006575,18:24913920
rs12571685-<b>G</b>,6 x 10-6,(EA),0.08,2.33,'-,[1.60-3.39],CELF2-DT,Takayasu arteritis,Takayasu arteritis,GCST006575,10:10522460
rs2069837-<b>?</b>,7 x 10-9,,0.91,2.0833335,'-,[NR],IL6,Takayasu arteritis,Takayasu arteritis,GCST006575,7:22728408
rs12980600-<b>?</b>,2 x 10-8,,NR,1.6666665,'-,[NR],RPS9,Takayasu arteritis,Takayasu arteritis,GCST006575,19:54203380
rs10921544-<b>T</b>,3 x 10-7,(Turkish),0.05,2.59,'-,[1.78-3.78],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,1:194360431
rs9615754-<b>?</b>,4 x 10-6,(Turkish),0.85,1.923077,'-,[1.45-2.56],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,22:48083349
rs9917659-<b>?</b>,5 x 10-6,(Turkish),0.64,1.5625,'-,[1.3-1.89],"TRANK1, LINC02033",Takayasu arteritis,Takayasu arteritis,GCST006575,3:36822669
rs2660739-<b>A</b>,7 x 10-6,(EA),0.06,2.46,'-,[1.64-3.69],ROBO1,Takayasu arteritis,Takayasu arteritis,GCST006575,3:78644690
rs4981676-<b>G</b>,5 x 10-6,(EA),0.11,2.17,'-,[1.55-3.04],FOXG1-AS1,Takayasu arteritis,Takayasu arteritis,GCST006575,14:28744190
rs10144053-<b>T</b>,6 x 10-6,(EA),0.15,2.04,'-,[1.49-2.79],LINC01146,Takayasu arteritis,Takayasu arteritis,GCST006575,14:88038597
rs7743661-<b>C</b>,1 x 10-6,(Turkish),0.25,1.62,'-,[1.33-1.97],DDR1,Takayasu arteritis,Takayasu arteritis,GCST006575,6:30890477
chr6:26264671-<b>A</b>,5 x 10-7,(EA),0.01,4.71,'-,[2.43-9.16],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,Mapping not available
rs4624865-<b>C</b>,5 x 10-6,(EA),0.02,3.56,'-,[1.99-6.36],"GPX5, GPX6",Takayasu arteritis,Takayasu arteritis,GCST006575,6:28525919
rs3869115-<b>C</b>,6 x 10-7,(Turkish),0.06,2.23,'-,[1.62-3.08],"HLA-C, HCG27",Takayasu arteritis,Takayasu arteritis,GCST006575,6:31236917
rs5875188-<b>?</b>,7 x 10-6,(EA),0.06,2.52,'-,[1.66-3.83],"OR2U2P, OR14J1",Takayasu arteritis,Takayasu arteritis,GCST006575,6:29280788
chr6:31570670-<b>T</b>,1 x 10-9,(Turkish),0.06,2.56,'-,[1.88-3.50],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,Mapping not available
rs28399987-<b>A</b>,8 x 10-8,(Turkish),0.02,3.55,'-,[2.17-5.79],MSH5-SAPCD1,Takayasu arteritis,Takayasu arteritis,GCST006575,6:31762974
rs8111-<b>?</b>,1 x 10-6,(Turkish),0.6,1.5873016,'-,[1.32-1.92],ATF6B,Takayasu arteritis,Takayasu arteritis,GCST006575,6:32115398
rs12111032-<b>G</b>,1 x 10-9,(EA),0.24,2.32,'-,[1.76-3.06],"USP8P1, HLA-C",Takayasu arteritis,Takayasu arteritis,GCST006575,6:31274414
rs12524487-<b>T</b>,3 x 10-15,(EA),0.07,3.78,'-,[2.66-5.36],"MICA, HLA-S",Takayasu arteritis,Takayasu arteritis,GCST006575,6:31386461
rs9271539-<b>?</b>,2 x 10-7,(Turkish),0.56,1.6393442,'-,[1.35-1.96],"HLA-DQA1, HLA-DRB1",Takayasu arteritis,Takayasu arteritis,GCST006575,6:32622251
chr6:33036435-<b>G</b>,4 x 10-6,(Turkish),0.14,1.75,'-,[1.38-2.22],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,Mapping not available
rs2069837-<b>?</b>,2 x 10-7,(Turkish),0.81,1.9607843,'-,[1.52-2.56],IL6,Takayasu arteritis,Takayasu arteritis,GCST006575,7:22728408
rs7005183-<b>?</b>,6 x 10-6,(Turkish),0.6,1.5384616,'-,[1.28-1.85],PTK2B,Takayasu arteritis,Takayasu arteritis,GCST006575,8:27402967
rs7843437-<b>?</b>,1 x 10-6,(Turkish),0.62,1.6129031,'-,[1.32-1.96],"RN7SL675P, RNA5SP270",Takayasu arteritis,Takayasu arteritis,GCST006575,8:69925162
rs10816540-<b>?</b>,3 x 10-6,(Turkish),0.47,1.5384616,'-,[1.28-1.85],"RNU6-996P, PPIAP88",Takayasu arteritis,Takayasu arteritis,GCST006575,9:107608174
rs2457837-<b>T</b>,3 x 10-7,(Turkish),0.22,1.74,'-,[1.41-2.15],FRMD4A,Takayasu arteritis,Takayasu arteritis,GCST006575,10:14009457
rs12419742-<b>?</b>,9 x 10-6,(Turkish),0.92,2.5,'-,[1.64-3.7],OPCML,Takayasu arteritis,Takayasu arteritis,GCST006575,11:132452811
rs12321966-<b>?</b>,1 x 10-6,(Turkish),0.92,2.7027025,'-,[1.75-4],"Y_RNA, CLEC4E",Takayasu arteritis,Takayasu arteritis,GCST006575,12:8548569
rs7956657-<b>A</b>,4 x 10-6,(Turkish),0.11,1.83,'-,[1.41-2.37],SLC16A7,Takayasu arteritis,Takayasu arteritis,GCST006575,12:59835076
rs11666543-<b>?</b>,4 x 10-8,(Turkish),0.7,1.7857143,'-,[1.45-2.22],RPS9,Takayasu arteritis,Takayasu arteritis,GCST006575,19:54208113
rs4817984-<b>?</b>,1 x 10-10,,NR,1.8518518,'-,[NR],RPL23AP12,Takayasu arteritis,Takayasu arteritis,GCST006575,21:39093140
rs6560480-<b>C</b>,9 x 10-7,,NR,1.49,'-,[NR],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,Mapping not available
rs1113601-<b>?</b>,2 x 10-6,,NR,1.7857143,'-,[NR],ZFPM2,Takayasu arteritis,Takayasu arteritis,GCST006575,8:105325989
rs9615754-<b>?</b>,4 x 10-6,,NR,1.724138,'-,[NR],'-,Takayasu arteritis,Takayasu arteritis,GCST006575,22:48083349
rs410852-<b>G</b>,4 x 10-6,,NR,1.47,'-,[NR],"LILRA5, MIR4752",Takayasu arteritis,Takayasu arteritis,GCST006575,19:54296519
rs7956657-<b>A</b>,6 x 10-6,,NR,1.67,'-,[NR],SLC16A7,Takayasu arteritis,Takayasu arteritis,GCST006575,12:59835076
rs11675428-<b>?</b>,8 x 10-6,,NR,1.8518518,'-,[NR],"PPM1G, NRBP1",Takayasu arteritis,Takayasu arteritis,GCST006575,2:27419867
rs13260543-<b>?</b>,9 x 10-6,,NR,1.4285715,'-,[NR],PTK2B,Takayasu arteritis,Takayasu arteritis,GCST006575,8:27393808
rs55703767-<b>G</b>,5 x 10-12,,0.794,1.2658228,'-,[NR],"COL4A3, MFF-DT",Diabetic nephropathy in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009278,2:227256385
rs191449639-<b>A</b>,1 x 10-8,,0.005,32.42,'-,[NR],"MUC7, AMTN",Diabetic nephropathy in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009278,4:70493059
rs115061173-<b>A</b>,4 x 10-8,,0.014,9.4,'-,[NR],LINC01266,End-stage renal disease in Type 1 diabetics,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009279,3:884662
rs551191707-<b>CA</b>,4 x 10-8,,0.122,1.7,'-,[NR],"CASC19, PRNCR1, PCAT1",Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes,"albuminuria, type I diabetes mellitus, type 1 diabetes nephropathy",GCST009285,8:127087785
rs12615970-<b>A</b>,9 x 10-9,,0.867,1.3157895,'-,[NR],ALLC,Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009286,2:3697625
rs185299109-<b>T</b>,1 x 10-8,,0.007,20.75,'-,[NR],'-,Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009286,18:1811107
rs149641852-<b>T</b>,1 x 10-8,,0.012,9.01,'-,[NR],"MGC32805, SNCAIP",Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009287,5:122438887
rs55703767-<b>G</b>,5 x 10-9,,0.794,1.2987013,'-,[NR],"COL4A3, MFF-DT",Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009289,2:227256385
rs55703767-<b>G</b>,4 x 10-10,,0.794,1.2048193,'-,[NR],"COL4A3, MFF-DT",Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes,"albuminuria, type I diabetes mellitus, type 1 diabetes nephropathy",GCST009292,2:227256385
rs7588550-<b>A</b>,2 x 10-7,(T1DN),0.95,1.52,'-,[1.30-1.79],ERBB4,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,2:212304043
rs12437854-<b>G</b>,2 x 10-9,(ESRD vs. non-ESRD),0.04,1.8,'-,[1.48-2.17],'-,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,15:93598604
rs7583877-<b>C</b>,1 x 10-8,(ESRD vs. non-ESRD),0.29,1.29,'-,[1.18-1.40],AFF3,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,2:99844192
rs6027506-<b>A</b>,5 x 10-6,(ESRD vs. non-ESRD),0.63,1.22,'-,[1.12-1.32],MIR646HG,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,20:60321657
rs7583877-<b>C</b>,3 x 10-7,(ESRD),0.3,1.29,'-,[1.17-1.42],AFF3,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,2:99844192
rs11723864-<b>G</b>,7 x 10-7,(ESRD),0.11,1.51,'-,[1.29-1.78],HAND2-AS1,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,4:173653255
rs878889-<b>A</b>,8 x 10-7,(ESRD),0.13,1.43,'-,[1.24-1.65],OTX2,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,14:56754421
rs614226-<b>C</b>,2 x 10-6,(ESRD),0.83,1.35,'-,[1.19-1.54],RNF10,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,12:120536707
rs13045180-<b>T</b>,9 x 10-6,(ESRD),0.19,1.28,'-,[1.15-1.43],EFCAB8,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,20:32943738
rs11698685-<b>G</b>,1 x 10-6,(ESRD),0.68,1.27,'-,[1.15-1.39],MIR646HG,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,20:60320788
rs4871297-<b>A</b>,2 x 10-6,(ESRD),0.52,1.23,'-,[1.14-1.35],LINC01151,Type 1 diabetes nephropathy,type 1 diabetes nephropathy,GCST001688,8:122693916
rs718314-<b>?</b>,9 x 10-10,,NR,1.19,'-,[1.13-1.26],"SSPN, ITPR2",Renal cell carcinoma,renal cell carcinoma,GCST001283,12:26300350
rs4980785-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"LINC02747, MYEOV",Renal cell carcinoma,renal cell carcinoma,GCST001283,11:69419726
rs25422-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,CEP85L,Renal cell carcinoma,renal cell carcinoma,GCST001283,6:118486684
rs4765623-<b>?</b>,3 x 10-8,,0.34,1.15,'-,[1.09-1.20],SCARB1,Renal cell carcinoma,renal cell carcinoma,GCST000907,12:124836304
rs7579899-<b>?</b>,2 x 10-9,,0.4,1.15,'-,[1.10-1.21],EPAS1,Renal cell carcinoma,renal cell carcinoma,GCST000907,2:46310465
rs7105934-<b>?</b>,8 x 10-14,,0.93,1.45,'-,[1.32-1.61],"LINC02747, MYEOV",Renal cell carcinoma,renal cell carcinoma,GCST000907,11:69424973
rs9839909-<b>?</b>,3 x 10-6,(dominant),0.66,1.2,'-,[1.11-1.32],PLD1,Renal cell carcinoma,renal cell carcinoma,GCST000907,3:171790673
rs12531711-<b>?</b>,5 x 10-10,(EA),'-,'-,'-,'-,TNPO3,Systemic sclerosis,systemic scleroderma,GCST005336,7:128977412
rs2056626-<b>?</b>,6 x 10-6,(EA),'-,'-,'-,'-,CD247,Systemic sclerosis,systemic scleroderma,GCST005336,1:167451188
rs2290405-<b>?</b>,2 x 10-6,(EA),'-,'-,'-,'-,TMEM175,Systemic sclerosis,systemic scleroderma,GCST005336,4:953186
rs10186029-<b>?</b>,1 x 10-6,(AA),'-,'-,'-,'-,IKZF2,Systemic sclerosis,systemic scleroderma,GCST005336,2:213064562
rs12363310-<b>?</b>,4 x 10-6,(AA),'-,'-,'-,'-,TRPC6,Systemic sclerosis,systemic scleroderma,GCST005336,11:101871526
rs644637-<b>?</b>,5 x 10-6,(AA),'-,'-,'-,'-,"TULP4, GTF2H5",Systemic sclerosis,systemic scleroderma,GCST005336,6:158203782
rs10174238-<b>?</b>,5 x 10-13,(EA),NR,'-,'-,'-,STAT4,Systemic sclerosis,systemic scleroderma,GCST005554,2:191108308
rs17340351-<b>?</b>,2 x 10-10,(EA),NR,'-,'-,'-,"CYCSP20, TPI1P2",Systemic sclerosis,systemic scleroderma,GCST005554,7:129068743
rs12534421-<b>?</b>,7 x 10-10,(EA),NR,'-,'-,'-,TNPO3,Systemic sclerosis,systemic scleroderma,GCST005554,7:128984019
rs10463312-<b>?</b>,5 x 10-6,(EA),NR,'-,'-,'-,TNIP1,Systemic sclerosis,systemic scleroderma,GCST005554,5:151031333
rs2201584-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,IL12RB2,Systemic sclerosis,systemic scleroderma,GCST005554,1:67322032
rs2409781-<b>?</b>,3 x 10-8,(EA),NR,'-,'-,'-,BLK,Systemic sclerosis,systemic scleroderma,GCST005554,8:11502048
rs11893432-<b>?</b>,4 x 10-11,(EA),NR,'-,'-,'-,STAT4,Systemic sclerosis,systemic scleroderma,GCST005554,2:191057148
rs4554699-<b>?</b>,3 x 10-8,(EA),NR,'-,'-,'-,"FCGR2B, FCGR3B",Systemic sclerosis,systemic scleroderma,GCST005554,1:161638578
rs4317805-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,CR2,Systemic sclerosis,systemic scleroderma,GCST005554,1:207479647
rs6073976-<b>?</b>,1 x 10-7,(EA),NR,'-,'-,'-,"MMP9, FTLP1",Systemic sclerosis,systemic scleroderma,GCST005554,20:45980011
rs6659932-<b>A</b>,1 x 10-11,,'-,'-,'-,[NR],IL12RB2,Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,1:67336688
rs2548998-<b>G</b>,2 x 10-11,,'-,'-,'-,[NR],IRF1,Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,5:132496822
rs68191-<b>C</b>,1 x 10-10,,'-,'-,'-,[NR],"GGNBP1, ZBTB9",Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,6:33512961
rs4796791-<b>T</b>,3 x 10-8,,'-,'-,'-,[NR],STAT3,Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,17:42378745
rs3790566-<b>T</b>,4 x 10-10,,0.24,1.16,'-,'-,IL12RB2,Systemic sclerosis,systemic scleroderma,GCST009131,1:67348757
rs2056626-<b>?</b>,1 x 10-11,,0.61,1.2345679,'-,'-,CD247,Systemic sclerosis,systemic scleroderma,GCST009131,1:167451188
rs1857066-<b>?</b>,5 x 10-9,,0.25,1.1494253,'-,'-,PRDX6-AS1,Systemic sclerosis,systemic scleroderma,GCST009131,1:173363490
rs16832798-<b>C</b>,5 x 10-9,,0.14,1.18,'-,'-,NAB1,Systemic sclerosis,systemic scleroderma,GCST009131,2:190669646
rs3821236-<b>A</b>,2 x 10-23,,0.2,1.31,'-,'-,STAT4,Systemic sclerosis,systemic scleroderma,GCST009131,2:191038032
rs4076852-<b>G</b>,1 x 10-10,,0.26,1.16,'-,'-,PXK,Systemic sclerosis,systemic scleroderma,GCST009131,3:58389559
rs9884090-<b>?</b>,2 x 10-10,,0.84,1.2048193,'-,'-,ARHGAP31,Systemic sclerosis,systemic scleroderma,GCST009131,3:119397303
rs589446-<b>?</b>,2 x 10-10,,0.65,1.1627907,'-,'-,IL12A-AS1,Systemic sclerosis,systemic scleroderma,GCST009131,3:160015740
rs11724804-<b>A</b>,5 x 10-11,,0.44,1.17,'-,'-,DGKQ,Systemic sclerosis,systemic scleroderma,GCST009131,4:971991
rs230534-<b>T</b>,5 x 10-9,,0.34,1.15,'-,'-,NFKB1,Systemic sclerosis,systemic scleroderma,GCST009131,4:102527884
rs3792783-<b>G</b>,2 x 10-12,,0.16,1.2,'-,'-,TNIP1,Systemic sclerosis,systemic scleroderma,GCST009131,5:151076171
rs633724-<b>T</b>,3 x 10-9,,0.35,1.13,'-,'-,ATG5,Systemic sclerosis,systemic scleroderma,GCST009131,6:106286165
rs36073657-<b>T</b>,3 x 10-21,,0.1,1.4,'-,'-,TNPO3,Systemic sclerosis,systemic scleroderma,GCST009131,7:129011468
rs2736340-<b>T</b>,3 x 10-21,,0.24,1.24,'-,'-,"BLK, FAM167A",Systemic sclerosis,systemic scleroderma,GCST009131,8:11486464
rs685985-<b>?</b>,4 x 10-8,,0.53,1.1494253,'-,'-,"RAB2A, CHD7",Systemic sclerosis,systemic scleroderma,GCST009131,8:60652405
rs6598008-<b>?</b>,2 x 10-8,,0.56,1.25,'-,'-,CDHR5,Systemic sclerosis,systemic scleroderma,GCST009131,11:618172
rs2651804-<b>?</b>,3 x 10-10,,0.83,1.2195122,'-,'-,"CD81-AS1, RNU6-878P",Systemic sclerosis,systemic scleroderma,GCST009131,11:2327389
rs11217020-<b>?</b>,2 x 10-11,,0.8,1.1904762,'-,'-,DDX6,Systemic sclerosis,systemic scleroderma,GCST009131,11:118768644
rs1378942-<b>C</b>,2 x 10-14,,0.39,1.18,'-,'-,CSK,Systemic sclerosis,systemic scleroderma,GCST009131,15:74785026
rs11117420-<b>?</b>,4 x 10-15,,0.81,1.2345679,'-,'-,LINC02132,Systemic sclerosis,systemic scleroderma,GCST009131,16:85938316
rs883770-<b>T</b>,5 x 10-9,,0.5,1.13,'-,'-,GSDMB,Systemic sclerosis,systemic scleroderma,GCST009131,17:39907128
rs1005714-<b>?</b>,2 x 10-8,,0.8,1.1764705,'-,'-,NUP85,Systemic sclerosis,systemic scleroderma,GCST009131,17:75228544
rs2305743-<b>?</b>,5 x 10-10,,0.8,1.2048193,'-,'-,IL12RB1,Systemic sclerosis,systemic scleroderma,GCST009131,19:18082381
rs7574865-<b>T</b>,2 x 10-13,,0.22,1.38,'-,[1.27-1.50],STAT4,Systemic sclerosis,systemic scleroderma,GCST001146,2:191099907
rs10488631-<b>C</b>,4 x 10-7,,0.09,1.35,'-,[1.20-1.51],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST001146,7:128954129
rs2056626-<b>T</b>,1 x 10-6,,0.61,1.2,'-,[1.12-1.30],CD247,Systemic sclerosis,systemic scleroderma,GCST001146,1:167451188
rs3130573-<b>G</b>,6 x 10-10,,0.32,1.25,'-,[1.17-1.35],'-,Systemic sclerosis,systemic scleroderma,GCST001146,Mapping not available
rs6457617-<b>T</b>,2 x 10-37,,0.5,1.61,'-,[1.49-1.72],"HLA-DQB1, MTCO3P1",Systemic sclerosis,systemic scleroderma,GCST001146,6:32696074
rs13021401-<b>T</b>,3 x 10-6,,0.23,1.21,'-,[1.12-1.31],"NDUFAF2P1, Y_RNA",Systemic sclerosis,systemic scleroderma,GCST001146,2:20488758
rs2233287-<b>A</b>,5 x 10-9,,0.1,1.31,'-,[1.15-1.43],TNIP1,Systemic sclerosis,systemic scleroderma,GCST001146,5:151060536
rs7574865-<b>T</b>,4 x 10-12,,0.3284,1.43,'-,[1.29-1.58],STAT4,Systemic sclerosis,systemic scleroderma,GCST011709,2:191099907
rs76285340-<b>T</b>,2 x 10-11,,0.0077,3.3,'-,[2.30-4.74],"FLG2, FLG-AS1",Systemic sclerosis,systemic scleroderma,GCST011709,1:152357053
rs45471499-<b>A</b>,1 x 10-9,,0.1021,1.55,'-,[1.35-1.79],IGHM,Systemic sclerosis,systemic scleroderma,GCST011709,14:105855225
rs4317244-<b>G</b>,4 x 10-8,,0.1199,1.53,'-,[1.31-1.79],"UFSP2, ANKRD37",Systemic sclerosis,systemic scleroderma,GCST011709,4:185399752
rs7574865-<b>T</b>,4 x 10-14,,NR,1.477,'-,[1.335-1.634],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001708,2:191099907
rs12531711-<b>A</b>,6 x 10-13,,NR,1.593,'-,[1.403-1.808],TNPO3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001708,7:128977412
rs13277113-<b>A</b>,2 x 10-10,,NR,1.391,'-,[1.256-1.540],BLK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001708,8:11491677
rs729302-<b>A</b>,4 x 10-8,,NR,1.29,'-,[1.41-1.18],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001708,7:128928906
rs11150612-<b>A</b>,1 x 10-8,(EA),0.36,1.19,'-,[NR],"ITGAM, ITGAX",IgA nephropathy,IGA glomerulonephritis,GCST002655,16:31346439
rs4077515-<b>T</b>,2 x 10-8,(EA),0.4,1.18,'-,[NR],CARD9,IgA nephropathy,IGA glomerulonephritis,GCST002655,9:136372044
rs17019602-<b>G</b>,8 x 10-7,(EA),0.19,1.19,'-,[NR],VAV3,IgA nephropathy,IGA glomerulonephritis,GCST002655,1:107646236
rs17019602-<b>G</b>,7 x 10-9,,0.19,1.17,'-,[NR],VAV3,IgA nephropathy,IGA glomerulonephritis,GCST002655,1:107646236
rs6677604-<b>G</b>,5 x 10-14,,0.8,1.35,'-,[NR],CFH,IgA nephropathy,IGA glomerulonephritis,GCST002655,1:196717788
rs7763262-<b>C</b>,2 x 10-38,,0.69,1.41,'-,[NR],"HLA-DRB9, HLA-DRA",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32457105
rs10086568-<b>A</b>,1 x 10-9,,0.33,1.16,'-,[NR],"DEFA5, DEFA7P",IgA nephropathy,IGA glomerulonephritis,GCST002655,8:7042814
rs4077515-<b>T</b>,1 x 10-9,,0.4,1.16,'-,[NR],CARD9,IgA nephropathy,IGA glomerulonephritis,GCST002655,9:136372044
rs11150612-<b>A</b>,1 x 10-11,,0.36,1.18,'-,[NR],"ITGAM, ITGAX",IgA nephropathy,IGA glomerulonephritis,GCST002655,16:31346439
rs11574637-<b>T</b>,8 x 10-13,(EA),0.82,1.32,'-,[NR],ITGAX,IgA nephropathy,IGA glomerulonephritis,GCST002655,16:31357553
rs3803800-<b>A</b>,9 x 10-6,,0.2,1.12,'-,[NR],"TNFSF12-TNFSF13, TNFSF13",IgA nephropathy,IGA glomerulonephritis,GCST002655,17:7559652
rs2412971-<b>G</b>,5 x 10-12,,0.54,1.2,'-,[NR],HORMAD2,IgA nephropathy,IGA glomerulonephritis,GCST002655,22:30098382
rs12568771-<b>G</b>,2 x 10-6,,NR,1.12,'-,[NR],"PADI4, PADI3",IgA nephropathy,IGA glomerulonephritis,GCST002655,1:17287314
rs1883414-<b>G</b>,5 x 10-7,(EA),0.68,1.2,'-,[NR],HLA-DPB2,IgA nephropathy,IGA glomerulonephritis,GCST002655,6:33118671
rs6677604-<b>G</b>,2 x 10-9,(EA),0.8,1.3,'-,[NR],CFH,IgA nephropathy,IGA glomerulonephritis,GCST002655,1:196717788
rs2412971-<b>G</b>,6 x 10-11,(East Asian),0.67,1.35,'-,[NR],HORMAD2,IgA nephropathy,IGA glomerulonephritis,GCST002655,22:30098382
rs3129269-<b>C</b>,5 x 10-7,(East Asian),NR,1.29,'-,[NR],"HLA-DPB2, HLA-DPA3",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:33129837
rs2071543-<b>G</b>,2 x 10-9,(East Asian),0.8,1.41,'-,[NR],PSMB8,IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32843852
rs2738048-<b>T</b>,1 x 10-7,(East Asian),0.68,1.23,'-,[NR],"DEFA10P, DEFA9P",IgA nephropathy,IGA glomerulonephritis,GCST002655,8:6965263
rs7763262-<b>C</b>,1 x 10-30,(EA),0.69,1.49,'-,[NR],"HLA-DRB9, HLA-DRA",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32457105
rs7763262-<b>C</b>,1 x 10-10,(East Asian),0.72,1.3,'-,[NR],"HLA-DRB9, HLA-DRA",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32457105
rs6677604-<b>G</b>,7 x 10-7,(East Asian),0.93,1.57,'-,[NR],CFH,IgA nephropathy,IGA glomerulonephritis,GCST002655,1:196717788
rs1883414-<b>G</b>,2 x 10-11,,0.68,1.22,'-,[NR],HLA-DPB2,IgA nephropathy,IGA glomerulonephritis,GCST002655,6:33118671
rs9275224-<b>G</b>,6 x 10-30,,0.51,1.36,'-,[NR],"HLA-DQB1, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32692101
rs9275224-<b>G</b>,6 x 10-18,(EA),0.51,1.38,'-,[NR],"HLA-DQB1, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32692101
rs9275224-<b>G</b>,8 x 10-14,(East Asian),0.59,1.38,'-,'-,"HLA-DQB1, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32692101
rs2856717-<b>G</b>,1 x 10-15,,0.62,1.27,'-,[NR],"HLA-DQB1, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32702531
rs2856717-<b>G</b>,5 x 10-8,(EA),0.62,1.21,'-,[NR],"HLA-DQB1, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32702531
rs2856717-<b>G</b>,5 x 10-10,(East Asian),0.77,1.38,'-,[NR],"HLA-DQB1, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32702531
rs9275596-<b>T</b>,3 x 10-31,,0.65,1.44,'-,[NR],"HLA-DQB3, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32713854
rs9275596-<b>T</b>,2 x 10-15,(EA),0.65,1.35,'-,'-,"HLA-DQB3, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32713854
rs9275596-<b>T</b>,1 x 10-19,(East Asian),0.8,1.69,'-,[NR],"HLA-DQB3, MTCO3P1",IgA nephropathy,IGA glomerulonephritis,GCST002655,6:32713854
rs10783124-<b>G</b>,1 x 10-6,,0.09,2.23,'-,[NR],"AGL, SLC35A3",Incident chronic kidney disease,chronic kidney disease,GCST007734,1:99937719
rs1505141-<b>C</b>,6 x 10-7,,0.675,1.61,'-,[NR],'-,Incident chronic kidney disease,chronic kidney disease,GCST007734,13:76307915
rs200787930-<b>C</b>,5 x 10-8,,0.988,4.347826,'-,'-,PLCB2,Chronic kidney disease,chronic kidney disease,GCST010478,15:40289298
rs188378669-<b>G</b>,8 x 10-8,,0.988,4.347826,'-,'-,CXCL8,Chronic kidney disease,chronic kidney disease,GCST010478,4:73741568
rs199921354-<b>C</b>,8 x 10-8,,0.988,4.347826,'-,'-,VPS33B,Chronic kidney disease,chronic kidney disease,GCST010478,15:91013841
rs115287176-<b>G</b>,1 x 10-7,,0.988,4.347826,'-,'-,TMOD4,Chronic kidney disease,chronic kidney disease,GCST010478,1:151170961
rs192210727-<b>G</b>,2 x 10-7,,0.987,4,'-,'-,ADGRL3,Chronic kidney disease,chronic kidney disease,GCST010478,4:61909615
rs146879198-<b>G</b>,3 x 10-7,,0.988,4.166667,'-,'-,ZNF77,Chronic kidney disease,chronic kidney disease,GCST010478,19:2934109
rs146092501-<b>C</b>,3 x 10-7,,0.988,4.166667,'-,'-,COL6A3,Chronic kidney disease,chronic kidney disease,GCST010478,2:237371861
rs200982668-<b>G</b>,5 x 10-9,,0.987,4.7619047,'-,'-,COL6A5,Chronic kidney disease,chronic kidney disease,GCST010478,3:130470894
rs61734696-<b>G</b>,2 x 10-8,,0.988,4.5454545,'-,'-,"MARCHF1, ANP32C",Chronic kidney disease,chronic kidney disease,GCST010478,4:164197303
rs78010183-<b>A</b>,2 x 10-8,,0.982,3.448276,'-,'-,MUC17,Chronic kidney disease,chronic kidney disease,GCST010478,7:101035329
rs139537100-<b>C</b>,5 x 10-8,,0.988,4.347826,'-,'-,"MOB3C, MKNK1",Chronic kidney disease,chronic kidney disease,GCST010478,1:46615006
rs11133665-<b>A</b>,6 x 10-12,,0.28,'-,0.17 unit decrease,[0.13-0.21],"CTD-3080P12.3, SLC6A19",Urine 6-bromotryptophan levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST010559,5:1188170
rs145600547-<b>A</b>,3 x 10-13,,0.03,'-,0.45 unit decrease,[0.33-0.57],ERO1A,Urine 6-bromotryptophan levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST010559,14:52648633
rs13111638-<b>T</b>,2 x 10-13,,0.19,'-,0.31 mg/dl decrease,[0.23-0.39],SLC2A9,Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,4:9995266
rs2231142-<b>T</b>,9 x 10-14,,0.11,'-,0.4 mg/dl increase,[0.3-0.5],ABCG2,Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,4:88131171
rs9379832-<b>G</b>,9 x 10-7,,0.33,'-,0.18 mg/dl decrease,[0.11-0.25],"H4C4, H2BC6",Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,6:26185972
rs62416056-<b>C</b>,1 x 10-7,,0.17,'-,0.23 mg/dl increase,[0.14-0.32],GJA10,Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,6:89918054
rs76909566-<b>A</b>,5 x 10-8,,0.09,'-,0.33 mg/dl increase,[0.21-0.45],NFIC,Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,19:3456658
rs4805497-<b>A</b>,5 x 10-8,,0.92,'-,0.34 mg/dl increase,[0.22-0.46],"CCNE1, PPIAP58",Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,19:29914778
rs78260152-<b>T</b>,2 x 10-7,,0.07,'-,0.34 mg/dl increase,[0.21-0.47],LINC01721,Serum urate levels in chronic kidney disease,"urate measurement, chronic kidney disease",GCST006426,20:24146125
rs4821469-<b>?</b>,2 x 10-19,,0.056,2.86,'-,[2.27-3.57],"APOL4, APOL2",End-stage renal disease (non-diabetic),chronic kidney disease,GCST000696,22:36220399
rs2648875-<b>A</b>,2 x 10-6,,0.53,2.97,'-,[1.90-4.65],PVT1,End-stage renal disease,chronic kidney disease,GCST000020,8:128059915
rs2681019-<b>?</b>,8 x 10-8,,0.28,2.58,'-,[1.82-3.66],'-,Dialysis-related mortality,chronic kidney disease,GCST001066,2:22964632
rs926392-<b>?</b>,5 x 10-7,,0.29,2.37,'-,[1.69-3.33],DHX35,Dialysis-related mortality,chronic kidney disease,GCST001066,20:39061821
rs6816344-<b>?</b>,1 x 10-6,,0.49,1.7,'-,[1.37-2.12],RNU4ATAC9P,Dialysis-related mortality,chronic kidney disease,GCST001066,4:72917687
rs594442-<b>?</b>,1 x 10-6,,0.05,1.99,'-,[1.50-2.64],COPS5P1,Dialysis-related mortality,chronic kidney disease,GCST001066,6:93138166
rs1009170-<b>?</b>,2 x 10-6,,0.57,2,'-,[1.49-2.63],CPSF2,Dialysis-related mortality,chronic kidney disease,GCST001066,14:92170369
rs1452093-<b>?</b>,2 x 10-6,,0.23,1.59,'-,[1.31-1.94],"EIF4A1P1, RPL10P1",Dialysis-related mortality,chronic kidney disease,GCST001066,21:27372037
rs1497828-<b>?</b>,4 x 10-6,,0.63,1.41,'-,[1.22-1.64],GPATCH2,Dialysis-related mortality,chronic kidney disease,GCST001066,1:217353682
rs17364464-<b>?</b>,4 x 10-6,,0.08,1.76,'-,[1.38-2.25],STEAP1B,Dialysis-related mortality,chronic kidney disease,GCST001066,7:22474434
rs9977499-<b>?</b>,4 x 10-6,,0.24,1.57,'-,[1.29-1.91],EIF4A1P1,Dialysis-related mortality,chronic kidney disease,GCST001066,21:27362678
rs17232789-<b>?</b>,6 x 10-6,,0.63,1.59,'-,[1.30-1.92],HAS2,Dialysis-related mortality,chronic kidney disease,GCST001066,8:121610260
rs6560517-<b>?</b>,7 x 10-6,,0.71,1.56,'-,[1.28-1.89],GCNT1,Dialysis-related mortality,chronic kidney disease,GCST001066,9:76423254
rs4904947-<b>?</b>,8 x 10-6,,0.05,1.9,'-,[1.43-2.52],"SLC24A4, RIN3",Dialysis-related mortality,chronic kidney disease,GCST001066,14:92505818
rs9921518-<b>?</b>,9 x 10-6,,0.28,2.11,'-,[1.52-2.93],"LINC02183, LINC02140",Dialysis-related mortality,chronic kidney disease,GCST001066,16:54460512
rs6546886-<b>?</b>,3 x 10-6,,0.29,2.13,'-,[1.55-2.93],TET3,Dialysis-related mortality,chronic kidney disease,GCST001066,2:74018650
rs11128347-<b>?</b>,6 x 10-7,,0.89,1.85,'-,[1.45-2.33],PDZRN3,Dialysis-related mortality,chronic kidney disease,GCST001066,3:73570410
rs815815-<b>?</b>,7 x 10-7,,0.19,1.51,'-,[1.28-1.77],CALM2,Dialysis-related mortality,chronic kidney disease,GCST001066,2:47171925
rs7111546-<b>?</b>,2 x 10-6,,0.44,1.72,'-,[1.37-2.16],GAS2,Dialysis-related mortality,chronic kidney disease,GCST001066,11:22808211
rs2412980-<b>?</b>,4 x 10-6,,0.09,1.65,'-,[1.33-2.04],"LIF-AS1, HORMAD2",Dialysis-related mortality,chronic kidney disease,GCST001066,22:30196080
rs8098064-<b>?</b>,4 x 10-6,,0.26,1.42,'-,[1.22-1.65],PTPRM,Dialysis-related mortality,chronic kidney disease,GCST001066,18:8209271
rs17110736-<b>?</b>,5 x 10-6,,0.35,2.08,'-,[1.52-2.86],ABCA4,Dialysis-related mortality,chronic kidney disease,GCST001066,1:93997213
rs4814615-<b>?</b>,5 x 10-6,,0.19,1.59,'-,[1.30-1.95],'-,Dialysis-related mortality,chronic kidney disease,GCST001066,Mapping not available
rs712022-<b>?</b>,6 x 10-6,,0.53,1.61,'-,[1.32-1.96],SVIP,Dialysis-related mortality,chronic kidney disease,GCST001066,11:22821609
rs2439312-<b>?</b>,7 x 10-6,,0.24,2.36,'-,[1.62-3.45],NRG1,Dialysis-related mortality,chronic kidney disease,GCST001066,8:32554841
rs7243299-<b>?</b>,8 x 10-6,,0.1,1.63,'-,[1.31-2.03],PTPRM,Dialysis-related mortality,chronic kidney disease,GCST001066,18:7755773
rs11676855-<b>?</b>,9 x 10-6,,0.67,1.43,'-,[1.22-1.67],SH3BP4,Dialysis-related mortality,chronic kidney disease,GCST001066,2:234991527
rs16844716-<b>?</b>,9 x 10-6,,0.09,1.65,'-,[1.32-2.07],LINC02789,Dialysis-related mortality,chronic kidney disease,GCST001066,1:199387388
rs12285658-<b>?</b>,4 x 10-6,"(AA, dominant )",0.9,1.4285715,'-,'-,KDM4D,Diabetic kidney disease,diabetic nephropathy,GCST003098,11:94990459
rs10766496-<b>?</b>,5 x 10-6,"(AA, dominant )",0.79,1.3333333,'-,'-,IGSF22,Diabetic kidney disease,diabetic nephropathy,GCST003098,11:18717171
rs12523822-<b>?</b>,6 x 10-9,"(American Indian, dominant )",0.74,1.754386,'-,'-,RPS4XP8,Diabetic kidney disease,diabetic nephropathy,GCST003098,6:154633286
rs13254600-<b>?</b>,6 x 10-8,"(American Indian, dominant )",0.77,1.724138,'-,'-,TBC1D31,Diabetic kidney disease,diabetic nephropathy,GCST003098,8:123077286
rs10952362-<b>C</b>,2 x 10-7,"(American Indian, additive )",0.5,1.42,'-,[1.24-1.63],5S_rRNA,Diabetic kidney disease,diabetic nephropathy,GCST003098,7:152565713
rs10019835-<b>?</b>,5 x 10-7,"(American Indian, additive )",0.63,1.4285715,'-,'-,GUCY1A1,Diabetic kidney disease,diabetic nephropathy,GCST003098,4:155712034
rs4667466-<b>T</b>,1 x 10-6,"(American Indian, additive )",0.39,1.39,'-,[1.21-1.58],KCNH7,Diabetic kidney disease,diabetic nephropathy,GCST003098,2:162832637
rs4453858-<b>?</b>,2 x 10-6,"(American Indian, additive )",0.41,1.4084507,'-,'-,SUCLG2,Diabetic kidney disease,diabetic nephropathy,GCST003098,3:67407074
rs10778560-<b>C</b>,2 x 10-6,"(American Indian, dominant )",0.07,2.11,'-,[1.56-2.86],BTBD11,Diabetic kidney disease,diabetic nephropathy,GCST003098,12:107407624
rs13421350-<b>?</b>,3 x 10-6,"(American Indian, additive )",0.85,1.5873016,'-,'-,ITGA6,Diabetic kidney disease,diabetic nephropathy,GCST003098,2:172453843
rs12497655-<b>?</b>,3 x 10-6,"(American Indian, additive )",0.73,1.4285715,'-,'-,LSAMP,Diabetic kidney disease,diabetic nephropathy,GCST003098,3:117045163
rs2077212-<b>G</b>,4 x 10-6,"(American Indian, additive )",0.48,1.36,'-,[1.20-1.55],'-,Diabetic kidney disease,diabetic nephropathy,GCST003098,8:6124750
rs7975752-<b>G</b>,2 x 10-6,"(Mexican, dominant )",0.25,1.76,'-,[1.39-2.21],RN7SL865P,Diabetic kidney disease,diabetic nephropathy,GCST003098,12:115716849
rs731565-<b>T</b>,4 x 10-6,"(Mexican, additive )",0.2,1.58,'-,[1.30-1.92],CNTNAP2,Diabetic kidney disease,diabetic nephropathy,GCST003098,7:147709170
rs728571-<b>?</b>,6 x 10-6,"(Mexican, additive )",0.61,1.4925373,'-,'-,'-,Diabetic kidney disease,diabetic nephropathy,GCST003098,16:55180181
rs4849965-<b>C</b>,6 x 10-6,"(Mexican, additive )",0.28,1.5,'-,[1.26-1.79],"LINC01249, NPM1P48",Diabetic kidney disease,diabetic nephropathy,GCST003098,2:4561337
rs10004231-<b>?</b>,8 x 10-6,"(Mexican, recessive )",0.78,5.882353,'-,'-,RN7SKP82,Diabetic kidney disease,diabetic nephropathy,GCST003098,4:42855556
rs6910061-<b>A</b>,9 x 10-6,"(Mexican, additive )",0.11,1.74,'-,[1.36-2.22],SMIM13,Diabetic kidney disease,diabetic nephropathy,GCST003098,6:11101685
rs2168858-<b>?</b>,5 x 10-6,"(Mexican, additive )",0.58,1.4705882,'-,[1.25-1.72],STX8,Diabetic kidney disease,diabetic nephropathy,GCST003098,17:9484136
rs1424609-<b>G</b>,5 x 10-6,"(Mexican, dominant )",0.21,1.72,'-,[1.36-2.18],"RN7SL865P, LINC02463",Diabetic kidney disease,diabetic nephropathy,GCST003098,12:115725627
rs955333-<b>?</b>,1 x 10-8,(additive ),NR,1.369863,'-,'-,RPS4XP8,Diabetic kidney disease,diabetic nephropathy,GCST003098,6:154626274
rs5750250-<b>G</b>,8 x 10-8,(additive ),NR,1.27,'-,[1.16-1.38],MYH9,Diabetic kidney disease,diabetic nephropathy,GCST003098,22:36312438
rs136161-<b>G</b>,2 x 10-6,(recessive ),NR,1.27,'-,[1.10-1.46],APOL1,Diabetic kidney disease,diabetic nephropathy,GCST003098,22:36261386
rs11107616-<b>C</b>,1 x 10-6,(additive ),NR,1.38,'-,[1.21-1.57],NAV3,Diabetic kidney disease,diabetic nephropathy,GCST003098,12:77971000
rs12285658-<b>?</b>,2 x 10-6,(dominant ),NR,1.6129031,'-,'-,KDM4D,Diabetic kidney disease,diabetic nephropathy,GCST003098,11:94990459
rs4879670-<b>G</b>,2 x 10-6,(additive ),NR,1.15,'-,[1.09-1.22],"B4GALT1-AS1, SPINK4",Diabetic kidney disease,diabetic nephropathy,GCST003098,9:33205410
rs11582609-<b>?</b>,3 x 10-6,(dominant ),NR,1.2345679,'-,'-,'-,Diabetic kidney disease,diabetic nephropathy,GCST003098,1:82754973
rs1997066-<b>?</b>,4 x 10-6,(dominant ),NR,1.4705882,'-,'-,SORCS3,Diabetic kidney disease,diabetic nephropathy,GCST003098,10:105003805
rs13259109-<b>G</b>,5 x 10-6,(additive ),NR,1.19,'-,[1.11-1.27],RNU4-37P,Diabetic kidney disease,diabetic nephropathy,GCST003098,8:112103668
rs6432852-<b>?</b>,5 x 10-6,(additive ),NR,1.1764705,'-,'-,TTC21B,Diabetic kidney disease,diabetic nephropathy,GCST003098,2:165898043
rs5750250-<b>G</b>,8 x 10-8,"(AA, additive )",0.52,1.27,'-,[1.16-1.38],MYH9,Diabetic kidney disease,diabetic nephropathy,GCST003098,22:36312438
rs136161-<b>G</b>,5 x 10-7,"(AA, recessive )",0.74,1.36,'-,[1.21-1.54],APOL1,Diabetic kidney disease,diabetic nephropathy,GCST003098,22:36261386
rs1298908-<b>G</b>,9 x 10-7,"(AA, dominant )",0.22,1.36,'-,[1.21-1.54],"MAT1A, EIF5AP4",Diabetic kidney disease,diabetic nephropathy,GCST003098,10:80253378
rs304029-<b>G</b>,1 x 10-6,"(AA, additive )",0.28,1.26,'-,[1.15-1.38],ITPR1,Diabetic kidney disease,diabetic nephropathy,GCST003098,3:4504140
rs590884-<b>?</b>,2 x 10-6,"(AA, additive )",0.66,1.25,'-,'-,MAP3K4-AS1,Diabetic kidney disease,diabetic nephropathy,GCST003098,6:160957160
rs8067287-<b>?</b>,2 x 10-6,"(AA, recessive )",0.78,2.0833335,'-,'-,"COTL1P1, TBC1D27P",Diabetic kidney disease,diabetic nephropathy,GCST003098,17:16913342
rs6943931-<b>?</b>,2 x 10-6,"(AA, dominant )",0.72,1.3333333,'-,'-,"RAPGEF5, STEAP1B",Diabetic kidney disease,diabetic nephropathy,GCST003098,7:22375027
rs9510795-<b>A</b>,4 x 10-6,"(AA, additive )",0.61,1.23,'-,[1.13-1.34],TNFRSF19,Diabetic kidney disease,diabetic nephropathy,GCST003098,13:23641873
rs117989384-<b>?</b>,6 x 10-6,(EA),'-,2.26,'-,[1.15-4.42],"BCAS1, CYP24A1",Diabetic kidney disease in diabetes (ESRD vs. no ESRD),"diabetes mellitus, diabetic nephropathy",GCST005894,20:54129184
rs74796791-<b>?</b>,5 x 10-6,(EA),'-,2.04,'-,[1.13-3.70],TBC1D5,Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,3:17161837
rs158342-<b>?</b>,7 x 10-6,(EA),'-,1.25,'-,[1.15-1.36],"RNU6ATAC2P, HMGN1P17",Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,5:56329506
chr11:81277664:D-<b>?</b>,3 x 10-6,(EA),'-,1.28,'-,[1.14-1.44],'-,Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,Mapping not available
rs158342-<b>?</b>,4 x 10-6,,'-,1.24,'-,[1.15-1.34],"RNU6ATAC2P, HMGN1P17",Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,5:56329506
rs9942471-<b>A</b>,5 x 10-8,(EA),0.64,1.25,'-,[1.16-1.34],"GABRR2, GABRR1",Early diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005889,6:89238513
rs768920-<b>?</b>,2 x 10-6,(EA),'-,1.39,'-,[1.14-1.69],"RPL26P31, MTNR1B",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,11:93008790
rs1143914-<b>?</b>,3 x 10-6,(EA),'-,1.15,'-,[1.09-1.22],COL4A1,Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,13:110214888
rs7222331-<b>?</b>,1 x 10-7,(EA),'-,1.37,'-,[1.18-1.59],"KRTAP3-2, KRTAP3-3",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,17:40995605
rs768920-<b>?</b>,4 x 10-6,,'-,1.39,'-,[1.14-1.69],"RPL26P31, MTNR1B",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,11:93008790
rs7222331-<b>?</b>,1 x 10-6,,'-,1.37,'-,[1.18-1.59],"KRTAP3-2, KRTAP3-3",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,17:40995605
chr4:101507002:D-<b>?</b>,1 x 10-6,(EA),'-,1.29,'-,[1.20-1.38],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
rs9942471-<b>A</b>,4 x 10-7,(EA),0.64,1.18,'-,[1.11-1.25],"GABRR2, GABRR1",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,6:89238513
rs2150814-<b>?</b>,2 x 10-6,(EA),'-,1.18,'-,[1.11-1.26],"GABRR2, GABRR1",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,6:89233215
chr6:6415537:D-<b>?</b>,5 x 10-6,(EA),'-,1.19,'-,[1.09-1.31],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
rs7916840-<b>?</b>,6 x 10-7,(EA),'-,1.27,'-,[1.19-1.37],GPR158,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,10:25424152
rs768920-<b>?</b>,4 x 10-6,(EA),'-,1.44,'-,[1.14-1.80],"RPL26P31, MTNR1B",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,11:93008790
chr15:30372504:D-<b>?</b>,2 x 10-6,(EA),'-,1.79,'-,[1.22-2.63],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
chr17:39098885:D-<b>?</b>,4 x 10-6,(EA),'-,1.61,'-,[1.43-1.82],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
rs139484064-<b>?</b>,2 x 10-6,(EA),'-,1.73,'-,[1.53-1.96],"SAMHD1, RBL1",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,20:36992576
rs1326934-<b>T</b>,6 x 10-7,,0.57,1.19,'-,[1.11-1.27],SORBS1,Diabetic nephropathy in type 1 diabetes,"type I diabetes mellitus, diabetic nephropathy",GCST002716,10:95524324
rs7460469-<b>A</b>,1 x 10-8,,0.03,5.58,'-,[3.09-10.10],XKR6,Childhood onset systemic lupus erythematosus,"age at onset, systemic lupus erythematosus",GCST006260,8:11169932
rs7300146-<b>C</b>,1 x 10-8,,0.17,2.85,'-,[1.98-4.10],GLT1D1,Childhood onset systemic lupus erythematosus,"age at onset, systemic lupus erythematosus",GCST006260,12:128888528
rs57939992-<b>A</b>,4 x 10-6,,0.15,0.6935,'-,[NR],TNPO3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,7:129024628
rs13277113-<b>G</b>,2 x 10-9,,0.32,0.6838,'-,[NR],BLK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,8:11491677
rs10091786-<b>G</b>,9 x 10-6,,0.1,1.535,'-,[NR],R3HCC1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,8:23281923
rs6589706-<b>A</b>,6 x 10-7,,0.38,0.7551,'-,[NR],"CXCR5, Y_RNA",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,11:118877104
rs10845606-<b>A</b>,3 x 10-6,,0.31,0.7588,'-,[NR],GPR19,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,12:12681960
rs7299679-<b>A</b>,7 x 10-7,,0.11,1.5734,'-,[NR],"LINC02457, MIR4472-2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,12:116458870
rs1385374-<b>A</b>,8 x 10-8,,0.2,1.4605,'-,[NR],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,12:128816149
rs3751631-<b>A</b>,5 x 10-6,,0.1,1.5494,'-,[NR],MYO5C,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,15:52242147
rs1143679-<b>A</b>,6 x 10-8,,0.07,1.9136,'-,[NR],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,16:31265490
rs11564296-<b>G</b>,7 x 10-6,,0.03,2.0795,'-,[NR],CDH2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,18:28219995
rs34693543-<b>A</b>,7 x 10-6,,0.08,1.6944,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,18:73510701
rs2837982-<b>G</b>,9 x 10-6,,0.31,1.3029,'-,[NR],BACE2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,21:41244804
rs1109754-<b>A</b>,2 x 10-6,,0.13,1.5106,'-,[NR],"LINC00315, LINC00316",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011426,21:45333789
rs2051549-<b>?</b>,3 x 10-22,,NR,'-,'-,'-,HLA-DQB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001708,6:32762309
rs9275572-<b>A</b>,5 x 10-16,,0.4,1.74,'-,[1.64-1.85],"HLA-DQB3, MTCO3P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,6:32711222
rs2764208-<b>G</b>,7 x 10-6,,0.35,1.28,'-,[1.203-1.36],"SNRPC, ILRUN-AS1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,6:34746545
rs10946940-<b>A</b>,8 x 10-9,,0.35,1.45,'-,[1.37-1.54],"CD83P1, RNU6-471P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,6:27592808
HLA-DQA1*05:01-<b>?</b>,3 x 10-9,,NR,1.89,'-,[1.534-2.335],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,Mapping not available
HLA-DQB1*02:01-<b>?</b>,5 x 10-6,,NR,1.755,'-,[1.381-2.238],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,Mapping not available
HLA-DRB1*03:01-<b>?</b>,3 x 10-7,,NR,1.934,'-,[1.507-2.494],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,Mapping not available
rs1801274-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,1:161509955
rs12565776-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"LAMC2, LAMC1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,1:183147396
rs10911628-<b>A</b>,2 x 10-13,,0.073,1.954,'-,[1.77-2.16],"EDEM3, C1orf21",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,1:184680369
rs12993006-<b>T</b>,4 x 10-6,,0.21,1.45,'-,[1.349-1.56],"RNU7-182P, TEX51",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,2:127000872
rs4544377-<b>A</b>,2 x 10-6,,0.88,1.832,'-,[1.623-2.07],RNU6-546P,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,2:155400189
rs7574865-<b>T</b>,5 x 10-9,,0.33,1.5083,'-,[1.41-1.62],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,2:191099907
rs4684256-<b>T</b>,1 x 10-7,,0.28,1.48,'-,[1.382-1.58],RPL23AP38,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,3:1590669
rs558702-<b>A</b>,8 x 10-21,,0.1,2.276,'-,[2.097-2.47],C2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,6:31902549
rs6946131-<b>T</b>,2 x 10-6,,0.53,1.387,'-,[1.3-1.47],"RPL31P35, SEC61G",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,7:54715680
rs4728142-<b>A</b>,7 x 10-10,,0.46,1.454,'-,[1.368-1.55],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,7:128933913
rs10488631-<b>C</b>,2 x 10-13,,0.11,1.829,'-,[1.684-1.99],"IRF5, TNPO3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,7:128954129
rs10857712-<b>T</b>,3 x 10-6,,0.76,1.5129,'-,[1.39-1.64],MTG1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,10:133412162
rs10466455-<b>T</b>,2 x 10-7,,0.58,1.3774,'-,[1.3-1.47],"EHF, APIP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,11:34759389
rs11073328-<b>T</b>,1 x 10-14,,0.098,1.935,'-,[1.771-2.11],FAM98B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,15:38472642
rs8023715-<b>A</b>,1 x 10-8,,0.075,1.812,'-,[1.638-2.00],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,15:97064451
rs9888739-<b>T</b>,4 x 10-11,,0.13,1.638,'-,[1.512-1.78],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,16:31301932
rs11655550-<b>C</b>,7 x 10-7,,0.16,1.475,'-,[1.368-1.59],"CDK12, MED1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,17:39453870
rs6084875-<b>A</b>,2 x 10-6,,0.34,1.356,'-,[1.273-1.44],"PRNT, RASSF2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,20:4762059
rs11697848-<b>?</b>,1 x 10-11,,0.051,2.115,'-,[1.887-2.37],"KRT18P4, RNU6-147P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST002463,20:49958778
rs2056626-<b>?</b>,3 x 10-6,(IcSSc),NR,1.23,'-,[1.12-1.33],CD247,Systemic sclerosis,systemic scleroderma,GCST001160,1:167451188
rs3821236-<b>?</b>,9 x 10-8,(IcSSc),NR,1.31,'-,[1.19-1.48],STAT4,Systemic sclerosis,systemic scleroderma,GCST001160,2:191038032
rs10488631-<b>?</b>,2 x 10-10,(IcSSc),NR,1.5,'-,[1.32-1.69],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST001160,7:128954129
rs11047102-<b>?</b>,5 x 10-6,(IcSSc),0.1,1.24,'-,[1.13-1.35],SOX5,Systemic sclerosis,systemic scleroderma,GCST001160,12:23793212
rs11642873-<b>?</b>,2 x 10-12,(IcSSc),0.81,1.33,'-,[1.23-1.45],LINC02132,Systemic sclerosis,systemic scleroderma,GCST001160,16:85958099
rs12540874-<b>?</b>,1 x 10-6,(IcSSc),0.4,1.15,'-,[1.09-1.22],GRB10,Systemic sclerosis,systemic scleroderma,GCST001160,7:50597225
rs3129763-<b>?</b>,1 x 10-11,(ATA positive),0.25,1.65,'-,[1.42-1.91],"HLA-DQA1, HLA-DRB1",Systemic sclerosis,systemic scleroderma,GCST001156,6:32623148
rs10488631-<b>?</b>,8 x 10-7,(ATA positive),NR,1.63,'-,[1.34-1.98],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST001156,7:128954129
rs9296015-<b>?</b>,1 x 10-8,(ATA positive),0.81,1.85,'-,[1.49-2.27],"NOTCH4, TSBP1-AS1",Systemic sclerosis,systemic scleroderma,GCST001156,6:32251212
rs3129882-<b>?</b>,2 x 10-27,(ATA positive),0.44,2.17,'-,[1.88-2.50],HLA-DRA,Systemic sclerosis,systemic scleroderma,GCST001156,6:32441753
rs11047102-<b>?</b>,1 x 10-7,(ACA positive),0.1,1.36,'-,[1.21-1.52],SOX5,Systemic sclerosis,systemic scleroderma,GCST001156,12:23793212
rs443198-<b>?</b>,9 x 10-21,(ACA positive),0.63,1.82,'-,[1.59-2.04],NOTCH4,Systemic sclerosis,systemic scleroderma,GCST001156,6:32222629
rs9275390-<b>?</b>,3 x 10-54,(ACA positive),0.25,2.38,'-,[2.13-2.67],"MTCO3P1, HLA-DQB1",Systemic sclerosis,systemic scleroderma,GCST001156,6:32701379
rs11171747-<b>?</b>,6 x 10-8,(dcSSc),0.39,1.23,'-,[1.14-1.33],"ESYT1, ZC3H10",Systemic sclerosis,systemic scleroderma,GCST001156,12:56124624
rs10488631-<b>?</b>,1 x 10-9,(dcSSc),NR,1.61,'-,[1.38-1.88],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST001156,7:128954129
rs10488631-<b>?</b>,2 x 10-7,(ACA positive),NR,1.52,'-,[1.30-1.79],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST001156,7:128954129
rs9275390-<b>?</b>,1 x 10-7,(ATA positive),0.75,1.61,'-,[1.35-1.92],"MTCO3P1, HLA-DQB1",Systemic sclerosis,systemic scleroderma,GCST001156,6:32701379
rs987870-<b>?</b>,2 x 10-20,(ATA positive),0.15,2.09,'-,[1.78-2.45],HLA-DPA1,Systemic sclerosis,systemic scleroderma,GCST001156,6:33075103
rs10488631-<b>C</b>,2 x 10-13,,NR,1.5,'-,[1.35-1.67],"IRF5, TNPO3",Systemic sclerosis,systemic scleroderma,GCST000650,7:128954129
rs6457617-<b>?</b>,4 x 10-17,,0.53,1.37,'-,[1.28-1.47],"HLA-DQB1, MTCO3P1",Systemic sclerosis,systemic scleroderma,GCST000650,6:32696074
rs3821236-<b>A</b>,3 x 10-9,,0.2,1.3,'-,[1.19-1.41],STAT4,Systemic sclerosis,systemic scleroderma,GCST000650,2:191038032
rs2056626-<b>?</b>,3 x 10-9,,0.59,1.16,'-,[1.11-1.23],CD247,Systemic sclerosis,systemic scleroderma,GCST000650,1:167451188
rs174566-<b>G</b>,4 x 10-19,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.388595 unit increase,[0.3-0.47],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-22,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.420283 unit increase,[0.34-0.5],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-31,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.495456 unit increase,[0.41-0.58],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-60,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.69013 unit increase,[0.61-0.77],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,4 x 10-61,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.690358 unit increase,[0.61-0.77],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-32,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.510299 unit increase,[0.43-0.59],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,3 x 10-37,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.54754 unit increase,[0.47-0.63],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,4 x 10-35,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.526618 unit increase,[0.45-0.61],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-20,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.404913 unit increase,[0.32-0.49],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-19,(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C34:1),NR,'-,0.385622 unit decrease,[0.3-0.47],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-22,(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.419622 unit decrease,[0.34-0.5],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,8 x 10-24,(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.427452 unit decrease,[0.35-0.51],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,5 x 10-21,(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C38:0),NR,'-,0.405654 unit decrease,[0.32-0.49],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-20,(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C38:3),NR,'-,0.400939 unit decrease,[0.32-0.48],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-15,(Phosphatidylcholine with diacyl residue sum C30:0/Phosphatidylcholine with diacyl residue sum C34:3),NR,'-,0.350305 unit decrease,[0.27-0.44],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,6 x 10-28,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.460557 unit increase,[0.38-0.54],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.381532 unit increase,[0.3-0.46],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-16,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:6),NR,'-,0.358584 unit increase,[0.27-0.44],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-31,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.501424 unit increase,[0.42-0.58],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C38:2/Phosphatidylcholine with acyl-alkyl residue sum C40:4),NR,'-,0.378422 unit increase,[0.3-0.46],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,4 x 10-20,(Phosphatidylcholine with acyl-alkyl residue sum C38:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.392683 unit increase,[0.31-0.47],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-22,(Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.411168 unit increase,[0.33-0.49],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-15,(Phosphatidylcholine with acyl-alkyl residue sum C40:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.337478 unit increase,[0.26-0.42],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174567-<b>G</b>,2 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C42:5/Phosphatidylcholine with acyl-alkyl residue sum C44:3),NR,'-,0.31854 unit decrease,[0.23-0.4],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61825533
rs174568-<b>T</b>,3 x 10-14,(Phosphatidylcholine with diacyl residue sum C38:0/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.339 unit increase,[0.25-0.43],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61826344
rs174568-<b>T</b>,4 x 10-24,(Phosphatidylcholine with diacyl residue sum C38:5/Lysophosphatidylcholine with acyl residue C20:3),NR,'-,0.435294 unit decrease,[0.35-0.52],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61826344
rs5792235-<b>C</b>,6 x 10-15,(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.335276 unit increase,[0.25-0.42],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs174581-<b>A</b>,3 x 10-12,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C40:4),NR,'-,0.303191 unit increase,[0.22-0.39],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839211
rs174580-<b>G</b>,4 x 10-20,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.391712 unit increase,[0.31-0.47],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839170
rs174580-<b>G</b>,2 x 10-28,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.469249 unit increase,[0.39-0.55],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839170
rs97384-<b>C</b>,4 x 10-13,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5),NR,'-,0.304614 unit decrease,[0.22-0.39],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61856709
rs1535-<b>G</b>,5 x 10-16,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.353448 unit increase,[0.27-0.44],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs1535-<b>G</b>,8 x 10-16,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:6),NR,'-,0.353321 unit increase,[0.27-0.44],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs5792235-<b>C</b>,2 x 10-16,(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:1),NR,'-,0.360572 unit decrease,[0.28-0.45],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs5792235-<b>C</b>,3 x 10-17,(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:2),NR,'-,0.368846 unit decrease,[0.28-0.45],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs5792235-<b>C</b>,3 x 10-29,(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:3),NR,'-,0.481829 unit decrease,[0.4-0.56],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs5792235-<b>C</b>,2 x 10-22,(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C38:3),NR,'-,0.426484 unit decrease,[0.34-0.51],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs99780-<b>T</b>,2 x 10-16,(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.356899 unit decrease,[0.27-0.44],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61829161
rs174576-<b>A</b>,1 x 10-30,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.493266 unit increase,[0.41-0.57],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61836038
rs5792235-<b>C</b>,2 x 10-24,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.443353 unit increase,[0.36-0.53],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs5792235-<b>C</b>,3 x 10-34,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.531533 unit increase,[0.45-0.61],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61828851
rs3834458-<b>C</b>,1 x 10-21,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.421445 unit increase,[0.34-0.51],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61827449
rs174578-<b>A</b>,9 x 10-18,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.368288 unit increase,[0.29-0.45],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61838027
rs174581-<b>A</b>,4 x 10-15,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C40:4),NR,'-,0.337981 unit increase,[0.25-0.42],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839211
rs1535-<b>G</b>,1 x 10-13,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C42:1),NR,'-,0.329548 unit increase,[0.24-0.42],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs174580-<b>G</b>,6 x 10-21,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.399068 unit increase,[0.32-0.48],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839170
rs3834458-<b>C</b>,4 x 10-32,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.514307 unit increase,[0.43-0.6],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61827449
rs174580-<b>G</b>,9 x 10-31,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.486578 unit increase,[0.41-0.57],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61839170
rs1535-<b>G</b>,3 x 10-18,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.386446 unit increase,[0.3-0.47],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs1535-<b>G</b>,3 x 10-12,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:5),NR,'-,0.304566 unit increase,[0.22-0.39],FADS2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61830500
rs174548-<b>G</b>,3 x 10-14,(Phosphatidylcholine with diacyl residue sum C36:3/Lysophosphatidylcholine with acyl residue C16:0),NR,'-,0.32381 unit increase,[0.24-0.41],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174548-<b>G</b>,3 x 10-33,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C40:4),NR,'-,0.523084 unit increase,[0.44-0.61],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174549-<b>A</b>,2 x 10-18,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:4),NR,'-,0.385272 unit increase,[0.3-0.47],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803910
rs174560-<b>C</b>,7 x 10-18,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:5),NR,'-,0.38643 unit increase,[0.3-0.47],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174562-<b>G</b>,7 x 10-30,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.496589 unit increase,[0.41-0.58],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61817672
rs174562-<b>G</b>,3 x 10-22,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.424191 unit increase,[0.34-0.51],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61817672
rs174557-<b>G</b>,4 x 10-29,(Phosphatidylcholine with diacyl residue sum C36:4/Lysophosphatidylcholine with acyl residue C20:3),NR,'-,0.49858 unit decrease,[0.41-0.58],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61813896
rs174548-<b>G</b>,1 x 10-39,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C40:4),NR,'-,0.561158 unit increase,[0.48-0.64],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174549-<b>A</b>,4 x 10-12,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C42:4),NR,'-,0.30512 unit increase,[0.22-0.39],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803910
rs174554-<b>G</b>,3 x 10-17,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.370484 unit increase,[0.29-0.46],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61811991
rs174560-<b>C</b>,4 x 10-28,(Phosphatidylcholine with diacyl residue sum C38:4/Lysophosphatidylcholine with acyl residue C20:3),NR,'-,0.481575 unit decrease,[0.4-0.57],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174548-<b>G</b>,8 x 10-14,(Phosphatidylcholine with diacyl residue sum C40:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.332072 unit decrease,[0.25-0.42],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174560-<b>C</b>,4 x 10-15,(Phosphatidylcholine with diacyl residue sum C40:5/Lysophosphatidylcholine with acyl residue C20:3),NR,'-,0.348537 unit decrease,[0.26-0.43],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174548-<b>G</b>,1 x 10-15,(Phosphatidylcholine with diacyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.354703 unit decrease,[0.27-0.44],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174560-<b>C</b>,4 x 10-12,(Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C42:3),NR,'-,0.310284 unit decrease,[0.22-0.4],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174560-<b>C</b>,5 x 10-20,(Phosphatidylcholine with diacyl residue sum C42:4/Phosphatidylcholine with acyl-alkyl residue sum C38:3),NR,'-,0.397827 unit decrease,[0.31-0.48],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174560-<b>C</b>,3 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.369914 unit decrease,[0.29-0.45],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174562-<b>G</b>,1 x 10-19,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.396611 unit increase,[0.31-0.48],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61817672
rs174545-<b>G</b>,7 x 10-21,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.407966 unit increase,[0.32-0.49],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61801834
rs174548-<b>G</b>,5 x 10-12,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:2),NR,'-,0.307499 unit increase,[0.22-0.39],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174560-<b>C</b>,5 x 10-24,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.444499 unit increase,[0.36-0.53],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174548-<b>G</b>,6 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:0),NR,'-,0.335386 unit increase,[0.25-0.42],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803876
rs174560-<b>C</b>,1 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.383918 unit increase,[0.3-0.47],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174560-<b>C</b>,3 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C18:1),NR,'-,0.325269 unit increase,[0.24-0.41],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174549-<b>A</b>,1 x 10-20,(Phosphatidylcholine with acyl-alkyl residue sum C42:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4),NR,'-,0.416489 unit decrease,[0.33-0.5],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61803910
rs102275-<b>C</b>,3 x 10-32,(Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.502958 unit decrease,[0.42-0.58],TMEM258,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61790331
rs102274-<b>C</b>,8 x 10-21,(Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.407955 unit decrease,[0.32-0.49],TMEM258,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61790354
rs7394579-<b>G</b>,2 x 10-8,(Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.264318 unit decrease,[0.17-0.36],"FADS2, FADS1",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61813978
rs174560-<b>C</b>,3 x 10-10,(Phosphatidylcholine with diacyl residue sum C36:3),NR,'-,0.278836 unit increase,[0.19-0.36],"FADS2, FADS1",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61814292
rs57668028-<b>G</b>,1 x 10-8,(Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.261806 unit decrease,[0.17-0.35],"FADS2, FADS1",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61824524
rs174566-<b>G</b>,5 x 10-14,(Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.320688 unit decrease,[0.24-0.4],"FADS1, FADS2",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61824890
rs174568-<b>T</b>,3 x 10-8,(Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.237543 unit decrease,[0.15-0.32],"FADS2, FADS1",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61826344
rs5792235-<b>C</b>,2 x 10-8,(Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.239467 unit decrease,[0.16-0.32],"FADS1, FADS2",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61828851
rs2014355-<b>C</b>,4 x 10-27,(Butyrylcarnitine / Isobutyrylcarnitine),NR,'-,0.417057 unit increase,[0.34-0.49],ACADS,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,12:120737721
rs7160525-<b>A</b>,7 x 10-15,(Phosphatidylcholine with diacyl residue sum C28:1),NR,'-,0.415635 unit increase,[0.31-0.52],SYNE2,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,14:63765502
rs112329286-<b>TTTTA</b>,5 x 10-12,(Hydroxysphingomyelin with acyl residue sum C14:1),NR,'-,0.363114 unit increase,[0.26-0.47],SYNE2,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,14:63773160
rs1077989-<b>C</b>,2 x 10-12,(Phosphatidylcholine with acyl-alkyl residue sum C32:1),NR,'-,0.278589 unit decrease,[0.2-0.36],TMEM229B,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,14:67509105
rs1077989-<b>C</b>,2 x 10-8,(Phosphatidylcholine with acyl-alkyl residue sum C32:2),NR,'-,0.212349 unit decrease,[0.14-0.29],TMEM229B,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,14:67509105
rs2282377-<b>G</b>,1 x 10-11,(Asparagine),NR,'-,0.426586 unit increase,[0.3-0.55],ASPG,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,14:104105483
rs850799-<b>G</b>,5 x 10-8,(Phosphatidylcholine with acyl-alkyl residue sum C42:3),NR,'-,0.285624 unit increase,[0.18-0.39],"NDN, MAGEL2",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,15:23679185
rs55888180-<b>C</b>,4 x 10-8,(Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.400252 unit increase,[0.26-0.54],DNAH17,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,17:78447415
rs117935223-<b>A</b>,2 x 10-17,(Proline),NR,'-,0.619758 unit increase,[0.48-0.76],PRODH,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,22:18923820
rs12134854-<b>C</b>,1 x 10-12,(Decanoylcarnitine),NR,'-,0.297101 unit decrease,[0.22-0.38],"ACADM, SLC44A5",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,1:75671921
rs28415528-<b>A</b>,4 x 10-9,(Nonanoylcarnitine),NR,'-,0.224275 unit increase,[0.15-0.3],THEM4,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,1:151907285
rs375811360-<b>G</b>,1 x 10-62,(Acetylornithine),NR,'-,0.839768 unit decrease,[0.75-0.93],ALMS1P1,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,2:73643197
rs3764913-<b>C</b>,1 x 10-35,(Nonanoylcarnitine),NR,'-,0.457998 unit increase,[0.39-0.53],ACADL,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,2:210210185
rs1047891-<b>A</b>,2 x 10-20,(Glycine),NR,'-,0.394115 unit increase,[0.31-0.48],CPS1,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,2:210675783
rs1066621-<b>T</b>,3 x 10-8,(Phosphatidylcholine with diacyl residue sum C36:0),NR,'-,0.245354 unit increase,[0.16-0.33],Y_RNA,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,3:191708066
rs57802047-<b>T</b>,9 x 10-10,(Phosphatidylcholine with acyl-alkyl residue sum C38:0),NR,'-,0.490673 unit increase,[0.34-0.65],"SLIT2, PACRGL",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,4:20645949
rs17253658-<b>T</b>,1 x 10-8,(Serine),NR,'-,0.475572 unit increase,[0.31-0.64],'-,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,5:21172184
rs12194000-<b>G</b>,3 x 10-11,(Octadecadienoylcarnitine),NR,'-,0.306187 unit decrease,[0.22-0.4],SLC22A16,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,6:110454809
rs146203232-<b>T</b>,2 x 10-18,"(Butyrylcarnitine, Isobutyrylcarnitine)",NR,'-,0.541769 unit decrease,[0.42-0.66],IGF2R,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,6:160100853
rs4725366-<b>G</b>,2 x 10-12,(Putrescine),NR,'-,0.356606 unit decrease,[0.26-0.46],AOC1,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,7:150824966
rs1242780-<b>G</b>,2 x 10-8,(Lysophosphatidylcholine with acyl residue C18:1),NR,'-,0.294109 unit decrease,[0.19-0.4],PTPRN2,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,7:157757146
rs1020120-<b>T</b>,3 x 10-9,(Histidine),NR,'-,0.242898 unit decrease,[0.16-0.32],NTRK2,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,9:84611173
rs814698-<b>T</b>,2 x 10-8,(Phosphatidylcholine with acyl-alkyl residue sum C44:4),NR,'-,0.26961 unit increase,[0.18-0.36],ZNF618,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,9:113967563
rs1171616-<b>T</b>,3 x 10-15,(Carnitine (free)),NR,'-,0.377038 unit increase,[0.28-0.47],SLC16A9,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,10:59708831
rs11320420-<b>G</b>,2 x 10-10,(Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.281823 unit decrease,[0.2-0.37],"TMEM258, MYRF",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61774535
rs11320420-<b>G</b>,3 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.3281 unit decrease,[0.24-0.42],"TMEM258, MYRF",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61774535
rs11320420-<b>G</b>,1 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.343113 unit decrease,[0.26-0.43],"TMEM258, MYRF",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61774535
rs174537-<b>T</b>,5 x 10-10,(Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.272908 unit decrease,[0.19-0.36],"MYRF, TMEM258",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61785208
rs174537-<b>T</b>,9 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.317125 unit decrease,[0.23-0.4],"MYRF, TMEM258",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61785208
rs174537-<b>T</b>,2 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.336305 unit decrease,[0.25-0.42],"MYRF, TMEM258",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61785208
rs174537-<b>T</b>,1 x 10-16,(Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.357607 unit decrease,[0.27-0.44],"MYRF, TMEM258",Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61785208
rs102275-<b>C</b>,1 x 10-20,(Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.399628 unit decrease,[0.32-0.48],TMEM258,Serum metabolite concentrations in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005648,11:61790331
rs6657658-<b>C</b>,1 x 10-12,(Decadienoylcarnitine/Glutarylcarnitine),NR,'-,0.304258 unit increase,[0.22-0.39],"KRT8P28, S100A10",Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,1:151967388
rs375811360-<b>G</b>,2 x 10-12,(Carnitine (free)/Propionylcarnitine),NR,'-,0.349493 unit decrease,[0.25-0.45],ALMS1P1,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,2:73643197
rs10178409-<b>T</b>,6 x 10-18,(Tryptophan/Acetylornithine),NR,'-,0.44248 unit increase,[0.34-0.54],"NAT8, ALMS1",Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,2:73628380
rs10178409-<b>T</b>,7 x 10-18,(Acetylornithine/Propionylcarnitine),NR,'-,0.448751 unit decrease,[0.35-0.55],"NAT8, ALMS1",Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,2:73628380
rs10178409-<b>T</b>,2 x 10-16,(Tyrosine/Acetylornithine),NR,'-,0.422951 unit increase,[0.32-0.52],"NAT8, ALMS1",Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,2:73628380
rs12460876-<b>C</b>,2 x 10-23,(Lysine/Glutamine),NR,'-,0.415753 unit increase,[0.34-0.5],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs12460876-<b>C</b>,3 x 10-22,(Lysine/Tyrosine),NR,'-,0.406924 unit increase,[0.33-0.49],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs7252778-<b>C</b>,6 x 10-22,(Lysine/Threonine),NR,'-,0.402279 unit increase,[0.32-0.48],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32869463
rs12460876-<b>C</b>,2 x 10-19,(Lysine/Alanine),NR,'-,0.378875 unit increase,[0.3-0.46],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs12460876-<b>C</b>,5 x 10-19,(Lysine/Glycine),NR,'-,0.36788 unit increase,[0.29-0.45],SLC7A9,Urinary metabolite ratios in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005649,19:32865985
rs11320420-<b>G</b>,1 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C34:1/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.371764 unit increase,[0.29-0.45],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs7943728-<b>A</b>,4 x 10-19,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.484582 unit decrease,[0.38-0.59],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61779596
rs174533-<b>A</b>,5 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.365851 unit increase,[0.28-0.45],"MYRF, TMEM258",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61781553
rs174537-<b>T</b>,2 x 10-19,(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C16:0),NR,'-,0.389852 unit decrease,[0.31-0.47],"MYRF, TMEM258",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61785208
rs174537-<b>T</b>,7 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4),NR,'-,0.32504 unit decrease,[0.24-0.41],"MYRF, TMEM258",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61785208
rs11320420-<b>G</b>,5 x 10-20,(Phosphatidylcholine with diacyl residue sum C32:1/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.406939 unit increase,[0.32-0.49],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,5 x 10-24,(Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.440476 unit increase,[0.36-0.52],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs11320420-<b>G</b>,7 x 10-15,(Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C36:6),NR,'-,0.347264 unit increase,[0.26-0.43],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61774535
rs174530-<b>G</b>,2 x 10-12,(Phosphatidylcholine with diacyl residue sum C32:3/Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.303616 unit increase,[0.22-0.39],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61779120
rs174528-<b>C</b>,5 x 10-18,(Phosphatidylcholine with diacyl residue sum C32:3/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.363709 unit increase,[0.28-0.44],"TMEM258, MYRF",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61776027
rs35574015-<b>C</b>,3 x 10-13,(Lysophosphatidylcholine with acyl residue C18:1/Lysophosphatidylcholine with acyl residue C20:3),NR,'-,0.31705 unit increase,[0.23-0.4],"NTAN1, PDXDC1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,16:15052204
rs603424-<b>A</b>,3 x 10-13,(Lysophosphatidylcholine with acyl residue C16:0/Lysophosphatidylcholine with acyl residue C16:1),NR,'-,0.35231 unit increase,[0.26-0.45],PKD2L1,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,10:100315722
rs8008070-<b>T</b>,5 x 10-22,(Hydroxysphingomyelin with acyl residue sum C14:1/Hydroxysphingomyelin with acyl residue sum C16:1),NR,'-,0.535136 unit increase,[0.43-0.64],SYNE2,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:63767002
rs1171614-<b>C</b>,3 x 10-12,(Valine/Propionylcarnitine),NR,'-,0.328612 unit decrease,[0.24-0.42],SLC16A9,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,10:59709780
rs12134854-<b>C</b>,2 x 10-18,(Decanoylcarnitine/Tetradecenoylcarnitine),NR,'-,0.368137 unit decrease,[0.29-0.45],"ACADM, SLC44A5",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,1:75671921
rs76963882-<b>C</b>,4 x 10-30,(Decanoylcarnitine/Dodecanoylcarnitine),NR,'-,0.504574 unit decrease,[0.42-0.59],"ACADM, SLC44A5",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,1:75702239
rs72719193-<b>A</b>,3 x 10-16,(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Phosphatidylcholine with acyl-alkyl residue sum C34:1),NR,'-,0.330504 unit decrease,[0.25-0.41],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67502391
rs72719193-<b>A</b>,4 x 10-21,(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.376328 unit decrease,[0.3-0.45],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67502391
rs1077989-<b>C</b>,3 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Hydroxysphingomyelin with acyl residue sum C22:2),NR,'-,0.308987 unit decrease,[0.23-0.39],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67509105
rs1077989-<b>C</b>,6 x 10-16,(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.328811 unit decrease,[0.25-0.41],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67509105
rs1077989-<b>C</b>,2 x 10-20,(Phosphatidylcholine with acyl-alkyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.368982 unit increase,[0.29-0.45],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67509105
rs1885041-<b>T</b>,5 x 10-30,(Phosphatidylcholine with acyl-alkyl residue sum C32:1/Phosphatidylcholine with acyl-alkyl residue sum C34:1),NR,'-,0.452313 unit decrease,[0.38-0.53],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67509608
rs1885041-<b>T</b>,5 x 10-22,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C32:1),NR,'-,0.384229 unit increase,[0.31-0.46],TMEM229B,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,14:67509608
rs102275-<b>C</b>,2 x 10-75,(Lysophosphatidylcholine with acyl residue C20:3/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.753679 unit increase,[0.68-0.83],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-40,(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.565899 unit increase,[0.49-0.65],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,7 x 10-27,(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.462963 unit increase,[0.38-0.55],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-32,(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.505096 unit increase,[0.42-0.59],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-15,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.348733 unit increase,[0.26-0.43],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,5 x 10-32,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.490688 unit increase,[0.41-0.57],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-31,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.490477 unit increase,[0.41-0.57],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-30,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.49379 unit increase,[0.41-0.58],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,6 x 10-15,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.340896 unit increase,[0.26-0.43],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,5 x 10-49,(Phosphatidylcholine with diacyl residue sum C36:3/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.597844 unit increase,[0.52-0.67],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-82,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.786835 unit increase,[0.71-0.86],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-26,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.454031 unit increase,[0.37-0.54],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-38,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.555338 unit increase,[0.47-0.64],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-35,(Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.523961 unit decrease,[0.44-0.6],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,4 x 10-26,(Phosphatidylcholine with diacyl residue sum C36:4/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.460145 unit decrease,[0.38-0.54],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,5 x 10-18,(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with diacyl residue sum C36:6),NR,'-,0.36532 unit decrease,[0.28-0.45],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-73,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.747911 unit increase,[0.67-0.82],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-42,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.578435 unit increase,[0.5-0.66],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,4 x 10-30,(Phosphatidylcholine with diacyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.487475 unit decrease,[0.41-0.57],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,6 x 10-26,(Phosphatidylcholine with diacyl residue sum C38:4/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.457665 unit decrease,[0.37-0.54],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-30,(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.491381 unit decrease,[0.41-0.57],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-20,(Phosphatidylcholine with diacyl residue sum C38:5/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.407048 unit decrease,[0.32-0.49],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-20,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.384988 unit increase,[0.31-0.46],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-30,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.478987 unit increase,[0.4-0.56],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.366763 unit increase,[0.28-0.45],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-24,(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.425111 unit increase,[0.35-0.5],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-26,(Phosphatidylcholine with acyl-alkyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.43919 unit increase,[0.36-0.52],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs2393778-<b>T</b>,3 x 10-14,"(Butyrylcarnitine, Isobutyrylcarnitine)",NR,'-,0.344447 unit decrease,[0.26-0.43],"UNC119B, MLEC",Fractional excretion of metabolites in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005666,12:120702516
rs77138376-<b>A</b>,2 x 10-7,,0.009,2.63,'-,[1.83-3.78],"GIPC2, RNFT1P2",End-stage kidney disease,chronic kidney disease,GCST008395,1:78168337
rs12032578-<b>C</b>,3 x 10-7,,0.088,1.44,'-,[1.25-1.66],LINC00624,End-stage kidney disease,chronic kidney disease,GCST008395,1:147339048
rs112407915-<b>A</b>,9 x 10-8,,0.02,1.96,'-,[1.53-2.51],'-,End-stage kidney disease,chronic kidney disease,GCST008395,3:5505762
rs114425659-<b>A</b>,9 x 10-7,,0.039,1.87,'-,[1.45-2.39],LINC02264,End-stage kidney disease,chronic kidney disease,GCST008395,4:117920116
rs74614630-<b>C</b>,9 x 10-7,,0.012,2.25,'-,[1.63-3.11],THSD7A,End-stage kidney disease,chronic kidney disease,GCST008395,7:11578298
rs115747230-<b>C</b>,4 x 10-7,,0.021,1.88,'-,[1.47-2.39],"FOXB2, LYPLA2P3",End-stage kidney disease,chronic kidney disease,GCST008395,9:76994030
rs116510623-<b>G</b>,6 x 10-7,,0.034,1.65,'-,[1.35-2.01],LINC02686,End-stage kidney disease,chronic kidney disease,GCST008395,11:24209937
rs60236946-<b>T</b>,9 x 10-7,,0.021,1.86,'-,[1.45-2.38],ZAR1L,End-stage kidney disease,chronic kidney disease,GCST008395,13:32309059
rs115007604-<b>A</b>,9 x 10-7,,0.008,2.67,'-,[1.81-3.95],LINC02284,End-stage kidney disease,chronic kidney disease,GCST008395,14:56358353
rs7189997-<b>G</b>,3 x 10-7,,0.009,2.44,'-,[1.73-3.42],FTO,End-stage kidney disease,chronic kidney disease,GCST008395,16:53852312
rs8050506-<b>A</b>,8 x 10-7,,0.211,1.29,'-,[1.17-1.43],LINC02140,End-stage kidney disease,chronic kidney disease,GCST008395,16:54379818
rs191540116-<b>A</b>,9 x 10-7,,0.011,2.32,'-,[1.66-3.25],"CDRT15, HS3ST3B1",End-stage kidney disease,chronic kidney disease,GCST008395,17:14286592
rs12963285-<b>T</b>,1 x 10-6,,0.834,1.3513513,'-,[1.19-1.52],"LINC-ROR, BOD1L2",End-stage kidney disease,chronic kidney disease,GCST008395,18:57097183
rs138572244-<b>A</b>,2 x 10-7,,0.008,2.9,'-,[1.94-4.35],"KREMEN1, C22orf31",End-stage kidney disease,chronic kidney disease,GCST008395,22:29065297
rs73885319-<b>G</b>,2 x 10-9,,0.077,1.51,'-,[1.32-1.72],APOL1,End-stage kidney disease,chronic kidney disease,GCST008395,22:36265860
rs76064236-<b>G</b>,1 x 10-6,,0.005,2.28,'-,[1.69-3.16],"YBX1P9, PARP1",Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,1:226335330
rs146639727-<b>C</b>,5 x 10-8,,0.004,3.05,'-,[2.04-4.56],RPN1,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,3:128669172
rs138873021-<b>T</b>,2 x 10-7,,0.629,1.17,'-,[1.11-1.25],ADCY8,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,8:130951170
rs186208070-<b>A</b>,7 x 10-8,,0.009,2.07,'-,[1.59-2.70],'-,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,9:12141349
rs10906850-<b>C</b>,4 x 10-8,,0.225,1.18,'-,[1.11-1.25],"FAM171A1, NMT2",Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,10:15183055
rs183951714-<b>T</b>,7 x 10-7,,0.011,1.66,'-,[1.36-2.02],CDON,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,11:125970250
rs117329947-<b>C</b>,9 x 10-7,,0.014,1.79,'-,[1.42-2.25],C12orf75,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,12:105391125
rs11645800-<b>G</b>,1 x 10-7,,0.184,1.2,'-,[1.12-1.28],'-,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,16:62966386
rs147084429-<b>C</b>,5 x 10-7,,0.981,1.5873016,'-,[1.32-1.89],LINC02188,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,16:86727784
rs144210385-<b>A</b>,8 x 10-8,,0.006,2.85,'-,[1.94-4.17],LUC7L3,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,17:50748155
rs2837554-<b>G</b>,3 x 10-7,,0.701,1.16,'-,[1.10-1.24],DSCAM,Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,21:40295451
rs187652497-<b>C</b>,1 x 10-7,,0.007,2.23,'-,[1.66-3.00],"LINC00111, PCSEAT",Mild to moderate chronic kidney disease,chronic kidney disease,GCST008394,21:41628325
rs174564-<b>G</b>,1 x 10-35,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.537812 unit increase,[0.46-0.62],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,3 x 10-19,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C40:5),NR,'-,0.391509 unit increase,[0.31-0.48],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,5 x 10-27,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.465781 unit increase,[0.38-0.55],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,1 x 10-29,(Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.477627 unit decrease,[0.4-0.56],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,6 x 10-25,(Phosphatidylcholine with diacyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.441026 unit decrease,[0.36-0.52],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,2 x 10-28,(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.474674 unit decrease,[0.39-0.56],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,3 x 10-16,(Phosphatidylcholine with diacyl residue sum C30:0/Phosphatidylcholine with diacyl residue sum C32:2),NR,'-,0.351995 unit decrease,[0.27-0.44],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,2 x 10-13,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:5),NR,'-,0.312607 unit increase,[0.23-0.39],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,4 x 10-25,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C34:2),NR,'-,0.450238 unit decrease,[0.37-0.53],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,2 x 10-38,(Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.553333 unit increase,[0.47-0.63],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs28456-<b>G</b>,3 x 10-15,(Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C36:2),NR,'-,0.350198 unit decrease,[0.26-0.44],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61822009
rs28456-<b>G</b>,1 x 10-18,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:5),NR,'-,0.385672 unit increase,[0.3-0.47],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61822009
rs28456-<b>G</b>,6 x 10-19,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.39209 unit decrease,[0.31-0.48],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61822009
rs57668028-<b>G</b>,6 x 10-15,(Phosphatidylcholine with diacyl residue sum C34:2/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.35035 unit increase,[0.26-0.44],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824524
rs57668028-<b>G</b>,6 x 10-15,(Phosphatidylcholine with diacyl residue sum C36:2/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.355135 unit increase,[0.27-0.44],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824524
rs57668028-<b>G</b>,1 x 10-19,(Phosphatidylcholine with diacyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:1),NR,'-,0.414122 unit increase,[0.33-0.5],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824524
rs57668028-<b>G</b>,8 x 10-14,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.339838 unit increase,[0.25-0.43],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824524
rs174566-<b>G</b>,3 x 10-44,(Lysophosphatidylcholine with acyl residue C18:1/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.587293 unit increase,[0.51-0.67],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-22,(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.418673 unit increase,[0.34-0.5],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,6 x 10-18,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.366984 unit increase,[0.29-0.45],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,3 x 10-23,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.42408 unit increase,[0.34-0.51],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-17,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6),NR,'-,0.37028 unit increase,[0.29-0.45],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,6 x 10-32,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C34:4),NR,'-,0.504805 unit increase,[0.42-0.59],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,2 x 10-33,(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:5),NR,'-,0.511064 unit increase,[0.43-0.59],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174566-<b>G</b>,1 x 10-19,(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3),NR,'-,0.390098 unit decrease,[0.31-0.47],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61824890
rs174560-<b>C</b>,2 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C44:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.336433 unit increase,[0.25-0.42],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174560-<b>C</b>,2 x 10-32,(Phosphatidylcholine with acyl-alkyl residue sum C44:4/Phosphatidylcholine with acyl-alkyl residue sum C44:5),NR,'-,0.518862 unit increase,[0.44-0.6],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs174560-<b>C</b>,1 x 10-30,(Phosphatidylcholine with acyl-alkyl residue sum C44:4/Phosphatidylcholine with acyl-alkyl residue sum C44:6),NR,'-,0.510583 unit increase,[0.43-0.59],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61814292
rs35473591-<b>CT</b>,8 x 10-15,(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.343554 unit increase,[0.26-0.43],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,3 x 10-22,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1),NR,'-,0.42944 unit increase,[0.34-0.51],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,8 x 10-17,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.365477 unit increase,[0.28-0.45],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,3 x 10-13,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5),NR,'-,0.320303 unit increase,[0.24-0.41],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,1 x 10-17,(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:5),NR,'-,0.375213 unit increase,[0.29-0.46],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,2 x 10-48,(Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with diacyl residue sum C38:3),NR,'-,0.624654 unit decrease,[0.54-0.7],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,7 x 10-41,(Phosphatidylcholine with diacyl residue sum C38:3/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.551355 unit increase,[0.47-0.63],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,3 x 10-44,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.601789 unit increase,[0.52-0.68],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,2 x 10-18,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.381911 unit increase,[0.3-0.47],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,1 x 10-23,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.438861 unit increase,[0.35-0.52],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,2 x 10-23,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.430615 unit increase,[0.35-0.51],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs35473591-<b>CT</b>,6 x 10-14,(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5),NR,'-,0.328617 unit increase,[0.24-0.41],"FADS2, FADS1",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61818857
rs174564-<b>G</b>,2 x 10-42,(Lysophosphatidylcholine with acyl residue C16:0/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.575391 unit increase,[0.5-0.65],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,3 x 10-36,(Phosphatidylcholine with diacyl residue sum C34:2/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.524786 unit increase,[0.45-0.6],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,1 x 10-52,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.645129 unit increase,[0.57-0.72],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,2 x 10-35,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.533243 unit increase,[0.45-0.61],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,3 x 10-34,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C38:5),NR,'-,0.524021 unit increase,[0.44-0.61],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,4 x 10-32,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.507788 unit increase,[0.43-0.59],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,2 x 10-26,(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.458945 unit increase,[0.38-0.54],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,3 x 10-36,(Phosphatidylcholine with diacyl residue sum C36:2/Lysophosphatidylcholine with acyl residue C20:4),NR,'-,0.521575 unit increase,[0.44-0.6],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,3 x 10-43,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C36:4),NR,'-,0.588171 unit increase,[0.51-0.67],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs174564-<b>G</b>,2 x 10-42,(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C38:4),NR,'-,0.582478 unit increase,[0.5-0.66],"FADS1, FADS2",Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61820833
rs102275-<b>C</b>,2 x 10-30,(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.48109 unit increase,[0.4-0.56],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-47,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4),NR,'-,0.586854 unit increase,[0.51-0.66],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-56,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5),NR,'-,0.649031 unit increase,[0.57-0.72],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-39,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.557815 unit increase,[0.48-0.64],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-56,(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5),NR,'-,0.639075 unit increase,[0.56-0.71],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-23,(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.434116 unit decrease,[0.35-0.52],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,5 x 10-20,(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C24:1),NR,'-,0.394712 unit decrease,[0.31-0.48],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-21,(Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4),NR,'-,0.406293 unit increase,[0.32-0.49],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-23,(Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4),NR,'-,0.417262 unit increase,[0.34-0.5],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,3 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C44:4),NR,'-,0.365504 unit decrease,[0.28-0.45],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,2 x 10-14,(Phosphatidylcholine with acyl-alkyl residue sum C38:4/Sphingomyelin with acyl residue sum C24:0),NR,'-,0.339909 unit decrease,[0.25-0.43],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,8 x 10-17,(Phosphatidylcholine with acyl-alkyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4),NR,'-,0.357382 unit decrease,[0.27-0.44],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs102275-<b>C</b>,1 x 10-15,(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C34:3),NR,'-,0.337497 unit decrease,[0.26-0.42],TMEM258,Serum metabolite ratios in chronic kidney disease,"chronic kidney disease, serum metabolite measurement",GCST005650,11:61790331
rs6587640-<b>T</b>,9 x 10-9,(Decadienoylcarnitine),NR,'-,0.248976 unit increase,[0.16-0.33],"KRT8P28, S100A10",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,1:151982754
rs10178409-<b>T</b>,1 x 10-11,(Acetylornithine),NR,'-,0.342181 unit decrease,[0.24-0.44],"NAT8, ALMS1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,2:73628380
rs142864856-<b>TACAC</b>,4 x 10-8,(Glutamine),NR,'-,0.493745 unit decrease,[0.32-0.67],FABP5P10,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,2:151100757
rs12634709-<b>T</b>,4 x 10-8,(Decanoylcarnitine),NR,'-,0.297105 unit increase,[0.19-0.4],Metazoa_SRP,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,3:59603270
rs112201728-<b>T</b>,5 x 10-8,"(Butyrylcarnitine, Isobutyrylcarnitine)",NR,'-,0.389716 unit decrease,[0.25-0.53],SLC22A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,6:160130454
rs1317947-<b>A</b>,5 x 10-8,(Alanine),NR,'-,0.232435 unit increase,[0.15-0.32],MMP20,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,11:102617342
rs12460876-<b>C</b>,5 x 10-12,(Lysine),NR,'-,0.290828 unit increase,[0.21-0.37],SLC7A9,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,19:32865985
rs447707-<b>G</b>,5 x 10-8,(Octanoylcarnitine),NR,'-,0.513646 unit decrease,[0.33-0.7],"NPHS1, KIRREL2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,19:35856498
rs6022039-<b>T</b>,3 x 10-8,(Serotonin),NR,'-,0.549885 unit increase,[0.36-0.74],LINC01524,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005651,20:52676385
rs11662622-<b>G</b>,3 x 10-8,(Lysine),NR,'-,0.258826 unit decrease,[0.17-0.35],'-,Fractional excretion of metabolites in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005666,18:65592400
rs12460876-<b>C</b>,2 x 10-9,(Lysine),NR,'-,0.253759 unit increase,[0.17-0.34],SLC7A9,Fractional excretion of metabolites in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005666,19:32865985
rs72881923-<b>C</b>,4 x 10-8,(Dodecanoylcarnitine),NR,'-,0.264461 unit increase,[0.17-0.36],'-,Fractional excretion of metabolites in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST005666,6:67286779
rs4822523-<b>T</b>,3 x 10-16,(gamma-glutamyl-epsilon-lysine),0.34,'-,0.564 unit increase,[0.43-0.7],GGT1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:24615934
rs9612676-<b>A</b>,2 x 10-12,(gamma-glutamylglycine),0.34,'-,0.424 unit increase,[0.31-0.54],GGT1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:24616973
rs4822523-<b>T</b>,5 x 10-12,(gamma-glutamylhistidine),0.34,'-,0.484 unit increase,[0.35-0.62],GGT1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:24615934
rs5751909-<b>A</b>,3 x 10-15,(gamma-glutamylleucine),0.34,'-,0.527 unit increase,[0.4-0.66],GGT1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:24617379
rs4822523-<b>T</b>,3 x 10-14,(gamma-glutamylphenylalanine),0.34,'-,0.575 unit increase,[0.43-0.72],GGT1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:24615934
rs28364331-<b>G</b>,1 x 10-21,(gluconate),0.02,'-,0.811 unit decrease,[0.64-0.98],ADH1A,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:99280138
rs3863632-<b>T</b>,4 x 10-14,(glucuronide of C10H18O2 (11)),0.12,'-,0.388 unit increase,[0.29-0.49],CYP4Z2P,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:46844161
rs1126742-<b>G</b>,6 x 10-20,(glucuronide of C10H18O2 (12)),0.14,'-,0.345 unit increase,[0.27-0.42],CYP4A11,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:46932824
rs7666195-<b>C</b>,2 x 10-14,(glucuronide of C12H22O4 (2)),0.47,'-,0.31 unit increase,[0.23-0.39],"UGT2B11, UGT2B7",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:69113765
rs10148571-<b>G</b>,2 x 10-37,(glutamate),0.33,'-,0.296 unit increase,[0.25-0.34],DGLUCY,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,14:91154810
rs75303441-<b>A</b>,3 x 10-37,(glycerophosphoserine),0.06,'-,0.406 unit decrease,[0.34-0.47],CABIN1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:24175884
rs2286963-<b>G</b>,4 x 10-181,(glycine conjugate of C9H16O2),0.36,'-,1.54 unit increase,[1.43-1.65],ACADL,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210195326
rs45446698-<b>G</b>,1 x 10-13,(glyco-beta-muricholate),0.03,'-,1.623 unit increase,[1.2-2.05],"CYP3A7, CYP3A4",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:99735325
rs12317268-<b>G</b>,2 x 10-29,(glycochenodeoxycholate glucuronide (1)),0.18,'-,0.976 unit increase,[0.81-1.15],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21199607
rs4149056-<b>C</b>,4 x 10-32,(glycocholenate sulfate),0.18,'-,0.677 unit increase,[0.57-0.79],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21178615
rs56165099-<b>T</b>,5 x 10-12,(glycodeoxycholate sulfate),0.21,'-,0.649 unit increase,[0.46-0.83],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21204797
rs12134854-<b>C</b>,3 x 10-14,(heptanoylglutamine),0.29,'-,0.486 unit decrease,[0.36-0.61],"ACADM, SLC44A5",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75671921
rs2817188-<b>A</b>,2 x 10-20,(heptanoylglutamine),0.47,'-,0.537 unit decrease,[0.42-0.65],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25807375
rs12134854-<b>C</b>,2 x 10-20,(hexanoylglutamine),0.29,'-,0.325 unit decrease,[0.26-0.39],"ACADM, SLC44A5",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75671921
rs2762353-<b>A</b>,1 x 10-43,(hexanoylglutamine),0.47,'-,0.432 unit decrease,[0.37-0.49],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25794203
rs1251075-<b>G</b>,5 x 10-23,(hexanoylglycine),0.32,'-,0.331 unit decrease,[0.26-0.4],ACADM,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75724884
rs1047891-<b>A</b>,9 x 10-23,(hexanoylglycine),0.33,'-,0.34 unit increase,[0.27-0.41],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs13408433-<b>A</b>,6 x 10-20,(homocitrulline),0.21,'-,0.406 unit decrease,[0.32-0.49],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73655945
rs10801690-<b>C</b>,6 x 10-13,(imidazole lactate),0.49,'-,0.195 unit increase,[0.14-0.25],"KYAT3, GTF2B",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:88907688
rs11646417-<b>T</b>,3 x 10-19,(imidazole lactate),0.07,'-,0.478 unit increase,[0.37-0.58],"RPL12P36, WWP2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:58831118
rs6151429-<b>C</b>,9 x 10-13,(O-sulfo-L-tyrosine),0.08,'-,0.184 unit increase,[0.13-0.23],ARSA,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:50625049
rs11133665-<b>A</b>,2 x 10-15,(phenylalanine),0.27,'-,0.167 unit decrease,[0.13-0.21],"CTD-3080P12.3, SLC6A19",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:1188170
rs1772719-<b>C</b>,7 x 10-13,(phosphoethanolamine),0.18,'-,0.303 unit decrease,[0.22-0.39],ALPL,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:21577881
rs2250598-<b>T</b>,4 x 10-20,(picolinate),0.46,'-,0.226 unit increase,[0.18-0.27],DPEP1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:89631662
rs17713514-<b>T</b>,2 x 10-11,(pregnanediol-3-glucuronide),0.05,'-,0.635 unit decrease,[0.45-0.82],"TUBAP7, SLC22A8",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:63035630
rs62129970-<b>T</b>,5 x 10-26,(pregnenediol disulfate (C21H34O8S2)),0.16,'-,0.691 unit decrease,[0.56-0.82],"SULT2A1, BSPH1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:47890094
rs420332-<b>T</b>,1 x 10-99,(prolylglycine),0.46,'-,0.77 unit decrease,[0.7-0.84],DPEP1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:89632344
rs6913474-<b>C</b>,1 x 10-29,(pterin),0.42,'-,0.391 unit increase,[0.32-0.46],"NQO2, NQO2-AS1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:2996087
rs1165152-<b>A</b>,4 x 10-11,(pyridoxal),0.47,'-,0.39 unit decrease,[0.27-0.51],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25818538
rs2790-<b>G</b>,4 x 10-15,(ribonate),0.21,'-,0.141 unit decrease,[0.11-0.18],"ENOSF1, TYMS",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,18:673086
rs115560420-<b>T</b>,7 x 10-15,(succinylcarnitine (C4-DC)),0.13,'-,0.176 unit increase,[0.13-0.22],SUCLG2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,3:67375539
rs11071733-<b>A</b>,3 x 10-19,(succinylcarnitine (C4-DC)),0.4,'-,0.14 unit increase,[0.11-0.17],LACTB,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,15:63124282
rs34670419-<b>T</b>,6 x 10-18,(tauro-beta-muricholate),0.03,'-,1.245 unit increase,[0.96-1.53],ZKSCAN5,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:99533211
rs58310495-<b>T</b>,1 x 10-15,(taurocholenate sulfate),0.18,'-,0.585 unit increase,[0.44-0.73],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21204777
rs1047891-<b>A</b>,7 x 10-17,(tigloylglycine),0.33,'-,0.223 unit increase,[0.17-0.28],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs3213737-<b>G</b>,2 x 10-25,(trans-urocanate),0.48,'-,0.227 unit decrease,[0.18-0.27],HAL,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:95986028
rs11133665-<b>A</b>,5 x 10-23,(tryptophan),0.27,'-,0.271 unit decrease,[0.22-0.33],"CTD-3080P12.3, SLC6A19",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:1188170
rs11133665-<b>A</b>,1 x 10-16,(tyrosine),0.27,'-,0.228 unit decrease,[0.17-0.28],"CTD-3080P12.3, SLC6A19",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:1188170
rs56768485-<b>A</b>,1 x 10-56,(X - 10457),0.28,'-,0.355 unit increase,[0.31-0.4],RNPEP,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:201983470
rs12208357-<b>T</b>,8 x 10-16,(nicotinamide riboside),0.1,'-,0.376 unit increase,[0.28-0.47],SLC22A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:160122116
rs7905265-<b>G</b>,7 x 10-81,(N-methylpipecolate),0.38,'-,1.064 unit decrease,[0.95-1.17],PYROXD2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:98383436
rs1251075-<b>G</b>,2 x 10-18,(N-octanoylglutamine),0.32,'-,0.37 unit decrease,[0.29-0.45],ACADM,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75724884
rs13197514-<b>T</b>,9 x 10-18,(N-octanoylglutamine),0.45,'-,0.343 unit decrease,[0.26-0.42],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25785763
rs7159760-<b>T</b>,2 x 10-25,(nonenedioate (C9:1-DC)),0.22,'-,0.296 unit decrease,[0.24-0.35],"ACOT4, ACOT2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,14:73589444
rs3744032-<b>T</b>,2 x 10-28,(nonenedioate (C9:1-DC)),0.06,'-,0.586 unit decrease,[0.48-0.69],ACOX1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,17:75973754
rs3799340-<b>T</b>,8 x 10-20,(X - 23196),0.45,'-,0.246 unit decrease,[0.19-0.3],SLC17A4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25762418
rs453881-<b>T</b>,2 x 10-27,(X - 23299),0.15,'-,1.087 unit increase,[0.89-1.28],GBA3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:22805140
rs168578-<b>T</b>,2 x 10-14,(X - 23311),0.15,'-,0.593 unit increase,[0.44-0.75],GBA3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:22825888
rs358231-<b>A</b>,2 x 10-38,(X - 23314),0.15,'-,1.807 unit increase,[1.53-2.08],GBA3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:22818881
rs13408433-<b>A</b>,2 x 10-30,(X - 23423),0.21,'-,0.326 unit decrease,[0.27-0.38],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73655945
rs36209093-<b>C</b>,7 x 10-86,(X - 23438),0.36,'-,0.425 unit increase,[0.38-0.47],GSTM2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:109687165
rs2817188-<b>A</b>,5 x 10-21,(X - 23518),0.47,'-,0.594 unit decrease,[0.47-0.72],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25807375
rs112992077-<b>T</b>,3 x 10-11,(X - 23581),0.02,'-,1.467 unit increase,[1.04-1.9],RPS6KA2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:166695228
rs6546861-<b>T</b>,9 x 10-48,(X - 23590),0.21,'-,0.289 unit increase,[0.25-0.33],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73622734
rs6464114-<b>A</b>,2 x 10-20,(X - 23656),0.46,'-,0.33 unit decrease,[0.26-0.4],AOC1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:150842165
rs6464114-<b>A</b>,6 x 10-13,(X - 23668),0.46,'-,0.458 unit decrease,[0.33-0.58],AOC1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:150842165
rs4488133-<b>T</b>,2 x 10-209,(X - 23776),0.36,'-,1.155 unit decrease,[1.08-1.23],PYROXD2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:98399379
rs61987137-<b>T</b>,1 x 10-52,(X - 24330),0.22,'-,0.636 unit decrease,[0.55-0.72],ACOT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,14:73569909
rs1165213-<b>G</b>,8 x 10-44,(X - 24339),0.47,'-,0.333 unit decrease,[0.29-0.38],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25799448
rs1698237-<b>C</b>,2 x 10-12,(X - 24339),0.5,'-,0.179 unit increase,[0.13-0.23],NME4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:401306
rs3757130-<b>A</b>,3 x 10-13,(X - 24347),0.45,'-,0.224 unit decrease,[0.16-0.28],SLC17A4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25770638
rs6889699-<b>T</b>,1 x 10-70,(X - 24348),0.14,'-,1.216 unit decrease,[1.08-1.35],UGT3A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35980373
rs1892249-<b>G</b>,2 x 10-11,(X - 24350),0.45,'-,0.373 unit decrease,[0.26-0.48],SLC17A4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25768764
rs776746-<b>T</b>,9 x 10-30,(X - 24353),0.07,'-,0.777 unit decrease,[0.64-0.91],CYP3A5,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:99672916
rs12611275-<b>A</b>,4 x 10-20,(X - 24359),0.27,'-,0.362 unit decrease,[0.29-0.44],"CLEC4O, CYP4F36P",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:15868125
rs37369-<b>T</b>,2 x 10-24,(X - 24387),0.08,'-,0.476 unit decrease,[0.38-0.57],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs1047891-<b>A</b>,1 x 10-12,(X - 24402),0.33,'-,0.438 unit increase,[0.32-0.56],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs71659190-<b>C</b>,2 x 10-12,(X - 24403),0.04,'-,0.771 unit increase,[0.56-0.98],PLPPR4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:99247284
rs72897838-<b>G</b>,2 x 10-13,(X - 24455),0.1,'-,0.331 unit increase,[0.24-0.42],AFMID,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,17:78202506
rs1043657-<b>T</b>,2 x 10-412,(X - 24462),0.09,'-,1.114 unit increase,[1.06-1.16],AKR7A2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:19308517
rs6977081-<b>T</b>,1 x 10-32,(1-methylhistamine),0.35,'-,0.381 unit decrease,[0.32-0.44],AOC1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:150845427
rs4921914-<b>C</b>,1 x 10-11,(1-methylurate),0.22,'-,0.405 unit decrease,[0.29-0.52],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18414928
rs1495741-<b>G</b>,6 x 10-21,(1-methylxanthine),0.22,'-,0.589 unit decrease,[0.47-0.71],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18415371
rs1047891-<b>A</b>,3 x 10-22,(2-methylbutyrylglycine),0.33,'-,0.224 unit increase,[0.18-0.27],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs7849270-<b>A</b>,6 x 10-30,(2-methylmalonylcarnitine (C4-DC)),0.28,'-,0.158 unit decrease,[0.13-0.19],PTPA,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,9:129112362
rs55758160-<b>G</b>,1 x 10-55,(2'-O-methylcytidine),0.39,'-,0.302 unit increase,[0.26-0.34],PHYHD1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,9:128922736
rs231976-<b>G</b>,2 x 10-19,(3-hydroxyindolin-2-one sulfate),0.45,'-,0.342 unit increase,[0.27-0.42],NUPR1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:28534266
rs11133665-<b>A</b>,1 x 10-15,(3-hydroxykynurenine),0.27,'-,0.457 unit decrease,[0.35-0.57],"CTD-3080P12.3, SLC6A19",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:1188170
rs1047891-<b>A</b>,4 x 10-14,(3-methylcrotonylglycine),0.33,'-,0.246 unit increase,[0.18-0.31],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs73224656-<b>A</b>,4 x 10-43,(3-methylcytidine),0.13,'-,0.304 unit increase,[0.26-0.35],"BST1, FAM200B",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:15698170
rs1047891-<b>A</b>,3 x 10-25,(3-methylglutaconate),0.33,'-,0.226 unit increase,[0.18-0.27],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs820503-<b>A</b>,3 x 10-22,(3-methylglutaconate),0.14,'-,0.292 unit decrease,[0.23-0.35],"RPS3AP54, RNF2P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,9:6667928
rs1047891-<b>A</b>,5 x 10-26,(3-methylglutarate/2-methylglutarate),0.33,'-,0.335 unit increase,[0.27-0.4],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs820503-<b>A</b>,2 x 10-19,(3-methylglutarate/2-methylglutarate),0.14,'-,0.398 unit decrease,[0.31-0.48],"RPS3AP54, RNF2P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,9:6667928
rs7094385-<b>G</b>,4 x 10-21,(4-ureidobutyrate),0.22,'-,0.268 unit increase,[0.21-0.32],DHTKD1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:12091253
rs35246381-<b>C</b>,6 x 10-24,(5-acetylamino-6-amino-3-methyluracil),0.22,'-,0.534 unit increase,[0.43-0.64],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18415025
rs7683000-<b>G</b>,8 x 10-26,(2'-deoxyguanosine),0.17,'-,0.479 unit decrease,[0.39-0.57],FBXL5,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:15645451
rs12555901-<b>T</b>,3 x 10-37,(2'-O-methyluridine),0.39,'-,0.626 unit increase,[0.53-0.72],PHYHD1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,9:128937261
rs37369-<b>T</b>,6 x 10-119,(3-aminoisobutyrate),0.08,'-,2.114 unit increase,[1.94-2.29],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs11613331-<b>G</b>,5 x 10-15,(3-aminoisobutyrate),0.46,'-,0.446 unit decrease,[0.33-0.56],SLC6A13,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:242301
rs1047891-<b>A</b>,2 x 10-21,(3-methylglutarylcarnitine (2)),0.33,'-,0.322 unit increase,[0.26-0.39],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs820503-<b>A</b>,2 x 10-18,(3-methylglutarylcarnitine (2)),0.14,'-,0.407 unit decrease,[0.31-0.5],"RPS3AP54, RNF2P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,9:6667928
rs4921915-<b>G</b>,1 x 10-19,(4-acetamidobutanoate),0.22,'-,0.163 unit increase,[0.13-0.2],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18414956
rs3980014-<b>C</b>,1 x 10-44,(4-guanidinobutanoate),0.43,'-,0.43 unit increase,[0.37-0.49],DNAJC16,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:15549419
rs2688412-<b>A</b>,3 x 10-11,(4-hydroxyphenylpyruvate),0.13,'-,0.533 unit increase,[0.38-0.69],PSMD9,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:121911152
rs35246381-<b>C</b>,1 x 10-72,(5-acetylamino-6-formylamino-3-methyluracil),0.23,'-,1.141 unit increase,[1.02-1.26],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18415025
rs37369-<b>T</b>,1 x 10-14,(5-aminovalerate),0.08,'-,0.632 unit increase,[0.47-0.79],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs12460876-<b>C</b>,2 x 10-23,(5-hydroxylysine),0.38,'-,0.65 unit increase,[0.52-0.78],SLC7A9,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:32865985
rs1706821-<b>A</b>,8 x 10-25,(adenosine),0.35,'-,0.289 unit increase,[0.23-0.34],SHF,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,15:45184814
rs1165187-<b>C</b>,1 x 10-39,"(adenosine 3',5'-cyclic monophosphate (cAMP))",0.25,'-,0.219 unit decrease,[0.19-0.25],SLC17A3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25851141
rs12611275-<b>A</b>,2 x 10-18,(alpha-CEHC glucuronide),0.27,'-,0.397 unit decrease,[0.31-0.49],"CLEC4O, CYP4F36P",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:15868125
rs55744319-<b>A</b>,2 x 10-15,(alpha-CEHC sulfate),0.27,'-,0.422 unit decrease,[0.32-0.53],"CLEC4O, CYP4F36P",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:15871011
rs34670419-<b>T</b>,2 x 10-12,(andro steroid monosulfate C19H28O6S (1)),0.03,'-,1.162 unit increase,[0.84-1.49],ZKSCAN5,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:99533211
rs2972516-<b>T</b>,4 x 10-20,"(androstenediol (3beta,17beta))",0.17,'-,0.8 unit decrease,[0.63-0.97],"BSPH1, SULT2A1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:47962055
rs7108196-<b>A</b>,3 x 10-25,(beta-citrylglutamate),0.15,'-,0.272 unit decrease,[0.22-0.32],"UBTFL1, NAALAD2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:90107954
rs6666886-<b>G</b>,6 x 10-31,(beta-guanidinopropanoate),0.36,'-,1.013 unit decrease,[0.84-1.19],DNAJC16,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:15587837
rs6425194-<b>C</b>,2 x 10-15,(cysteinylglycine),0.33,'-,0.3 unit decrease,[0.23-0.37],"SRP14P4, GM2AP2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:171358944
rs420332-<b>T</b>,9 x 10-25,(cysteinylglycine disulfide),0.46,'-,0.194 unit decrease,[0.16-0.23],DPEP1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:89632344
rs66731853-<b>A</b>,2 x 10-17,(cytidine),0.33,'-,0.296 unit decrease,[0.23-0.36],CDA,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:20589745
rs4617507-<b>G</b>,1 x 10-14,(diacetylspermidine),0.23,'-,0.257 unit increase,[0.19-0.32],PAOX,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:133379745
rs61748567-<b>A</b>,1 x 10-24,(diacetylspermidine),0.02,'-,0.894 unit increase,[0.72-1.06],"MAPK12, HDAC10",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:50246903
rs685607-<b>A</b>,1 x 10-12,(dimethylmalonic acid),0.45,'-,0.139 unit increase,[0.1-0.178],ACSM6,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:95227255
rs2514022-<b>C</b>,2 x 10-13,(dimethylmalonic acid),0.4,'-,0.141 unit increase,[0.1-0.18],TBX10,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:67634642
rs45446698-<b>G</b>,4 x 10-12,(epiandrosterone sulfate),0.03,'-,1.589 unit decrease,[1.14-2.04],"CYP3A7, CYP3A4",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:99735325
rs1799958-<b>A</b>,8 x 10-169,(ethylmalonate),0.27,'-,0.514 unit increase,[0.48-0.55],ACADS,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:120738280
rs2817188-<b>A</b>,1 x 10-32,(ferulic acid 4-sulfate),0.47,'-,0.534 unit decrease,[0.45-0.62],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25807375
rs151232-<b>T</b>,3 x 10-31,(furaneol sulfate),0.45,'-,0.364 unit increase,[0.3-0.42],SGF29,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:28569012
rs12611275-<b>A</b>,3 x 10-12,(gamma-CEHC glucuronide),0.27,'-,0.244 unit decrease,[0.18-0.31],"CLEC4O, CYP4F36P",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:15868125
rs765285-<b>G</b>,4 x 10-14,(gamma-CEHC sulfate),0.49,'-,0.498 unit decrease,[0.37-0.63],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25828014
rs6546861-<b>T</b>,2 x 10-123,(X - 11357),0.21,'-,0.873 unit increase,[0.8-0.95],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73622734
rs2972516-<b>T</b>,4 x 10-31,(X - 11440),0.17,'-,0.623 unit decrease,[0.52-0.73],"BSPH1, SULT2A1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:47962055
rs13384756-<b>T</b>,1 x 10-109,(X - 12093),0.21,'-,1.118 unit increase,[1.02-1.22],ALMS1P1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73644538
rs2147896-<b>G</b>,2 x 10-309,(X - 12093),0.36,'-,1.3 unit decrease,[1.23-1.37],PYROXD2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:98388419
rs37369-<b>T</b>,6 x 10-27,(X - 12096),0.08,'-,0.657 unit decrease,[0.54-0.78],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs1554597-<b>C</b>,6 x 10-16,(X - 12097),0.36,'-,0.335 unit increase,[0.25-0.42],DDAH1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:85411415
rs37369-<b>T</b>,4 x 10-48,(X - 12097),0.08,'-,1.009 unit decrease,[0.87-1.14],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs4488133-<b>T</b>,1 x 10-234,(X - 12112),0.36,'-,1.461 unit decrease,[1.37-1.55],PYROXD2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:98399379
rs37369-<b>T</b>,6 x 10-50,(X - 12117),0.08,'-,0.627 unit decrease,[0.54-0.71],AGXT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,5:35037010
rs6711001-<b>G</b>,2 x 10-257,(X - 12124),0.21,'-,0.709 unit increase,[0.67-0.75],ALMS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73623693
rs10201159-<b>C</b>,2 x 10-570,(X - 12125),0.21,'-,1.657 unit increase,[1.59-1.72],"ALMS1, NAT8",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73631838
rs13538-<b>G</b>,9 x 10-15,(X - 12379),0.21,'-,0.241 unit increase,[0.18-0.3],"NAT8, ALMS1P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73641201
rs4921914-<b>C</b>,5 x 10-18,(X - 12410),0.22,'-,0.377 unit increase,[0.29-0.46],NAT2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,8:18414928
rs7513363-<b>G</b>,5 x 10-18,(X - 12636),0.32,'-,0.336 unit decrease,[0.26-0.41],"ACADM, SLC44A5",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75677758
rs4680-<b>G</b>,2 x 10-11,(X - 12707),0.5,'-,0.163 unit decrease,[0.12-0.21],COMT,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:19963748
rs4680-<b>G</b>,2 x 10-28,(X - 12708),0.5,'-,0.228 unit increase,[0.19-0.27],COMT,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:19963748
rs231977-<b>T</b>,1 x 10-12,(X - 12714),0.45,'-,0.213 unit decrease,[0.15-0.27],"NUPR1, IL27",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:28530851
rs1165152-<b>A</b>,5 x 10-46,(X - 12822),0.47,'-,0.299 unit decrease,[0.26-0.34],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25818538
rs1892249-<b>G</b>,1 x 10-22,(X - 12839),0.45,'-,0.392 unit decrease,[0.31-0.47],SLC17A4,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25768764
rs2286963-<b>G</b>,4 x 10-75,(X - 13431),0.36,'-,0.637 unit increase,[0.57-0.71],ACADL,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210195326
rs1531022-<b>A</b>,1 x 10-13,(X - 13688),0.46,'-,0.187 unit increase,[0.14-0.24],UGT2B15,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:68666410
rs10201159-<b>C</b>,4 x 10-280,(X - 13698),0.21,'-,0.81 unit increase,[0.76-0.86],"ALMS1, NAT8",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73631838
rs358228-<b>C</b>,1 x 10-30,(X - 13847),0.16,'-,0.861 unit increase,[0.71-1.01],GBA3,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:22821957
rs1165151-<b>T</b>,2 x 10-14,(X - 13866),0.49,'-,0.594 unit decrease,[0.44-0.75],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25821388
rs77289848-<b>A</b>,2 x 10-11,(X - 14662),0.13,'-,0.579 unit increase,[0.41-0.75],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21207827
rs556339-<b>T</b>,2 x 10-18,"(adenosine 3, 5-cyclic monophosphate, biopterin)",0.25,'-,0.008 unit decrease,[0.006-0.01],SLC17A3,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:25870517
rs776746-<b>T</b>,3 x 10-18,"(X-24327, X-24353)",0.07,'-,0.015 unit decrease,[0.011-0.019],CYP3A5,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,7:99672916
rs45446698-<b>G</b>,1 x 10-10,"(glyco-beta-muricholatemtauro-beta-muricholate, X-23157)",0.03,'-,0.017 unit increase,[0.011-0.023],"CYP3A7, CYP3A4",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,7:99735325
rs35246381-<b>C</b>,2 x 10-25,"(4-acetamidobutanoate, allo-threonine, N-acetylputrescine)",0.22,'-,0.01 unit increase,[0.008-0.012],NAT2,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,8:18415025
rs7023900-<b>C</b>,2 x 10-14,"(2-methylmalonylcarnitine(C4-DC), succinylcarnitine(C4-DC), X-24699)",0.28,'-,0.007 unit decrease,[0.005-0.009],PTPA,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,9:129128873
rs2147896-<b>G</b>,3 x 10-917,"(X-12093, X-12112, X-23776, X-24809, X-24983)",0.36,'-,0.03 unit decrease,[0.028-0.032],PYROXD2,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,10:98388419
rs4240520-<b>G</b>,9 x 10-17,"(acisoga, diacetylspermidine, N1, N12-diacetylspermine, X-23656, X-23668)",0.14,'-,0.01 unit increase,[0.008-0.012],PAOX,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,10:133383915
rs2514032-<b>T</b>,9 x 10-12,"(N-acetylkynurenine, N-acetylphenylalanine, N-acetyltryptophan, N-acetyltyrosine)",0.17,'-,0.007 unit decrease,[0.005-0.009],ACY3,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,11:67643949
rs7108196-<b>A</b>,2 x 10-14,"(beta-citrylglutamate, saccharopine)",0.15,'-,0.009 unit decrease,[0.007-0.011],"UBTFL1, NAALAD2",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,11:90107954
rs55695203-<b>C</b>,3 x 10-16,"(glycochenodeoxycholate sulfate, glycocholenate sulfate, X-14658, X-21448, X-21467)",0.18,'-,0.009 unit increase,[0.007-0.011],SLCO1B1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,12:21204819
rs55695203-<b>C</b>,1 x 10-17,"(taurocholenate sulfate, X-24669)",0.18,'-,0.009 unit increase,[0.007-0.011],SLCO1B1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,12:21204819
rs1799958-<b>A</b>,7 x 10-25,"(5-hydroxyhexanoate, ethylmalonate, N-formylmethionine, triacetate lactone)",0.27,'-,0.009 unit increase,[0.007-0.011],ACADS,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,12:120738280
rs12460876-<b>C</b>,2 x 10-17,"(homoarginine, lysine, X-24736)",0.38,'-,0.007 unit increase,[0.005-0.009],SLC7A9,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,19:32865985
rs4680-<b>G</b>,5 x 10-54,"(X-12708, X-21785)",0.5,'-,0.012 unit increase,[0.01-0.014],COMT,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,22:19963748
rs4694429-<b>A</b>,6 x 10-24,(11-ketoetiocholanolone sulfate),0.34,'-,0.617 unit increase,[0.5-0.74],TMPRSS11E,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:68492323
rs62129966-<b>A</b>,2 x 10-11,(11-ketoetiocholanolone sulfate),0.16,'-,0.522 unit decrease,[0.37-0.67],SULT2A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:47871693
rs34670419-<b>T</b>,6 x 10-12,(16a-hydroxy DHEA 3-sulfate),0.03,'-,1.515 unit increase,[1.08-1.95],ZKSCAN5,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,7:99533211
rs118186763-<b>A</b>,4 x 10-53,(17alpha-hydroxypregnanolone glucuronide),0.06,'-,1.987 unit decrease,[1.73-2.24],SLC22A24,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:63084951
rs7607014-<b>G</b>,8 x 10-25,"(N-acetylkynurenine,  N-acetylphenylalanine,  N-acetyltryptophan,  N-acetyltyrosine)",0.22,'-,0.01 unit increase,[0.008-0.012],ALMS1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73503047
rs6711001-<b>G</b>,7 x 10-14,"(1-methylhistidine, homocitrulline, X-23587)",0.21,'-,0.008 unit decrease,[0.006-0.01],ALMS1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73623693
rs6718843-<b>A</b>,5 x 10-24,"(homocitrate, X-24519)",0.21,'-,0.01 unit decrease,[0.008-0.012],"NAT8, ALMS1",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73625378
rs10201159-<b>C</b>,1 x 10-363,"(N-acetylarginine, N-acetylcitrulline, X-13698)",0.21,'-,0.03 unit increase,[0.028-0.032],"ALMS1, NAT8",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73631838
rs4547554-<b>C</b>,5 x 10-13,"(N-acetylalanine, N-acetylmethionine, N-acetylmethionine sulfoxide, sarcosine, X-12199)",0.21,'-,0.007 unit increase,[0.005-0.009],NAT8,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73640735
rs2286963-<b>G</b>,7 x 10-132,"(glycine conjugate of C9H16O2, X-12459, X-13431)",0.36,'-,0.019 unit increase,[0.017-0.021],ACADL,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:210195326
rs1047891-<b>A</b>,3 x 10-24,"(hexanoylglycine, isocaproylglycine, X-16567, X-24402)",0.33,'-,0.009 unit increase,[0.007-0.011],CPS1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:210675783
rs453881-<b>T</b>,2 x 10-30,"(X-13847, X-23299, X-23314, X-23502)",0.15,'-,0.013 unit increase,[0.011-0.015],GBA3,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,4:22805140
rs1043657-<b>T</b>,2 x 10-26,"(4-hydroxyglutamate,  5-hydroxylysine,  X-24462)",0.09,'-,0.015 unit decrease,[0.013-0.017],AKR7A2,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,1:19308517
rs13375749-<b>C</b>,2 x 10-10,"(methylsuccinoylcarnitine,  X-24468,  X-24469,  X-24971)",0.21,'-,0.006 unit decrease,[0.004-0.008],MAGOH,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,1:53230210
rs11161430-<b>T</b>,8 x 10-26,"(hexanoylglycine,  isocaproylglycine,  X-16567,  X-24402)",0.32,'-,0.009 unit decrease,[0.007-0.011],ACADM,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,1:75715193
rs71659190-<b>C</b>,3 x 10-11,"(X-11852,  X-21803,  X-24403)",0.04,'-,0.015 unit increase,[0.011-0.019],PLPPR4,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,1:99247284
rs72841887-<b>C</b>,2 x 10-10,"(N-acetylarginine,  N-acetylcitrulline,  X-13698)",0.05,'-,0.013 unit increase,[0.0091-0.0169],RAB11FIP5,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73131402
rs9461218-<b>A</b>,1 x 10-13,(X - 15497 ),0.23,'-,0.293 unit decrease,[0.22-0.37],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25818527
rs13538-<b>G</b>,1 x 10-104,(X - 15666),0.21,'-,0.875 unit decrease,[0.8-0.95],"NAT8, ALMS1P1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:73641201
rs2071426-<b>C</b>,2 x 10-14,(X - 16087),0.32,'-,0.219 unit increase,[0.16-0.28],CYP2C8,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,10:95068566
rs1251075-<b>G</b>,2 x 10-20,(X - 16567),0.32,'-,0.426 unit decrease,[0.34-0.52],ACADM,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:75724884
rs1047891-<b>A</b>,3 x 10-13,(X - 16567),0.33,'-,0.347 unit increase,[0.25-0.44],CPS1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,2:210675783
rs55695203-<b>C</b>,1 x 10-12,(X - 16654),0.18,'-,0.732 unit increase,[0.53-0.93],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21204819
rs662138-<b>G</b>,2 x 10-13,(X - 17323),0.16,'-,0.307 unit decrease,[0.22-0.39],SLC22A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:160143444
rs1747522-<b>T</b>,6 x 10-13,(X - 18888),0.48,'-,0.229 unit decrease,[0.17-0.29],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25821579
rs2460451-<b>A</b>,4 x 10-34,(X - 18889 ),0.45,'-,0.362 unit decrease,[0.3-0.42],DPEP1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,16:89631384
rs1165152-<b>A</b>,2 x 10-11,(X - 18938),0.47,'-,0.351 unit decrease,[0.25-0.45],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25818538
rs34103191-<b>A</b>,4 x 10-93,(X - 19141),0.34,'-,0.574 unit decrease,[0.52-0.63],TMPRSS11E,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:68493562
rs34594059-<b>C</b>,2 x 10-27,(X - 19434 ),0.34,'-,0.764 unit decrease,[0.62-0.9],TMPRSS11E,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,4:68495042
rs9461218-<b>A</b>,3 x 10-13,(X - 19561 ),0.23,'-,0.259 unit decrease,[0.19-0.33],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25818527
rs2344686-<b>G</b>,1 x 10-21,(X - 19913),0.13,'-,0.254 unit decrease,[0.2-0.31],"AACS, BRI3BP",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:125036471
rs55695203-<b>C</b>,5 x 10-17,(X - 21467),0.18,'-,0.526 unit increase,[0.4-0.65],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21204819
rs4149056-<b>C</b>,2 x 10-11,(X - 21470),0.18,'-,0.588 unit increase,[0.42-0.76],SLCO1B1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,12:21178615
rs2972516-<b>T</b>,6 x 10-15,(X - 21470),0.17,'-,0.708 unit decrease,[0.53-0.89],"BSPH1, SULT2A1",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,19:47962055
rs4680-<b>G</b>,2 x 10-59,(X - 21785),0.5,'-,0.221 unit increase,[0.19-0.25],COMT,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:19963748
rs11626972-<b>G</b>,3 x 10-145,(X - 21792),0.43,'-,1.021 unit decrease,[0.94-1.1],"HEATR4, ACOT2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,14:73566890
rs36209093-<b>C</b>,8 x 10-16,(X - 21796),0.36,'-,0.103 unit decrease,[0.078-0.128],GSTM2,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:109687165
rs28597732-<b>A</b>,5 x 10-13,(X - 21827),0.13,'-,0.572 unit decrease,[0.42-0.73],CYP4Z2P,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:46899620
rs1165152-<b>A</b>,6 x 10-12,(X - 21829),0.47,'-,0.173 unit decrease,[0.12-0.22],SLC17A1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,6:25818538
rs1018392-<b>T</b>,1 x 10-17,(X - 21842),0.34,'-,0.582 unit decrease,[0.45-0.72],"SRP14P4, GM2AP2",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,1:171384725
rs60032274-<b>T</b>,6 x 10-46,(X - 22162),0.03,'-,0.455 unit decrease,[0.39-0.52],GTSE1,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:46297163
rs118072533-<b>T</b>,3 x 10-43,(X - 22834),0.06,'-,2.583 unit decrease,[2.22-2.95],SLC22A24,Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,11:63132110
rs12898179-<b>C</b>,9 x 10-6,,0.79,'-,0.08 unit decrease,[0.041-0.119],TMEM229B,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,14:67497454
rs55847827-<b>G</b>,7 x 10-6,,0.18,1.8,'-,[1.39–2.32],"PHBP17, LINC02727",Proteinuria in chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003142,11:123318295
rs6036759-<b>A</b>,2 x 10-6,,0.41,'-,0.07 unit increase,[0.05-0.09],ZNF343,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,20:2510563
rs145768835-<b>?</b>,7 x 10-6,,0.82,1.82,'-,[1.41-2.38],FAM151B,Proteinuria in chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003142,5:80538468
rs894638-<b>C</b>,8 x 10-6,(EA),0.19,'-,0.1 unit decrease,[0.061-0.139],"PROM1, TAPT1",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,4:16118049
rs6497441-<b>T</b>,5 x 10-6,,0.29,1.44,'-,[1.23–1.69],GRIN2A,Chronic kidney disease,chronic kidney disease,GCST003140,16:9735991
rs8117834-<b>T</b>,6 x 10-6,,0.14,1.68,'-,[1.34–2.10],PLCB1,Chronic kidney disease,chronic kidney disease,GCST003140,20:8109993
rs13072153-<b>?</b>,3 x 10-6,,0.62,1.43,'-,[1.23-1.67],"HACD2, ADCY5",Chronic kidney disease,chronic kidney disease,GCST003140,3:123459285
rs9535020-<b>G</b>,4 x 10-6,,0.13,1.69,'-,[1.35–2.10],RB1,Chronic kidney disease,chronic kidney disease,GCST003140,13:48349672
rs792064-<b>T</b>,2 x 10-6,,0.42,1.64,'-,[1.33–2.01],'-,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,2:5378545
rs11720887-<b>A</b>,4 x 10-6,,0.13,1.87,'-,[1.44–2.43],SGO1-AS1,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,3:20899351
rs4963124-<b>C</b>,9 x 10-6,,0.71,1.71,'-,[1.34–2.18],TALDO1,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,11:762791
rs35219335-<b>?</b>,4 x 10-6,,0.86,2.04,'-,[1.49-2.86],GAS7,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,17:10174519
rs9895232-<b>C</b>,3 x 10-6,,0.35,1.62,'-,[1.32–1.99],LINC01996,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,17:4615844
rs12601558-<b>?</b>,6 x 10-6,,0.78,1.79,'-,[1.37-2.33],SLC16A3,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,17:82221271
rs56052703-<b>?</b>,3 x 10-6,,0.66,1.67,'-,[1.33-2.08],CACNA1A,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,19:13322126
rs78057470-<b>C</b>,7 x 10-6,,0.32,1.61,'-,[1.31–1.98],SH3GL3,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,15:83481232
rs7541937-<b>G</b>,4 x 10-6,,0.47,'-,0.07 unit decrease,[0.05-0.09],DLGAP3,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,1:34876381
rs71413769-<b>G</b>,5 x 10-6,,0.1,'-,0.11 unit increase,[0.071-0.149],'-,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,2:139075570
rs10928150-<b>A</b>,7 x 10-6,,0.46,'-,0.07 unit decrease,[0.05-0.09],UBE2V1P14,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,2:142497154
rs138904061-<b>C</b>,6 x 10-6,,0.16,'-,0.09 unit decrease,[0.051-0.129],ALCAM,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,3:105455358
rs10054413-<b>G</b>,7 x 10-6,,0.14,'-,0.1 unit decrease,[0.061-0.139],MEF2C-AS1,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,5:89309812
rs62441014-<b>C</b>,4 x 10-6,,0.41,'-,0.07 unit increase,[0.031-0.109],FBXL18,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,7:5493688
rs11066679-<b>C</b>,3 x 10-6,,0.23,'-,0.08 unit decrease,[0.041-0.119],LINC01234,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,12:113685597
rs61201007-<b>T</b>,9 x 10-6,,0.37,1.54,'-,[1.27–1.87],SAMD3,Proteinuria in chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003142,6:130194349
rs344364-<b>A</b>,5 x 10-6,,0.22,'-,0.08 unit increase,[0.041-0.119],"HS3ST6, MSRB1",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,16:1923515
rs76158983-<b>?</b>,5 x 10-6,,0.95,2.86,'-,[1.82-4.55],UACA,Proteinuria in chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003142,15:55016808
rs4487103-<b>C</b>,2 x 10-6,(EA),0.6,'-,0.08 unit decrease,[0.041-0.119],"GRB14, COBLL1",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,2:164629468
rs7129190-<b>?</b>,5 x 10-6,,0.47,1.41,'-,[1.20-1.61],HTR3B,Chronic kidney disease,chronic kidney disease,GCST003140,11:113948030
rs7674118-<b>T</b>,1 x 10-6,(EA),0.1,'-,0.15 unit decrease,[0.091-0.209],TLL1,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,4:165929313
rs10054413-<b>G</b>,5 x 10-6,(EA),0.14,'-,0.12 unit decrease,[0.061-0.179],MEF2C-AS1,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,5:89309812
rs10872424-<b>T</b>,4 x 10-6,(EA),0.14,'-,0.12 unit decrease,[0.061-0.179],"CT69, LINC01010",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,6:134503073
rs11677592-<b>T</b>,6 x 10-6,(Turkish ancestry),0.37,'-,0.13 unit decrease,[0.071-0.189],LINC01320,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,2:33948334
rs111226991-<b>A</b>,6 x 10-6,(Turkish ancestry),0.14,'-,0.18 unit increase,[0.1-0.26],KDM3A,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,2:86441699
rs181394970-<b>T</b>,4 x 10-6,(Turkish ancestry),0.14,'-,0.19 unit increase,[0.11-0.27],"CHMP3, RNF103-CHMP3",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,2:86549112
rs11011653-<b>?</b>,1 x 10-6,,0.66,1.69,'-,[1.35-2.13],PLXDC2,Proteinuria and chronic kidney disease,"chronic kidney disease, Proteinuria",GCST003141,10:19875064
rs13180077-<b>G</b>,6 x 10-6,(Turkish ancestry),0.65,'-,0.14 unit increase,[0.081-0.199],LINC02064,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,5:29489684
rs9785234-<b>G</b>,9 x 10-6,(Turkish ancestry),0.28,'-,0.13 unit increase,[0.071-0.189],"EIF4BP3, HSD17B3",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,9:96167968
rs1771792-<b>C</b>,4 x 10-6,(Turkish ancestry),0.9,'-,0.21 unit decrease,[0.11-0.31],"OR1J1, PTGS1",Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,9:122458945
rs12635820-<b>T</b>,2 x 10-6,(Turkish ancestry),0.33,'-,0.14 unit increase,[0.081-0.199],'-,Glomerular filtration rate in chronic kidney disease,"glomerular filtration rate, chronic kidney disease",GCST003139,3:80386640
rs59834205-<b>C</b>,1 x 10-7,,0.83,1.45,'-,[1.27-1.67],SLC2A9,Gout in chronic kidney disease,"gout, chronic kidney disease",GCST006425,4:9959397
rs4148155-<b>G</b>,5 x 10-9,,0.11,1.55,'-,[1.34-1.79],ABCG2,Gout in chronic kidney disease,"gout, chronic kidney disease",GCST006425,4:88133515
rs6066043-<b>G</b>,2 x 10-9,,0.62,2.13,'-,[NR],SLC13A3,Chronic kidney disease,chronic kidney disease,GCST002313,20:46659814
rs4293393-<b>T</b>,4 x 10-10,(CKD),0.798,1.25,'-,[1.17-1.35],UMOD,Chronic kidney disease and serum creatinine levels,chronic kidney disease,GCST000742,16:20353266
rs10941694-<b>A</b>,9 x 10-6,(CKD),0.06,1.35,'-,[1.19-1.56],HCN1,Chronic kidney disease and serum creatinine levels,chronic kidney disease,GCST000742,5:45197677
rs9310709-<b>C</b>,2 x 10-6,(CKD),0.41,1.15,'-,[1.09-1.22],"SALL4P5, RPL24P7",Chronic kidney disease and serum creatinine levels,chronic kidney disease,GCST000742,3:23052083
rs13070584-<b>T</b>,2 x 10-6,(CKD),0.05,1.42,'-,[1.23-1.65],COL8A1,Chronic kidney disease and serum creatinine levels,chronic kidney disease,GCST000742,3:99547493
rs116216059-<b>A</b>,1 x 10-8,,0.016,8.73,'-,[NR],STAC,Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, diabetic nephropathy",GCST009280,3:36524820
rs7582694-<b>C</b>,4 x 10-7,,0.216,1.811,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,2:191105394
rs1478897-<b>T</b>,8 x 10-6,,0.337,1.56,'-,[NR],BLK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,8:11537723
rs2187668-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,HLA-DQA1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,6:32638107
rs3129716-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,"MTCO3P1, HLA-DQB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,6:32689659
rs1150753-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,TNXB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,6:32092090
rs3131379-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,"MSH5, MSH5-SAPCD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,6:31753256
rs9267531-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,CSNK2B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003103,6:31668965
rs4850410-<b>?</b>,1 x 10-6,,NR,1.56,'-,[1.19-2.08],ANKRD44,Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,2:197055445
rs7897633-<b>?</b>,3 x 10-8,(EA),NR,1.6949153,'-,[1.28-2.27],PRKG1,Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,10:51197961
rs1049564-<b>T</b>,1 x 10-7,(EA),NR,2.08,'-,[1.34-3.21],PNP,Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,14:20472447
rs1028488-<b>?</b>,2 x 10-7,(EA),NR,1.9607843,'-,[1.43-2.63],"LINC01624, DLL1",Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,6:170281387
rs6850606-<b>?</b>,2 x 10-6,(EA),NR,1.5625,'-,[1.20-2.00],RN7SKP82,Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,4:42862679
rs7411387-<b>C</b>,3 x 10-6,(EA),NR,1.61,'-,[1.24-2.10],CHIA,Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,1:111294513
rs3934007-<b>T</b>,3 x 10-6,(EA),NR,1.55,'-,[1.19-2.00],TMPRSS5,Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,11:113668358
rs1429411-<b>C</b>,5 x 10-6,(EA),NR,1.55,'-,[1.20-2.00],"ANKRD44-IT1, ANKRD44",Interferon alpha levels in systemic lupus erythematosus,"interferon alpha measurement, systemic lupus erythematosus",GCST002666,2:197279278
rs5029939-<b>?</b>,3 x 10-12,,0.03,2.28,'-,[NR],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,6:137874586
rs11101442-<b>?</b>,3 x 10-6,,0.32,'-,'-,[NR],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,10:48728291
rs17039212-<b>?</b>,9 x 10-6,,0.1,'-,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,2:49728359
rs12949531-<b>?</b>,8 x 10-6,,0.22,'-,'-,[NR],COX10-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,17:13830489
rs11150610-<b>?</b>,2 x 10-6,,0.42,'-,'-,[NR],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,16:31322915
rs2618476-<b>?</b>,2 x 10-8,,0.26,1.29,'-,[NR],BLK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,8:11495032
rs2313132-<b>?</b>,8 x 10-6,,0.12,'-,'-,[NR],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,4:137771096
rs3821236-<b>?</b>,8 x 10-11,,0.19,1.49,'-,[NR],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000216,2:191038032
rs1150754-<b>A</b>,6 x 10-29,(anti-dsDNA +),0.13,2.21,'-,[1.93-2.53],TNXB,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,6:32082981
rs7574865-<b>T</b>,2 x 10-20,(anti-dsDNA +),0.23,1.77,'-,[1.57-1.99],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,2:191099907
rs10488631-<b>C</b>,7 x 10-18,(anti-dsDNA +),0.11,1.92,'-,[1.66-2.22],"IRF5, TNPO3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,7:128954129
rs6695567-<b>?</b>,4 x 10-6,(anti-dsDNA +),0.57,1.32,'-,[1.18-1.47],"CPT2, SLC1A7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,1:53163913
rs12629106-<b>?</b>,4 x 10-6,(case-only),0.81,1.56,'-,[1.30-1.89],"LINC00501, LINC00578",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,3:177377284
rs7574865-<b>T</b>,8 x 10-6,(case-only),0.28,1.41,'-,[1.21-1.63],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,2:191099907
rs6049839-<b>T</b>,8 x 10-6,(case-only),0.4,1.37,'-,[1.19-1.58],TMC2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,20:2537919
rs2736340-<b>T</b>,3 x 10-7,(anti-dsDNA +),0.23,1.38,'-,[1.23-1.56],"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,8:11486464
rs525410-<b>?</b>,6 x 10-7,(anti-dsDNA +),0.49,1.33,'-,[1.19-1.47],LAMC2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,1:183207295
rs5754217-<b>T</b>,2 x 10-6,(anti-dsDNA +),0.19,1.38,'-,[1.21-1.57],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,22:21585386
rs10737562-<b>?</b>,7 x 10-6,(anti-dsDNA +),0.5,1.3,'-,[1.16-1.45],"RNA5SP73, LINC01701",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,1:189754493
rs12531711-<b>G</b>,6 x 10-9,(anti-dsDNA -),0.11,1.58,'-,[1.36-1.83],TNPO3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,7:128977412
rs918959-<b>?</b>,2 x 10-6,(anti-dsDNA -),0.91,1.72,'-,[1.39-2.17],SCHLAP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,2:180649002
rs7927370-<b>?</b>,7 x 10-6,(anti-dsDNA -),0.94,1.92,'-,[1.45-2.56],OR4A15,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,11:55368743
rs2187668-<b>A</b>,6 x 10-28,(anti-dsDNA +),0.12,2.23,'-,[1.94-2.57],HLA-DQA1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,6:32638107
rs9888739-<b>T</b>,1 x 10-15,(anti-dsDNA +),0.13,1.8,'-,[1.56-2.07],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,16:31301932
rs4956211-<b>A</b>,1 x 10-6,(anti-dsDNA +),0.35,1.33,'-,[1.19-1.48],"COL25A1, RCC2P8",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,4:108801970
rs2431697-<b>?</b>,2 x 10-6,(anti-dsDNA +),0.56,1.32,'-,[1.18-1.47],MIR3142HG,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,5:160452971
rs4963128-<b>?</b>,4 x 10-6,(anti-dsDNA +),0.66,1.33,'-,[1.18-1.49],PHRF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,11:589564
rs2301271-<b>T</b>,2 x 10-12,(anti-dsDNA -),0.4,1.47,'-,[1.32-1.63],HLA-DQB2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,6:32757416
rs2669010-<b>A</b>,5 x 10-6,(anti-dsDNA -),0.4,1.28,'-,[1.16-1.42],"RPL7AP9, YWHAQP7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,12:76615280
rs3130320-<b>T</b>,3 x 10-6,(case-only),0.39,1.39,'-,[1.21-1.60],TSBP1-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,6:32255481
rs1463525-<b>?</b>,8 x 10-6,(case-only),0.43,1.37,'-,[1.19-1.59],"NAALADL2-AS2, NAALADL2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,3:175243598
rs2647012-<b>A</b>,8 x 10-6,(case-only),0.44,1.38,'-,[1.20-1.59],"HLA-DQB1, MTCO3P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000996,6:32696681
rs7329174-<b>G</b>,1 x 10-8,,0.22,1.26,'-,[1.16-1.36],ELF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000858,13:40983974
rs1128334-<b>A</b>,2 x 10-11,,0.35,1.29,'-,[1.20-1.39],ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000592,11:128459064
rs7097397-<b>G</b>,8 x 10-12,,0.28,1.3,'-,[1.21-1.40],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000592,10:48817351
rs13277113-<b>A</b>,1 x 10-10,,0.23,1.39,'-,[1.28-1.51],BLK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,8:11491677
rs979233-<b>T</b>,4 x 10-6,,0.46,'-,'-,'-,GHR,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,5:42375141
rs12141391-<b>A</b>,7 x 10-6,,0.02,'-,'-,'-,"NEGR1-IT1, NEGR1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,1:71808790
rs10488631-<b>C</b>,2 x 10-11,,0.12,'-,'-,'-,"IRF5, TNPO3",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,7:128954129
rs7574865-<b>T</b>,9 x 10-14,,0.23,'-,'-,'-,STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,2:191099907
rs11574637-<b>C</b>,3 x 10-11,,0.19,1.33,'-,[1.22-1.46],ITGAX,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,16:31357553
rs2187668-<b>A</b>,3 x 10-21,,0.11,'-,'-,'-,HLA-DQA1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,6:32638107
rs17083844-<b>A</b>,6 x 10-6,,0.03,'-,'-,'-,'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,18:71175007
rs11243676-<b>A</b>,3 x 10-6,,0.07,'-,'-,'-,NTNG2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000144,9:132221380
rs10516487-<b>G</b>,4 x 10-10,,0.77,1.38,'-,[1.25-1.53],BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000143,4:101829919
rs3892097-<b>T</b>,6 x 10-16,(alpha-hydroxymetoprolol),0.18,'-,1.698 unit decrease,[1.29-2.11],"CYP2D6, NDUFA6-DT",Urinary metabolite levels in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009733,22:42128945
rs9461218-<b>A</b>,9 x 10-18,"(3-(4-hydroxyphenyl)lactate, 4-hydroxyphenylpyruvate, indolelactate, phenyllactate(PLA), X-16071)",0.23,'-,0.009 unit decrease,[0.007-0.011],SLC17A1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:25818527
rs1165150-<b>C</b>,2 x 10-11,"(3-hydroxysebacate, X-13874, X-18888, X-18938, X-21827)",0.49,'-,0.006 unit decrease,[0.004-0.008],SLC17A3,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:25841804
rs34107459-<b>C</b>,9 x 10-11,"(3-(4-hydroxyphenyl)lactate, 4-hydroxyphenylpyruvate, indolelactate, phenyllactate (PLA), X-16071)",0.09,'-,0.01 unit decrease,[0.0061-0.0139],"BTN3A2, H3C9P",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:26328125
rs820503-<b>A</b>,6 x 10-24,"(3-hydroxy-3-methylglutarate, 3-methylglutaconate, 3-methylglutarate, 2-methylglutarate, 3-methylglutarylcarnitine)",0.14,'-,0.012 unit decrease,[0.01-0.014],"RPS3AP54, RNF2P1",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,9:6667928
rs55695203-<b>C</b>,4 x 10-22,"(glycochenodeoxycholate glucuronide, glycodeoxycholate sulfate, glycolithocholate sulfate, taurolithocholate 3-sulfate, X-14626, X-16654, X-22520, X-22834)",0.18,'-,0.01 unit increase,[0.008-0.012],SLCO1B1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,12:21204819
rs55744319-<b>A</b>,6 x 10-20,"(alpha-CEHC glucuronide, alpha-CEHC glycine, alpha-CEHC sulfate, alpha-CEHC taurine, X-13689, X-24359)",0.27,'-,0.009 unit decrease,[0.007-0.011],"CLEC4O, CYP4F36P",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,19:15871011
rs4822523-<b>T</b>,2 x 10-11,"(gamma-glutamyl-epsilon-lysine, gamma-glutamylglycine, gamma-glutamylhistidine, gamma-glutamylleucine, gamma-glutamylphenylalanine, gamma-glutamylthreonine, tryptamine, tyramine, X-23593)",0.34,'-,0.006 unit increase,[0.004-0.008],GGT1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,22:24615934
rs1430346-<b>C</b>,5 x 10-18,"(N2-acetyllysine,  N-alpha-acetylornithine,  X-12124,  X-12125,  X-15666)",0.28,'-,0.008 unit increase,[0.006-0.01],RAB11FIP5,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73140117
rs6546861-<b>T</b>,9 x 10-182,"(N-acetyl-1-methylhistidine,  N-delta-acetylornithine,  X-11357,  X-23590)",0.21,'-,0.024 unit increase,[0.022-0.026],ALMS1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73622734
rs4547554-<b>C</b>,2 x 10-165,"(N2, N6-diacetyllysine, N-acetylasparagine, N-acetylglutamine, N-acetylhistidine, N-acetylleucine)",0.21,'-,0.023 unit increase,[0.021-0.025],NAT8,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73640735
rs13538-<b>G</b>,4 x 10-635,"(N2-acetyllysine, N-alpha-acetylornithine, X-12124, X-12125, X-15666)",0.21,'-,0.035 unit increase,[0.033-0.037],"NAT8, ALMS1P1",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73641201
rs1047891-<b>A</b>,2 x 10-16,"(2-methylbutyrylglycine, 3-methylcrotonylglycine, indoleacetylglutamine, indoleacetylglycine, isobutyrylglycine, isovalerylglutamine, isovalerylglycine, tigloylglycine, X-17688)",0.33,'-,0.007 unit increase,[0.005-0.009],CPS1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:210675783
rs1047891-<b>A</b>,8 x 10-30,"(3-hydroxy-3-methylglutarate, 3-methylglutaconate, 3-methylglutarate, 2-methylglutarate, 3-methylglutarylcarnitine)",0.33,'-,0.01 unit increase,[0.008-0.012],CPS1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:210675783
rs37369-<b>T</b>,1 x 10-96,"(3-aminoisobutyrate, 5-aminovalerate, X-12096, X-12097, X-12117, X-24518)",0.08,'-,0.028 unit decrease,[0.026-0.03],AGXT2,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,5:35037010
rs12212049-<b>T</b>,7 x 10-12,"(X-12822, X-17682, X-19913, X-24339, X-24588)",0.44,'-,0.006 unit decrease,[0.004-0.008],SLC17A4,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:25758838
rs1892249-<b>G</b>,2 x 10-30,"(heptanoylglutamine, hexanoylglutamine, isocaproylglutamine, N-octanoylglutamine, X-12636, X-12839, X-24347, X-24350)",0.45,'-,0.009 unit decrease,[0.007-0.011],SLC17A4,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:25768764
rs9461218-<b>A</b>,2 x 10-12,"(X-13529, X-15497, X-18889, X-19561, X-22102)",0.23,'-,0.007 unit decrease,[0.005-0.009],SLC17A1,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,6:25818527
rs7513363-<b>G</b>,8 x 10-13,"(heptanoylglutamine,  hexanoylglutamine,  isocaproylglutamine,  N-octanoylglutamine,  X-12636,  X-12839,  X-24347,  X-24350)",0.32,'-,0.006 unit decrease,[0.004-0.008],"ACADM, SLC44A5",Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,1:75677758
rs1430346-<b>C</b>,2 x 10-12,"(N2,  N6-diacetyllysine,  N-acetylasparagine,  N-acetylglutamine,  N-acetylhistidine,  N-acetylleucine)",0.28,'-,0.006 unit increase,[0.004-0.008],RAB11FIP5,Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,"chronic kidney disease, urinary metabolite measurement",GCST009735,2:73140117
rs138730015-<b>G</b>,2 x 10-6,,0.012,'-,6.13 ml/min/1.73m2 increase,[0.078-12.182],GLI2,Estimated glomerular filtration rate in coronary artery disease and impaired kidney function,"glomerular filtration rate, chronic kidney disease, coronary artery disease",GCST007495,2:120757583
rs139401390-<b>G</b>,6 x 10-8,,0.025,'-,3.72 ml/min/1.73m2 decrease,[0.3-7.14],"RPL7P34, LIPF",Estimated glomerular filtration rate in coronary artery disease and impaired kidney function,"glomerular filtration rate, chronic kidney disease, coronary artery disease",GCST007495,10:88643382
rs12917707-<b>G</b>,2 x 10-12,(CKD),0.82,1.25,'-,[1.18-1.33],"PDILT, UMOD",Renal function and chronic kidney disease,chronic kidney disease,GCST000397,16:20356368
rs4917385-<b>?</b>,1 x 10-8,,0.648,1.3888888,'-,[1.25-1.54],NT5C2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,10:103243964
rs61732491-<b>T</b>,2 x 10-6,,0.006,3.36,'-,[2.03-5.55],CERCAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,9:128424504
rs181502228-<b>T</b>,2 x 10-6,,0.012,4.35,'-,[2.35-8.07],"RNU2-19P, CDK18",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,1:205540170
rs1059702-<b>?</b>,8 x 10-14,,0.5,1.724138,'-,[1.47-2.04],IRAK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,X:154018741
rs1143679-<b>A</b>,3 x 10-21,,0.071,2.3,'-,[1.97-2.70],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,16:31265490
rs10254284-<b>A</b>,8 x 10-6,,0.583,1.29,'-,[1.16-1.42],JAZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,7:28127772
rs4641121-<b>?</b>,8 x 10-6,,0.851,1.4705882,'-,[1.25-1.72],KDM4C,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,9:7071706
rs10032909-<b>G</b>,1 x 10-6,,0.013,2.42,'-,[1.69-3.48],LINC01088,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,4:79049054
rs12736195-<b>?</b>,7 x 10-11,,0.721,1.5151515,'-,[1.35-1.69],PRDX6-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,1:173338762
rs13306575-<b>A</b>,3 x 10-8,,0.105,1.62,'-,[1.39-1.91],"NCF2, SMG7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,1:183563302
rs3862260-<b>?</b>,7 x 10-6,,0.566,1.4285715,'-,[1.23-1.67],"HSD3BP5, ZNF697",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,1:119618166
rs2797780-<b>C</b>,5 x 10-6,,0.167,1.37,'-,[1.21-1.55],"LINC02520, MIR4462",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,6:37538639
rs4574684-<b>G</b>,7 x 10-6,,0.208,1.34,'-,[1.19-1.5],MIR3144,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,6:119953631
rs330048-<b>A</b>,7 x 10-6,,0.766,1.41,'-,[1.22-1.64],"PPP1R3B, RNU6-1151P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,8:9229768
rs643955-<b>T</b>,4 x 10-7,,0.748,1.49,'-,[1.28-1.73],MSRA,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,8:10033744
rs17807624-<b>T</b>,7 x 10-6,,0.64,1.31,'-,[1.17-1.45],"LINC00208, GATA4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,8:11605506
rs7031325-<b>C</b>,7 x 10-6,,0.512,1.45,'-,[1.24-1.70],"GLDC, RN7SL123P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,9:6655056
rs190029011-<b>?</b>,3 x 10-6,,0.977,2.857143,'-,[1.85-4.35],GAS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,9:86916761
rs931127-<b>G</b>,7 x 10-6,,0.703,1.33,'-,[1.18-1.48],"PCNX3, SIPA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,11:65637829
rs7892586-<b>?</b>,3 x 10-6,,0.712,1.369863,'-,[1.14-1.67],PRPS2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,X:12814981
rs17301013-<b>?</b>,8 x 10-6,,0.583,1.4285715,'-,[1.23-1.64],RABGAP1L,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,1:174343675
rs1878186-<b>C</b>,1 x 10-7,,0.047,1.82,'-,[1.45-2.28],SLC12A1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,15:48216203
rs11231824-<b>C</b>,7 x 10-7,,0.111,1.51,'-,[1.3-1.76],"SLC22A12, SLC22A11",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,11:64587323
rs11889341-<b>T</b>,7 x 10-13,,0.407,1.5,'-,[1.36-1.66],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,2:191079016
rs7708392-<b>C</b>,2 x 10-11,,0.499,1.76,'-,[1.50-2.07],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,5:151077924
rs12539741-<b>T</b>,6 x 10-31,,0.222,2.11,'-,[1.88-2.37],TNPO3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,7:128956751
rs2928402-<b>C</b>,1 x 10-6,,0.182,1.39,'-,[1.23-1.57],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,10:48810120
A*01:01-<b>?</b>,6 x 10-6,,0.0542,1.58,'-,[1.30-1.93],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
B*08:01-<b>?</b>,1 x 10-8,,0.0299,2.06,'-,[1.61-2.65],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DQA1*01:02-<b>?</b>,2 x 10-13,,0.0811,1.94,'-,[1.63-2.31],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DQA1*05:05-<b>?</b>,1 x 10-8,,0.8716,1.6949153,'-,[1.43-2.04],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DQB1*02:01-<b>?</b>,7 x 10-11,,0.0502,1.92,'-,[1.58-2.33],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DQB1*03:01-<b>?</b>,8 x 10-12,,0.791,1.6666665,'-,[1.45-1.92],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DQB1*06:02-<b>?</b>,1 x 10-12,,0.0469,2.16,'-,[1.75-2.67],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DRB1*03:01-<b>?</b>,4 x 10-11,,0.0496,1.94,'-,[1.59-2.35],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
DRB1*15:01-<b>?</b>,7 x 10-12,,0.045,2.1,'-,[1.70-2.59],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
rs7098187-<b>T</b>,3 x 10-6,,0.009,2.62,'-,[1.75-3.94],ITGA8,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,10:15496384
DQA1*05:01-<b>?</b>,6 x 10-11,,0.0502,1.91,'-,[1.58-2.33],'-,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,Mapping not available
rs4728142-<b>A</b>,1 x 10-23,,0.387,1.76,'-,[1.59-1.95],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,7:128933913
rs8105429-<b>G</b>,5 x 10-6,,0.392,1.29,'-,[1.17-1.43],"PGPEP1, GDF15",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003252,19:18370523
rs4916342-<b>?</b>,8 x 10-9,,NR,1.33,'-,[1.22-1.49],"PRDX6-AS1, PSMB2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,1:173378698
rs2267828-<b>?</b>,6 x 10-8,,NR,1.2345679,'-,[1.14-1.32],GTF2IRD1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,7:74511782
rs11235667-<b>?</b>,7 x 10-11,,NR,1.5873016,'-,[1.39-1.82],"FCHSD2, P2RY2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,11:73152652
rs1048257-<b>?</b>,9 x 10-7,,NR,1.2195122,'-,[1.12-1.32],AHNAK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,14:104938047
rs76413021-<b>?</b>,3 x 10-13,,NR,1.52,'-,[1.36-1.71],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,1:173237158
rs12612769-<b>?</b>,2 x 10-19,,NR,1.59,'-,[1.43-1.75],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,2:191089272
rs2230926-<b>?</b>,2 x 10-14,,NR,1.93,'-,[1.63-2.28],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,6:137874929
rs11185602-<b>?</b>,2 x 10-16,,NR,1.5151515,'-,[1.37-1.67],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,7:50259481
rs113478424-<b>?</b>,4 x 10-12,,NR,1.59,'-,[1.39-1.81],"KCP, IRF5",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,7:128935744
rs2736345-<b>?</b>,8 x 10-11,,NR,1.4285715,'-,[1.28-1.59],BLK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,8:11494976
rs7097397-<b>?</b>,2 x 10-9,,NR,1.33,'-,[1.21-1.46],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,10:48817351
rs1801274-<b>?</b>,7 x 10-6,,NR,1.35,'-,[1.18-1.53],FCGR2A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,1:161509955
rs13385731-<b>?</b>,1 x 10-6,,NR,1.4492754,'-,[1.25-1.69],RASGRP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,2:33476823
rs1059312-<b>?</b>,2 x 10-6,,NR,1.25,'-,[1.14-1.37],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,12:128794319
rs10521318-<b>?</b>,4 x 10-6,,NR,1.4925373,'-,[1.27-1.79],LINC02132,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,16:85977731
rs139110493-<b>?</b>,1 x 10-12,,NR,2.48,'-,1.93-3.19,HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,7:75580635
rs5986948-<b>?</b>,4 x 10-10,,NR,1.56,'-,[1.35-1.79],"TMEM187, IRAK1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,X:154000721
rs1128334-<b>?</b>,7 x 10-12,,NR,1.39,'-,1.26-1.52,ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST003599,11:128459064
rs2222631-<b>?</b>,5 x 10-8,,'-,1.16,'-,[1.10-1.23],CD80,Systemic lupus erythematosus,systemic lupus erythematosus,GCST002845,3:119553544
rs340630-<b>A</b>,8 x 10-9,,0.52,1.21,'-,[1.14-1.30],AFF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001384,4:87037243
rs956237-<b>A</b>,2 x 10-6,,0.33,1.18,'-,[1.10-1.26],LEF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001384,4:108125804
rs2205960-<b>A</b>,3 x 10-32,,0.27,1.46,'-,[1.37-1.56],TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,1:173222336
rs10036748-<b>A</b>,2 x 10-9,,0.76,1.23,'-,[1.15-1.33],TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,5:151078585
rs4917014-<b>A</b>,3 x 10-23,,0.68,1.39,'-,[1.30-1.47],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,7:50266267
rs7812879-<b>G</b>,2 x 10-24,,0.76,1.45,'-,[1.35-1.56],"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,8:11482672
rs6590330-<b>A</b>,2 x 10-25,,0.34,1.37,'-,[1.29-1.45],ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,11:128441164
rs131654-<b>A</b>,1 x 10-16,,0.48,1.28,'-,[1.20-1.35],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,22:21562901
rs7186852-<b>A</b>,3 x 10-7,,0.08,1.29,'-,[1.17-1.42],"PRR14, ZNF689",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,16:30624338
rs9271100-<b>?</b>,1 x 10-12,,NR,1.9,'-,[1.59-2.27],"HLA-DQA1, HLA-DRB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,6:32608701
rs4728142-<b>A</b>,8 x 10-19,,0.13,1.43,'-,[1.32-1.54],"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,7:128933913
rs13385731-<b>A</b>,1 x 10-15,,0.85,1.43,'-,[1.32-1.56],RASGRP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,2:33476823
rs7574865-<b>A</b>,5 x 10-42,,0.33,1.51,'-,[1.43-1.61],STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,2:191099907
rs548234-<b>G</b>,5 x 10-12,,0.26,1.25,'-,[1.17-1.33],ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,6:106120159
rs2230926-<b>C</b>,1 x 10-17,,0.04,1.72,'-,[1.52-1.94],TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,6:137874929
rs1913517-<b>A</b>,7 x 10-12,,0.29,1.24,'-,[1.17-1.32],"WDFY4, LRRC18",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,10:48911009
rs4639966-<b>G</b>,1 x 10-16,,0.3,1.29,'-,[1.22-1.37],"DDX6, RNU6-376P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,11:118702810
rs1385374-<b>A</b>,2 x 10-11,,0.2,1.26,'-,[1.18-1.35],SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,12:128816149
rs7197475-<b>A</b>,3 x 10-8,,0.08,1.31,'-,[1.20-1.46],"ZNF689, PRR14",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,16:30631546
rs1167796-<b>G</b>,2 x 10-8,,0.71,1.2,'-,[1.12-1.28],HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000507,7:75543861
rs6445975-<b>C</b>,7 x 10-9,,0.28,1.25,'-,[1.16-1.35],PXK,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000142,3:58384450
rs10798269-<b>?</b>,1 x 10-7,,0.64,1.22,'-,[1.14-1.32],PRDX6-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000142,1:173340574
rs4963128-<b>?</b>,3 x 10-10,,0.34,1.28,'-,[1.18-1.37],PHRF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000142,11:589564
rs9888739-<b>T</b>,2 x 10-23,,0.13,1.62,'-,[1.47-1.78],ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST000142,16:31301932
rs3131379-<b>A</b>,2 x 10-52,,0.1,2.36,'-,[2.11-2.64],"MSH5, MSH5-SAPCD1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000142,6:31753256
rs12537284-<b>A</b>,4 x 10-19,,0.13,1.54,'-,[1.40-1.70],"CYCSP20, TPI1P2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST000142,7:129077852
rs75886247-<b>?</b>,5 x 10-6,(EA),'-,1.45,'-,[1.29-1.63],NPHP4,Chronic kidney disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005882,1:5975370
rs17151401-<b>?</b>,3 x 10-6,(EA),'-,1.31,'-,[1.12-1.53],ATXN7L1,Chronic kidney disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005882,7:105705501
rs12251637-<b>?</b>,8 x 10-6,(EA),'-,1.5,'-,[1.16-1.94],LHPP,Chronic kidney disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005882,10:124549008
rs11622435-<b>?</b>,2 x 10-7,(EA),'-,1.48,'-,[1.20-1.81],"TSHR, GTF2A1",Chronic kidney disease in diabetes,"chronic kidney disease, diabetes mellitus",GCST005880,14:81151652
rs73206603-<b>?</b>,1 x 10-7,(EA),'-,1.83,'-,[1.17-2.87],RNU7-88P,End-stage renal disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005885,13:59495931
rs117897666-<b>?</b>,3 x 10-7,(EA),'-,3.02,'-,[0.95-9.59],"INSYN1-AS1, TBC1D21",End-stage renal disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005885,15:73811619
rs875860-<b>T</b>,5 x 10-6,(eGFRchange CKD),0.12,'-,0.31 unit decrease,[NR],CDH23,Kidney function decline traits,"chronic kidney disease, GFR change measurement",GCST002720,10:71549772
rs759341-<b>A</b>,3 x 10-6,(CKDi25),0.31,'-,0.16 unit increase,[NR],"RRM2, RN7SL66P",Kidney function decline traits,chronic kidney disease,GCST002720,2:10240083
rs12917707-<b>T</b>,9 x 10-8,(CKDi),0.18,'-,0.2 unit decrease,[0.12-0.28],"PDILT, UMOD",Kidney function decline traits,chronic kidney disease,GCST002720,16:20356368
rs12917707-<b>T</b>,4 x 10-6,(CKDi25),0.18,'-,0.22 unit decrease,[0.12-0.32],"PDILT, UMOD",Kidney function decline traits,chronic kidney disease,GCST002720,16:20356368
rs4972593-<b>A</b>,4 x 10-8,(Women),0.14,1.81,'-,[1.47-2.24],'-,End-stage renal disease in Type 1 diabetics,"type I diabetes mellitus, chronic kidney disease",GCST002182,2:173598126
rs34857077-<b>GA</b>,6 x 10-19,,0.237,'-,'-,'-,UMOD,Chronic kidney disease x type 2 diabetes interaction,"chronic kidney disease, type II diabetes mellitus",GCST010552,16:20344691
rs2177223-<b>C</b>,3 x 10-8,,0.038,'-,'-,'-,'-,Chronic kidney disease x type 2 diabetes interaction,"chronic kidney disease, type II diabetes mellitus",GCST010552,4:180895717
rs1444766-<b>G</b>,1 x 10-8,,NR,1.1384,'-,'-,KALRN,Diffuse large B-cell lymphoma or systemic lupus erythematosus,"diffuse large B-cell lymphoma, systemic lupus erythematosus",GCST008728,3:124206424
rs1439112-<b>?</b>,3 x 10-8,,NR,1.1698643,'-,'-,MGAT5,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,2:134305027
rs1444766-<b>G</b>,2 x 10-8,,NR,1.1692,'-,'-,KALRN,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,3:124206424
rs7382170-<b>?</b>,6 x 10-8,,NR,1.1456066,'-,'-,'-,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,6:16970739
rs2941509-<b>T</b>,2 x 10-8,,NR,1.4118,'-,'-,IKZF3,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,17:39764941
rs6705628-<b>C</b>,7 x 10-17,,0.78,1.3333,'-,'-,DGUOK-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,2:73981235
rs4852324-<b>T</b>,6 x 10-14,,0.76,1.2658,'-,'-,DGUOK-AS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,2:73975451
rs6804441-<b>A</b>,3 x 10-16,,0.61,1.2658,'-,'-,CD80,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,3:119542097
rs4948496-<b>C</b>,5 x 10-11,,0.63,1.1765,'-,'-,ARID5B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,10:62045858
rs12822507-<b>A</b>,2 x 10-8,,0.57,1.1628,'-,'-,CREBL2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,12:12620587
rs10845606-<b>C</b>,4 x 10-17,,0.71,1.2658,'-,'-,GPR19,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,12:12681960
rs34330-<b>C</b>,5 x 10-12,,0.52,1.1905,'-,'-,CDKN1B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,12:12717761
rs4622329-<b>A</b>,9 x 10-12,,0.56,1.1905,'-,'-,DRAM1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,12:101928157
rs10911390-<b>T</b>,6 x 10-6,,0.06,1.13,'-,'-,"RGL1, APOBEC4",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,1:183647749
rs11717455-<b>T</b>,7 x 10-6,,0.93,1.4085,'-,'-,SCN10A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,3:38802156
rs12529935-<b>C</b>,9 x 10-6,,0.91,1.3514,'-,'-,"MIR4464, BACH2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,6:90305320
rs2252996-<b>A</b>,3 x 10-6,,0.68,1.2195,'-,'-,SLC29A3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,10:71356185
rs12917712-<b>T</b>,7 x 10-6,,0.29,1.07,'-,'-,SEZ6L2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,16:29871169
rs2303745-<b>A</b>,1 x 10-6,,0.39,1.07,'-,'-,ABHD8,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,19:17309480
rs4522865-<b>A</b>,5 x 10-6,,0.54,1.3514,'-,'-,BANK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,4:101794731
rs2254546-<b>G</b>,2 x 10-13,,0.73,1.4925,'-,'-,"BLK, FAM167A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,8:11486171
rs10276619-<b>G</b>,6 x 10-6,,0.63,1.1765,'-,'-,IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,7:50273756
rs729302-<b>A</b>,1 x 10-9,,0.66,1.4706,'-,'-,"IRF5, KCP",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,7:128928906
rs7574865-<b>T</b>,1 x 10-21,,0.34,1.63,'-,'-,STAT4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,2:191099907
rs2785197-<b>C</b>,2 x 10-7,,0.74,1.2346,'-,'-,"CD44, PDHX",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,11:35071523
rs9270984-<b>T</b>,5 x 10-24,,0.18,1.73,'-,'-,"HLA-DRB1, HLA-DQA1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,6:32606214
rs742108-<b>T</b>,4 x 10-6,,0.34,1.24,'-,'-,ATG5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,6:106135045
rs2230926-<b>G</b>,1 x 10-13,,0.02,2.71,'-,'-,TNFAIP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,6:137874929
rs2205960-<b>T</b>,3 x 10-12,,0.25,1.36,'-,'-,TNFSF4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,1:173222336
rs877819-<b>A</b>,8 x 10-9,,0.18,1.46,'-,'-,WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,10:48834906
rs6590330-<b>A</b>,3 x 10-8,,0.35,1.51,'-,'-,ETS1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,11:128441164
rs1385374-<b>A</b>,8 x 10-8,,0.17,1.41,'-,'-,SLC15A4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,12:128816149
rs7329174-<b>G</b>,6 x 10-6,,0.21,1.45,'-,'-,ELF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,13:40983974
rs13385731-<b>A</b>,4 x 10-6,,0.83,1.3889,'-,'-,RASGRP3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,2:33476823
rs10036748-<b>T</b>,3 x 10-6,,0.74,1.25,'-,'-,TNIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,5:151078585
rs5754217-<b>T</b>,5 x 10-6,,0.56,1.1236,'-,'-,UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,22:21585386
rs3734266-<b>G</b>,1 x 10-12,,0.13,1.56,'-,'-,UHRF1BP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,6:34855410
rs12599402-<b>A</b>,5 x 10-7,,0.56,1.2821,'-,'-,CLEC16A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,16:11096031
rs9937837-<b>G</b>,7 x 10-6,,0.02,1.86,'-,'-,ITGAM,Systemic lupus erythematosus,systemic lupus erythematosus,GCST001795,16:31287618
rs75163761-<b>T</b>,5 x 10-24,,0.042,1.631,'-,[1.54-1.73],WAKMAR2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:137836352
rs10239000-<b>A</b>,2 x 10-25,,0.242,1.189,'-,[1.16-1.22],IKZF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:50292600
rs372942110-<b>T</b>,6 x 10-9,,0.008,2.294,'-,[2.02-2.57],LAT2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74214690
rs78290495-<b>T</b>,2 x 10-6,,0.965,0.799,'-,[0.71-0.89],"CLIP2, RFC2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74283211
rs530634980-<b>T</b>,5 x 10-18,,0.016,2.016,'-,[1.86-2.17],GTF2IRD1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74495911
rs13244581-<b>C</b>,2 x 10-20,,0.092,0.667,'-,[0.58-0.75],GTF2IRD1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74580705
rs116991837-<b>A</b>,4 x 10-15,,0.016,2.654,'-,[2.41-2.9],GTF2IRD1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74589381
rs150724213-<b>A</b>,3 x 10-15,,0.01,3.882,'-,[3.55-4.22],"GTF2IRD1, GTF2I",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74606017
rs7800325-<b>T</b>,1 x 10-280,,0.826,0.449,'-,[0.41-0.49],"GTF2IRD1, GTF2I",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74618332
rs67955681-<b>T</b>,4 x 10-10,,0.157,0.849,'-,[0.8-0.9],"GTF2IRD1, GTF2I",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74625354
rs68008267-<b>T</b>,3 x 10-12,,0.025,1.406,'-,[1.31-1.5],GTF2I,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74673141
rs79171842-<b>A</b>,3 x 10-23,,0.99,0.405,'-,[0.23-0.58],GTF2I,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74684288
rs143176121-<b>T</b>,2 x 10-66,,0.98,0.292,'-,[0.15-0.43],GTF2I,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74694107
rs587680541-<b>T</b>,4 x 10-62,,0.014,4.14,'-,[3.97-4.31],NCF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74781289
rs199789198-<b>A</b>,3 x 10-194,,0.073,3.098,'-,[3.02-3.17],NCF1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:74781840
rs794368-<b>A</b>,2 x 10-26,,0.567,1.185,'-,[1.15-1.22],HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:75556681
rs4573208-<b>A</b>,2 x 10-15,,0.149,1.173,'-,[1.13-1.21],HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:75649229
rs41298401-<b>C</b>,5 x 10-45,,0.785,1.294,'-,[1.26-1.33],IRF5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:128938253
rs78724056-<b>T</b>,2 x 10-32,,0.039,1.596,'-,[1.52-1.67],TNPO3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:129013997
rs7072606-<b>T</b>,2 x 10-12,,0.809,0.884,'-,[0.85-0.92],WDFY4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,10:48725929
rs11032994-<b>A</b>,1 x 10-17,,0.256,1.147,'-,[1.12-1.18],"PDHX, CD44",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,11:35089610
rs10845602-<b>A</b>,6 x 10-31,,0.71,1.21,'-,[1.18-1.24],GPR19,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,12:12672303
rs447632-<b>A</b>,7 x 10-28,,0.495,0.851,'-,[0.82-0.88],"LINC02132, IRF8",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:85934034
rs3794986-<b>T</b>,1 x 10-14,,0.428,0.89,'-,[0.86-0.92],"SIGLEC6, SIGLEC29P",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:51544061
rs4830478-<b>A</b>,2 x 10-9,,0.797,1.136,'-,[1.09-1.18],"TLR8-AS1, TLR7",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,X:12900169
rs11117432-<b>A</b>,1 x 10-32,,0.088,0.728,'-,[0.68-0.78],LINC02132,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,16:85985665
rs61759532-<b>T</b>,3 x 10-11,,0.076,1.235,'-,[1.17-1.3],ACAP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,17:7337072
rs35966917-<b>A</b>,5 x 10-9,,0.423,0.914,'-,[0.88-0.94],TNFRSF13B,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,17:16936587
rs2671655-<b>T</b>,5 x 10-8,,0.651,1.087,'-,[1.06-1.12],"PHB, ZNF652",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,17:49390658
rs113417153-<b>T</b>,2 x 10-8,,0.193,0.893,'-,[0.85-0.93],"PGS1, SOCS3-DT",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,17:78377098
rs1788097-<b>T</b>,6 x 10-10,,0.392,1.096,'-,[1.07-1.13],CD226,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,18:69876452
rs118075465-<b>A</b>,1 x 10-10,,0.147,1.14,'-,[1.1-1.18],"CTDP1, NFATC1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,18:79626912
rs10414086-<b>T</b>,3 x 10-14,,0.374,0.885,'-,[0.85-0.92],ARID3A,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:937136
rs11085192-<b>T</b>,1 x 10-10,,0.927,0.84,'-,[0.79-0.89],C3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:6689054
rs55882956-<b>A</b>,1 x 10-16,,0.029,0.674,'-,[0.58-0.77],TYK2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:10359243
rs11673604-<b>T</b>,4 x 10-12,,0.759,1.144,'-,[1.11-1.18],SSBP4,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:18430178
rs12461589-<b>T</b>,5 x 10-10,,0.248,0.898,'-,[0.86-0.93],PDCD5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:32581862
rs8108669-<b>T</b>,5 x 10-12,,0.299,0.893,'-,[0.86-0.92],"TEAD2, CD37",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:49342638
rs4801882-<b>A</b>,2 x 10-18,,0.532,0.882,'-,[0.85-0.91],SIGLEC5,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,19:51623800
rs4819670-<b>T</b>,6 x 10-11,,0.21,1.151,'-,[1.11-1.19],USP18,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,22:18166589
rs5754344-<b>A</b>,2 x 10-45,,0.622,0.805,'-,[0.78-0.83],UBE2L3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,22:21609497
rs9611155-<b>T</b>,8 x 10-9,,0.761,1.137,'-,[1.09-1.18],"RPL3, SYNGR1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,22:39343182
rs6641111-<b>C</b>,3 x 10-25,,0.694,1.191,'-,[1.16-1.22],PRPS2,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,X:12821671
rs5914012-<b>T</b>,7 x 10-9,,0.353,1.104,'-,[1.07-1.14],SPIN3,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,X:56882269
rs1059702-<b>A</b>,6 x 10-54,,0.783,1.356,'-,[1.32-1.4],IRAK1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,X:154018741
rs5945199-<b>A</b>,3 x 10-12,,0.104,0.778,'-,[0.71-0.85],"G6PD, FAM3A",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,X:154521643
rs9274384-<b>A</b>,5 x 10-31,(conditional),0.727,1.415,'-,[1.36-1.47],HLA-DQB1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32664858
rs34723256-<b>A</b>,4 x 10-68,(conditional),0.059,2.282,'-,[2.19-2.37],"MTCO3P1, HLA-DQB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32690917
rs113523948-<b>C</b>,3 x 10-21,(conditional),0.063,0.578,'-,[0.46-0.69],"MTCO3P1, HLA-DQB1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32695381
rs36030018-<b>C</b>,3 x 10-36,(conditional),0.109,1.586,'-,[1.51-1.66],"HLA-DQB1, MTCO3P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32700187
rs9275599-<b>T</b>,2 x 10-16,(conditional),0.032,1.585,'-,[1.48-1.69],"HLA-DQB3, MTCO3P1",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32714652
rs11426605-<b>T</b>,3 x 10-15,(conditional),0.966,0.648,'-,[0.54-0.76],"HLA-DQB3, HLA-DQA2",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32740588
rs144227975-<b>CTTT</b>,4 x 10-15,(conditional),0.665,0.864,'-,[0.83-0.9],"HLA-DQB2, HLA-DOB",Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,6:32810139
rs118048475-<b>T</b>,4 x 10-15,(conditional),0.975,2.302,'-,[2.09-2.51],HIP1,Systemic lupus erythematosus,systemic lupus erythematosus,GCST011956,7:75628053
rs1933182-<b>A</b>,1 x 10-7,(eGFRcrea),0.3,'-,0.01 unit decrease,[0.006-0.010],"SYPL2, PSMA5",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,1:109457216
rs626277-<b>C</b>,3 x 10-11,(eGFRcrea),0.4,'-,0.01 unit increase,[0.007-0.011],DACH1,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,13:71773564
rs1394125-<b>A</b>,3 x 10-17,(eGFRcrea),0.35,'-,0.01 unit decrease,[0.007-0.011],UBE2Q2,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,15:75866642
rs9895661-<b>C</b>,1 x 10-15,(eGFRcrea),0.19,'-,0.01 unit decrease,[0.007-0.015],BCAS3,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,17:61379228
rs16864170-<b>C</b>,2 x 10-7,(CKD),0.05,1.3,'-,[1.18-1.43],"SOX11, LINC01810",Chronic kidney disease,chronic kidney disease,GCST000649,2:5767748
rs347685-<b>C</b>,3 x 10-11,(eGFRcrea),0.28,'-,1.09 unit increase,[0.007-0.011],TFDP2,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,3:142088295
rs267734-<b>C</b>,1 x 10-12,(eGFRcrea),0.2,'-,0.01 unit increase,[0.004-0.016],"CERS2, ANXA9",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,1:150979001
rs12460876-<b>C</b>,3 x 10-15,(eGFRcrea),0.39,'-,0.01 unit increase,[0.006-0.01],SLC7A9,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,19:32865985
rs2279463-<b>G</b>,6 x 10-12,(eGFRcrea),0.12,'-,0.01 unit decrease,[0.009-0.017],SLC22A2,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,6:160247357
rs10774021-<b>C</b>,1 x 10-9,(eGFRcrea),0.36,'-,1.05 unit increase,[0.006-0.010],SLC6A13,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,12:240132
rs881858-<b>G</b>,9 x 10-14,(eGFRcrea),0.28,'-,1.08 unit increase,[0.007-0.015],"VEGFA, LINC02537",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,6:43838872
rs7805747-<b>A</b>,4 x 10-12,(CKD),0.24,1.18,'-,[1.12-1.25],PRKAG2,Chronic kidney disease,chronic kidney disease,GCST000649,7:151710715
rs4014195-<b>G</b>,1 x 10-7,(eGFRcrea),0.35,'-,0.01 unit decrease,[0.006-0.010],"AP5B1, KRT8P26",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,11:65739351
rs13538-<b>G</b>,5 x 10-14,(eGFRcrea),0.23,'-,0.01 unit increase,[0.005-0.013],"NAT8, ALMS1P1",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,2:73641201
rs6465825-<b>C</b>,2 x 10-9,(eGFRcrea),0.39,'-,0.01 unit decrease,[0.006-0.01],"RSBN1L, TMEM60",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,7:77787122
rs17319721-<b>A</b>,1 x 10-19,(eGFRcrea),0.43,'-,'-,'-,SHROOM3,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,4:76447694
rs2453533-<b>?</b>,5 x 10-22,(eGFRcrea),0.38,'-,'-,'-,"SLC28A2, RNU6-953P",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,15:45349027
rs12917707-<b>T</b>,1 x 10-20,(eGFRcrea),0.18,'-,'-,'-,"PDILT, UMOD",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,16:20356368
rs10109414-<b>T</b>,1 x 10-8,(eGFRcrea),0.42,'-,'-,'-,STC1,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,8:23893638
rs911119-<b>?</b>,2 x 10-138,(eGFRcys),0.21,'-,'-,'-,CST3,Chronic kidney disease,"cystatin C measurement, chronic kidney disease",GCST000649,20:23632100
rs1260326-<b>T</b>,3 x 10-14,(eGFRcrea),0.41,'-,0.01 unit increase,[0.007-0.011],'-,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,Mapping not available
rs11959928-<b>A</b>,1 x 10-7,(eGFRcrea),0.44,'-,0.01 unit decrease,[0.007-0.011],"C9, DAB2",Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,5:39397030
rs6420094-<b>G</b>,1 x 10-14,(eGFRcrea),0.34,'-,0.01 unit decrease,[0.007-0.015],SLC34A1,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,5:177390635
rs653178-<b>T</b>,4 x 10-11,(eGFRcys),0.5,'-,0.01 unit increase,[0.009-0.017],'-,Chronic kidney disease,"cystatin C measurement, chronic kidney disease",GCST000649,Mapping not available
rs7422339-<b>A</b>,1 x 10-15,(eGFRcrea),0.32,'-,0.01 unit decrease,[0.005-0.013],CPS1,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,2:210675783
rs10794720-<b>T</b>,1 x 10-8,(eGFRcrea),0.08,'-,0.01 unit decrease,[0.010-0.018],WDR37,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,10:1110225
rs491567-<b>C</b>,3 x 10-13,(eGFRcrea),0.22,'-,0.01 unit increase,[0.005-0.013],WDR72,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,15:53654396
rs4744712-<b>A</b>,8 x 10-14,(eGFRcrea),0.39,'-,0.01 unit decrease,[0.008-0.016],PIP5K1B,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,9:68819791
rs3925584-<b>?</b>,8 x 10-18,,NR,'-,0.0075 ml/min/1.73m^2 decrease,[0.0057-0.0093],DCDC1,Chronic kidney disease,chronic kidney disease,GCST001466,11:30738788
rs6431731-<b>?</b>,4 x 10-8,,NR,'-,0.0127 ml/min/1.73m^2 decrease,[0.0082-0.0172],LINC01804,Chronic kidney disease,chronic kidney disease,GCST001466,2:15722878
rs1439112-<b>?</b>,7 x 10-9,,NR,1.1409012,'-,'-,MGAT5,Chronic lymphocytic leukemia or systemic lupus erythematosus,"systemic lupus erythematosus, chronic lymphocytic leukemia",GCST008727,2:134305027
rs13069553-<b>?</b>,2 x 10-9,,NR,1.1627907,'-,'-,"MYNN, LRRC34",Chronic lymphocytic leukemia or systemic lupus erythematosus,"systemic lupus erythematosus, chronic lymphocytic leukemia",GCST008727,3:169790484
rs10069690-<b>T</b>,5 x 10-9,,NR,1.1573,'-,'-,TERT,Chronic lymphocytic leukemia or systemic lupus erythematosus,"systemic lupus erythematosus, chronic lymphocytic leukemia",GCST008727,5:1279675
rs7941765-<b>?</b>,1 x 10-8,,NR,1.1280316,'-,'-,"FLI1, ETS1",Chronic lymphocytic leukemia or systemic lupus erythematosus,"systemic lupus erythematosus, chronic lymphocytic leukemia",GCST008727,11:128629105
rs1032843-<b>T</b>,6 x 10-6,,0.07,'-,0.1174 unit increase,[0.067-0.168],RNU6-627P,Chronic kidney disease,chronic kidney disease,GCST003374,2:163327819
rs11039182-<b>T</b>,3 x 10-6,,0.7,'-,0.0678 unit decrease,[0.040-0.096],MADD,Chronic kidney disease,chronic kidney disease,GCST003374,11:47325172
rs7422339-<b>A</b>,8 x 10-9,,0.32,1.11,'-,[1.07-1.15],CPS1,Chronic kidney disease,chronic kidney disease,GCST003374,2:210675783
rs17319721-<b>A</b>,8 x 10-6,,0.43,1.07,'-,[1.04-1.10],SHROOM3,Chronic kidney disease,chronic kidney disease,GCST003374,4:76447694
rs6420094-<b>G</b>,4 x 10-9,,0.34,1.098901,'-,[1.06-1.14],SLC34A1,Chronic kidney disease,chronic kidney disease,GCST003374,5:177390635
rs7805747-<b>A</b>,2 x 10-14,,0.25,1.16,'-,[1.11-1.20],PRKAG2,Chronic kidney disease,chronic kidney disease,GCST003374,7:151710715
rs1044261-<b>T</b>,4 x 10-7,,0.08,1.15,'-,[1.09-1.22],"IDI2, GTPBP4",Chronic kidney disease,chronic kidney disease,GCST003374,10:1019770
rs963837-<b>T</b>,9 x 10-8,,0.54,1.09,'-,[1.05-1.12],MPPED2-AS1,Chronic kidney disease,chronic kidney disease,GCST003374,11:30727543
rs2467853-<b>G</b>,2 x 10-11,,0.38,1.1111112,'-,[1.08-1.15],SPATA5L1,Chronic kidney disease,chronic kidney disease,GCST003374,15:45406595
rs13329952-<b>T</b>,2 x 10-25,,0.81,1.24,'-,[1.19-1.29],UMOD,Chronic kidney disease,chronic kidney disease,GCST003374,16:20355185
rs72743477-<b>G</b>,8 x 10-11,,0.21,'-,'-,'-,SMAD3,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,15:67171953
rs12598357-<b>G</b>,4 x 10-9,,0.39,'-,'-,'-,"NPIPB6, SBK1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:28329624
rs12928404-<b>C</b>,6 x 10-7,,0.38,'-,'-,'-,ATXN2L,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:28835925
rs117372389-<b>T</b>,8 x 10-11,,0.02,'-,'-,'-,NKD1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:50634166
rs12232497-<b>C</b>,3 x 10-7,,0.45,'-,'-,'-,"ZPBP2, GSDMB",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,17:39883866
rs62131887-<b>T</b>,4 x 10-7,,0.28,'-,'-,'-,"KEAP1, PDE4A",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,19:10476920
rs602662-<b>G</b>,5 x 10-8,,0.49,'-,'-,'-,FUT2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,19:48703728
rs2738774-<b>A</b>,9 x 10-7,,0.32,'-,'-,'-,"STMN3, MHENCR",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,20:63637985
rs2836882-<b>A</b>,5 x 10-8,,0.27,'-,'-,'-,RPL23AP12,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,21:39094644
rs2066363-<b>C</b>,8 x 10-11,,0.34,'-,'-,'-,ADGRL2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:81771892
rs114846446-<b>A</b>,2 x 10-7,,0.01,'-,'-,'-,LINC01250,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, psoriasis, ankylosing spondylitis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:2944140
rs7672495-<b>C</b>,1 x 10-7,,0.18,'-,'-,'-,"RN7SKP113, CYTL1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,4:4990640
rs7660520-<b>A</b>,8 x 10-11,,0.26,'-,'-,'-,"TENM3, DCTD",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,4:182824168
rs7831697-<b>G</b>,5 x 10-7,,0.25,'-,'-,'-,RNU6-144P,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,8:137124061
rs7042370-<b>T</b>,1 x 10-7,,0.43,'-,'-,'-,"LURAP1L-AS1, LURAP1L",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:12785074
rs10988542-<b>C</b>,7 x 10-7,,0.08,'-,'-,'-,FNBP1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:129894985
rs7100025-<b>G</b>,8 x 10-11,,0.34,'-,'-,'-,LINC00993,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:37303610
rs11839053-<b>C</b>,1 x 10-6,,0.02,'-,'-,'-,"LINC00460, RPL35P9",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,13:106410694
rs77150043-<b>T</b>,6 x 10-9,,0.23,'-,'-,'-,ADCY7,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:50270338
rs2807264-<b>C</b>,1 x 10-8,,0.21,'-,'-,'-,"RNU6-320P, LINC00892",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,X:136583619
rs12863738-<b>T</b>,6 x 10-8,,0.17,'-,'-,'-,"RPL22P23, SRRM1P3",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,X:136949968
rs11580078-<b>G</b>,8 x 10-11,,0.43,'-,'-,'-,"IL23R, C1orf141",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:67203951
rs6679677-<b>A</b>,8 x 10-11,,0.09,'-,'-,'-,"RSBN1, PHTF1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:113761186
rs34884278-<b>C</b>,4 x 10-7,,0.3,'-,'-,'-,AIMP1P2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:172869708
rs6689858-<b>C</b>,2 x 10-7,,0.29,'-,'-,'-,CRB1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:197406337
rs55705316-<b>G</b>,1 x 10-6,,0.14,'-,'-,'-,"Y_RNA, IL10",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:206760172
rs2075184-<b>T</b>,9 x 10-8,,0.23,'-,'-,'-,"IL18RAP, SLC9A4",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:102464132
rs36001488-<b>C</b>,8 x 10-11,,0.48,'-,'-,'-,ATG16L1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:233276621
rs4676410-<b>A</b>,2 x 10-7,,0.19,'-,'-,'-,GPR35,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:240624322
rs4625-<b>G</b>,8 x 10-11,,0.31,'-,'-,'-,DAG1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,3:49534707
rs62324212-<b>A</b>,3 x 10-8,,0.42,'-,'-,'-,IL21-AS1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,4:122639784
rs7725052-<b>C</b>,8 x 10-11,,0.43,'-,'-,'-,TTC33,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:40487168
rs7731626-<b>A</b>,1 x 10-10,,0.39,'-,'-,'-,ANKRD55,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:56148856
rs4869313-<b>T</b>,9 x 10-8,,0.42,'-,'-,'-,ERAP2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:96888176
rs11741255-<b>A</b>,2 x 10-9,,0.42,'-,'-,'-,"IRF1-AS1, IRF1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:132475490
rs755374-<b>T</b>,2 x 10-10,,0.32,'-,'-,'-,"LINC01845, IL12B",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:159402286
rs36051895-<b>T</b>,9 x 10-8,,0.29,'-,'-,'-,"JAK2, HNRNPA1P41",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:4981866
rs4246905-<b>T</b>,1 x 10-8,,0.28,'-,'-,'-,TNFSF15,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:114790969
rs11145763-<b>C</b>,3 x 10-8,,0.4,'-,'-,'-,CARD9,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:136369144
rs706778-<b>T</b>,6 x 10-9,,0.41,'-,'-,'-,IL2RA,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:6056986
rs10822050-<b>C</b>,8 x 10-11,,0.39,'-,'-,'-,ALDH7A1P4,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:62679011
rs1250563-<b>C</b>,1 x 10-8,,0.29,'-,'-,'-,ZMIZ1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:79287626
rs1332099-<b>T</b>,9 x 10-11,,0.46,'-,'-,'-,"NKX2-3, SLC25A28",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:99538694
rs17885785-<b>T</b>,8 x 10-11,,0.2,'-,'-,'-,"IGF2-AS, INS-IGF2",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,11:2146620
rs17466626-<b>G</b>,3 x 10-10,,0.02,'-,'-,'-,LRRK2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,12:40366829
rs1689510-<b>C</b>,4 x 10-9,,0.31,'-,'-,'-,SUOX,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,12:56002984
rs11123169-<b>C</b>,2 x 10-10,,0.32,1.0544075,'-,[1.04-1.07],"PSD4, PAX8-AS1",Chronic kidney disease,chronic kidney disease,GCST008064,2:113209498
rs4976646-<b>C</b>,2 x 10-10,,0.35,1.0535188,'-,[1.04-1.07],RGS14,Chronic kidney disease,chronic kidney disease,GCST008064,5:177361569
rs9895661-<b>C</b>,5 x 10-7,,0.35,1.0505306,'-,[1.03-1.07],BCAS3,Chronic kidney disease,chronic kidney disease,GCST008064,17:61379228
rs7740107-<b>T</b>,1 x 10-6,,0.26,1.0490978,'-,[1.03-1.07],L3MBTL3,Chronic kidney disease,chronic kidney disease,GCST008064,6:130053316
rs1813937-<b>C</b>,1 x 10-7,,0.28,1.0485477,'-,[1.03-1.07],'-,Chronic kidney disease,chronic kidney disease,GCST008064,11:50509630
rs868822-<b>G</b>,3 x 10-8,,0.67,1.0484378,'-,[1.03-1.07],LINC01006,Chronic kidney disease,chronic kidney disease,GCST008064,7:156460245
rs2440165-<b>C</b>,3 x 10-7,,0.36,1.0479983,'-,[1.03-1.07],SLC47A1,Chronic kidney disease,chronic kidney disease,GCST008064,17:19525406
rs7127946-<b>C</b>,6 x 10-8,,0.36,1.046682,'-,[1.03-1.06],"OR4B2P, OR4X2",Chronic kidney disease,chronic kidney disease,GCST008064,11:48229123
rs61897431-<b>C</b>,3 x 10-7,,0.35,1.0465724,'-,[1.03-1.07],"SLC39A13, MIR4487",Chronic kidney disease,chronic kidney disease,GCST008064,11:47406116
rs2039424-<b>G</b>,5 x 10-8,,0.36,1.0443864,'-,[1.03-1.06],PIP5K1B,Chronic kidney disease,chronic kidney disease,GCST008064,9:68817258
rs8101667-<b>C</b>,2 x 10-6,,0.61,1.0397172,'-,[1.02-1.06],CEP89,Chronic kidney disease,chronic kidney disease,GCST008064,19:32911513
rs1548945-<b>C</b>,2 x 10-6,,0.56,1.0397172,'-,[1.02-1.06],"FABP5P14, RNA5SP120",Chronic kidney disease,chronic kidney disease,GCST008064,2:216801065
rs12913015-<b>C</b>,3 x 10-6,,0.59,1.039393,'-,[1.02-1.06],LINC02694,Chronic kidney disease,chronic kidney disease,GCST008064,15:39013242
rs7475348-<b>C</b>,7 x 10-6,,0.54,1.0379905,'-,[1.02-1.05],MYPN,Chronic kidney disease,chronic kidney disease,GCST008064,10:68205420
rs1719934-<b>G</b>,4 x 10-6,,0.42,1.0378827,'-,[1.02-1.05],EPB41L3,Chronic kidney disease,chronic kidney disease,GCST008064,18:5585159
rs2971880-<b>A</b>,5 x 10-6,,0.37,1.0372,'-,[1.0211-1.0536],SPTBN1,Chronic kidney disease,chronic kidney disease,GCST008064,2:54658503
rs13157326-<b>A</b>,3 x 10-6,,0.45,1.0375,'-,[1.0216-1.0537],'-,Chronic kidney disease,chronic kidney disease,GCST008064,5:34504172
rs1078442-<b>A</b>,3 x 10-6,,0.46,1.038,'-,[1.022-1.0542],TFCP2L1,Chronic kidney disease,chronic kidney disease,GCST008064,2:121231348
rs4408777-<b>A</b>,2 x 10-6,,0.51,1.0388,'-,[1.0224-1.0554],RGS19,Chronic kidney disease,chronic kidney disease,GCST008064,20:64074752
rs2749153-<b>A</b>,5 x 10-6,,0.69,1.0394,'-,[1.0222-1.0569],"ZNF436-AS1, TCEA3",Chronic kidney disease,chronic kidney disease,GCST008064,1:23372847
rs34861762-<b>T</b>,1 x 10-7,,0.39,1.0443,'-,[1.0277-1.0612],STC1,Chronic kidney disease,chronic kidney disease,GCST008064,8:23890907
rs9375818-<b>A</b>,2 x 10-6,,0.25,1.0446,'-,[1.026-1.0636],ARG1,Chronic kidney disease,chronic kidney disease,GCST008064,6:131560938
rs10846157-<b>A</b>,2 x 10-6,,0.76,1.0451,'-,[1.0263-1.0644],RERG,Chronic kidney disease,chronic kidney disease,GCST008064,12:15172097
rs2411192-<b>A</b>,4 x 10-9,,0.6,1.0475,'-,[1.0315-1.0639],MYO19,Chronic kidney disease,chronic kidney disease,GCST008064,17:36527167
rs2823139-<b>A</b>,1 x 10-8,,0.33,1.0485,'-,[1.0316-1.0657],'-,Chronic kidney disease,chronic kidney disease,GCST008064,21:15204463
rs77924615-<b>G</b>,7 x 10-86,,0.8,1.2318305,'-,[1.21-1.26],PDILT,Chronic kidney disease,chronic kidney disease,GCST008064,16:20381010
rs187355703-<b>G</b>,3 x 10-10,,0.03,1.2155099,'-,[1.14-1.29],HOXD-AS2,Chronic kidney disease,chronic kidney disease,GCST008064,2:176128855
rs80282103-<b>T</b>,1 x 10-10,,0.09,1.0967317,'-,[1.07-1.13],LARP4B,Chronic kidney disease,chronic kidney disease,GCST008064,10:853131
rs17730281-<b>G</b>,1 x 10-18,,0.71,1.0816658,'-,[1.06-1.1],WDR72,Chronic kidney disease,chronic kidney disease,GCST008064,15:53615751
rs8096658-<b>G</b>,2 x 10-12,,0.41,1.066098,'-,[1.05-1.09],NFATC1,Chronic kidney disease,chronic kidney disease,GCST008064,18:79396537
rs12736457-<b>G</b>,2 x 10-6,,0.13,1.0655301,'-,[1.04-1.09],"PPM1J, PPM1J-DT",Chronic kidney disease,chronic kidney disease,GCST008064,1:112715671
rs6546869-<b>G</b>,7 x 10-8,,0.77,1.0588734,'-,[1.04-1.08],ALMS1P1,Chronic kidney disease,chronic kidney disease,GCST008064,2:73668638
rs1047891-<b>A</b>,3 x 10-8,,0.29,1.0532,'-,[1.034-1.0728],CPS1,Chronic kidney disease,chronic kidney disease,GCST008064,2:210675783
rs2727040-<b>T</b>,8 x 10-7,,0.24,1.055,'-,[1.0329-1.0776],TRIM49B,Chronic kidney disease,chronic kidney disease,GCST008064,11:49036051
rs1362800-<b>T</b>,5 x 10-11,,0.38,1.0571,'-,[1.0399-1.0747],"C9, DAB2",Chronic kidney disease,chronic kidney disease,GCST008064,5:39378013
rs7123489-<b>A</b>,2 x 10-11,,0.31,1.0592,'-,[1.0417-1.077],"AP5B1, KRT8P26",Chronic kidney disease,chronic kidney disease,GCST008064,11:65756781
rs13230625-<b>A</b>,9 x 10-13,,0.53,1.0681,'-,[1.049-1.0875],UNCX,Chronic kidney disease,chronic kidney disease,GCST008064,7:1246608
rs3812036-<b>T</b>,1 x 10-12,,0.26,1.0684,'-,[1.0491-1.088],SLC34A1,Chronic kidney disease,chronic kidney disease,GCST008064,5:177386403
rs28817415-<b>T</b>,2 x 10-16,,0.4,1.069,'-,[1.0522-1.0861],SHROOM3,Chronic kidney disease,chronic kidney disease,GCST008064,4:76480299
rs12509595-<b>T</b>,5 x 10-14,,0.7,1.0692,'-,[1.0508-1.0881],"FGF5, PRDM8",Chronic kidney disease,chronic kidney disease,GCST008064,4:80261400
rs2490391-<b>A</b>,4 x 10-17,,0.41,1.0698,'-,[1.0531-1.0867],SDCCAG8,Chronic kidney disease,chronic kidney disease,GCST008064,1:243306367
rs1145077-<b>T</b>,2 x 10-16,,0.42,1.0746,'-,[1.0562-1.0933],GATM,Chronic kidney disease,chronic kidney disease,GCST008064,15:45391597
rs16942751-<b>A</b>,2 x 10-10,,0.18,1.076,'-,[1.052-1.1005],AQP4-AS1,Chronic kidney disease,chronic kidney disease,GCST008064,18:26813249
rs963837-<b>T</b>,2 x 10-21,,0.57,1.0838,'-,[1.0661-1.1018],MPPED2-AS1,Chronic kidney disease,chronic kidney disease,GCST008064,11:30727543
rs12207180-<b>A</b>,1 x 10-10,,0.11,1.0877,'-,[1.0603-1.1158],SLC22A2,Chronic kidney disease,chronic kidney disease,GCST008064,6:160212075
rs73728279-<b>T</b>,7 x 10-24,,0.27,1.1124,'-,[1.0896-1.1358],PRKAG2,Chronic kidney disease,chronic kidney disease,GCST008064,7:151714408
rs72929920-<b>T</b>,8 x 10-7,,0.03,1.1395,'-,[1.082-1.2],"HOXD1, RPSAP25",Chronic kidney disease,chronic kidney disease,GCST008064,2:176232294
rs10937329-<b>?</b>,8 x 10-12,,'-,'-,0.4044 unit decrease,[0.29-0.52],LINC01991,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005794,3:187995930
rs914615-<b>A</b>,4 x 10-9,,0.476,'-,0.068 mmol/L increase,[0.044-0.092],THBS3,Serum urea levels,serum urea measurement,GCST007536,1:155206101
rs4686914-<b>T</b>,3 x 10-17,,0.308,'-,0.107 mmol/L decrease,[0.082-0.132],LINC01991,Serum urea levels,serum urea measurement,GCST007536,3:187999752
rs998394-<b>A</b>,4 x 10-7,,0.458,'-,0.058 mmol/L decrease,[0.036-0.08],ADAMTS9-AS2,Serum urea levels,serum urea measurement,GCST007536,3:64815512
rs11954639-<b>T</b>,6 x 10-10,,0.071,'-,0.168 mmol/L decrease,[0.12-0.22],TTC33,Serum urea levels,serum urea measurement,GCST007536,5:40674877
rs2503107-<b>C</b>,5 x 10-7,,0.449,'-,0.065 mmol/L decrease,[0.04-0.09],RSPO3,Serum urea levels,serum urea measurement,GCST007536,6:127142231
rs2003313-<b>T</b>,1 x 10-9,,0.448,'-,0.073 mmol/L decrease,[0.049-0.097],"MIR4491, COLCA2",Serum urea levels,serum urea measurement,GCST007536,11:111333268
rs1553091-<b>G</b>,4 x 10-9,,0.302371,'-,0.0675 unit decrease,[0.046-0.089],LINC01991,Urea levels,serum urea measurement,GCST007878,3:187999098
rs17663555-<b>G</b>,6 x 10-11,,0.302437,'-,0.075703 unit increase,[0.054-0.097],"TMEM171, TMEM174",Urea levels,serum urea measurement,GCST007878,5:73136209
rs10480299-<b>C</b>,3 x 10-11,,0.277872,'-,0.078771 unit increase,[0.057-0.101],PRKAG2,Urea levels,serum urea measurement,GCST007878,7:151708732
rs795230-<b>T</b>,5 x 10-8,,0.447805,'-,0.058577 unit increase,[0.038-0.079],DCDC1,Urea levels,serum urea measurement,GCST007878,11:30752978
rs41350349-<b>A</b>,1 x 10-12,,NR,'-,0.0215 unit increase,[0.016-0.027],IGF1R,Urea levels,serum urea measurement,GCST90019525,15:98742151
rs117154502-<b>G</b>,1 x 10-12,,NR,'-,0.0358 unit increase,[0.026-0.046],MYL4,Urea levels,serum urea measurement,GCST90019525,17:47203436
rs8103121-<b>G</b>,4 x 10-12,,NR,'-,0.0175 unit increase,[0.013-0.022],SEC1P,Urea levels,serum urea measurement,GCST90019525,19:48654881
rs75803555-<b>T</b>,1 x 10-12,,NR,'-,0.0227 unit increase,[0.016-0.029],GNAS,Urea levels,serum urea measurement,GCST90019525,20:58882764
rs12131777-<b>C</b>,5 x 10-11,,NR,'-,0.0166 unit increase,[0.012-0.021],LMNA,Urea levels,serum urea measurement,GCST90019525,1:156111681
rs4282786-<b>A</b>,2 x 10-11,,NR,'-,0.0183 unit decrease,[0.013-0.024],PROX1,Urea levels,serum urea measurement,GCST90019525,1:214003526
rs62279868-<b>A</b>,2 x 10-20,,NR,'-,0.0625 unit increase,[0.049-0.076],"LPP-AS2, LINC01991",Urea levels,serum urea measurement,GCST90019525,3:188060636
rs12917707-<b>T</b>,3 x 10-20,,NR,'-,0.0288 unit decrease,[0.023-0.035],"PDILT, UMOD",Urea levels,serum urea measurement,GCST90019525,16:20356368
rs62071986-<b>T</b>,7 x 10-20,,NR,'-,0.0561 unit decrease,[0.044-0.068],WNT9B,Urea levels,serum urea measurement,GCST90019525,17:46854033
rs75925257-<b>A</b>,2 x 10-19,,NR,'-,0.0338 unit increase,[0.026-0.041],"HMGN2P18, KRTCAP2",Urea levels,serum urea measurement,GCST90019525,1:155166366
rs2955742-<b>A</b>,6 x 10-19,,NR,'-,0.0283 unit increase,[0.022-0.035],TMEM266,Urea levels,serum urea measurement,GCST90019525,15:76153791
rs923074-<b>C</b>,3 x 10-19,,NR,'-,0.028 unit increase,[0.022-0.034],SLC14A2,Urea levels,serum urea measurement,GCST90019525,18:45656173
rs6701295-<b>C</b>,1 x 10-18,,NR,'-,0.0212 unit decrease,[0.016-0.026],"SEMA4A, SLC25A44",Urea levels,serum urea measurement,GCST90019525,1:156178374
rs7502052-<b>G</b>,2 x 10-18,,NR,'-,0.0242 unit increase,[0.019-0.03],SLC16A3,Urea levels,serum urea measurement,GCST90019525,17:82233313
rs35529250-<b>T</b>,4 x 10-17,,NR,'-,0.1316 unit increase,[0.1-0.16],RBM47,Urea levels,serum urea measurement,GCST90019525,4:40426074
rs2244608-<b>G</b>,3 x 10-17,,NR,'-,0.0217 unit increase,[0.017-0.027],"HNF1A, HNF1A-AS1",Urea levels,serum urea measurement,GCST90019525,12:120979185
rs9599885-<b>A</b>,6 x 10-17,,NR,'-,0.0219 unit decrease,[0.017-0.027],DACH1,Urea levels,serum urea measurement,GCST90019525,13:71797589
rs12976464-<b>A</b>,5 x 10-16,,NR,'-,0.0414 unit decrease,[0.031-0.051],"RN7SL836P, GIPR",Urea levels,serum urea measurement,GCST90019525,19:45659141
rs62360691-<b>G</b>,3 x 10-15,,NR,'-,0.0248 unit increase,[0.019-0.031],"FCHO2-DT, TNPO1",Urea levels,serum urea measurement,GCST90019525,5:72938362
rs12407219-<b>G</b>,7 x 10-14,,NR,'-,0.049 unit decrease,[0.036-0.062],"ASH1L-AS1, DAP3P1",Urea levels,serum urea measurement,GCST90019525,1:155579771
rs1052067-<b>A</b>,3 x 10-14,,NR,'-,0.02 unit decrease,[0.015-0.025],"PMF1, PMF1-BGLAP",Urea levels,serum urea measurement,GCST90019525,1:156236330
rs28930677-<b>T</b>,3 x 10-14,,NR,'-,0.0431 unit increase,[0.032-0.054],EPB41L5,Urea levels,serum urea measurement,GCST90019525,2:120090473
rs73051566-<b>T</b>,4 x 10-14,,NR,'-,0.0314 unit decrease,[0.023-0.039],LINC01991,Urea levels,serum urea measurement,GCST90019525,3:187979882
rs79563968-<b>T</b>,7 x 10-14,,NR,'-,0.0645 unit decrease,[0.048-0.081],LINC00604,Urea levels,serum urea measurement,GCST90019525,5:40203917
rs2180314-<b>G</b>,1 x 10-14,,NR,'-,0.0187 unit increase,[0.014-0.023],GSTA2,Urea levels,serum urea measurement,GCST90019525,6:52752933
rs35739771-<b>T</b>,1 x 10-14,,NR,'-,0.0228 unit decrease,[0.017-0.029],"TBXT, GAPDHP72",Urea levels,serum urea measurement,GCST90019525,6:166069051
rs2979489-<b>A</b>,4 x 10-14,,NR,'-,0.0206 unit decrease,[0.015-0.026],RBPMS,Urea levels,serum urea measurement,GCST90019525,8:30423317
rs507666-<b>A</b>,9 x 10-14,,NR,'-,0.0231 unit increase,[0.017-0.029],ABO,Urea levels,serum urea measurement,GCST90019525,9:133273983
rs3781619-<b>A</b>,6 x 10-14,,NR,'-,0.0245 unit decrease,[0.018-0.031],DDB2,Urea levels,serum urea measurement,GCST90019525,11:47233766
rs2855793-<b>G</b>,1 x 10-14,,NR,'-,0.0251 unit increase,[0.019-0.032],KCNJ1,Urea levels,serum urea measurement,GCST90019525,11:128836860
rs836968-<b>T</b>,6 x 10-14,,NR,'-,0.0204 unit increase,[0.015-0.026],FAIM2,Urea levels,serum urea measurement,GCST90019525,12:49873552
rs72799387-<b>T</b>,2 x 10-9,,NR,'-,0.0276 unit decrease,[0.019-0.037],"NFAT5, CYB5B",Urea levels,serum urea measurement,GCST90019525,16:69534190
rs17233497-<b>A</b>,4 x 10-9,,NR,'-,0.0248 unit increase,[0.017-0.033],FANCA,Urea levels,serum urea measurement,GCST90019525,16:89748744
rs35551980-<b>C</b>,2 x 10-9,,NR,'-,0.0151 unit decrease,[0.01-0.02],HNF1B,Urea levels,serum urea measurement,GCST90019525,17:37689547
rs75672398-<b>T</b>,5 x 10-9,,NR,'-,0.0373 unit decrease,[0.025-0.05],SLC14A2,Urea levels,serum urea measurement,GCST90019525,18:45420428
rs36024031-<b>C</b>,3 x 10-9,,NR,'-,0.0157 unit decrease,[0.011-0.021],'-,Urea levels,serum urea measurement,GCST90019525,18:61206009
rs2548957-<b>A</b>,2 x 10-9,,NR,'-,0.0143 unit increase,[0.0096-0.019],"FGF21, RNU6-317P",Urea levels,serum urea measurement,GCST90019525,19:48759243
rs2762943-<b>G</b>,2 x 10-9,,NR,'-,0.027 unit increase,[0.018-0.036],"PFDN4, CYP24A1",Urea levels,serum urea measurement,GCST90019525,20:54174247
rs12654812-<b>A</b>,4 x 10-26,,NR,'-,0.0265 unit increase,[0.022-0.031],RGS14,Urea levels,serum urea measurement,GCST90019525,5:177367190
rs11989898-<b>G</b>,2 x 10-26,,NR,'-,0.0356 unit increase,[0.029-0.042],RNU6-869P,Urea levels,serum urea measurement,GCST90019525,8:126476785
rs62132803-<b>T</b>,5 x 10-26,,NR,'-,0.0281 unit decrease,[0.023-0.033],"FGF21, RNU6-317P",Urea levels,serum urea measurement,GCST90019525,19:48768326
rs780094-<b>C</b>,6 x 10-25,,NR,'-,0.0254 unit decrease,[0.02-0.03],'-,Urea levels,serum urea measurement,GCST90019525,Mapping not available
rs10175462-<b>A</b>,5 x 10-24,,NR,'-,0.0251 unit increase,[0.02-0.03],"PAX8-AS1, PAX8",Urea levels,serum urea measurement,GCST90019525,2:113230915
rs2216405-<b>G</b>,3 x 10-24,,NR,'-,0.0319 unit decrease,[0.026-0.038],CPS1,Urea levels,serum urea measurement,GCST90019525,2:210752170
rs9836926-<b>G</b>,2 x 10-23,,NR,'-,0.0411 unit decrease,[0.033-0.049],LINC01991,Urea levels,serum urea measurement,GCST90019525,3:187991329
rs1229984-<b>C</b>,2 x 10-23,,NR,'-,0.0775 unit decrease,[0.062-0.093],ADH1B,Urea levels,serum urea measurement,GCST90019525,4:99318162
rs117392811-<b>G</b>,5 x 10-23,,NR,'-,0.0762 unit decrease,[0.061-0.091],FBXO22,Urea levels,serum urea measurement,GCST90019525,15:75930937
rs17723260-<b>A</b>,9 x 10-22,,NR,'-,0.0331 unit decrease,[0.026-0.04],EFNA3,Urea levels,serum urea measurement,GCST90019525,1:155086187
rs111297126-<b>C</b>,7 x 10-22,,NR,'-,0.0846 unit decrease,[0.067-0.102],GCSHP1,Urea levels,serum urea measurement,GCST90019525,5:39876959
rs62436674-<b>T</b>,4 x 10-22,,NR,'-,0.0305 unit decrease,[0.024-0.037],UNCX,Urea levels,serum urea measurement,GCST90019525,7:1262500
rs2472297-<b>T</b>,1 x 10-22,,NR,'-,0.0268 unit decrease,[0.022-0.032],"CYP1A2, CYP1A1",Urea levels,serum urea measurement,GCST90019525,15:74735539
rs4021-<b>G</b>,1 x 10-22,,NR,'-,0.0259 unit increase,[0.021-0.031],FUT1,Urea levels,serum urea measurement,GCST90019525,19:48750004
rs187355703-<b>G</b>,9 x 10-21,,NR,'-,0.0752 unit increase,[0.06-0.091],HOXD-AS2,Urea levels,serum urea measurement,GCST90019525,2:176128855
rs6504635-<b>A</b>,3 x 10-21,,NR,'-,0.0232 unit decrease,[0.018-0.028],LRRC37A17P,Urea levels,serum urea measurement,GCST90019525,17:46980460
rs75192386-<b>G</b>,1 x 10-21,,NR,'-,0.0297 unit decrease,[0.024-0.036],PITPNC1,Urea levels,serum urea measurement,GCST90019525,17:67586682
rs4848698-<b>T</b>,3 x 10-20,,NR,'-,0.0294 unit increase,[0.023-0.036],TFCP2L1,Urea levels,serum urea measurement,GCST90019525,2:121222889
rs529224-<b>C</b>,2 x 10-9,,NR,'-,0.0148 unit increase,[0.0099-0.0197],CDC14A,Urea levels,serum urea measurement,GCST90019525,1:100352622
rs116698232-<b>G</b>,1 x 10-9,,NR,'-,0.0516 unit increase,[0.035-0.068],ASH1L,Urea levels,serum urea measurement,GCST90019525,1:155513995
rs78716403-<b>G</b>,3 x 10-9,,NR,'-,0.0312 unit increase,[0.021-0.042],ARHGEF2,Urea levels,serum urea measurement,GCST90019525,1:155984293
rs111467838-<b>T</b>,2 x 10-9,,NR,'-,0.0155 unit increase,[0.01-0.021],LGR6,Urea levels,serum urea measurement,GCST90019525,1:202206023
rs907866-<b>A</b>,1 x 10-9,,NR,'-,0.0146 unit increase,[0.0099-0.0193],"RN7SL140P, RPS16P2",Urea levels,serum urea measurement,GCST90019525,2:20171619
rs9873976-<b>C</b>,2 x 10-9,,NR,'-,0.0258 unit decrease,[0.017-0.034],'-,Urea levels,serum urea measurement,GCST90019525,3:135778104
rs761296397-<b>TG</b>,4 x 10-9,,NR,'-,0.0239 unit increase,[0.016-0.032],ARHGEF26,Urea levels,serum urea measurement,GCST90019525,3:154161101
rs79468737-<b>A</b>,4 x 10-9,,NR,'-,0.0575 unit decrease,[0.038-0.077],BCL6,Urea levels,serum urea measurement,GCST90019525,3:187769153
rs62370608-<b>C</b>,2 x 10-9,,NR,'-,0.0584 unit decrease,[0.039-0.077],GHR,Urea levels,serum urea measurement,GCST90019525,5:42433133
rs62372061-<b>T</b>,2 x 10-9,,NR,'-,0.0244 unit decrease,[0.016-0.032],SELENOP,Urea levels,serum urea measurement,GCST90019525,5:42847764
rs76026733-<b>C</b>,1 x 10-9,,NR,'-,0.0326 unit decrease,[0.022-0.043],ARL15,Urea levels,serum urea measurement,GCST90019525,5:53968133
rs9397738-<b>A</b>,3 x 10-9,,NR,'-,0.0202 unit decrease,[0.014-0.027],"RPS4XP8, SCAF8",Urea levels,serum urea measurement,GCST90019525,6:154665530
rs4602817-<b>G</b>,2 x 10-9,,NR,'-,0.0173 unit decrease,[0.012-0.023],MYL10,Urea levels,serum urea measurement,GCST90019525,7:101620642
rs6964591-<b>C</b>,2 x 10-9,,NR,'-,0.0172 unit increase,[0.012-0.023],"PRKAR2B, PIK3CG",Urea levels,serum urea measurement,GCST90019525,7:106987620
rs4881540-<b>T</b>,3 x 10-9,,NR,'-,0.0211 unit decrease,[0.014-0.028],LARP4B,Urea levels,serum urea measurement,GCST90019525,10:908336
rs1044261-<b>T</b>,1 x 10-9,,NR,'-,0.0277 unit increase,[0.019-0.037],"IDI2, GTPBP4",Urea levels,serum urea measurement,GCST90019525,10:1019770
rs543302184-<b>TA</b>,3 x 10-9,,NR,'-,0.0145 unit decrease,[0.0098-0.0192],PLCE1,Urea levels,serum urea measurement,GCST90019525,10:94249426
rs12363523-<b>A</b>,3 x 10-9,,NR,'-,0.0231 unit increase,[0.015-0.031],"KLC2, RAB1B",Urea levels,serum urea measurement,GCST90019525,11:66267865
rs943559-<b>C</b>,2 x 10-9,,NR,'-,0.0179 unit decrease,[0.012-0.024],"RNU6-66P, RNU4-10P",Urea levels,serum urea measurement,GCST90019525,13:73141204
rs9583500-<b>T</b>,2 x 10-9,,NR,'-,0.0177 unit increase,[0.012-0.023],COL4A2,Urea levels,serum urea measurement,GCST90019525,13:110469273
rs28929474-<b>T</b>,2 x 10-9,,NR,'-,0.0519 unit increase,[0.035-0.069],'-,Urea levels,serum urea measurement,GCST90019525,Mapping not available
rs745338-<b>G</b>,1 x 10-9,,NR,'-,0.0147 unit decrease,[0.01-0.0194],APH1B,Urea levels,serum urea measurement,GCST90019525,15:63306231
rs55973697-<b>C</b>,2 x 10-9,,NR,'-,0.0548 unit decrease,[0.037-0.073],ULK3,Urea levels,serum urea measurement,GCST90019525,15:74837243
rs11637353-<b>T</b>,2 x 10-9,,NR,'-,0.0157 unit increase,[0.011-0.021],"ODF3L1, CSPG4",Urea levels,serum urea measurement,GCST90019525,15:75722088
rs7192797-<b>A</b>,2 x 10-9,,NR,'-,0.0158 unit decrease,[0.011-0.021],PDILT,Urea levels,serum urea measurement,GCST90019525,16:20400441
rs117867773-<b>A</b>,5 x 10-14,,NR,'-,0.0372 unit increase,[0.028-0.047],GLS2,Urea levels,serum urea measurement,GCST90019525,12:56487830
rs2823139-<b>A</b>,2 x 10-14,,NR,'-,0.0192 unit increase,[0.014-0.024],'-,Urea levels,serum urea measurement,GCST90019525,21:15204463
rs6712340-<b>T</b>,2 x 10-13,,NR,'-,0.0249 unit decrease,[0.018-0.032],TFCP2L1,Urea levels,serum urea measurement,GCST90019525,2:121274193
rs11929195-<b>G</b>,6 x 10-13,,NR,'-,0.0179 unit decrease,[0.013-0.023],ILDR1,Urea levels,serum urea measurement,GCST90019525,3:122011052
rs115260650-<b>C</b>,1 x 10-13,,NR,'-,0.0572 unit decrease,[0.042-0.072],PLCXD3,Urea levels,serum urea measurement,GCST90019525,5:41409069
rs703873-<b>A</b>,2 x 10-13,,NR,'-,0.0178 unit decrease,[0.013-0.023],TMEM171,Urea levels,serum urea measurement,GCST90019525,5:73130258
rs17817449-<b>G</b>,1 x 10-13,,NR,'-,0.0181 unit increase,[0.013-0.023],FTO,Urea levels,serum urea measurement,GCST90019525,16:53779455
rs9890413-<b>A</b>,6 x 10-13,,NR,'-,0.018 unit decrease,[0.013-0.023],WNT3,Urea levels,serum urea measurement,GCST90019525,17:46824083
rs151245-<b>T</b>,3 x 10-13,,NR,'-,0.0179 unit increase,[0.013-0.023],AQP4-AS1,Urea levels,serum urea measurement,GCST90019525,18:26869085
rs4420638-<b>G</b>,3 x 10-13,,NR,'-,0.0221 unit decrease,[0.016-0.028],"APOC1, APOC1P1",Urea levels,serum urea measurement,GCST90019525,19:44919689
rs1800027-<b>T</b>,8 x 10-13,,NR,'-,0.0342 unit increase,[0.025-0.044],FUT2,Urea levels,serum urea measurement,GCST90019525,19:48703469
rs1887251-<b>C</b>,6 x 10-12,,NR,'-,0.0171 unit increase,[0.012-0.022],'-,Urea levels,serum urea measurement,GCST90019525,1:82492162
rs72925159-<b>G</b>,4 x 10-12,,NR,'-,0.0418 unit increase,[0.03-0.054],MTX2,Urea levels,serum urea measurement,GCST90019525,2:176335290
rs1290788-<b>G</b>,2 x 10-12,,NR,'-,0.0193 unit increase,[0.014-0.025],MECOM,Urea levels,serum urea measurement,GCST90019525,3:169372338
rs1918970-<b>A</b>,4 x 10-12,,NR,'-,0.0464 unit increase,[0.033-0.06],MECOM,Urea levels,serum urea measurement,GCST90019525,3:169425310
rs62279150-<b>A</b>,5 x 10-12,,NR,'-,0.0438 unit increase,[0.031-0.056],BCL6,Urea levels,serum urea measurement,GCST90019525,3:187789551
rs115634741-<b>A</b>,1 x 10-12,,NR,'-,0.0718 unit decrease,[0.052-0.092],"CCDC11P1, LINC02104",Urea levels,serum urea measurement,GCST90019525,5:39566231
rs76052928-<b>A</b>,6 x 10-12,,NR,'-,0.0389 unit decrease,[0.028-0.05],LINC00603,Urea levels,serum urea measurement,GCST90019525,5:39923253
rs17645325-<b>C</b>,5 x 10-12,,NR,'-,0.025 unit decrease,[0.018-0.032],EBF1,Urea levels,serum urea measurement,GCST90019525,5:159049701
rs199690076-<b>T</b>,2 x 10-12,,NR,'-,0.2771 unit increase,[0.2-0.35],SLC34A3,Urea levels,serum urea measurement,GCST90019525,9:137233223
rs787351-<b>C</b>,3 x 10-12,,NR,'-,0.0197 unit decrease,[0.014-0.025],LINC01517,Urea levels,serum urea measurement,GCST90019525,10:28891379
rs1893140-<b>C</b>,1 x 10-12,,NR,'-,0.0213 unit increase,[0.015-0.027],KCNJ1,Urea levels,serum urea measurement,GCST90019525,11:128861409
rs112639655-<b>A</b>,3 x 10-12,,NR,'-,0.0306 unit decrease,[0.022-0.039],R3HDM2,Urea levels,serum urea measurement,GCST90019525,12:57317546
rs79972752-<b>T</b>,2 x 10-12,,NR,'-,0.0305 unit decrease,[0.022-0.039],"UBE2Q2, DNM1P49",Urea levels,serum urea measurement,GCST90019525,15:75825793
rs932046-<b>T</b>,7 x 10-12,,NR,'-,0.0584 unit increase,[0.042-0.075],"RN7SL278P, RCN2",Urea levels,serum urea measurement,GCST90019525,15:76955213
rs11710971-<b>C</b>,1 x 10-33,,NR,'-,0.0354 unit increase,[0.03-0.041],LINC01991,Urea levels,serum urea measurement,GCST90019525,3:188042074
rs6427128-<b>C</b>,1 x 10-32,,NR,'-,0.0411 unit decrease,[0.034-0.048],ADAM15,Urea levels,serum urea measurement,GCST90019525,1:155054466
rs2228058-<b>T</b>,1 x 10-145,,NR,'-,0.1182 unit decrease,[0.11-0.13],"TTC33, PTGER4",Urea levels,serum urea measurement,GCST90019525,5:40681152
rs16862782-<b>A</b>,9 x 10-102,,NR,'-,0.0711 unit decrease,[0.065-0.078],LINC01991,Urea levels,serum urea measurement,GCST90019525,3:187970102
rs7805747-<b>A</b>,7 x 10-79,,NR,'-,0.0501 unit increase,[0.045-0.055],PRKAG2,Urea levels,serum urea measurement,GCST90019525,7:151710715
rs11264341-<b>T</b>,1 x 10-70,,NR,'-,0.0428 unit decrease,[0.038-0.048],TRIM46,Urea levels,serum urea measurement,GCST90019525,1:155179017
rs4452185-<b>C</b>,7 x 10-11,,NR,'-,0.0164 unit decrease,[0.012-0.021],ACP1,Urea levels,serum urea measurement,GCST90019525,2:276346
rs6436090-<b>G</b>,1 x 10-11,,NR,'-,0.0161 unit decrease,[0.011-0.021],CYP27A1,Urea levels,serum urea measurement,GCST90019525,2:218804279
rs4957107-<b>A</b>,9 x 10-11,,NR,'-,0.0212 unit decrease,[0.015-0.028],"TPPP, ZDHHC11B",Urea levels,serum urea measurement,GCST90019525,5:699532
rs117045205-<b>T</b>,2 x 10-11,,NR,'-,0.0432 unit increase,[0.031-0.056],PRKAG2,Urea levels,serum urea measurement,GCST90019525,7:151697524
rs34485659-<b>TG</b>,8 x 10-11,,NR,'-,0.0229 unit increase,[0.016-0.03],PCAT1,Urea levels,serum urea measurement,GCST90019525,8:126566745
rs34312154-<b>A</b>,2 x 10-11,,NR,'-,0.026 unit decrease,[0.018-0.034],RAPSN,Urea levels,serum urea measurement,GCST90019525,11:47448793
rs601100-<b>A</b>,2 x 10-11,,NR,'-,0.0223 unit increase,[0.016-0.029],"C11orf68, FOSL1",Urea levels,serum urea measurement,GCST90019525,11:65912364
rs79604958-<b>C</b>,7 x 10-11,,NR,'-,0.0341 unit increase,[0.024-0.044],"IMP3, SNUPN",Urea levels,serum urea measurement,GCST90019525,15:75637650
rs62027653-<b>G</b>,4 x 10-11,,NR,'-,0.0343 unit increase,[0.024-0.044],TMEM266,Urea levels,serum urea measurement,GCST90019525,15:76063371
rs11640962-<b>G</b>,6 x 10-11,,NR,'-,0.0244 unit increase,[0.017-0.032],PDILT,Urea levels,serum urea measurement,GCST90019525,16:20392505
rs72839768-<b>A</b>,7 x 10-11,,NR,'-,0.0512 unit increase,[0.036-0.066],DVL2,Urea levels,serum urea measurement,GCST90019525,17:7226579
rs34080163-<b>A</b>,5 x 10-11,,NR,'-,0.0236 unit increase,[0.017-0.031],"YWHAEP7, HNF1B",Urea levels,serum urea measurement,GCST90019525,17:37791174
rs62083214-<b>T</b>,1 x 10-11,,NR,'-,0.0237 unit decrease,[0.017-0.031],DLGAP1,Urea levels,serum urea measurement,GCST90019525,18:3640787
rs1462152-<b>C</b>,4 x 10-11,,NR,'-,0.0453 unit increase,[0.032-0.059],SLC14A2,Urea levels,serum urea measurement,GCST90019525,18:45377877
rs11662183-<b>T</b>,1 x 10-11,,NR,'-,0.0209 unit decrease,[0.015-0.027],ZBTB7C,Urea levels,serum urea measurement,GCST90019525,18:48125093
rs769449-<b>A</b>,8 x 10-11,,NR,'-,0.0236 unit decrease,[0.017-0.031],APOE,Urea levels,serum urea measurement,GCST90019525,19:44906745
rs41264945-<b>T</b>,2 x 10-10,,NR,'-,0.0338 unit increase,[0.023-0.044],YY1AP1,Urea levels,serum urea measurement,GCST90019525,1:155670324
rs4848700-<b>C</b>,3 x 10-10,,NR,'-,0.0172 unit decrease,[0.012-0.022],TFCP2L1,Urea levels,serum urea measurement,GCST90019525,2:121270541
rs10498060-<b>A</b>,4 x 10-10,,NR,'-,0.0171 unit decrease,[0.012-0.022],USP37,Urea levels,serum urea measurement,GCST90019525,2:218566568
rs41301139-<b>A</b>,7 x 10-61,,NR,'-,0.1526 unit increase,[0.13-0.17],SLC14A2,Urea levels,serum urea measurement,GCST90019525,18:45682443
rs34783010-<b>T</b>,1 x 10-59,,NR,'-,0.0493 unit decrease,[0.043-0.055],GIPR,Urea levels,serum urea measurement,GCST90019525,19:45677156
rs963837-<b>C</b>,5 x 10-53,,NR,'-,0.0368 unit decrease,[0.032-0.042],MPPED2-AS1,Urea levels,serum urea measurement,GCST90019525,11:30727543
rs55733296-<b>A</b>,6 x 10-50,,NR,'-,0.0935 unit increase,[0.081-0.106],DCDC1,Urea levels,serum urea measurement,GCST90019525,11:30733290
rs1394125-<b>A</b>,8 x 10-37,,NR,'-,0.0314 unit increase,[0.026-0.036],UBE2Q2,Urea levels,serum urea measurement,GCST90019525,15:75866642
rs1484873-<b>G</b>,9 x 10-35,,NR,'-,0.0645 unit increase,[0.054-0.075],SLC14A2,Urea levels,serum urea measurement,GCST90019525,18:45627020
rs3008858-<b>C</b>,6 x 10-26,,NR,'-,0.0286 unit increase,[0.023-0.034],DNAI4,Urea levels,serum urea measurement,GCST90019525,1:66924733
rs79831708-<b>C</b>,1 x 10-32,,NR,'-,0.1182 unit decrease,[0.099-0.138],TTC33,Urea levels,serum urea measurement,GCST90019525,5:40581298
rs17785813-<b>G</b>,6 x 10-32,,NR,'-,0.0519 unit increase,[0.043-0.061],STC1,Urea levels,serum urea measurement,GCST90019525,8:23876753
rs12453279-<b>T</b>,1 x 10-32,,NR,'-,0.0292 unit decrease,[0.024-0.034],LINC01974,Urea levels,serum urea measurement,GCST90019525,17:46910425
rs9883650-<b>G</b>,3 x 10-10,,NR,'-,0.0273 unit decrease,[0.019-0.036],MECOM,Urea levels,serum urea measurement,GCST90019525,3:169362397
rs11097396-<b>G</b>,1 x 10-10,,NR,'-,0.0176 unit decrease,[0.012-0.023],SHROOM3,Urea levels,serum urea measurement,GCST90019525,4:76519180
rs62370948-<b>T</b>,2 x 10-10,,NR,'-,0.0605 unit decrease,[0.042-0.079],SELENOP,Urea levels,serum urea measurement,GCST90019525,5:42832222
rs7703225-<b>A</b>,1 x 10-10,,NR,'-,0.0224 unit increase,[0.016-0.029],"FGFR4, NSD1",Urea levels,serum urea measurement,GCST90019525,5:177103643
rs9467077-<b>C</b>,6 x 10-10,,NR,'-,0.0185 unit increase,[0.013-0.024],DCDC2,Urea levels,serum urea measurement,GCST90019525,6:24210071
rs4714678-<b>G</b>,3 x 10-10,,NR,'-,0.0153 unit increase,[0.011-0.02],"ABCC10, ZNF318",Urea levels,serum urea measurement,GCST90019525,6:43374853
rs73670554-<b>T</b>,6 x 10-10,,NR,'-,0.0268 unit decrease,[0.018-0.035],UNCX,Urea levels,serum urea measurement,GCST90019525,7:1255909
rs10269789-<b>T</b>,4 x 10-10,,NR,'-,0.0165 unit increase,[0.011-0.022],PRKAG2,Urea levels,serum urea measurement,GCST90019525,7:151697537
rs2727562-<b>G</b>,5 x 10-10,,NR,'-,0.0168 unit decrease,[0.012-0.022],PRKAG2,Urea levels,serum urea measurement,GCST90019525,7:151707367
rs11557049-<b>T</b>,9 x 10-10,,NR,'-,0.0296 unit increase,[0.02-0.039],PDE7A,Urea levels,serum urea measurement,GCST90019525,8:65779776
rs17740564-<b>C</b>,3 x 10-10,,NR,'-,0.0344 unit increase,[0.024-0.045],"RNU6-869P, LRATD2",Urea levels,serum urea measurement,GCST90019525,8:126508503
rs36073865-<b>T</b>,7 x 10-10,,NR,'-,0.0247 unit increase,[0.017-0.033],ANXA11,Urea levels,serum urea measurement,GCST90019525,10:80156299
rs3842752-<b>A</b>,3 x 10-10,,NR,'-,0.018 unit increase,[0.012-0.024],"INS-IGF2, INS",Urea levels,serum urea measurement,GCST90019525,11:2159843
rs11032739-<b>T</b>,7 x 10-10,,NR,'-,0.0148 unit decrease,[0.01-0.02],ELF5,Urea levels,serum urea measurement,GCST90019525,11:34519594
rs1350171-<b>T</b>,8 x 10-10,,NR,'-,0.0208 unit increase,[0.014-0.027],PRSS23,Urea levels,serum urea measurement,GCST90019525,11:86933347
rs5795281-<b>CTT</b>,7 x 10-10,,NR,'-,0.017 unit decrease,[0.012-0.022],SORL1,Urea levels,serum urea measurement,GCST90019525,11:121700977
rs11056396-<b>C</b>,8 x 10-10,,NR,'-,0.0222 unit decrease,[0.015-0.029],RERG,Urea levels,serum urea measurement,GCST90019525,12:15191473
rs12437561-<b>T</b>,3 x 10-10,,NR,'-,0.0211 unit increase,[0.015-0.028],IGF1R,Urea levels,serum urea measurement,GCST90019525,15:98771392
rs35258807-<b>A</b>,3 x 10-10,,NR,'-,0.0268 unit decrease,[0.018-0.035],"NFAT5, CYB5B",Urea levels,serum urea measurement,GCST90019525,16:69523940
rs62093664-<b>C</b>,4 x 10-10,,NR,'-,0.0245 unit increase,[0.017-0.032],SLC14A2,Urea levels,serum urea measurement,GCST90019525,18:45275635
rs34945724-<b>C</b>,4 x 10-10,,NR,'-,0.0293 unit increase,[0.02-0.039],EPG5,Urea levels,serum urea measurement,GCST90019525,18:45864921
rs56235411-<b>A</b>,9 x 10-10,,NR,'-,0.0184 unit decrease,[0.013-0.024],'-,Urea levels,serum urea measurement,GCST90019525,Mapping not available
rs218634-<b>A</b>,9 x 10-10,,NR,'-,0.0213 unit decrease,[0.014-0.028],"CHAF1B, CLDN14",Urea levels,serum urea measurement,GCST90019525,21:36422623
rs2006023-<b>G</b>,4 x 10-9,,NR,'-,0.0143 unit decrease,[0.0096-0.019],TMEM51,Urea levels,serum urea measurement,GCST90019525,1:15184315
rs12748874-<b>A</b>,3 x 10-9,,NR,'-,0.0196 unit decrease,[0.013-0.026],NKAIN1,Urea levels,serum urea measurement,GCST90019525,1:31217560
rs72660103-<b>?</b>,9 x 10-9,,NR,'-,0.02288 unit decrease,[0.015-0.031],PHC2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,1:33420920
rs111900181-<b>?</b>,7 x 10-11,,NR,'-,0.0249 unit increase,[0.017-0.032],SSBP3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,1:54383167
rs4630723-<b>?</b>,4 x 10-8,,NR,'-,0.02186 unit decrease,[0.014-0.03],"MRPL33, RBKS",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,2:27801464
rs7596689-<b>?</b>,4 x 10-10,,NR,'-,0.04939 unit increase,[0.034-0.065],TFCP2L1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,2:121281519
rs9816720-<b>?</b>,3 x 10-8,,NR,'-,0.02324 unit increase,[0.015-0.031],ILDR1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,3:121995837
rs12509595-<b>?</b>,2 x 10-8,,NR,'-,0.02227 unit decrease,[0.015-0.03],"FGF5, PRDM8",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,4:80261400
rs62363475-<b>?</b>,1 x 10-11,,NR,'-,0.02421 unit increase,[0.017-0.031],"TMEM174, TMEM171",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,5:73145987
rs3798519-<b>?</b>,4 x 10-15,,NR,'-,0.03085 unit increase,[0.023-0.039],TFAP2B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,6:50821065
rs4715491-<b>?</b>,3 x 10-13,,NR,'-,0.03139 unit increase,[0.023-0.04],FAM83B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,6:54899522
rs300132-<b>?</b>,3 x 10-11,,NR,'-,0.03418 unit increase,[0.024-0.044],"GAPDHP72, LINC00602",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,6:166003730
rs819195-<b>?</b>,4 x 10-9,,NR,'-,0.0261 unit decrease,[0.017-0.035],STC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,8:23885024
rs8176644-<b>?</b>,3 x 10-8,,NR,'-,0.02575 unit decrease,[0.017-0.035],ABO,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,9:133273734
rs2493661-<b>?</b>,2 x 10-10,,NR,'-,0.02428 unit decrease,[0.017-0.032],"RNU6ATAC11P, FXYD4",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,10:43342894
rs2033149-<b>?</b>,2 x 10-9,,NR,'-,0.02188 unit decrease,[0.015-0.029],BICC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,10:58504981
rs1275609-<b>?</b>,6 x 10-9,,NR,'-,0.02257 unit decrease,[0.015-0.03],RN7SL734P,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,12:75877403
rs1169286-<b>?</b>,3 x 10-10,,NR,'-,0.02229 unit increase,[0.015-0.029],HNF1A,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,12:120981253
rs12583267-<b>?</b>,9 x 10-9,,NR,'-,0.02042 unit decrease,[0.013-0.027],DGKH,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,13:42201303
rs1325339-<b>?</b>,2 x 10-12,,NR,'-,0.03503 unit decrease,[0.025-0.045],DACH1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,13:71763622
rs9517448-<b>?</b>,1 x 10-13,,NR,'-,0.02774 unit increase,[0.02-0.035],"SLC15A1, DOCK9",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,13:98786364
rs17237465-<b>?</b>,1 x 10-15,,NR,'-,0.02874 unit increase,[0.022-0.036],RORA,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,15:60897812
rs28657002-<b>?</b>,4 x 10-10,,NR,'-,0.02585 unit increase,[0.018-0.034],IGF1R,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,15:98726649
rs12921916-<b>?</b>,7 x 10-29,,NR,'-,0.04923 unit decrease,[0.041-0.058],PDILT,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,16:20395874
rs11642015-<b>?</b>,4 x 10-15,,NR,'-,0.03452 unit increase,[0.026-0.043],FTO,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,16:53768582
rs11648249-<b>?</b>,6 x 10-11,,NR,'-,0.02393 unit decrease,[0.017-0.031],NFAT5,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,16:69593344
rs3110641-<b>?</b>,1 x 10-12,,NR,'-,0.0273 unit decrease,[0.02-0.035],HNF1B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,17:37687414
rs10853087-<b>?</b>,8 x 10-17,,NR,'-,0.0295 unit decrease,[0.023-0.036],GOSR2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,17:46928746
rs271681-<b>?</b>,2 x 10-8,,NR,'-,0.02028 unit increase,[0.013-0.027],"RNU6-1313P, TAC4",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,17:49908833
rs2706702-<b>?</b>,9 x 10-13,,NR,'-,0.02534 unit decrease,[0.018-0.032],PITPNC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,17:67582757
rs549752-<b>?</b>,6 x 10-9,,NR,'-,0.02266 unit decrease,[0.015-0.03],NFATC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,18:79398225
rs10423928-<b>?</b>,2 x 10-10,,NR,'-,0.02677 unit decrease,[0.019-0.035],GIPR,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,19:45679046
rs2974929-<b>?</b>,4 x 10-21,,NR,'-,0.05212 unit decrease,[0.041-0.063],"GBAP1, MTX1P1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,1:155227477
rs7576384-<b>?</b>,1 x 10-34,,NR,'-,0.04703 unit increase,[0.04-0.055],"PAX8, PAX8-AS1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,2:113235808
rs142177694-<b>?</b>,1 x 10-29,,NR,'-,0.0547 unit increase,[0.045-0.064],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,3:66767117
rs76273615-<b>?</b>,2 x 10-26,,NR,'-,0.04904 unit increase,[0.04-0.058],MECOM,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,3:169374250
rs9859787-<b>?</b>,2 x 10-48,,NR,'-,0.05576 unit decrease,[0.048-0.063],LINC01991,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,3:187992185
rs1936806-<b>?</b>,4 x 10-16,,NR,'-,0.02881 unit increase,[0.022-0.036],RSPO3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,6:127130520
rs1533988-<b>?</b>,2 x 10-31,,NR,'-,0.0505 unit increase,[0.042-0.059],UNCX,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,7:1253374
rs963837-<b>?</b>,2 x 10-26,,NR,'-,0.04352 unit decrease,[0.035-0.052],MPPED2-AS1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,11:30727543
rs79105258-<b>?</b>,1 x 10-25,,NR,'-,0.04625 unit increase,[0.038-0.055],CUX2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,12:111280427
rs1906412-<b>?</b>,2 x 10-30,,NR,'-,0.04201 unit decrease,[0.035-0.049],WDR72,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,15:53638906
rs8073894-<b>?</b>,2 x 10-26,,NR,'-,0.04336 unit increase,[0.035-0.051],BCAS3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,17:61163794
rs4890293-<b>?</b>,6 x 10-37,,NR,'-,0.05539 unit increase,[0.047-0.064],SLC14A2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,18:45632973
rs6026578-<b>?</b>,3 x 10-13,,NR,'-,0.02895 unit decrease,[0.021-0.037],GNAS,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,20:58888417
rs143297173-<b>?</b>,2 x 10-12,,NR,'-,0.08667 unit increase,[0.062-0.111],"GFRAL, HMGCLL1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST005986,6:55418058
rs760077-<b>T</b>,6 x 10-9,,0.4247,'-,0.0638853 mg/dl decrease,[0.042-0.085],'-,Urea levels,blood urea nitrogen measurement,GCST004215,Mapping not available
rs16862780-<b>A</b>,3 x 10-10,,0.1574,'-,0.09280443 mg/dl decrease,[0.064-0.122],LINC01991,Urea levels,blood urea nitrogen measurement,GCST004215,3:187970052
rs112647987-<b>T</b>,3 x 10-8,,0.068,'-,0.11901747 mg/dl decrease,[0.077-0.161],TTC33,Urea levels,blood urea nitrogen measurement,GCST004215,5:40635818
rs6950388-<b>A</b>,2 x 10-8,,0.1872,'-,0.07970589 mg/dl increase,[0.052-0.107],"UNCX, ZFAND2A-DT",Urea levels,blood urea nitrogen measurement,GCST004215,7:1231063
rs10224210-<b>C</b>,6 x 10-9,,0.2799,'-,0.07304283 mg/dl increase,[0.048-0.098],PRKAG2,Urea levels,blood urea nitrogen measurement,GCST004215,7:151716108
rs16853722-<b>C</b>,3 x 10-14,,0.29,'-,0.0064 mg/dl increase,[0.0048-0.0080],MECOM,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,3:169432844
rs2049805-<b>T</b>,2 x 10-12,,0.17,'-,0.0072 mg/dl increase,[0.0052-0.0092],GBAP1,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,1:155225189
rs11123170-<b>G</b>,3 x 10-10,,0.35,'-,0.0051 mg/dl increase,[0.0035-0.0067],"PAX8, PAX8-AS1",Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,2:113221363
rs17730281-<b>G</b>,3 x 10-11,,0.58,'-,0.0051 mg/dl increase,[0.0035-0.0067],WDR72,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,15:53615751
rs11868441-<b>G</b>,2 x 10-9,,0.75,'-,0.0059 mg/dl increase,[0.0039-0.0079],BCAS3,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,17:61161860
rs6026584-<b>T</b>,9 x 10-9,,0.32,'-,0.0052 mg/dl increase,[0.0034-0.0070],GNAS,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,20:58894018
rs10275044-<b>T</b>,4 x 10-9,,0.34,'-,0.0069 mg/dl increase,[0.0046-0.0093],UNCX,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,7:1234209
rs10767873-<b>C</b>,5 x 10-16,,0.69,'-,0.0068 mg/dl increase,[0.0052-0.0084],DCDC1,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,11:30747131
rs2074356-<b>A</b>,2 x 10-9,,0.23,'-,0.0064 mg/dl increase,[0.0042-0.0086],HECTD4,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,12:112207597
rs13069000-<b>G</b>,1 x 10-19,,0.17,'-,0.0093 mg/dl increase,[0.0073-0.0113],'-,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,3:66748526
rs10937329-<b>T</b>,9 x 10-30,,0.69,'-,0.01 mg/dl increase,[0.0082-0.0118],LINC01991,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,3:187995930
rs17663555-<b>G</b>,2 x 10-6,,0.34,'-,0.004 mg/dl increase,[0.0024-0.0056],"TMEM171, TMEM174",Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,5:73136209
rs2206271-<b>A</b>,2 x 10-7,,0.32,'-,0.0055 mg/dl increase,[0.0035-0.0075],"TFAP2B, TFAP2D",Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,6:50818295
rs1936800-<b>T</b>,1 x 10-11,,0.5,'-,0.0052 mg/dl increase,[0.0036-0.0068],RSPO3,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,6:127114919
rs7227483-<b>G</b>,7 x 10-18,,0.8,'-,0.0083 mg/dl increase,[0.0063-0.0103],SLC14A2,Renal function-related traits (BUN),"renal system measurement, blood urea nitrogen measurement",GCST001610,18:45607165
rs283558-<b>T</b>,1 x 10-28,,0.437,'-,0.0079 unit increase,[0.0065-0.0093],RPS6KA2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:51076754
rs16853637-<b>A</b>,5 x 10-28,,0.1552,'-,0.0106 unit increase,[0.0086-0.0126],MECOM,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:169392231
rs11123170-<b>C</b>,1 x 10-27,,0.6449,'-,0.0077 unit decrease,[0.0063-0.0091],"PAX8, PAX8-AS1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:113221363
rs2238691-<b>A</b>,5 x 10-26,,0.212,'-,0.0089 unit decrease,[0.0073-0.0105],GIPR,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,19:45675785
rs17663555-<b>C</b>,5 x 10-26,,0.6814,'-,0.0077 unit decrease,[0.0063-0.0091],"TMEM171, TMEM174",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:73136209
rs3110641-<b>A</b>,1 x 10-24,,0.2658,'-,0.0085 unit increase,[0.0069-0.0101],HNF1B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:37687414
rs17730281-<b>A</b>,2 x 10-24,,0.293,'-,0.0078 unit decrease,[0.0062-0.0094],WDR72,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,15:53615751
rs838144-<b>T</b>,4 x 10-24,,0.5299,'-,0.0087 unit increase,[0.0069-0.0105],"IZUMO1, FUT1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,19:48746982
rs6504021-<b>T</b>,2 x 10-23,,0.77,'-,0.0082 unit increase,[0.0066-0.0098],BCAS3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:61163112
rs8050136-<b>A</b>,3 x 10-23,,0.353,'-,0.0073 unit increase,[0.0059-0.0087],FTO,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,16:53782363
rs12134456-<b>C</b>,2 x 10-22,,0.6221,'-,0.0106 unit decrease,[0.0084-0.0128],GON4L,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:155752715
rs28817415-<b>T</b>,3 x 10-22,,0.3753,'-,0.007 unit increase,[0.0056-0.0084],SHROOM3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,4:76480299
rs28680305-<b>A</b>,9 x 10-22,,0.4151,'-,0.0075 unit decrease,[0.0059-0.0091],PITPNC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:67583612
rs35320690-<b>T</b>,5 x 10-21,,0.7247,'-,0.0087 unit increase,[0.0069-0.0105],"MSL2, PCCB",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:136213652
rs11989898-<b>A</b>,3 x 10-20,,0.7844,'-,0.008 unit decrease,[0.0062-0.0098],RNU6-869P,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,8:126476785
rs2264750-<b>T</b>,6 x 10-20,,0.3861,'-,0.0066 unit increase,[0.0052-0.008],C12orf43,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:121012362
rs4976646-<b>T</b>,1 x 10-19,,0.6477,'-,0.0066 unit decrease,[0.0052-0.008],RGS14,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:177361569
rs7834797-<b>A</b>,3 x 10-19,,0.4854,'-,0.0065 unit increase,[0.0051-0.0079],STC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,8:23902022
rs12908437-<b>T</b>,5 x 10-19,,0.4282,'-,0.0062 unit increase,[0.0048-0.0076],IGF1R,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,15:98744146
rs8096658-<b>C</b>,2 x 10-17,,0.5917,'-,0.0077 unit decrease,[0.0059-0.0095],NFATC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,18:79396537
rs1551210-<b>T</b>,2 x 10-17,,0.402,'-,0.0059 unit increase,[0.0045-0.0073],PRICKLE1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:42472072
rs2122982-<b>A</b>,3 x 10-17,,0.2077,'-,0.0079 unit decrease,[0.0061-0.0097],R3HDM2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:57388110
rs11745300-<b>C</b>,5 x 10-17,,0.5678,'-,0.0058 unit decrease,[0.0044-0.0072],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:34504563
rs2755256-<b>A</b>,3 x 10-16,,0.2278,'-,0.0071 unit decrease,[0.0053-0.0089],SLC35D1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:67006009
rs55914958-<b>T</b>,4 x 10-16,,0.2932,'-,0.0064 unit decrease,[0.0048-0.008],"MYL10, LINC01007",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,7:101594473
rs56411466-<b>A</b>,6 x 10-11,,0.5445,'-,0.005 unit decrease,[0.0034-0.0066],RBPMS,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,8:30422549
rs7327286-<b>A</b>,7 x 10-11,,0.7192,'-,0.0052 unit decrease,[0.0036-0.0068],"RNU4-10P, RNU6-66P",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,13:73139310
rs72658302-<b>T</b>,7 x 10-11,,0.8096,'-,0.006 unit increase,[0.0042-0.0078],PHC2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:33418145
rs2395811-<b>C</b>,7 x 10-11,,0.274,'-,0.005 unit increase,[0.0034-0.0066],"PIK3CG, PRKAR2B",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,7:106986584
rs2470893-<b>T</b>,9 x 10-11,,0.307,'-,0.0064 unit decrease,[0.0044-0.0084],"CYP1A2, CYP1A1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,15:74727108
rs4811741-<b>A</b>,9 x 10-11,,0.3877,'-,0.0047 unit decrease,[0.0033-0.0061],"RNU6-929P, PTMAP6",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,20:56712343
rs3791760-<b>T</b>,1 x 10-10,,0.7192,'-,0.005 unit increase,[0.0034-0.0066],GRHL1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:9978296
rs700753-<b>C</b>,2 x 10-10,,0.3066,'-,0.0049 unit decrease,[0.0033-0.0065],"HMGN1P19, EPS15P1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,7:46714086
rs148703751-<b>T</b>,2 x 10-10,,0.2022,'-,0.0067 unit increase,[0.0045-0.0089],CCDC57,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:82208417
rs12509595-<b>T</b>,3 x 10-10,,0.7028,'-,0.005 unit increase,[0.0034-0.0066],"FGF5, PRDM8",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,4:80261400
rs6473252-<b>T</b>,4 x 10-10,,0.4385,'-,0.0043 unit increase,[0.0029-0.0057],"PAG1, ZNF704",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,8:80887958
rs4498196-<b>A</b>,6 x 10-10,,0.5335,'-,0.0045 unit decrease,[0.0031-0.0059],"LINC02600, LINC02171",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,4:3746115
rs1275609-<b>A</b>,2 x 10-9,,0.4278,'-,0.0046 unit decrease,[0.003-0.0062],RN7SL734P,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:75877403
rs115403343-<b>T</b>,2 x 10-9,,0.9783,'-,0.0182 unit increase,[0.012-0.024],CCDC11P1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:39591500
rs836968-<b>T</b>,2 x 10-9,,0.3856,'-,0.0046 unit increase,[0.003-0.0062],FAIM2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:49873552
rs2834310-<b>A</b>,2 x 10-9,,0.547,'-,0.0041 unit decrease,[0.0027-0.0055],LINC00649,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,21:33971633
rs116760613-<b>A</b>,2 x 10-9,,0.0238,'-,0.0178 unit increase,[0.012-0.024],"CDKN2C, MIR4421",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:51025037
rs8106700-<b>A</b>,3 x 10-9,,0.2894,'-,0.0044 unit increase,[0.003-0.0058],INSR,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,19:7200547
rs7259714-<b>T</b>,3 x 10-9,,0.435,'-,0.0047 unit decrease,[0.0031-0.0063],PLPPR3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,19:817394
rs35451331-<b>A</b>,3 x 10-9,,0.1574,'-,0.0067 unit decrease,[0.0045-0.0089],"CYP26A1, NIP7P1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,10:93082289
rs832805-<b>T</b>,4 x 10-9,,0.3501,'-,0.0046 unit decrease,[0.003-0.0062],PLCD4,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:218609014
rs1168404-<b>T</b>,5 x 10-9,,0.3809,'-,0.0045 unit increase,[0.0029-0.0061],RAD17,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:69410998
rs2978981-<b>T</b>,5 x 10-9,,0.4781,'-,0.0041 unit decrease,[0.0027-0.0055],"JRK, PSCA",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,8:142677719
rs7214509-<b>T</b>,6 x 10-9,,0.1559,'-,0.0097 unit decrease,[0.0064-0.013],PPM1D,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:60662309
rs11065904-<b>A</b>,6 x 10-9,,0.5472,'-,0.0072 unit increase,[0.0048-0.0096],"ATXN2, SH2B3",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:111449163
rs9879531-<b>A</b>,5 x 10-16,,0.7557,'-,0.0078 unit increase,[0.0058-0.0098],NCK1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:136920133
rs9517448-<b>A</b>,6 x 10-16,,0.7605,'-,0.007 unit decrease,[0.0052-0.0088],"SLC15A1, DOCK9",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,13:98786364
rs584480-<b>T</b>,1 x 10-15,,0.5001,'-,0.006 unit decrease,[0.0046-0.0074],DACH1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,13:71771373
rs73114872-<b>T</b>,1 x 10-15,,0.8386,'-,0.0076 unit decrease,[0.0058-0.0094],MIP,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:56467250
rs1047891-<b>A</b>,1 x 10-15,,0.2779,'-,0.0068 unit decrease,[0.0052-0.0084],CPS1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:210675783
rs635634-<b>T</b>,2 x 10-15,,0.2219,'-,0.0066 unit increase,[0.005-0.0082],"ABO, Y_RNA",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,9:133279427
rs10874312-<b>A</b>,8 x 10-15,,0.625,'-,0.0055 unit increase,[0.0041-0.0069],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:82478888
rs17237465-<b>T</b>,2 x 10-14,,0.6666,'-,0.0055 unit decrease,[0.0041-0.0069],RORA,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,15:60897812
rs7243437-<b>A</b>,2 x 10-14,,0.6646,'-,0.0055 unit increase,[0.0041-0.0069],ZBTB7C,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,18:48131676
rs80020578-<b>A</b>,8 x 10-14,,0.2154,'-,0.007 unit increase,[0.0052-0.0088],SSBP3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:54383154
rs1609783-<b>A</b>,3 x 10-13,,0.5364,'-,0.0052 unit increase,[0.0038-0.0066],RNA5SP125,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:25054420
rs924981-<b>A</b>,3 x 10-13,,0.7911,'-,0.0076 unit increase,[0.0056-0.0096],KRT18P56,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:40100268
rs963740-<b>A</b>,4 x 10-13,,0.6024,'-,0.0052 unit decrease,[0.0038-0.0066],"DLEU7, DLEU1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,13:50521959
rs11127126-<b>T</b>,5 x 10-13,,0.3777,'-,0.0057 unit decrease,[0.0041-0.0073],"MRPL33, RBKS",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:27800417
rs4567493-<b>A</b>,6 x 10-13,,0.3789,'-,0.005 unit decrease,[0.0036-0.0064],PRSS23,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:86923381
rs1078442-<b>A</b>,7 x 10-13,,0.4554,'-,0.005 unit increase,[0.0036-0.0064],TFCP2L1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:121231348
rs7084402-<b>A</b>,1 x 10-12,,0.5159,'-,0.0051 unit increase,[0.0037-0.0065],BICC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,10:58505644
rs2332036-<b>T</b>,1 x 10-12,,0.5368,'-,0.0053 unit increase,[0.0039-0.0067],ILDR1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:121995544
rs219778-<b>A</b>,1 x 10-12,,0.7406,'-,0.0067 unit increase,[0.0049-0.0085],CLDN14,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,21:36462343
rs11940694-<b>A</b>,3 x 10-12,,0.4654,'-,0.0048 unit increase,[0.0034-0.0062],KLB,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,4:39413373
rs2823139-<b>A</b>,8 x 10-12,,0.3165,'-,0.005 unit increase,[0.0036-0.0064],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,21:15204463
rs7123489-<b>A</b>,2 x 10-11,,0.3085,'-,0.0051 unit decrease,[0.0035-0.0067],"AP5B1, KRT8P26",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:65756781
rs703037-<b>A</b>,2 x 10-11,,0.1845,'-,0.0065 unit decrease,[0.0045-0.0085],LINC01517,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,10:28907726
rs271679-<b>C</b>,3 x 10-11,,0.4344,'-,0.0051 unit decrease,[0.0035-0.0067],"TAC4, RNU6-1313P",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:49908065
rs16942713-<b>T</b>,5 x 10-11,,0.2054,'-,0.0067 unit increase,[0.0047-0.0087],AQP4-AS1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,18:26806571
rs9290867-<b>A</b>,4 x 10-108,,0.314,'-,0.0161 unit decrease,[0.015-0.017],LINC01991,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:188003749
rs79575541-<b>C</b>,4 x 10-84,,0.9225,'-,0.0304 unit increase,[0.027-0.034],TTC33,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:40672320
rs760077-<b>A</b>,2 x 10-67,,0.3457,'-,0.0138 unit increase,[0.012-0.015],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,Mapping not available
rs13230625-<b>A</b>,7 x 10-57,,0.5269,'-,0.0139 unit increase,[0.012-0.016],UNCX,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,7:1246608
rs3925584-<b>T</b>,8 x 10-50,,0.5968,'-,0.0104 unit increase,[0.009-0.0118],DCDC1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:30738788
rs1484873-<b>A</b>,4 x 10-49,,0.1351,'-,0.0169 unit decrease,[0.015-0.019],SLC14A2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,18:45627020
rs73728279-<b>T</b>,2 x 10-46,,0.2742,'-,0.0148 unit increase,[0.013-0.017],PRKAG2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,7:151714408
rs77924615-<b>A</b>,5 x 10-42,,0.2056,'-,0.0123 unit decrease,[0.011-0.014],PDILT,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,16:20381010
rs11720938-<b>T</b>,1 x 10-40,,0.8185,'-,0.0118 unit decrease,[0.01-0.014],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:66756404
rs998394-<b>A</b>,5 x 10-36,,0.4015,'-,0.0095 unit decrease,[0.0079-0.0111],ADAMTS9-AS2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:64815512
rs9482773-<b>C</b>,3 x 10-34,,0.4777,'-,0.0083 unit increase,[0.0069-0.0097],RSPO3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:127138407
rs300143-<b>A</b>,2 x 10-32,,0.6225,'-,0.0096 unit increase,[0.008-0.0112],"GAPDHP72, LINC00602",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:166007639
rs4886755-<b>A</b>,5 x 10-30,,0.4953,'-,0.008 unit decrease,[0.0066-0.0094],NRG4,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,15:76005791
rs7213526-<b>T</b>,2 x 10-29,,0.4345,'-,0.0077 unit increase,[0.0063-0.0091],GOSR2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:46933791
rs7543734-<b>C</b>,6 x 10-6,,0.2056,'-,0.0046 unit decrease,[0.0026-0.0066],BCAR3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:93585354
rs80282103-<b>A</b>,1 x 10-6,,0.9143,'-,0.0061 unit decrease,[0.0037-0.0085],LARP4B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,10:853131
rs10790452-<b>T</b>,5 x 10-6,,0.7369,'-,0.0035 unit decrease,[0.0019-0.0051],SORL1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:121714223
rs61897431-<b>T</b>,2 x 10-6,,0.6472,'-,0.0041 unit decrease,[0.0023-0.0059],"SLC39A13, MIR4487",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:47406116
rs117113238-<b>A</b>,3 x 10-7,,0.0939,'-,0.0081 unit decrease,[0.005-0.0112],BCL2L14,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:12056269
rs10846157-<b>A</b>,4 x 10-6,,0.7602,'-,0.0037 unit increase,[0.0021-0.0053],RERG,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:15172097
rs9932625-<b>A</b>,4 x 10-7,,0.2566,'-,0.0039 unit increase,[0.0023-0.0055],"RN7SKP142, LINC01571",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,16:51701835
rs4794813-<b>A</b>,6 x 10-6,,0.2439,'-,0.0037 unit increase,[0.0021-0.0053],CDK12,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,17:39514741
rs281380-<b>T</b>,3 x 10-7,,0.5628,'-,0.0041 unit decrease,[0.0025-0.0057],"FUT2, MAMSTR",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,19:48711213
rs17050272-<b>A</b>,9 x 10-7,,0.4351,'-,0.0034 unit increase,[0.002-0.0048],LINC01101,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:120548864
rs807624-<b>T</b>,3 x 10-6,,0.4216,'-,0.0035 unit decrease,[0.0021-0.0049],"LINC01804, DDX1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:15642347
rs187355703-<b>C</b>,3 x 10-6,,0.9741,'-,0.0137 unit decrease,[0.008-0.0194],HOXD-AS2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:176128855
rs4666821-<b>T</b>,5 x 10-6,,0.5295,'-,0.0032 unit decrease,[0.0018-0.0046],PDE1A,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:182212527
rs3791221-<b>A</b>,2 x 10-7,,0.6714,'-,0.0038 unit decrease,[0.0024-0.0052],SH3YL1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:226933
rs6546869-<b>A</b>,4 x 10-6,,0.2289,'-,0.0046 unit decrease,[0.0026-0.0066],ALMS1P1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:73668638
rs76272256-<b>T</b>,1 x 10-7,,0.2426,'-,0.0044 unit decrease,[0.0028-0.006],MECOM,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:169170324
rs9823161-<b>A</b>,7 x 10-6,,0.577,'-,0.0036 unit decrease,[0.002-0.0052],"LINC02028, HES1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,3:194093379
rs13200335-<b>A</b>,6 x 10-6,,0.4626,'-,0.0032 unit decrease,[0.0018-0.0046],TFEB,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:41723085
rs34277475-<b>A</b>,6 x 10-9,,0.1978,'-,0.0081 unit decrease,[0.0054-0.0108],"BLACAT1, LEMD1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:205447536
rs62374016-<b>T</b>,8 x 10-9,,0.6668,'-,0.0043 unit increase,[0.0029-0.0057],ADGRV1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,5:90915456
rs1229984-<b>T</b>,1 x 10-8,,0.571,'-,0.0079 unit increase,[0.0052-0.0106],ADH1B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,4:99318162
rs7096822-<b>T</b>,1 x 10-8,,0.7537,'-,0.0045 unit increase,[0.0029-0.0061],ZRANB1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,10:124975597
rs11039216-<b>T</b>,1 x 10-8,,0.4448,'-,0.0044 unit increase,[0.0028-0.006],"MIR4487, SPI1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:47385041
rs10821944-<b>T</b>,1 x 10-8,,0.6893,'-,0.0042 unit decrease,[0.0028-0.0056],ARID5B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,10:62025330
rs72661397-<b>T</b>,1 x 10-8,,0.9751,'-,0.0166 unit decrease,[0.011-0.022],EPS15-AS1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:51548243
rs116626164-<b>A</b>,1 x 10-8,,0.0233,'-,0.0177 unit increase,[0.012-0.024],FAF1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:50509555
rs7931938-<b>A</b>,2 x 10-8,,0.3915,'-,0.0042 unit decrease,[0.0028-0.0056],"COLCA2, MIR4491",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:111336380
rs10922532-<b>T</b>,2 x 10-8,,0.3876,'-,0.0048 unit increase,[0.003-0.0066],KYAT3,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:88977050
rs10880213-<b>A</b>,2 x 10-8,,0.5183,'-,0.0042 unit increase,[0.0028-0.0056],'-,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,12:41955239
rs6026580-<b>T</b>,2 x 10-8,,0.6572,'-,0.0052 unit decrease,[0.0034-0.007],GNAS,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,20:58893095
rs6974343-<b>A</b>,2 x 10-8,,0.2381,'-,0.0045 unit decrease,[0.0029-0.0061],"CHN2, GTF3C6P3",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,7:29551328
rs17528077-<b>T</b>,3 x 10-8,,0.7635,'-,0.0054 unit decrease,[0.0034-0.0074],CDC42BPA,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:227004579
rs7936300-<b>A</b>,3 x 10-8,,0.634,'-,0.0044 unit decrease,[0.0028-0.006],UBASH3B,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,11:122730326
rs7766720-<b>T</b>,3 x 10-8,,0.8573,'-,0.0064 unit decrease,[0.004-0.0088],LINC02532,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:106725104
rs162185-<b>T</b>,3 x 10-8,,0.5534,'-,0.0041 unit decrease,[0.0027-0.0055],"TCF21, TBPL1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:133905009
rs4454139-<b>A</b>,3 x 10-8,,0.212,'-,0.0048 unit increase,[0.003-0.0066],HCRTR2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,6:55178438
rs72929920-<b>T</b>,3 x 10-8,,0.0308,'-,0.0137 unit increase,[0.0088-0.0186],"HOXD1, RPSAP25",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,2:176232294
rs12856221-<b>A</b>,4 x 10-8,,0.2624,'-,0.0052 unit increase,[0.0032-0.0072],COL4A2,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,13:110442142
rs7359387-<b>T</b>,4 x 10-8,,0.7662,'-,0.0046 unit decrease,[0.003-0.0062],NFAT5,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,16:69699762
rs2383531-<b>A</b>,4 x 10-8,,0.9351,'-,0.0093 unit decrease,[0.006-0.0126],"PACERR, PLA2G4A",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:186760269
rs17216707-<b>T</b>,6 x 10-8,,0.8134,'-,0.0057 unit increase,[0.0037-0.0077],"CYP24A1, BCAS1",Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,20:54115823
rs74748843-<b>T</b>,3 x 10-6,,0.0707,'-,0.0077 unit increase,[0.0044-0.011],CASZ1,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:10670853
rs679843-<b>T</b>,3 x 10-6,,0.334,'-,0.0036 unit decrease,[0.002-0.0052],MGC27382,Blood urea nitrogen levels,blood urea nitrogen measurement,GCST008062,1:78241809
